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Abstract 
 
In 2006, the concept of “frustrated Lewis pairs” (called FLPs) was introduced. The main 
characteristic of these compounds is their ability to activate cooperatively small molecules 
without the use of a metal (H2, CO2, alkene alkyne…). Initially based on P/B combination, the 
concept has been extended to several other main group elements (N/B, P/Al, N/Al…). 
Recently, FLPs have been extended to the transition metal realm. These organometallic FLPs 
(OmFLPs) are obviously non-metal free systems but they extend significantly the scope of FLP 
applications. Seeking to develop such systems, a research towards new OmFLP combinations 
(N/Ti+, N/Zr+) has been initiated in our group, based on the synthesis of N-based titanocene 
and zirconocene complexes. The first part of this manuscript deals with a survey of the 
literature on such compounds, and a more detailed presentation of FLPs and related concepts 
(metal-ligand cooperativity, ambiphilic ligands) is also developed. In a second chapter, the 
synthesis of new N-based cyclopentadienyl ligands and their coordination to group 4 metals is 
presented. The formation of a cationic complex is then developed in a third part on selected 
titanocenes. In these complexes, the amine function undergoes CH activation by the cationic 
metal centre, leading to unexpected rearrangements. Investigations on their plausible 
mechanism are also presented. In a fourth part, the synthesis of new cationic phosphido- and 
amidotitanocenes, discovered in the course of our study on OmFLPs, is developed. The 
cationic amidotitanocenes are shown to be catalytically active towards hydrogenation of small 
molecules. Lastly, the potential of cationic titanocenyl iminophosphoranes as OmFLPs, was 
developed. 
  
VI 
 
Résumé 
 
Le concept de “paires frustrées de Lewis” (plus communément désignées par 
l’acronyme anglais FLPs) a suscité un vif intérêt depuis sa formulation en 2006. Initialement 
décrit à partir d’une phosphine encombrée comme base de Lewis et d’un borane comme acide 
de Lewis pour l’activation coopérative d’hydrogène sans métal, ce concept a été ensuite très 
largement développé en utilisant divers éléments du groupe principal (N/B, P/Al, N/Al …). Le 
concept a ensuite été étendu aux métaux de transitions : sont ainsi apparues les premières 
paires frustrées de Lewis organométalliques (OmFLPs). Dans le but de développer de telles 
OmFLPs, nous nous sommes intéressés à la synthèse de complexes cationiques 
titanocèniques et zirconocèniques en présence d’une amine. La première partie de cette thèse 
présente les travaux précédemment décrits sur les ligands azotés, en vue de synthétiser des 
complexes du groupe 4 N-fonctionnalisés. Une description plus détaillée du concept de FLP 
est ensuite réalisée, et un parallèle est fait avec des concepts connexes (coopérativité métal-
ligand, systèmes ambiphiles). La seconde partie de ce manuscrit développe la synthèse de 
nouveaux ligands (aminomethyl)cyclopentadiènylure de potassium ainsi qu’une étude de leur 
coordination aux métaux du groupe 4. Cette étude a permis d’accéder à toute une série de 
nouveaux complexes dichlorotitanocènes et zirconocènes porteurs d’une fonction amine 
tertiaire encombrée à proximité du centre métallique. Ces travaux ont montré que l’amine ne 
se coordine pas au centre métallique. Les métallocènes ainsi formés ont ensuite été 
transformés en cation afin de renforcer l’ acidité de Lewis du centre métallique. Ces espèces 
ont montré une réactivité inattendue donnant lieu à des réarrangements par activation CH au 
voisinage de l’atome d’azote. Ces réarrangements ainsi que des études mécanistiques font 
l’objet du troisième chapitre. La quatrième partie de ce mémoire porte sur la synthèse de 
complexes amido- et phosphidotitanocènes cationiques. Ces complexes montrent une très 
bonne activité en catalyse d’hydrogénation de petites molécules dans des conditions 
relativement douces, vraisemblablement pour des raisons d’effets coopératifs entre le métal 
et le ligand. Dans une dernière partie, la synthèse de complexes titanocéniques cationiques 
portant une fonction iminophosphorane est développée, suivie d’une étude de réactivité de 
ces complexes en tant que paires frustrées de Lewis organométalliques.  
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General Remarks: 
A. Operating conditions and source of reagents: 
 All reactions were carried out under an atmosphere of Ar using Schlenk techniques or an Ar 
glovebox. Alumina (Brockman grade II) and 3Å molecular sieves were activated by heating for 
at least 6 hours above 230°C under vacuum (< 10-1 mbar), and stored in the glovebox in order 
to be used as drying agents (see below). Dichloromethane, diethyl ether, pentane, 
tetrahydrofuran and toluene were dried using a solvent purification system (MBraun SPS-800) 
whilst acetonitrile, benzonitrile, bromobenzene, chlorobenzene, and heptane were distilled 
over CaH2 and stored over activate 3Å molecular sieves under Ar. Deuterated solvents were 
dried by passage through a short column of activated neutral alumina  and stored over 
activated molecular sieves in the glovebox, either at room temperature (C6D6, C6D5Br, d6-
DMSO) or at -18°C (d8-THF, CD2Cl2, CDCl3, CD3CN). A short column of activated neutral 
alumina and storage over activated molecular sieves in the glovebox were used for 1,4-
cyclohexadiene, 3,3-dimethylbutene, perfluorostyrene, phenylacetylene and styrene. 
Chlorotrimethylsilane was distilled under atmospheric pressure before use. Tert-butanol was 
distilled under reduced pressure (7.5 mmHg) at 37°C before use. Diphenylacetylene was 
crystallized from warm ethanol or pentane. The following chemicals CpNa,1 TiCl4(THF)2 and 
ZrCl4(THF)2,2 B(C6F5)3,3 [Li][B(C6F5)4],4 [(Et2O)2H][B(C6F5)4],5 [Ph3C][B(C6F5)4],6 
[Et3Si][B(C6F5)4],7 TTBPO• (TTBP = 2,4,6-tritertbutylphenyl),8 and N-phenylbenzylimine,9 were 
synthesized according to literature procedures. In addition, [Cp2Fe][BPh4],10 PPh2Li (with a 
modified procedure: pentane as reaction solvent and isolation by filtration),11 KC8,12 and 
CpTiCl3,13 Cp*TiCl3,14 Cp(CH2CH2PR2)CpTiCl2 (R = Ph or Cy),15a,b were synthesized according 
to literature procedures by Dr. Adrien Normand or Cédric Balan respectively. Azides were 
synthesized by Dr. Laure Monnereau by using an adapted literature procedure.16 Cp2TiMe2 
was synthesized according to the procedure described by Petasis, and further stored in the 
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dark in the freezer (-18°C).17 Benzotriazole derivatives were synthesized as described by 
Katritzky, or improved protocoles.18a,b,c CpZrCl3 was sublimed (1.9x10-2 mbar, 170°C). All other 
reagents were commercially available and used as received or purified according to the 
purification guide of laboratory chemicals if required.19 
B. Gas specifications: 
HCl (sigma Aldrich): Reagentplus > 99% 295426-230g-EU 
The following gases were purified by passage through a column filled with P2O5 coupled with 
a coloured indicator (drierite). These home-made apparatuses were directly connected to a 
Schlenk line for H2 or CO2 reactions. 
H2: ALPHAGAZTM 2 (Air liquide) N60: 99.9999% purity, H2O < 0.5 ppm/mol, O2 < 0.1 ppm/mol 
CO2: N48 (Air liquide): 99.998% purity, H2O < 3 ppm/mol, O2 < 2 ppm/mol 
C. Analyses 
All of the analyses were performed at the “Plateforme d’Analyses Chimiques et de Synthèse 
Moléculaire de l’Université de Bourgogne”. The identity and purity (> 95%) of the complexes 
were unambiguously established using elemental analysis, high-resolution mass spectrometry 
(Electrospray Ionization), NMR and IR spectroscopy. Elemental analyses were obtained on a 
Flash EA 1112 CHNS-O Thermo Electron Flash instrument by Marcel Soustelle. Exact masses 
of the isolated compounds were obtained on a Bruker micrOTOF-Q ESI-MS by Mari-José 
Penouilh-Suzette. 1H (300.13, 500.03, or 600.23 MHz), 11B (160.42 MHz), 13C (125.77 or 
150.94 MHz), 15N (43.3 MHz) and 19F (470.45 MHz) NMR spectra were recorded on Bruker 
300 Avance III, 500 Avance III, or 600 Avance II spectrometers. Chemical shifts are quoted in 
parts per million (δ) relative to TMS (1H and 13C), BF3.Et2O (for 19F), CH3NO2 (for 15N), or H3PO4 
(for 31P). For 1H and 13C spectra, values were determined by using solvent residual signals as 
internal standards. The 31P, 19F and 11B NMR spectra were referenced according to IUPAC 
recommendations (absolute referencing), using the residual protonated solvent (1H) or the 
deuterated solvent (13C) as an internal standard.20 IR spectra were recorded on a FT BRUKER 
Vertex 70v spectrophotometer (Glowbar MIR et Hg FIR sources, Ge/KBr (MIR) et silicium (FIR) 
dividing and Ge/KBr (MIR) and silicium (FIR) detectors). Continuous wave (CW) EPR spectra 
were recorded on a Bruker ELEXSYS 500 spectrometer. The instrument was equipped with a 
                                               
17
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4122SHQE/0405 X-band resonant cavity operating at 9.43 GHz, a X-band high-power dual-
gun-oscillator bridge, and a quartz cryostat cooled at 100 K with a stream of nitrogen. The 
temperature was regulated with an ER 4131VT accessory. All apparatus as well as data 
acquisition were controlled using Xepr software. The magnetic field was swept from 250 to 360 
mT through 2048 points. EPR spectrometer BRUKER ELEXSYS 500 records X-band 
equipped with a 10” electromagnet. The irradiation experiments were operated with a medium 
pressure Hg lamp (Heraeus TQ 150).  
D. Computational details: 
The geometries of Bq620 and the two fragments were taken directly from the X-ray analysis 
parameters without any optimization. The wavefunctions were computed using Density 
functional theory (DFT) based on Becke’s three parameter hybrid exchange functional and 
Perdew Wang 91 correlation functional (B3PW91) employing a 6-31+G(d,p) basis for all atoms. 
Three methods have been used to analyse the wavefunction and gain chemical insights: Atom 
In Molecules (AIM), Natural Bond Orbitals (NBO) and Electron Localization Function (ELF). 
Only the AIM and ELF results are presented in the text. 
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General introduction 
 
In 1951 Kealy and Pauson discovered a new organometallic molecule accidentally by 
attempting to synthesize fulvalene.1 One year later, Woodward and Wilkinson rediscovered 
this ubiquitous molecule in the organometallic field, which was subsequently named 
“ferrocene”.2a,b Fischer then described the synthesis of two analogous organometallic 
complexes based on nickel and cobalt: the new family of metallocenes was born. Wilkinson 
and Fischer obtained the Nobel Prize for their pioneering work on sandwich complexes of d-
block metals in 1973.3 A wide variety of metallocenes have been described over the years and 
exhibited various geometries and reactivity: one can cite cationic group 4 metallocenes used 
for Ziegler-Natta polymerization of alkenes which yield stereoregular polymers. Wilkinson and 
Birmingham described the first group 4 metallocenes in 1954 and the structure of Cp2TiCl2 was 
unambiguously established 21 years later.4,5 Contrarily to ferrocene with its sandwich 
geometry, group 4 metallocenes adopt a “bent” or pseudo tetrahedral geometry, considering 
the centroids of both Cp and the two Cl atoms around the metal centre (Scheme 0-1). 
 
Scheme 0-1: Sandwich and bent geometries of metallocenes 
 
After the discovery of metallocenes, extensive work has been done in the 
organometallic field, in order to design functionalized cyclopentadienes, bringing functionalities 
in the proximity to the metal centre. Indeed, functionalization can confer specific properties to 
metallocenes: for example, incorporating a phosphanyl arm into a metallocene would be a 
useful tool for the synthesis of bimetallic complexes; or could favor a reaction in which a base 
is required in addition to the metallocene. Both donors such as O, N, P… or acceptors such as 
B have been incorporated into Cp rings. As illustrated below, recent works developed the 
synthesis of polyfunctionalized metallocenes in which several donor atoms were grafted on the 
Cp rings. In rarer cases, both donor and acceptor sites will be present. In the present 
manuscript, a survey of the literature is presented on the synthesis of N-functionalized 
                                               
1
 T. J. Kealy; Pauson, P. L. Nature. 1951, 168, 1039 
2
 (a):Wilkinson, G.; Rosenblum, M.; Whiting, M. C.; Woodward, R. B. J. Am. Chem. Soc. 1952, 74, 2125, Woodward, R. B.; 
Rosenblum, M.; Whiting, M. C. J. Am. Chem. Soc. 1952, 74, 3458 
3
 Pfab, W.; Fischer, E. O. Z. Für Anorg. Allg. Chem. 1953, 274, 316 
4
 Birmingham, J. M. J. Am. Chem. Soc. 1954, 76, 4281 
5
 Clearfield, A.; Warner, D. K.; Saldarriaga-Molina, C. H.; Ropal, R.; Bernal, I. Can. J. Chem. 1975, 53, 1622 
General introduction 
2 
 
cyclopentadienides and their coordination to group 4 metals over the past six decades. In the 
first part, particular attention will be devoted to the carbon-based spacer between the Cp ring 
and the N atom. Limitations of these syntheses will also be discussed. A second part will focus 
on the coordination of these ligands to group 4 metals. This bibliographic introduction will be 
followed by the discussion of the synthesis of new group 4 (aminomethyl)metallocenes as 
potential precursors for OmFLPs in a first chapter. A second chapter will then be developed 
on the generation of related cationic species and the study of their reactivity. A third chapter 
will describe the results obtained on the synthesis and the reactivity of new amido- and 
phosphidotitanocenes. Lastly, a brief chapter will focus on the reactivity of new titanocenyl 
iminophosphoranes previously developed in our group. 
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I. Bibliographic introduction 
A. Aminocyclopentadienides: synthesis and coordination 
Aminocyclopentadienides can be synthesized according to two different procedures. 
Boche presented the first example described in the literature,6 with the electrophilic amination 
of cyclopentadienyllithium (CpLi). The reaction required the synthesis of N,N-dimethyl-O-
(methylsulfonyl)hydroxylamine L1 which reacted with CpLi to form the corresponding 
aminocyclopentadiene L2. It was easily deprotonated with n-BuLi to yield L3 (Scheme I-1).  
 
Scheme I-1: synthesis of the first spacer-free aminocyclopentadienide L3 
 
The coordination potential of this ligand was first proved by formation of the corresponding (bis 
amino)ferrocene; it was then coordinated to titanium in 1984 to form the (bisamino)titanocene 
dichloride L4.7 This complex adopted a pseudo tetrahedral geometry in which both substituents 
were located on the open side of the bent metallocene so that both were as far as possible 
from each other due to steric effects. In 1999, Ostoja-Starzewski used L3 for the synthesis of 
a new donor / acceptor titanocene dichloride L5 (Scheme I-2).8 
 
Scheme I-2: synthesis of B-N titanocene dichloride L5 
 
The N-B interaction was proven to be strong in this structure with an interatomic distance of 
1.74 Å. In this special case, substituents were in the closed side of the bent metallocene so 
that Lewis adduct formation was possible. This example illustrates how important it is to 
manage the nature of various substituents on Cp rings, and shows that steric hindrance can 
be overcome easily in front of stronger forces, such as Lewis adduct formation. 
In 2000, the group of Bercaw used the previously described electrophilic amination to 
functionalize fluorene derivatives. The corresponding ligands L7-a-b were coordinated to 
zirconium and hafnium (Scheme I-3).9 In the zirconocene structure of type L9-a, the 
                                               
6
 Bernheim, M.; Boche, G. Angew. Chem. Int. Ed. Engl. 1980, 19, 1010 
7
 Stahl, K.-P.; Boche, G.; Massa, W. J. Organomet. Chem. 1984, 277, 113 
8
 Ostoja Starzewski, K. A.; Kelly, W. M.; Stumpf, A.; Freitag, D. Angew. Chem. Int. Ed. 1999, 38, 2439 
9
 Miller, S. A.; Bercaw, J. E. Organometallics. 2000, 19, 5608 
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aminofluorene ligand was XL2 according to Green formalism. Noteworthy, only one double 
bond from the Cp ring was coordinated to the titanium centre as the first L ligand whilst one 
amino group acted as the second. This feature conferred specific geometry to these 
zirconocenes. 
 
Scheme I-3: synthesis of aminofluorenes and their coordination to group 4 metals 
 
The narrow scope of the electrophilic amination reaction restricted its use in the literature, due 
to the low availability of hydroxylamines, and the associated danger of explosion. 
The second procedure widely used in the literature was inspired from the work on 
enamines of cyclopentenones and indanones,10a,b which yielded aminocyclopentadienides or 
aminoindanylides after deprotonation (Scheme I-4).  
O
HNR2
-H2O
NR2
NR2BuLi
Li
 
Scheme I-4: second route for aminocyclopentadienides 
 
This type of ligand has been widely used to synthesize d-block metallocenes. In 1995, the first 
pyrrolidino-ligands L10-12 were described by Plenio, and were used one year later, to form 
new bisaminozirconocenes L11 and L13. This procedure was also used by Plenio with N,N’-
dimethylethylene diamine to form the corresponding ligand L14 which opened a 
straightforward procedure for a new ansametallocene series (e.g. compound L15 Scheme 
I-5).11 
 
                                               
10
 (a): Treibs, W.; Schroth, W. Justus Liebigs Ann. Chem. 1961, 639, 204, Blomquist, A. T.; Moriconi, E. J. J. Org. Chem. 1961, 
26, 3761, Edlund, U.; Esperås, S.; Songstad, J.; Lundblad, G.; Nimmich, W. Acta Chem. Scand. 1973, 27, 4027 
11
 Plenio, H.; Burth, D. Angew. Chem. Int. Ed. Engl. 1995, 34, 800 
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Scheme I-5: synthesis of Plenio's aminozirconocenes 
 
Several other groups worked on this topic at the same time, such as Näsman,12a,b 
Britzinger,13 and Bochmann,14 using dimethylamine for the condensation reaction. Classical 
bis(aminoindenyl)zirconocene were quickly abandoned for the synthesis of mixed 
metallocenes and ansametallocenes. One example of the former is depicted in Scheme I-6 
from Bochmann’s work. All experimental analyses were in agreement with a B-Cl interaction 
instead of a B-N Lewis adduct as might be expected (compound L17).  
 
Scheme I-6: intriguing boryl-(aminoindenyl)titanocene from Bochmann’s work 
 
Two different ansabis(aminoindenyl)zirconocenes were also synthetized, described as good 
candidates for ethylene polymerization (L18 and L19 Scheme I-7). 
 
                                               
12
 (a): Luttikhedde, H. J. G.; Leino, R. P.; Wilén, C.-E.; Näsman, J. H.; Ahlgrén, M. J.; Pakkanen, T. A. Organometallics. 1996, 15, 
3092, (b): Luttikhedde, H. J. G.; Leino, R.; Ahlgrén, M. J.; Pakkanen, T. A.; Näsman, J. H. J. Organomet. Chem. 1998, 557, 227 
13
 Barsties, E.; Schaible, S.; Prosenc, M.-H.; Rief, U.; Röll, W.; Weyand, O.; Dorer, B.; Brintzinger, H.-H. J. Organomet. Chem. 
1996, 520, 63,  J. Organomet. Chem. 1996, 520, 63 
14
 Lancaster, S. J.; Al-Benna, S.; Thornton-Pett, M.; Bochmann, M. Organometallics. 2000, 19, 1599 
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Scheme I-7: syntheses of ansabis(aminoindenyl)zirconocenes Brintzinger (top) and Näsman (bottom) 
 
In 1999, the Ti (III) complex L21 was described by Stryker, by reacting L20 and TiCl3(THF)3 
(Scheme I-8).15a,b The allyl-derivative L23 was a precursor of stable titanocyclobutanes that 
were crystallized. Some of these complexes were used for homo- or co-polymerization of 
olefins such as ethylene. They were reviewed by Leino in his microreview of 2004 on group 4 
bis(indenyl)metallocenes.16  
 
 
Scheme I-8: synthesis of Stryker's bis(aminoindenyl)titanocenes 
 
Between 2000 and 2002, Erker and Hämäläinen extended the synthesis to various amines and 
coordinated their ligand to zirconium (Scheme I-9, top).17a,b,18 More complex amine can easily 
be introduced, such as morpholine (L23-a and L24-a) or allylethylamine (L23-d and L24-d). 
Erker also described a new series of aminocyclopentadienes (L25-e-f) derived from 
phenylcyclopentenone (Scheme I-9, bottom). 
 
                                               
15
 (a): Carter, C. A. G.; McDonald, R.; Stryker, J. M. Organometallics. 1999, 18, 820, Greidanus, G.; McDonald, R.; Stryker, J. M. 
Organometallics. 2001, 20, 2492 
16
 Leino, R.; Lehmus, P.; Lehtonen, A. Eur. J. Inorg. Chem. 2004, 3201 
17
 (a): Fauré, J.-L.; Erker, G.; Fröhlich, R.; Bergander, K. Eur. J. Inorg. Chem. 2000, 2000, 2603, Knüppel, S.; Fauré, J.-L.; Erker, 
G.; Kehr, G.; Nissinen, M.; Fröhlich, R. Organometallics. 2000, 19, 1262 
18
 Hämäläinen, M.; Korpi, H.; Polamo, M.; Leskelä, M. J. Organomet. Chem. 2002, 659, 64 
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Scheme I-9: aminocyclopentadienides reported by Erker and Hämäläinen 
 
In the early 2000s, a news series of mixed constrained geometry titanocenes L28 was 
described by Klosin,19a,b Resconi and De Rosa,20a,b for the synthesis of high-molecular-weight 
syndiotactic amorphous polypropylene. Resconi’s synthesis is depicted in Scheme I-10. These 
ligands are rather elaborated, and their synthesis required three steps to form the four fused 
rings. 
  
Scheme I-10: constrained geometry titanocenes with an amino(indenyl) ring 
 
Many other examples could have been added to this part, such as syntheses of 
polyfunctionalized aminocyclopentadienes that were not used as ligands but were designed 
for other purposes (total synthesis of natural fused molecules).21 
                                               
19
 (a): Klosin, J.; Kruper, W. J.; Nickias, P. N.; Roof, G. R.; De Waele, P.; Abboud, K. A. Organometallics. 2001, 20, 2663, Klosin, 
J.; Kruper, W. J.; Patton, J. T.; Abboud, K. A. J. Organomet. Chem. 2009, 694, 2581, Klosin, J.; Fontaine, P. P.; Figueroa, R. Acc. 
Chem. Res. 2015, 48, 2004 
20
 (a): De Rosa, C.; Auriemma, F.; Ruiz de Ballesteros, O.; Resconi, L.; Fait, A.; Ciaccia, E.; Camurati, I. J. Am. Chem. Soc. 2003, 
125, 10913, Grandini, C.; Camurati, I.; Guidotti, S.; Mascellani, N.; Resconi, L.; Nifant’ev, I. E.; Kashulin, I. A.; Ivchenko, P. V.; 
Mercandelli, P.; Sironi, A. Organometallics. 2004, 23, 344 
21
 Aumann, R.; Göttker-Schnetmann, I.; Fröhlich, R.; Meyer, O. Eur. J. Org. Chem. 1999, 2545 
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To summarize this first part, only two synthetic routes were found for the preparation of 
aminocyclopentadienides. The condensation of cyclopentenones and indanones with amines 
is a straightforward route to synthesize such ligands, which shows high versatility and tolerance 
towards various functionalized amines and ketones. 
B. (Aminomethyl)cyclopentadienides  
1. Synthesis 
a. Fulvene route from Thiele 
The fulvene route is a straightforward procedure to synthesize 
(aminomethyl)cyclopentadienes. The synthesis of fulvene, first reported by Thiele, has been 
widely improved over the years, in terms of yield and variety of substrates. 22 This reaction was 
based on a Mannich-type reaction involving the condensation of an aldehyde or a ketone with 
CpH in presence of a base (Scheme I-11).23a,b 
 
Scheme I-11: general fulvene synthesis 
 
Fulvenes exhibit two different kinds of reactivity: nucleophilic attack of the electrophilic carbon 
6 is possible to form various functionalized cyclopentadienides of type A. With an enolizable 
fulvene, deprotonation is also possible to form vinylcyclopentadienides B. Depending on the 
nature of the nucleophile, these two reactions can be in competition and yield mixtures of both 
A and B. To circumvent this drawback, the use of a non-enolizable fulvene was chosen such 
as tetramethylfulvene L29-Me first reported by Jutzi, and 6-tertbutylfulvene L30, 24a,b,25 in which 
only substitution was able to occur to form L31-a-b or c respectively. In the fulvene chemistry, 
the synthesis of the easiest fulvene L29-H is known to be tedious. This is the reason for its 
rare use, contrarily to L29-Me as illustrated above. 
                                               
22
 Thiele, J. Berichte Dtsch. Chem. Ges. 1900, 33, 666 
23
 (a): Freiesleben, W. Angew. Chem. 1963, 75, 576, (b): Buechi, G.; Berthet, D.; Decorzant, R.; Grieder, A.; Hauser, A. J. Org. 
Chem. 1976, 41, 3208, Stone, K. J.; Little, R. D. J. Org. Chem. 1984, 49, 1849 
24
 (a): Jutzi, P.; Heidemann, T.; Neumann, B.; Stammler, H. G. Synthesis. 1992, 1992, 1096, (b): Heidemann, T.; Jutzi, P. 
Synthesis. 1994, 1994, 777 
25
 Kunz, K.; Erker, G.; Döring, S.; Fröhlich, R.; Kehr, G. J. Am. Chem. Soc. 2001, 123, 6181 
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Scheme I-12: reactivity of fulvenes 
 
The fulvene route was extended to amides, to form N-functionalized fulvenes. An unexpected 
rearrangement on newly obtained 6-aminofulvenes yielded bis(dimethylamino)indenyl ligand 
L32 via an acid-catalysed ring closure reaction followed by deprotonation with n-BuLi. 3-
dimethylamino-1,2-dihydropentalene L33 could be obtained (Scheme I-13).26,27 
 
Scheme I-13: (aminomethyl)cyclopentadienide formed via Thiele condensation 
 
                                               
26
 Sierra, J. C.; Kehr, S. G.; Fröhlich, R.; Erker, G. Eur. J. Inorg. Chem. 2004, 2260 
27
 Xu, B.-H.; Kehr, G.; Fröhlich, R.; Nauha, E.; Erker, G. Dalton Trans. 2010, 39, 9973 
Bibliographic introduction 
10 
 
With an imidazolone, Kunz described a new synthesis of imidazole-based fulvene L34 via a 
Thiele condensation. L34 was coordinated to group 8 metals, forming new metallocenes.28 
b. The Hafner route 
During the 1960s, different syntheses of 6-dimethylaminofulvene L35 were described 
which are based on the use of activated dimethylformamide (Scheme I-14). The Arnold 
procedure used a tetramethylformamidinium salt, which required harsh synthesis conditions.29 
Meerwein described a more straightforward route via an amidoacetal intermediate by using 
[EtO3][[BF4],30 whilst Hafner used dimethylsulfate.31 
 
Scheme I-14: syntheses of 6-dimethylaminofulvene 
 
The later procedure also worked with dimethylacetamide to form L36 (Scheme I-15 left). L36 
was treated with primary amines to form 6-aminofulvenes of type L37 by Hafner. This 
procedure has subsequently been used by numerous authors. Several analogues have been 
synthesized such as diethylacetamide-derived  L38 (Scheme I-15 right).32 
 
Scheme I-15: 6-aminofulvenes obtained via Hafner's procedure 
 
                                               
28
 Kunz, D.; Johnsen, E. Ø.; Monsler, B.; Rominger, F. Chem. – Eur. J. 2008, 14, 10909 
29
 (a): Arnold, Z. Collect. Czechoslov. Chem. Commun. 1959, 24, 760, (b): Arnold, Z.; Žemlička, J. Collect. Czechoslov. Chem. 
Commun. 1960, 25, 1302 
30
 Meerwein, H.; Florian, W.; Schön, N.; Stopp, G. Justus Liebigs Ann. Chem. 1961, 641, 1 
31
 (a): Hafner, K.; Schulz, G.; Wagner, K. Justus Liebigs Ann. Chem. 1964, 678, 39, (b): Hafner, K.Organic syntheses1967 p 52 
32
 Venne-Dunker, S.; Kehr, G.; Fröhlich, R.; Erker, G. Organometallics. 2003, 22, 948 
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These 6-aminofulvenes reacted as fulvene (Scheme I-12), depending on the presence of 
acidic H on the 7 position, or the nucleophile used (Scheme I-16). In 1997, the synthesis of six 
news ligands (L39-a-f) was described by Erker.33 This was successfully achieved by a subtle 
control of the reaction conditions depending on the starting aminofulvene used (Scheme I-16 
top). The same author described the synthesis of amidoyl fulvene L40-a-d by treatment of L38-
a with various acyl chlorides.34a,b The coupling reaction was in competition with an electrophilic 
aromatic substitution on the Cp ring. A mixture of L40 and L41 was obtained, requiring a 
purification by column chromatography. The use of LDA as base on L40-d afforded L42-d, 
regioselectively. Some amines required activation or protection to avoid ortho C-acylation and 
enable N-acylation.35 L38-a was also used by Erker to form the TMS-analogue (L43-a), which 
was deprotonated twice, affording L44-a.  
 
Scheme I-16: Several examples of (aminomethyl)cyclopentadienide  
 
In 1999, the scope of amines used for the formation of 6-aminofulvenes was improved 
by Erker, who synthesized the corresponding pyrrolidino- morpholino- and piperidino-
methylcyclopentadienides L49-L52 (Scheme I-17),36,37 after deprotonation of L45-L48 by MeLi 
respectively. The scope of nucleophiles used on L35 was also extended to form L53-a-d.38 In 
2002, L35 was substituted with lithium anilide to form L54-a-b after treatment with alkyl or aryl 
lithium nucleophiles.  
                                               
33
 Bertuleit, A.; Fritze, C.; Erker, G.; Fröhlich, R. Organometallics. 1997, 16, 2891 
34
 (a): Duda, L.; Erker, G.; Fröhlich, R.; Zippel, F. Eur. J. Inorg. Chem. 1998, 1153, (b): Kunz, D.; Erker, G.; Fröhlich, R.; Kehr, G. 
Eur. J. Inorg. Chem. 2000, 2000, 409 
35
 Kunz, D.; Fröhlich, R.; Erker, G. Eur. J. Org. Chem. 2001, 3531 
36
 Knüppel, S.; Erker, G.; Fröhlich, R. Angew. Chem. Int. Ed. 1999, 38, 1923 
37
 Kotov, V. V.; Kehr, G.; Fröhlich, R.; Erker, G. Z. Für Naturforschung B. 2006, 61, 1319 
38
 Kunz, K.; Pflug, J.; Bertuleit, A.; Fröhlich, R.; Wegelius, E.; Erker, G.; Würthwein, E.-U. Organometallics. 2000, 19, 4208 
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Scheme I-17: other examples of (aminomethyl)cyclopentadienides  
 
After the 2000s many research groups worked on polyfunctionalized ligands. For 
example, new polyfunctionalized titanocenes for anticancer purpose were designed by Tacke. 
He showed that the fulvene route is versatile enough to get a new series of polyazaligands 
L55-a-f (Scheme I-18).39 
 
Scheme I-18: examples of polyfunctionalized (aminomethyl)cyclopentadienides  
 
The Hafner procedure was also used by Hierso, with a disubstituted CpLi L56 in order 
to form L57,40 which yielded the new P-N ligand L58 after reduction. This is one example of 
polyfunctionalized ligand. A new library of ferrocenes was designed by using L58 on iron. 
Various procedures for the polyfunctionalization of the Cp framework were investigated over 
                                               
39
 (a): Hickey, T.; Claffey, J.; Fitzpatrick, E.; Hogan, M.; Pampillón, C.; Tacke, M. Invest. New Drugs. 2007, 25, 425, (b): Hogan, 
M.; Claffey, J.; Pampillón, C.; Watson, R. W. G.; Tacke, M. Organometallics. 2007, 26, 2501 
40
 Allouch, F.; Dwadnia, N.; Vologdin, N. V.; Svyaschenko, Y. V.; Cattey, H.; Penouilh, M.-J.; Roger, J.; Naoufal, D.; Ben Salem, 
R.; Pirio, N.; Hierso, J.-C. Organometallics. 2015, 34, 5015 
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the years. Several examples could have been cited, would fall outside the scope of this 
dissertation. 
c. Aminomethynylation of cyclopentadiene 
In 1986,41 the aminomethynylation of CpH with 1-3-5-triazine was described by 
Kreutzberg, to form L37-a quantitatively. This compound was subsequently treated with cyclic 
secondary amines in order to form the corresponding 6-aminofulvene L59-a-d in moderate to 
good yield (28 to 72%). None of these cyclopentadienes was converted into an 
aminocyclopentadienide anion by Kreutzberg. Up to our knowledge, this procedure was used 
by only one group for ligand synthesis purpose: the 6-morpholinofulvene L59-e and a chiral 6-
pyrrolidinofulvene L59-f were synthesized by Wirth by this manner; in higher yield than with 
Hafner’s procedure.42 The chiral ligand was used to form an enantiopure ruthenocene. 
 
Scheme I-19: Kreutzberger synthesis 
 
d. C-H activation of cyclopentadiene 
In 1968, the potential of activated fulvenoid to undergo electrophilic aromatic 
substitution with isocyanates was shown by Effenberger, forming L61-a-b (Scheme I-20).43  
 
Scheme I-20: reactivity of cyclopentadiene derivatives with isocyanates 
 
                                               
41
 Kreutzberger, A.; Kolter, K. Liebigs Ann. Chem. 1986, 374 
42
 Herberich, G. E.; Englert, U.; Wirth, T. Eur. J. Inorg. Chem. 2005, 4924 
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This work was adapted by Erker to form new (aminomethyl)cyclopentadienides with a carbonyl 
function as a spacer.44 The ligand L62 formed by this manner was highly reactive towards the 
addition of another equivalent of isocyanate to form L63. Stoichiometry had to be carefully 
controlled to avoid or at least to limit the formation of L63. 
Such kind of reactivity was also highlighted by Müller-Westerhoff in 1970,45 with 6-
dimethylaminofulvene L35. This compound reacted smoothly with Vilsmeier-type reagents to 
form intermediate L64, which yielded aldimine L65 after further reaction with a primary amine 
(Scheme I-21). 
 
Scheme I-21: first synthesis of aldimine from the work of Müller-Westerhoff 
 
If two different amines were used to form aldimine by this procedure; and/or if the fulvene and 
the Vilsmeier complex were substituted, several isomers were observed (for example L65-a 
and b). According to Müller-Westerhoff, non-classical aromaticity in hydrogen-bonded systems 
was the course for this observation.46a,b After deprotonation of aldimines L65, these ligands 
can act as XL ligands under the form L66-A such as in copper,47a,b palladium or zinc 
complexes,48 or as XL2 ligands under the form L66-B in rarer cases.49a,b 
In summary, four routes were found to synthesize (aminomethyl)cyclopentadienides 
based on the work of Thiele, Hafner, Kreutzberg and Effenberger. These ligands have been 
coordinated to several metal centres but only group 4 metallocenes will be described in the 
following part. 
                                               
44
 Oberhoff, M.; Duda, L.; Karl, J.; Mohr, R.; Erker, G.; Fröhlich, R.; Grehl, M. Organometallics. 1996, 15, 4005 
45
 Mueller-Westerhoff, U. J. Am. Chem. Soc. 1970, 92, 4849 
46
 (a): Pietrzak, M.; Limbach, H.-H.; Pérez-Torralba, M.; Sanz, D.; Claramunt, R. M.; Elguero, J. Magn. Reson. Chem. 2001, 39, 
S100, (b): Perrin, C. L.; Ohta, B. K. Bioorganic Chem. 2002, 30, 3 
47
 (a): L. Johnson, A.; M. Willcocks, A.; R. Raithby, P.; R. Warren, M.; J. Kingsley, A.; Odedra, R. Dalton Trans. 2009, 922, (b): 
Willcocks, A. M.; Gilbank, A.; Richards, S. P.; Brayshaw, S. K.; Kingsley, A. J.; Odedra, R.; Johnson, A. L. Inorg. Chem. 2011, 50, 
937 
48
 Bailey, P. J.; Collins, A.; Haack, P.; Parsons, S.; Rahman, M.; Smith, D.; White, F. J. Dalton Trans. 2010, 39, 1591 
49
 (a): Willcocks, A. M.; Gilbank, A.; Richards, S. P.; Brayshaw, S. K.; Kingsley, A. J.; Odedra, R.; Johnson, A. L. Inorg. Chem. 
2011, 50, 937, (b): Bailey, P. J.; Loroño-González, D.; Parsons, S. Chem. Commun. 2003, 1426 
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2. Coordination to titanium, zirconium and hafnium 
Some of the ligands described above were developed for constrained geometry 
complexes (e.g L29 in Scheme I-10). Nevertheless, these complexes have already been 
reviewed elsewhere,50,51 and will not be discussed in this section which will be therefore be 
limited to metallocenic or half-metallocenic fragments. In 1996, the synthesis of the first 
carboxamido titanocenes L67-a-b was described by Erker,44 in which no coordination of the 
carboxamido moiety was observed to the titanium centre in the solid state (Scheme I-22). 
 
Scheme I-22: synthesis of the first carboxamidotitanocenes 
 
Between 1997 and 2003,33,52 the ligand L39-d was used for the synthesis of new 
(aminomethyl)metallocenes (L68) or bis(aminomethyl)metallocenes (L69-L71).  
 
Scheme I-23: coordination of L39-d to Ti and Zr 
 
                                               
50
 Braunschweig, H.; Breitling, F. M. Coord. Chem. Rev. 2006, 250, 2691 
51
 Britovsek, G. J. P.; Gibson, V. C.; Wass, D. F. Angew. Chem. Int. Ed. 1999, 38, 428 
52
 Pflug, J.; Bertuleit, A.; Kehr, G.; Fröhlich, R.; Erker, G. Organometallics. 1999, 18, 3818 
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The d1- titanocene L71 was the only example of this series exhibiting N coordination to the 
metal centre with a 2.420(2) Å Ti-N bond. 53 All complexes adopted a bent geometry in the 
solid state.  
Another series of “spiro-metals” was also described by Erker (L72-L74),25,34a,b using 
dilithium (amido)cyclopentadienides L42-d, L44-a and L54-a-b (Scheme I-24). 
 
 
Scheme I-24: synthesis of "spiro-metallocenes" 
 
On the other hand, an interesting reaction based on bis(aminomethyl)metallocenes 
obtained from L49 was fortuitously discovered at the same time by Zhou and Erker (Scheme 
I-25).36,54 Depending on the reaction conditions, the expected bis(aminomethyl)metallocene 
L75 was isolated (0°C, 1h stirring), and more surprisingly L76 was finally formed after 
prolonged stirring of 12h at room temperature. The formation of this compound was based on 
an acid-catalysed Mannich-type reaction. This rearrangement was observed on various metals 
and even with several amines that are not depicted in this section for clarity.55 In the case of 
NEt2, the rearrangement needed several days to be completed in solution, and several weeks 
when the compound was stored as a solid.32 These compounds underwent photochemical 
enamine [2+2] cycloaddition after irradiation.56 
                                               
53
 Kotov, V. V.; Fröhlich, R.; Kehr, G.; Erker, G. J. Organomet. Chem. 2003, 676, 1 
54
 Bai, S.-D.; Wei, X.-H.; Guo, J.-P.; Liu, D.-S.; Zhou, Z.-Y. Angew. Chem. Int. Ed. 1999, 38, 1926 
55
 Knüppel, S.; Wang, C.; Kehr, G.; Fröhlich, R.; Erker, G. J. Organomet. Chem. 2005, 690, 14 
56
 Tumay, T. A.; Kehr, G.; Fröhlich, R.; Erker, G. Organometallics. 2009, 28, 4513 
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Scheme I-25: an acid-catalysed Mannich-type reaction on group 4 (aminomethyl)metallocenes 
 
In 2002, Corey used a bis(aminomethyl)zirconocene for the dehydropolymerization of 
phenylsilane, and discovered a radical-based dehydrocoupling mechanism (Scheme I-26).57 
 
Scheme I-26: dehydropolymerization of phenylsilane with a bis(aminomethyl)zirconocene 
 
 Since Cp2TiCl2 was shown to have good cytotoxicity towards cancers cells, many 
functionalized derivatives have been synthesized as new antitumor drug candidates. In 2007, 
new (aminomethyl)titanocenes L78-a-f were designed by Tacke (Scheme I-27). No 
coordination of nitrogen to the titanium centre was observed in the solid state.39,58a,b,c,d,e,f 
 
Scheme I-27: (aminomethyl)titanocenes from Tacke’s work 
 
An interesting Bis(iminomethyl)zirconocene L80 was synthesized in 2009 by treating the new 
6-aminofulvene L79 with Cl2Zr(NMe2)2THF2.59 When L80 was mixed with the Lewis acid 
                                               
57
 Grimmond, B. J.; Corey, J. Y. Inorganica Chim. Acta. 2002, 330, 89 
58
 (a): Hogan, M.; Cotter, J.; Claffey, J.; Gleeson, B.; Wallis, D.; O’Shea, D.; Tacke, M. Helv. Chim. Acta. 2008, 91, 1787, (b): 
Pampillón, C.; Claffey, J.; Strohfeldt, K.; Tacke, M. Eur. J. Med. Chem. 2008, 43, 122, (c): Pampillón, C.; Claffey, J.; Hogan, M.; 
Tacke, M. BioMetals. 2008, 21, 197, (d): Weber, H.; Claffey, J.; Hogan, M.; Pampillón, C.; Tacke, M. Toxicol. In Vitro. 2008, 22, 
531, (e): Olszewski, U.; Claffey, J.; Hogan, M.; Tacke, M.; Zeillinger, R.; Bednarski, P. J.; Hamilton, G. Invest. New Drugs. 2010, 
29, 607, (f): Cuffe, S.; Dowling, C. M.; Claffey, J.; Pampillón, C.; Hogan, M.; Fitzpatrick, J. M.; Carty, M. P.; Tacke, M.; Watson, R. 
W. G. The Prostate. 2011, 71, 111 
59
 Axenov, K. V.; Kehr, G.; Fröhlich, R.; Erker, G. J. Am. Chem. Soc. 2009, 131, 3454,  Organometallics. 2009, 28, 5148 
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B(C6F5)3 and dihydrogen, hydrogenation of the enamine occurred to form the 
bis(aminomethyl)zirconocene L81. The bis(ammoniummethyl)zirconocene L82 can even be 
obtained by addition of two equivalents of  B(C6F5)3 were added (Scheme I-28). This complex 
was used for hydrogenation of imines and silyl enol ethers (2 bar of H2, room temperature). 
This study shows an example of a frustrated Lewis pairs, a concept developed further in this 
introduction. 
 
Scheme I-28: a new antagonist N/B Lewis pair for hydrogenation of imine and silyl enol ether 
 
The two bicyclic ligands L32 and L33-a-c, obtained by a fulvene route described in 
Scheme I-13, were also coordinated to Zirconium by using ZrCl4 or CpZrCl3, forming the 
corresponding bis(4,7-dimethylamino)indenylzirconocene L83, and the zirconocenes L84 and 
L85-a-c (Scheme I-29).26 The neutral form of L33-c was treated with Cl2Zr(NMe2)2 to yield the 
expected zirconocene L86-c. In the case of R1 = R2 = H, carbon-carbon bond formation yielded 
the ansazirconocene L86-b. In the case of L33-a a mixture of three compounds was formed.27 
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Scheme I-29: synthesis of polycyclic zirconocenes 
 
To resume this part, coordination of (aminomethyl)cyclopentadienides on group 4 
metals is possible and yield stable functionalized metallocenes. Noteworthy, numerous 
unexpected reactions were observed during the formation of these metallocenes. 
C. (Aminoalkyl)cyclopentadienides 
In the following part, an overview of the synthesis of cyclopentadienides bearing an 
amino function with a hydrocarbon spacer longer than one atom is described. Their 
coordination to group 4 metallocenes will be discussed too. This section would include 
numerous examples, but the list will be limited to some examples in order to best illustrate the 
field of possibilities.  
1. Synthesis 
The main route used in the literature is based on the nucleophilic substitution of 
halogenoalkylamines (or their ammonium salt form) by CpNa or CpLi, first described by Wang 
in 1991.60 
 
Scheme I-30: general procedure for the synthesis of (aminoalkyl)cyclopentadienides 
 
                                               
60
 (a): Wang, T.-F.; Lee, T.-Y.; We, Y.-S.; Liou, L.-K. J. Organomet. Chem. 1991, 403, 353, (b): Tein-Fu, W.; Tsung-Yi, L.; Jim-
Wen, C.; Chi-Wi, O. J. Organomet. Chem. 1992, 423, 31 
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The limitation of this reaction is the starting amine, which is not commercially available in most 
of the cases. The scope of this reaction is summarized in Scheme I-31 (compounds L87-a-b-
L97).61,62,63,64a,b,65,66,67,68,69,70 
 
Scheme I-31: Aminoligand synthesized over the years following Wang’s synthesis 
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 Hughes, A. K.; Meetsma, A.; Teuben, J. H. Organometallics. 1993, 12, 1936 
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63
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67
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69
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This method is very convenient, and has been used for a wide range of amines as illustrated 
above. In 2001, a similar procedure was described by using activated carboxylic acids instead 
of chloroamines, in order to incorporate amino acids on metallocenes (Compound L98-a-b 
Scheme I-32). 71 
 
Scheme I-32: synthesis of amino-acid-based cyclopentadienides 
 
  An alternative route was described earlier in 1980 by Woltermann based on the use of 
spirane derivatives such as spiro[2.4]hepta-4-6-diene L99.72,73 The treatment of this compound 
with a nucleophile yielded various (aminoalkyl)cyclopentadienides L100-a-e (Scheme I-33). 
The requirement for this synthesis was to synthesize the appropriate spirane derivative 
depending on the spacer required. 
 
Scheme I-33: synthesis of (aminoalkyl)cyclopentadienides via the spirane route 
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The last synthesis found is based on the use of the already described procedure of Thiele: the 
condensation of CpH with a carbonylated amine. Three examples are depicted in Scheme I-34 
with the synthesis of L101, L102-a-c and L104-a-c.74,75a,b,c  
 
 
Scheme I-34: (aminoalkyl)cyclopentadienides synthesized via the synthesis of Thiele  
 
Very recently, Lamač used 6,6-dimethylfulvene to synthesize new nitrile- and ketimide -
containing ligands. Their synthesis is resumed in Scheme I-35.76,77 The straightforward 
procedure started with the deprotonation of acetonitrile (or dimethylacetonitrile) followed by 
nucleophilic attack of the electrophilic carbon (C6) of dimethylfulvene forming L105 (L106).  
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 Clark, T. J.; Nile, T. A.; McPhail, D.; McPhail, A. T. Polyhedron. 1989, 8, 1804 
75
 (a): Tacke, M.; Allen, L. T.; Cuffe, L.; Gallagher, W. M.; Lou, Y.; Mendoza, O.; Müller-Bunz, H.; Rehmann, F.-J. K.; Sweeney, 
N. J. Organomet. Chem. 2004, 689, 2242, (b): Rehmann, F.-J. K.; Cuffe, L. P.; Mendoza, O.; Rai, D. K.; Sweeney, N.; Strohfeldt, 
K.; Gallagher, W. M.; Tacke, M. Appl. Organomet. Chem. 2005, 19, 293, (c): Sweeney, N. J.; Mendoza, O.; Müller-Bunz, H.; 
Pampillón, C.; Rehmann, F.-J. K.; Strohfeldt, K.; Tacke, M. J. Organomet. Chem. 2005, 690, 4537 
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Scheme I-35: synthesis of nitrile-based and ketimide-based cyclopentadienides 
Nucleophilic attack of the nitrile group on L106 afforded new ketimide-based ligand L107-a-c 
depending on the nature of the alkyllithium used. The corresponding reaction on L105 was 
tried but nucleophilic attack was shown to compete with deprotonation of C7. 
All syntheses described above were built on an unsubstituted cyclopentadiene. To 
incorporate substituents on the Cp moiety, depending on the nature of the ligand desired, the 
synthesis would be rather difficult to implement. As illustrated by Jutzi in 1993,78 the synthesis 
of the tetramethylated (aminoethyl)cyclopentadienide L110, was not possible via the Wang 
route starting from L108. Indeed, a mixture of L109-a and L109-b was obtained with no desired 
methylated cyclopentadiene. The amino chain had to be introduced prior to the formation of 
the Cp ring to form L110 (Scheme I-36). An alternative route was found by Enders in 1996, by 
reacting a lithium derivative with the 2,3,4,5-tetramethylcyclopent-2-ene-3-one L111 in order 
to form L112 (Scheme I-36).79 
 
 
Scheme I-36: synthetic route for permethylated (aminoalkyl)cyclopentadienides 
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Finally, it has to be noted that these ligands can be reacted with chlorosilane to form 
silylated Cp rings. In Scheme I-37, Jutzi described the synthesis of an ansa-ligand by using 
L92, with the appropriate chlorosilane to form L113 regioselectively.80 It is worth noting that 
several regioisomers could have been obtained (1-2 or 1-3 substitution). 
 
Scheme I-37: synthesis of an ansa precursor 
 
2. Coordination to titanium, zirconium and hafnium 
The use of TMSCl to silylate Cp rings has been exploited to form piano stool Ti(IV) (and more 
rarely zirconium and hafnium) complexes. The other route to synthesize piano stool group 4 
metallocenes, was based on the work of Lappert and the protonolysis of M(NMe2)4 precursors 
(M= Ti, Zr, Hf - Scheme I-38).81  
 
 
Scheme I-38: synthesis of piano stool group 4 complexes 
 
Depending on the nature of the reaction, trichloro (e.g. L114-118) or tris(dimethylamino) 
complexes (L119-b-d and L120) were described in the following Scheme I-39. 
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Scheme I-39: overview of group 4 piano stool complexes with an amino-functionalized ligand 
 
In most of these complexes, coordination of the amine is observed to the metal centre.82 This 
was experimentally determined by NMR (1H NMR signal of the CH2 spacer group downfield 
compared to the free ligand) and / or by X-ray diffraction.83a,b The M-N bond length is specified 
if available.63,77,79 The first complex exhibiting no M-N bond was described by Jutzi (L119), due 
to the steric hindrance of the amine; instead, coordination polymer formation was assumed by 
the authors.84 The same observation was made by Rausch on compounds L120-121. This 
characteristic was assumed to be due to the presence of NMe2 and isopropoxy ligands on 
titanium. These ligands were supposed to prevent coordination of the amino by a combination 
of steric hinderance and enhanced electron donation to the metal. Low purity of such kind of 
complexes was also observed and attributed to moisture sensitiveness. This was supposed to 
be directly connected to the non-coordinated pendant amine, which might act as a Brønsted 
base on water. Several µ-oxo complexes were obtained and characterized in this series. One 
example from the work of Van der Zeijden is depicted in Scheme I-40.85  
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Scheme I-40: hydrolysis product of a piano stool titanium complex 
 
Most of the complexes described in Scheme I-39, were active in Ziegler Natta 
polymerization of alkenes. They have been widely studied due to the potential additional 
stabilization brought by the coordinating arm during catalysis. Numerous half sandwich 
complexes have been synthesized for this end, and based on other metals than those from 
group 4. 
After describing half-sandwich complexes, the following section will develop the 
synthesis of some group 4 metallocenes. Some of the cyclopentadienides described previously 
on the synthesis of half-sandwich complexes have also been used for this purpose.  Due to 
their tendency to form coordination polymers, and their moisture sensitivity, some of them were 
isolated as their hydrochloric salts: a large number of these complexes were tested as 
anticancer agents by the group of Tacke, 75a,b,c,86,87 McGowan,88a,b,c,d or Baird (L132-133-L136-
137).89a,b,c,90 An overview of this type of metallocenes is depicted in Scheme I-41. 
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Scheme I-41: screening of various (aminoalkyl)metallocenes of group 4 
 
Early work on metallocenes (IV), by Jutzi and Beckhaus, enabled a better 
comprehension of the coordination sphere of these metals in the solid state or in 
solution.65,91,92,93,94,95 Usually, NMe2 arms (e.g. in complex L125) were used to coordinate in an 
intra- or intermolecular mode, unless the steric bulk around the metal centre was too 
important.93 As soon as the amino arm is hindered (e.g. in L126 and L128),65,92 no more 
                                               
91
 Jutzi, P.; Dahlhaus, J. Coord. Chem. Rev. 1994, 137, 179 
92
 Jutzi, P.; Kleimeier, J. J. Organomet. Chem. 1995, 486, 287 
93
 Jutzi, P.; Siemeling, U. J. Organomet. Chem. 1995, 500, 175 
94
 Jutzi, P.; Redeker, T.; Neumann, B.; Stammler, H.-G. Chem. Ber. 1996, 129, 1509 
95
 Beckhaus, R.; Oster, J.; Ganter, B.; Englert, U. Organometallics. 1997, 16, 3902 
Bibliographic introduction 
28 
 
intramolecular coordination was observed. Nevertheless, the synthesis of the Ti(III) analogues 
(L125 and L134-a-b),96,93 proved the intramolecular coordination potential of this framework in 
the solid state (2.428(9) Å < Ti-N <2.437(3) Å), even with bulky amines; as soon as the metal 
presents a vacant coordination site. Whereas protonated metallocenes were tested as 
anticancer metallodrugs, their deprotonated analogues showed good activities in alkene or 
phenylsilane polymerizations.97,65 
 Carboxamide group 4 metallocenes showed no interaction between the amide part 
and the electrophilic metal centre, as described by Erker in 2002 (Scheme I-42).98 Abstraction 
of a chloride from the corresponding titanocene yielded the formation of a cationic species in 
which oxygen from the amido function was coordinated to titanium.  
 
Scheme I-42: carboxamide group 4 metallocenes synthesized by Erker 
 
Complex L139-a is similar to the Gansäuer complexes of type L142 but their synthesis and 
behaviour are quite different. Indeed, a post functionalization of titanocenes was achieved by 
Gansäuer, via a modular synthesis.99 This reaction is depicted in Scheme I-43. Titanocenyl 
acyl chloride L141 was first formed and reacted with an amine in the presence of NaH to form 
compound L142. This is a rare example of post functionalization of group 4 metallocenes, 
which is more common in group 8 metal chemistry.100 
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Scheme I-43: Gansäuer’s synthesis of amido titanocenes 
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Some of these complexes were used as antitumor and antileukemic agents and some others 
were then reduced and used in hydrogen transfer catalysis for epoxide opening, and radical 
reduction.101a,b 
Another atypic functionality incorporated into the cyclopentadienylide framework was 
described by Lamač: a nitrile. Coordination of compound L143 to group 4 metals is 
straightforward. Bis(cyanoethyl)metallocenes L145-a-c were synthesized first (Scheme 
I-44).74 In the case of titanium, better yields were obtained if the half sandwich L122 was 
formed first. In these structures, no coordination of the nitrile to the titanium centre was 
observed. A second series of mono substituted (cyanoalkyl)metallocenes L147-a-b was 
synthesized (Scheme I-45).102,103  
 
Scheme I-44: synthesis of cyano functionalized group 4 metallocenes 
 
These nitrilo-based metallocenes were proved to be moisture sensitive. With the 
monofunctionalized metallocenes L147-a-b, water addition products were characterized for 
both titanium and zirconium complexes (L148-a-b). The dimethyl zirconocene L149 was also 
synthesized, and abstraction of one methide with [Ph3C][B(C6F5)4] yielded the cationic adduct 
L150 in THF. In dichloromethane, the nitrile moiety was inserted into the Zr-Me bond to form 
L151 (Scheme I-45 bottom). 
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Scheme I-45: reactivity of mono(cyanoethyl)zirconocene L147-a-b 
 
Lastly, one can cite the synthesis of some ansametallocenes, based on the coordination of 
ligands L89-b and L113 previously described (Scheme I-46). In 1997, Paolucci used L89-b 
(first designed by Qian),104 for the synthesis of the new ansazirconocene L152-b.  
 
Scheme I-46: synthesis of N-based ansazirconocenes 
 
Complex L153-b is the first stable dialkyl zirconocene with β hydrogens which was 
characterized by X-ray diffraction. The pyridinyl moiety was coordinated to the metal centre 
(Zr-N = 2.531(8) Å). The analogous ansatitanocene L152-a was synthesized in 1997 by Qian 
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but no crystal were obtained.96 Jutzi described the synthesis of various ligands for the synthesis 
of ansazirconocenes. 80,105a,b One example is depicted in Scheme I-46 (L154). 
 
In conclusion to this part, it has been shown that a carbonated chain longer than one 
carbon enables coordination of the amine moiety to the metal centre if no steric effect are 
present to prevent it. This has been exploited to design N-stabilized metallocene complexes 
for polymerization catalysis. Several reviews have been published over the years on this topic 
for further information.106  
 
The last part of this bibliographic introduction will deal with a new concept for activation 
of small molecules: the use of frustrated Lewis pairs (FLPs). After a short introduction to some 
of the main features of this concept and similar approaches (metal-ligand cooperativity and 
ambiphilic ligands), an overview of organometallic FLPs (OmFLPs) will be presented, with a 
focus on group 4 metals. 
D. Frustrated Lewis Pairs 
1. Concept and origins 
Frustrated Lewis pairs were first introduced by Stephan,107 and Erker.108 These species 
consist of unquenched mixtures of Lewis acids and bases due to steric hindrance (Figure I-1). 
Compared to classical Lewis adducts, FLPs are less stable mixtures brought together by weak 
interactions, which reduces the activation energy required for small molecule activation. The 
concept has been extended to any combination capable of activating small molecules, even if 
a slight interaction between both partners is observed in less constrained pairs. 
A B
Lewis acid Lewis base
A B
Lewis acid Lewis base
X Y
A BX Y
 
Figure I-1: illustration of an FLP 
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 In a few cases, Lewis pairs are not frustrated anymore but are still able to activate several 
substrates. These aspects will be illustrated further. 
 
a. Concept 
These energetic considerations were put forth by Pápai in 2008,109 with dihydrogen 
activation by a phosphine/borane FLP. Starting from a typical Lewis pair, quenching a Lewis 
acid with a Lewis base in the presence of dihydrogen will yield a Lewis adduct which is an 
potential energy well, precluding the activation of H2 (Figure I-2). Indeed, the energy required 
to reach the activation transition state, which corresponds to the cleavage of the donor-
acceptor-adduct cleavage and insertion of dihydrogen into the Lewis acid-Lewis base bond, is 
too high. In the case of FLPs, weak interaction between both partners causes a shallower 
energy well and hence a lower activation energy. Although no preactivation intermediates 
LB…H2 or LA…H2 were found when both are reacted alone with dihydrogen, it is no longer to be 
proved that several FLPs are able to split heterolitically H2. This tends to prove that both Lewis 
acid and Lewis base are activating dihydrogen cooperatively, which can be illustrated as the 
TS FLP drawn in Figure I-2. This diagram is drawn by using dihydrogen but can be extended 
to any other small molecules such as CO2, CO, NO2, N2O ... The nature of both partners will 
entail a certain energy supply which does not necessarily fit every substrate. Nevertheless 
some FLPs can activate (or react with) a variety of small molecules such as alkenes, alkynes, 
aldehydes, ketones and even ynones, as will be illustrated further. 
 
Figure I-2: Energetical illustration of the FLP concept adapted from Pápai 
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b. Ambiphilic molecules and metal-ligand cooperativity  
Before developing the origins of FLPs, and the scope of their use, a parallel has to be 
done with two other noteworthy concepts described in the last decade. Indeed, extensive work 
has been done on ambiphilic (or amphoteric) derivatives over the past ten years. By definition, 
such kind of compounds are composed of two antagonistic moieties: an electron acceptor site 
(or Lewis acid) and an electron donor site (or a Lewis base). These two sites have to be 
separated by at least one atom. In other words, many intramolecular FLPs described further 
could be considered as ambiphilic derivatives. Ambiphilic compounds usually combining group 
15 and 13 elements, were found to be able to act as L-ligand (L155-a), bridging ligand (L155-
b), L-Ligand accompanied with a Ligand-X abstraction from the Lewis acid (L156), or more 
surprisingly as Z-Ligand (L155-c) as illustrated in Scheme I-47.110,111,112  
(iPr)2P BCy2
Au
Cl
(iPr)2P BCy2
Pd Cl
(iPr)2P BMes2
Pd
Cl
Ni
P
P
Me
Ph2
P
BCy2
Me
L155-a L155-b L155-c L156
Bourissou 2006-2009 Tilley 2008
"L-Ligand" bridging Ligand "Z-ligand" "L-Ligand
with X-abstraction"
 
Scheme I-47: the different coordination modes of ambiphilic ligands 
 
Another example, based on a ferrocenic platform was developed in the group of Hierso 
as illustrated in Scheme I-48.113,114 
 
Scheme I-48: ambiphilic P/B ferrocenes 
 
 Numerous example of ambiphilic ligands have already been reported elsewhere and will not 
be developed in more details.115,116 
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Another concept has emerged in the transition metals realm, based on similar 
antagonistic combinations. Noyori and Milstein have described the notion of metal-ligand 
cooperativity in catalysis. The first described ruthenium-based complexes bearing secondary 
amines. These systems are able to cooperatively activate H2 before operating the 
enantioselective reduction of carbonylated derivatives (Scheme I-49).117,118 
 
Scheme I-49: cooperative ketone hydrogenation reported by Noyori 
 
The second showed the potential of non-innocent ligands such as PNP 
(di(phosphinomethyl)pyridines) in combination with ruthenium, in catalytic oxidation of alcohol 
by dehydrogenation (Scheme I-50). This catalysis was shown to process via metal-ligand 
cooperation based on an aromatization/de-aromatization process. 
 
Scheme I-50: non-innocent ligand for the dehydrogenation of alcohols 
 
In both cases, the Ru played the role of a Lewis acid whilst the ligand acted as a Lewis Base. 
Their cooperativity led to the activation of H2 in Noyori’s catalysis or elimination of H2 in 
Milstein’s catalysis.119 These two reactions are closely related to the FLP concept because 
they rely on the activation of small molecules by using synergistically a metal (Lewis acid) with 
a basic ligand (Lewis base). 
c. Origins 
Brown is generally recognized to have published, in 1942, the very first example of what 
would be described nowadays as an FLP.120 Trimethylborane was mixed with 2,6-
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dimethylpyridine, and no adduct was observed. This unexpected behaviour was not 
investigated further at the time. Six decades later, whilst investigating phosphine-borane 
adducts,107, Stephan discovered the nucleophilic substitution of B(C6F5)3 by P(Mes)2H to form 
the intermediate L161 (Scheme I-51). After an H-for-F exchange with Me2SiHCl, compound 
L162 was obtained: at 120 °C a loss of H2 was observed to liberate the FLP L163. H2 could be 
easily activated by L163 at 25°C in less than 5 min to recover L162. A new class of compounds 
was born, which led to the definition of the FLP concept shortly thereafter.121 The discovery of 
compound L163 was a milestone in metal-free hydrogenation and H2 storage research.122 It 
was first used as a catalyst for imine hydrogenation and benzaldehyde reduction. 
 
Scheme I-51: first organic FLP from Stephan 
 
Following these results, another intramolecular FLP L164 was decribed by Erker which 
was shown to activate various substrates in a number of papers (Scheme I-52).108,123a,b,c,d  
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Scheme I-52: some examples of small molecule activation with L164 
 
2. Scope of organic FLPs  
a. Pionnering P/B systems  
Intermolecular FLPs were then described by Stephan. The P(tBu)3 / B(C6F5)3 pair was 
shown to activate alkenes.124 The FLP chemistry has been growing over the past decade. The 
concept was extended to various partners, and used to design new kind of compounds. For 
example, one can cite the synthesis of new P-B-diphenylacetylene derivatives (e.g. compound 
of type L166) developed by Yamaguchi.125 The diphenylphosphine in compound L166-a was 
not nucleophilic enough to activate the alkynyl moiety, whilst L166-b and c underwent ring 
closing so quickly that they could not be isolated. L167-b-c were formed quantitatively without 
traces of the P-B-diphenylacetylene (Scheme I-53). 
 
Scheme I-53: Yamaguchi’s synthesis of π-ladder-conjugated skeleton 
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After H2-activation, much interest in FLP chemistry has been devoted to CO2 binding. 
Indeed, due to its involvement in global warming via the greenhouse effect, numerous research 
groups have started working on its use as a C-1 feedstock. For instance, Fontaine devised a 
CO2 reduction procedure involving the combination of L168 and an hydroborane [H]B. 
Mechanistic studies involving DFT calculations and experimental evidence enable Fontaine to 
put forth a three-component mechanism (intermediate L170), instead of the more classical 
two-step sequence involving CO2 activation followed by reduction. Indeed, compound L168 
was proved not to be able to bind CO2 alone, according to NMR analyses.126a,b Nevertheless, 
the combination of L168, H[B] and CO2 effected the reduction of CO2 as illustrated in Scheme 
I-54. A simplified view of this mechanism involves H[B] activation by the phosphine, whilst the 
catechol borane moiety activates CO2, in reality the mechanism is more complex.127 A series 
of analogous P/B ambiphilic pairs was then tested against CO2 reduction (with H[B] and 
BH3.Me2S). This study showed that L168 and L169 were the most active catalysts for CO2 
reduction.128 Adducts of the ambiphilic system and CH2O were shown to be the catalytically 
active species in this system. 
 
Scheme I-54: FLP-catalysed reduction of CO2 
 
This example highlights both the complexity and the efficiency of ambiphilic pairs / FLPs in 
catalysis. Using a weakly acidic partner as in L168, does not enable CO2 binding, but the 
combination of the P/B pair, H[B] and CO2 creates a synergy to effect CO2 reduction. The use 
                                               
126
 (a): Courtemanche, M.-A.; Légaré, M.-A.; Maron, L.; Fontaine, F.-G. J. Am. Chem. Soc. 2013, 135, 9326, Fontaine, F.-G.; 
Courtemanche, M.-A.; Légaré, M.-A. Chem. – Eur. J. 2014, 20, 2990 
127
 Courtemanche, M.-A.; Légaré, M.-A.; Maron, L.; Fontaine, F.-G. J. Am. Chem. Soc. 2014, 136, 10708 
128
 Declercq, R.; Bouhadir, G.; Bourissou, D.; Légaré, M.-A.; Courtemanche, M.-A.; Nahi, K. S.; Bouchard, N.; Fontaine, F.-G.; 
Maron, L. ACS Catal. 2015, 5, 2513 
Bibliographic introduction 
38 
 
of a more acidic and/or bulkier borane would lower the energy of some transition states, but 
would also over-stabilize some reaction intermediates, thus slowing down catalytic turnover. 
Several other FLPs have been designed, not solely based on P/B systems, and 
advances in this field have already been reviewed elsewhere.129a,b Examples of N-based FLPs 
(generally with B(C6F5)3 as the Lewis acid component) will now be presented, in an attempt to 
illustrate the wide range of FLPs and their applications. 
b. N-based organic FLPs 
Early work on N-based FLPs started with the catalytic hydrogenation of imines with 
B(C6F5)3 described by Stephan (Scheme I-55).130 By using only 5 mol % of this borane, very 
good conversion of imines into secondary amines was obtained in 1-8 h (L172-a-c and L174-
a). The SO2-based imine required 48h to get 94% of conversion. When the imine was too 
bulky, hydrogenation failed (L174-b).  
 
Scheme I-55: FLP-hydrogenation of imines and aromatic amines  
 
This pioneering work was the starting point of many developments in metal-free hydrogenation. 
In 2011, a diastereoselective version using chiral imines was described.131 Besides, Stephan 
extended this type of reactivity to aromatic amines (L175) which were hydrogenated with one 
equivalent of B(C6F5)3 (Scheme I-55-bottom).132 In 2015, Oestreich extended this methodology 
by using cyclohexa-1,4-dienes as a source of hydrogen.133 
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Whilst Rieger and Repo134 employed B(C6F5)3 with TMPH (2,2,6,6-
tetramethylpiperidine) and DIPA (Diisopropylamine) to activate dihydrogen, Stephan continued 
his investigations on N-based FLPs employing substituted pyridines treated with B(C6F5)3 and 
studied the nature of the B-N adduct.135 Whereas simple pyridines formed stable Lewis 
adducts, the bulkier 2,6-lutidine underwent reversible adduct formation with B(C6F5)3, (forming 
L167-a) and was able to activate dihydrogen. Ring-opening THF was also observed with this 
adduct.136 Bulkier 2-6 substituted pyridines showed no interaction whatsoever with B(C6F5)3, 
forming FLP L167-b-c, and were also able to split H2. In 2011, the conditions required for H2 
activation were explored by Berke with various bulky piperidines. Increasing bulkiness around 
piperidine reduced the energy required for activation (in the decreasing order: L179-a, L178 
and L179-b) as illustrated on Scheme I-56.137 
 
Scheme I-56: overview of intermolecular N-based FLP studied, and their reactivity towards H2 activation 
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TMPH has been widely used in FLP chemistry. Various combinations with borane other 
than B(C6F5)3 also showed H2 activation.138 Several studies on CO2 reduction involving TMPH 
/ B(C6F5)3 mixture have been published. Indeed, as mentioned before, CO2 reduction is an 
interesting way to use this greenhouse gas as C1 feedstock. In 2009, O’ Hare described the 
catalytic reduction of CO2 by using H2 in addition to L178 to form methanol (after aqueous 
treatment).139 Piers described the same kind of reactivity using Et3SiH instead of H2.140 More 
surprisingly, TMPH was used in 2015 with a disguised silylium (silanetriflate) to activate CO2.141  
L178 and L177-a were used for alkyne activation. TMPH acted as Brønsted base whilst 
2,6-lutidine was able to form the FLP-adduct.142 The reactivity of primary alkyne with FLPs is 
dependent of the nature of the Lewis partner involved. Classical FLPs operate the carbon-
carbon triple bond activation (e.g. 2,6-lutidine) whilst some Lewis base partners are too bulky 
to operate the same reactivity. In the latter case, deprotonation of the primary alkyne is 
observed (e.g. TMPH) which is a Brønsted type reactivity for a base. Berke showed the ability 
of L179a-b to activate cooperatively hydrogen.  
In 2012, an FLP reactivity was described by Erker and Stephan by using a less hindered 
amine.143 Various substrates were activated with the BnMe2N / B(C6F5)3 pair (Scheme I-57). 
The N-B bond is very long and therefore adduct formation is reversible. This particularity must 
help small molecule activation as already illustrated. 
 
Scheme I-57: low bulky N-based FLP 
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Wang described another example of less hindered amine than TMPH in 2013. 
Diethylamine or diisopropylamine were used in conjunction with an extremely bulky and Lewis 
acidic borane to activate CO2 and form L181-a-b (Scheme I-58).144 
 
Scheme I-58: CO2 activation from Wang's work 
 
An unusual ionic liquid-based FLP was designed by Dyson in 2017 by using 
imidazolium L182 with a pendant ethyldiisoproylamine in association with B(C6F5)3.145 The 
diisopropylamine moiety underwent an α-H abstraction to form an iminium hydrido borate. This 
ionic liquid-based FLP did not activate H2, but both iminium and hydroborate were not 
observable anymore, according to NMR measurements. Nevertheless, at least partial 
reduction of CO2 with H2 was observed according to multinuclear NMR spectroscopic analyses 
(Scheme I-59). 
 
Scheme I-59: an ionic liquid-based FLP 
 
 Many ambiphilic N/B systems have been reported over the years. Scheme I-60 
summarizes the main advances in this field. Before the introduction of the FLP concept, Piers 
reported the synthesis the ambiphilic phenylene-based aminoborane L184-a. An attempt at 
stepwise addition of H+ and H- was also reported but failed. The expected H2 addition product 
was unfortunately not obtained. 146 Inspired by this work, Rieger, Repo and Pápai have 
published (jointly or concurrently) several reports on related systems. Compound L184-b-c-d 
exhibited classical FLP-type chemistry, 147,148,149 with no B-N bond observed either in solid or 
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liquid states; on the other hand, a less frustrated ambiphilic compound (L184-e) was reported 
to activate dihydrogen at 80°C.148  
 
Scheme I-60: Scope of intramolecular N-based organic FLPs 
 
Surprisingly, prolonged heating of the hydrogen-addition product led to the formation of a new 
ambiphilic aminoborane (L184-f),150 which showed high potential in selective alkyne reduction 
for the first time. Interestingly, this compound was also used for aryl C-H activation.151 As 
previously described, Fontaine explored ambiphilic phenylene-based complexes and 
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synthesized various N/B systems of this type (L185-a-d,f).152a,b,c,d FLP-type reactivity was 
observed, along with C-H activation on heteroarenes,153 and S-H bond borylation.154a,b Erker 
designed a TMP-based intramolecular FLP with a longer spacer (L187),155 but no B-N 
interaction was found in the solid state. Würthwein and Uhl designed new N-based FLPs 
containing aluminum instead of a boron as the Lewis acid partner (L-186-a-d).156  
 In conclusion to this part on organic FLPs, they were able to be used in catalytic processes 
by activating small molecules as transition metals did earlier. With this new class of molecules, 
the main group elements were shown to react in a similar fashion as transition metal 
compounds as described by Power,157 but remained used in stoichiometric conditions. Despite 
being widely presented as advantageous because of their “metal-free” nature, it was not long 
before FLP would enter the realm of organometallic chemistry. Important reviews on this topic 
have been written by Stephan,158 Erker159 and Wass.160a,b,c In this last part, only group 4 metal 
examples will be described. 
 
3. Organometallic-based FLPs based on group 4 metals 
Amongst other properties, group 4 metals are known for their Lewis acidity. This 
character has been widely exploited in organic chemistry especially with TiCl4. The first 
example which comes to mind is the Knoevenagel reaction which is commonly performed with 
TiCl4 and a base.161 In fact, many reactions of this type use this combination of a Lewis pair in 
various reactions. 
An early example was described by Jordan in 1991 who discovered the ring opening 
of THF with NMe3 or PMe2Ph in combination with a cationic zirconocene, forming L189-a-b.162 
Even if the FLP concept did not exist at the time, it is fair to say that this reaction would probably 
be described in terms of FLP chemistry nowadays (Scheme I-61). Stephan described a related 
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reaction by starting with the THF adduct L190 and formed L191 by using a tertiary phosphine 
(Scheme I-61 down),163 this was also observed in 1997 by Polamo.164 
 
Scheme I-61: organometallic chemistry related to FLP chemistry 
 
Following the emergence of FLP concept, two categories of group 4-based OmFLPs 
were designed. The first is composed of examples in which the metallocene fragment is a 
platform on which FLP reactivity occurs, but without involving necessarily the metal centre. 
Erker designed three zirconocenes of this type; the first has already been described in Scheme 
I-28. Compound L80 was used in combination with B(C6F5)3 to hydrogenate imines on the 
metallocene fragment.58 In 2010 Erker described the hydrogenation of the enamino 
zirconocene L192 by the organic FLP L164 in presence of dihydrogen to form L193 (Scheme 
I-62). 165  
 
Scheme I-62: Zr or Ti based complexes: potential platforms for FLP chemistry 
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On the other hand, a troticenyl phosphane was combined with B(C6F5)3 by Tamm in 
2015 to activate H2, CO2 and N2O. The progress of these reactions was followed by a 
colorimetric detection.166 
 
The second category is based on the use of the metal as a Lewis partner. As with 
organic FLPs, two strategies were employed to obtain these OmFLPs as intra- or 
intermolecular pairs. 
a. Intermolecular OmFLPs 
Early OmFLPs of this type have already been described in Scheme I-61, even if these 
examples were developed before the introduction of the concept of FLP. Stephan described 
the first N2O addition product containing a group 4 metal.167 By using a preactivated N2O with 
an organic FLP L196, the possibility to exchange the Lewis acid by a cationic methyltitanocene 
or zirconocene to form L197-a-b respectively was shown by Stephan. Whilst all attempts at 
forming this adduct directly with the combination of PtBu3 and the corresponding cationic 
metallocene failed, combination of [Cp*2ZrOMe][B(C6F5)4] with PtBu3 was able to bind N2O to 
form L198 (Scheme I-63). This example highlights the importance of managing the acidity of 
the cationic metallocene, to use it as a Lewis partner. A similar example involving CO2 was 
later reported.168 
 
Scheme I-63: FLP exchange and first OmFLP reactivity 
 
In 2016 Wass described the combination of cationic zirconocenes with phosphines 
(Scheme I-64).169 Modification of the steric and electronic properties of these pairs enabled 
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FLP reactivity. For example, L200-a-b displayed no Zr/P interaction and are able to split D2 
quantitatively. Besides, L199-e and L200-e were OmFLPs in terms of frustration since no Zr/P 
interactions were observed; despite this, they were found to be completely unreactive towards 
any of the tested substrates. Surprisingly L199-a and L199-b, which showed strong Zr/P 
interactions, were able to activate CO2, THF and phenylacetylene but were inert towards D2. 
 
Scheme I-64: intermolecular OmFLPs from Wass 
 
This highlights again the complexity of FLP chemistry: indeed, frustration is not always required 
for small molecule activation, as long as a pre-equilibrium exists between the Lewis adduct 
and its components. In another study, Wass used cationic zirconocene L199 in combination 
with an imine and showed its activity in catalytic hydrogenation as Stephan did with B(C6F5)3 
(Scheme I-55). Surprisingly, the bulkier L200 was completely inactive in catalytic 
hydrogenation most probably due to excessive steric hindrance at the metal centre. A series 
of analogous cationic zirconocenes were designed and tested towards hydrogenation of 
imines. It was found that the most sterically hindered and most electron rich 
bis(indenyl)zirconocene were the best catalyst of this study which remained limited to sterically 
hindered imines.170 
b. Intramolecular OmFLPs 
Several examples of intramolecular group 4 metal OmFLPs have been reported over 
the last decade. Early examples were reported by Wass in 2011: a phosphinophenate was 
grafted onto a metallocene fragment.171 Coordination of the phosphine to zirconium is 
observed with Cp-based metallocenes (L201-a-b-c, L203), whilst Cp*-based complexes 
prevent coordination (L202-a-b). Likewise, mixed Cp/Cp* complexes containing relatively 
compact phosphane moiety displayed a Zr/P interaction. The potential of these compounds to 
act as OmFLPs was evaluated through their ability to activate H2. Compounds L202-a-b are 
able to split H2 quantitatively whereas L201-a-c do not react. More surprisingly, Zr compounds 
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L203 and L204, which are not frustrated, reacted as OmFLPs and were able to split H2 too. 
Otherwise, the study of analogous titanocenes compounds gave unexpected results.  
 
Scheme I-65: intramolecular phenate-based OmFLPs from Wass group 
 
Thus, L201-c is able to split H2 to form intermediately the phosphonium titanium hydride 
species L205. Ti-H bond are prone to rapid homolytic cleavage to form Ti (III) species along 
with H2. In the case of Wass, this reduction process was revealed by crystallization of L201-c-
III (Scheme I-66).172  
 
Scheme I-66: Reactivity of 201-c towards dihydrogen 
 
This work extended again the field of investigations to OmFLPs in which the “frustrated” 
character is not a requirement to observe FLP reactivity. The FLP reactivity of this series was 
mainly successful with L202-a for the activation of small molecules such as CO2, alkenes, 
alkynes or THF; C-X bond cleavage (X = Cl, F, O), or CO and CO2 reduction were also 
observed.173  
 Some of these complexes exhibited catalytic activity for the dehydrocoupling of 
dimethylamine borane. In a preliminary study, complex L201-a was more active than its Hf or 
Ti analogues L201-b-c respectively, whilst surprisingly, L202-a showed no activity (Scheme 
I-67). 
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Scheme I-67: catalytic dehydrocoupling of dimethylamine borane with various Zr-based OmFLPs 
 
To better understand this mechanism, Wass designed new zirconocenes with a less basic 
phosphine with L201-d which was completely inactive; or less bulky Cp-based complexes with 
the last series L206-L208. The best candidate of this work was L208, which contained a basic 
phosphanyl group with an indenide-based metallocene fragment with a TOF > 600 h-1.174  
 Wass also described (phosphinoalkoxy)zirconocenes175 but this series was not stable 
enough in its cationic form to be used as OmFLPs as described in the previous series. 
Nevertheless, an interesting reactivity was observed in which the Zr/P L209-b binds to a 
platinum complex to form L210 after methyl ligand migration to platinum (Scheme I-68). 
 
Scheme I-68: new Early-Late heterobimetallic complexes with OmFLPs precursors 
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To explore the limits of this unexpected reactivity, a chloro titanium-based precursor, 
L211 was reacted as L209-b to form the unusual Early-Late heterobimetallic complex L212.176 
A rare example of an Hf-based OmFLP was described in 2013 by Stephan (Scheme 
I-69).177 
 
Scheme I-69: an Hf-based OmFLP 
 
Compounds L213-a-b were able to bind two molecules of CO2 to form L215-a-b. In the case 
of PPh2 an intermediate was crystallized as a dimer (L214-a), which subsequently activated 
one more molecule of CO2 to form L215-a (Scheme I-69). 
Numerous examples of zirconocene-based OmFLPs were described by Erker. 
Between 2013 and 2016, intramolecular P/Zr+ OmFLPs, with different kinds of spacers, were 
described and are summarized in Scheme I-70. The zwitterionic species L216 and L217 were 
obtained by treating the already described organic FLPs L164 with the corresponding 
dimethylziroconocene.178 In the Cp2 parent, methide is completely abstracted from the Zr 
centre and a Zr-P adduct formed, whilst coordination of PMes2 is prevented with Cp* ligands. 
Instead, the cationic zirconocenium complex was stabilized by electrostatic interactions with 
the B-CH3 moiety. Nevertheless, both compounds were shown to act as OmFLPs. 
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Scheme I-70: P/Zr+ OmFLPs from Erker 
 
Via a controlled 1,1 or 1,2 carbometalation of alkynes with cationic hafnio- or 
zirconocene, vicinal or geminal P/Zr+ OmFLPs were synthesized in a very convenient fashion 
(compounds L218, L219 and 220 respectively).179a,b,180a,b Two other geminal OmFLPs were 
designed. L228 was obtained by methide abstraction from L227 whilst L226 was obtained by 
reacting phosphidozirconocene L224 with diphenylacetylene.181,182 Carbonyl insertion in the 
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Zr-P of L224 was a straightforward route to form OmFLPs too.183 These complexes were 
characterized as µ−alkoxy dimer, but were able to activate chalcone after dissociation. A 
similar dimer was also obtained after methide abstraction from L221-a forming L222.184 
Dimerization was prevented by increasing the bulk around oxygen as illustrated by L223. In all 
these examples, a relatively elongated Zr-P bond was observed (between 2.6670(7) and 
2.958(2)Å). It can be compared to the distance of a single covalent Zr-P bond (2.82 ± 0.10 Å) 
estimated empirically from the analysis of X-ray diffraction data.185 FLP reactivity was observed 
towards small molecules such as CO2, or substrate such as aldehydes or chalcone. Several 
example of FLP adducts with CO2 and chalcone are depicted in Scheme I-71. 
 
Scheme I-71: FLP adducts with CO2 and chalcone 
 
Whilst numerous examples of P/Zr+ OmFLPs have been described in the literature, N/Zr+ 
OmFLPs are much rarer. To the best of our knowledge, Erker reported the only example in 
2015.  This pair was able to activate dichloromethane, primary alkynes, and H2 (e.g. L231, 
L232-a-b or L233 respectively). Noteworthy, complex L230 was able to catalytically 
hydrogenate alkenes and alkynes in mild conditions (Scheme I-72).186 
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Scheme I-72: N/Zr+ OmFLP 
 
Interestingly, whereas in the last examples reported above, the zirconium centre was 
used in its cationic form and reacted as a Lewis acid, Erker has described a Zr(II)/B system 
(L234) in which the zirconium (II) was found to react as the Lewis base.187. In this example, 
compound L234 must be considered according to its limit form as a Zr(II) / alkyne complex 
(Scheme I-73).  
 
Scheme I-73: an unusual Zr(II)/B OmFLP 
 
 In this example, two different types of reactivity were observed depending on the substrate 
treated with L234. When the substrate was a single site donor, it was shown to act as a L-
ligand, and stabilized the metallacyclopropene form (L235 Scheme I-73 right). If the substrate 
was an alkyne, the Zr(II) / B pair was active and yielded the activated compound L236 (Scheme 
I-73 left). The activation of H2 was also observed and DFT calculation were conducted to 
determine that the more plausible mechanism implied an FLP reactivity.188 
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Interestingly only two examples of Ti-based OmFLP have been reported in the 
literature. The first one has already been described in Scheme I-66. The other one was 
reported by Erker and Le Gendre and consisted of a cationic titanocene fragment with a 
pendant phosphane. As Wass has already mentioned in 2012, titanium is more easily reduced 
than Zr and Hf due to lower-lying 3d orbitals.189 This was the key to the reactivity of L201-c 
where the H2 activation product was not stable due to Ti-H bond homolysis, which yielded a 
Ti(III) species. The reducibility of Ti was exploited in the synthesis of P/Ti+ FLPs as illustrated 
in Scheme I-74. Thus, various complexes of type L237 were converted to OmFLPs in a two-
step reduction/oxidation sequence. Although an interaction between P and Ti+ and no reactivity 
with classical gaseous substrates were observed in these complexes, FLP behaviour was 
demonstrated with benzaldehyde and forming L239. In this study, electronic and steric 
properties of both the phosphanyl group and the phenoxy ligand were investigated. Compound 
L238-PCy2 exhibited the best conditions of this series to activate a small molecule such as 
benzaldehyde (Scheme I-74).190  
 
 
Scheme I-74: Ti-based OmFLP reported by Erker and Le Gendre 
 
In light of these findings in FLP chemistry (organic or organometallic), many partners 
can be used to activate small molecules. Even if at first, frustration was a sine qua non 
condition to obtain reactivity, numerous examples have shown that some degree of interaction 
between the Lewis acid and Lewis base partners is not necessarily detrimental to reactivity. 
The bibliographic survey on group 4 OmFLPs showed that few examples of N-based or Ti-
based OmFLPs are described in the literature. This bring us to the first chapter of this thesis, 
and the synthesis of potential N/Ti+ or N/Zr+ OmFLPs.
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II. Chapter I: Synthesis of potential group 4 OmFLP precursors  
 
As previously described in the bibliographic introduction, group 4 transition metals have 
been used in the form of cationic metallocenes to act as Lewis acids in OmFLPs.1a,b,c,d In the 
present work, we propose to use an amine as the Lewis base partner. Two different strategies 
could have been followed: developing an intermolecular pair, or designing new intramolecular 
objects. The latter option has been chosen for this work. The general structures of the targeted 
complexes are composed of a cationic group 4 metallocene as Lewis acid, whilst the role of 
the Lewis base will be played by an amine grafted onto one of the cyclopentadienyl ring. These 
general structures are depicted in Scheme II-1. 
 
Scheme II-1: illustration of targeted complexes 
 
As shown before by Jutzi and others, two-carbon spacers or longer (e.g. in Scheme 
I-41) generally lead to coordination polymers or in some cases intramolecular coordination of 
the amine function to the metal centre (general structure of type C2 Scheme II-2).  
 
Scheme II-2: choice of the length of the spacer on the Cp ring 
 
Incorporating an amine directly connected to the Cp ring without any spacer (C0) would 
completely prevent any interaction between both Lewis partner. The only possibility for such 
compounds to form Lewis pairs would be in an intermolecular manner, yielding dimeric species 
in which the interaction might be too strong. For effective FLP reactivity, the amine ligand would 
have to show at least some degree of hemilability; hence the choice of a CH2 spacer, which 
should disfavour tight binding of the amine to titanium, whilst being flexible enough to activate 
a variety of substrates. This type of spacer (more generally one atom between the Cp ring and 
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the amide function) has already been employed for the design of constrained geometry 
complexes (CGc). The constraint is reflected by the bite angle of the 
(aminomethyl)cyclopentadienide ligand which is smaller than in comparable unbridged 
complexes.  
 
With the general structure C1 in mind, the retrosynthetic Scheme II-3 leads us to the 
synthesis of (aminomethyl)cyclopentadienides or bis(cyclopentadienidemethyl)amines of type 
E1 and F1 respectively. It required formally the use of fulvene L29-H with a primary or 
secondary amide (vide supra, I.B.1).  
 
Scheme II-3: retrosynthetic scheme envisaged initially for the synthesis of aminomethyl-group 4-
metallocenes 
 
However L29-H is known to be difficult to handle due to its propensity to easily dimerise. It has 
to be used freshly and kept away from oxygen and heat.2 The use of, e.g. 6,6-dimethylfulvene 
is proscribed, since the basic amides required for FLP reactivity would deprotonate the fulvene 
(vide supra, Scheme I-12) instead of adding to it. In addition, the use of the aminomethynylation 
route described by Kreutzberg (Scheme I-19), would be unfavoured. Indeed, in this case, the 
use of basic amines as nucleophiles is required. However, bulky amines as TMPH or 
diisopropylamine, required for this approach, are known to be poor nucleophiles.  
An alternative route to (aminomethyl)cyclopentadienides has been envisioned by using 
(aminomethyl)benzotriazoles as starting material (Scheme II-4), in order to circumvent the use 
of L29-H. The use of benzotriazole derivatives will be explained in the following section. 
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Scheme II-4: synthetic route developed for (aminomethyl)cyclopentadienides 
 
A. Synthesis of (aminomethyl)cyclopentadienides 
The chemistry of benzotriazole (Bt-H) was widely investigated by Katritzky,3 in the 1990s and 
has been a useful tool in organic chemistry. The Bt group was shown to behave differently 
depending on the nature of the Y-group in the α-position (Scheme II-5). 
  
Scheme II-5: Behaviour of the benzotriazole group and synthetic strategy 
 
If Y is electron rich, Bt will act as a good leaving group and form Bt-I in which the negative 
charge is well stabilized by the Bt system; whilst it will act as an electron donor if Y is a good 
nucleofuge and form Bt-II. In the case of (aminomethyl)benzotriazoles, Bt-I species was 
shown to prevail and to be in equilibrium with the iminium salt in solution (Bt-Iminium). 
Therefore, the Bt group may act as a leaving group in the reaction of 
(aminomethyl)benzotriazoles with the cyclopentadienide anion, as illustrated in Scheme II-5, 
forming (aminomethyl)cyclopentadienes.  
                                               
3
 Katritzky, A. R.; Lan, X.; Yang, J. Z.; Denisko, O. V. Chem. Rev. 1998, 98, 409 
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This work started with the synthesis of desired (aminomethyl)benzotriazoles according 
to Katritzky’s work.4a,b The benzotriazole derivatives Bt-1-3 were synthesized by refluxing 6h 
in a mixture of diethyl ether and methanol, and further recrystallized as white crystals. The 
synthesis of Bt-4-6 required harsher conditions, i.e. refluxing in toluene with a Dean-Stark 
apparatus. Both Bt-4 and Bt-5 were moisture sensitive and had to be stored under inert 
atmosphere as a light-yellow oil for the former and a white precipitate for the latter. These 
compounds were generally obtained in very good yields as described in the literature (Scheme 
II-6, 86-99%).  
 
Scheme II-6: synthesis of (aminomethyl)benzotriazoles. a: refluxing Et2O/Methanol 12h, b: Dean Stark 
apparatus, refluxing toluene 1h. 
 
The proof of concept for the synthesis of related (aminomethyl)cyclopentadienides had 
to be obtained. With this goal in mind, reaction conditions were optimized with Bt-1. An 
homogeneous reaction was first tried in THF by cannulating Bt-1 onto a solution of CpNa (1eq.) 
in THF at -25°C. The resulting solution became rapidly dim and yellowish. The reaction was 
followed by TLC (eluent 1:1 diethyl ether: pentane with several drops of methanol; stationary 
phase: silica) and GCMS. Whilst Bt-1 exhibited a low migration (retention factor ~ 0.2) the 
desired diene 1-H was observed almost in the solvent front. After 2 hours of stirring at room 
temperature, no more changes were observed by TLC and the residual Bt-1 was still observed. 
All attempts at purification by column chromatography failed, yielding decomposition of the 
diene. This was in fact most probably due to the sensitivity of the diene towards silica. In fact, 
Trost described the synthesis of L29-H by degradation of L35 on a silica column (Scheme 
II-7).5 
                                               
4
 (a): Katritzky, A. R.; Rachwal, S.; Rachwal, B. J. Chem. Soc. Perkin vol 1. 1987, 799, (b): Katritzky, A. R.; Yannakopoulou, K.; 
Lue, P.; Rasala, D.; Urogdi, L. J. Chem. Soc. Perkin vol 1. 1989, 225 
5
 Trost, B. M.; Cory, R. M. J. Org. Chem. 1972, 37, 1106 
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Scheme II-7: decomposition process of L-35 described by Trost 
  
With this information in hands, a heterogeneous synthesis was envisioned, in order to 
effect complete conversion of Bt-1 with an excess of CpNa. For this purpose, 1.2 eq of CpNa 
was used, and the resulting suspension in Et2O was refluxed for 12 hours. Analysis of the 
reaction mixture by TLC and GCMS revealed almost quantitative conversion of Bt-1 into 1-H. 
After filtration over a frit, and washing with Et2O (see supporting information for details), 1-H 
was isolated as a yellow oil, obtained after careful evaporation (25°C, mild vacuum). The 1H 
NMR spectrum (300 MHz, 300 K, dichloromethane-d2) of this oil showed a complex mixture of 
isomers. Monofunctionalized cyclopentadienes are known to exist as three isomers, as 
illustrated in Scheme II-8, due to [1,5] sigmatropic rearrangement of hydrogen.6 The first form 
CpR-k is the kinetic form, known to rapidly be converted into the two thermodynamic forms 
CpR-t1 and CpRt2. 
 
Scheme II-8: [1,5] sigmatropic rearrangement on a monosubstituted cyclopentadiene 
 
The purity of the diene was checked by TLC and it was used freshly for deprotonation. 
Initial attempts at deprotonation with n-BuLi (THF, 0°C) yielded 1-Li, however this compound 
was difficult to purify because of its oily nature. In order to circumvent this problem, the 
synthesis of 1-K by deprotonation with potassium hexamethyldisilazane (KHMDS) was 
envisaged. After treatment of an etheral solution of 1-H with KHMDS 1M in toluene at 0°C, 
followed by 2h of stirring at room temperature, a light brown precipitate formed. After filtration, 
washing and drying in vacuo, the desired product 1-K was obtained as a beige powder. This 
procedure was successfully applied to Bt-3, whilst Bt-6 was not converted and mainly yielded 
decomposition or starting material. The lone pair of the nitrogen atom, which is required for the 
iminium equilibrium depicted in Scheme II-5, may be partially delocalized into the phenyl rings, 
which could disfavour the reaction. Noteworthy, Bt-2-4-5 did not require the refluxing period 
and were completely converted within 4h of stirring at room temperature, yielding 1-5-K in 
moderate to good yield in a two-step synthesis (39-79% overall yield - Scheme II-9).  
                                               
6
 McLean, S.; Haynes, P. Tetrahedron. 1965, 21, 2329 
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Scheme II-9: synthesis of potassium (aminomethyl)cyclopentadienides salts. Conditions of the 
nucleophilic substitution: a: refluxing Et2O for 12h, b: room temperature for 4h. 
 
These compounds were characterized by NMR spectroscopy (1H, 13C and 2D correlations) and 
negative mode ESI HRMS. The 1H NMR spectra (600 MHz, 300 K, tetrahydrofuran-d8 or 
DMSO
-
d6) of compounds 1-5-K showed a similar set of signals for the Cp ring and the bridging 
CH2 protons, which resonate as two apparent triplets and one singlet in the 5.2-5.4 ppm and 
3.3-3.5 ppm ranges, respectively. The 1H NMR spectrum of 5-K is depicted in Spectrum II-1. 
In this spectrum, the two apparent triplets for the Cp protons appear at 5.46 and 5.38 ppm, 
whilst the bridging CH2 resonates at 3.55 ppm.  
Spectrum II-1: 1NMR spectrum of 5-K (600.23 MHz, 300 K, tetrahydrofuran-d8) 
 
N
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K
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All signals for the tetramethylpiperidine moiety are located in the 1.60 ppm - 1.12 ppm range 
as two multiplets for the CH2 groups and one singlet for the four equivalents methyl groups. All 
attempt at crystallizing these ligands failed. This was most probably due to the potassium 
cation, which imparts a very low solubility in apolar solvents and a high propensity to precipitate 
as amorphous powders. 
The successful synthesis of a new series of (aminomethyl)cyclopentadienide salts 
prompted us to try to synthesize bis(cyclopentadienidemethyl)amines via an analogous route. 
B. Attempted synthesis of bis (cyclopentadienylmethyl)amines 
The first step of this route required the successful synthesis of the corresponding 
bis(benzotriazole) derivatives. In light of Katritzky’s work,3 two benzotriazole precursors (Bt-7-
8) were synthesized for this topic, as illustrated in Scheme II-10. 
 
Scheme II-10: synthesis of bis(benzotriazolylmethyl)amines 
 
The substitution of the two benzotriazoles Bt-7 and Bt-8 by sodium cyclopentadienide was 
attempted. Initial trials were conducted under the same conditions as those used for the 
previous series (see Scheme II-9). Unfortunately, heterogeneous conditions did not convert 
the substrate into the desired molecule, only starting material was recovered after workup. The 
second strategy was to work under homogenous conditions by using THF, with a slight excess 
of CpNa. Whilst the reaction still did not work with Bt-7 (even with a refluxing period of 12h), 
the desired compound was formed according to GCMS with 5h of stirring at room temperature 
for Bt-8. GCMS analysis was not very convenient for monitoring the reaction since substrates 
(i.e. benzotriazole derivatives) do not appear. Analysis of the reaction mixture by TLC (eluent 
1:1 diethyl ether: pentane with several drops of methanol; mobile phase: silica) indicated the 
presence of residual starting material. Only traces of putative diene 8-H2 were obtained, along 
with starting material, after workup. As illustrated in Scheme II-8, a monosubstituted Cp ring 
can be found in three forms (CpR-k, Cp-t1 and Cp-t2), which means 32 = 9 forms for 8-H2. 
Therefore, 1H NMR spectroscopy is not the best analytical technique for purity determination 
in this case. In fact, cyclopentadienes are known to be temperature sensitive, and they easily 
dimerize via a [2+2] Diels-Alder process (for example, cyclopentadiene is commercially 
available under its dimeric stabilized form). If 8-H2 is prone to easily be dimerized, refluxing 
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period has to be avoided. As a last resort, the use of a four-fold excess of CpNa with Bt-8 (both 
as a nucleophile and a base) was attempted, to no avail.  
 
Scheme II-11: synthetic attempt at synthesis of bis(cyclopentadienylmethyl)amines 
.  
Despite our efforts to synthesize bis(cyclopentadienylmethyl)amines, no ligand of this 
type was obtained using our “benzotriazole” route, the corresponding synthesis of 
metallocenes of type D1 (Scheme II-1) was abandoned. 
C. Coordination chemistry to group 4 metals 
With the (aminomethyl)cyclopentadienides 1-5-K in hands, studying the coordination 
chemistry of these new ligands to group 4 metals was the next logical step. 
1. Titanium chemistry 
Although THF is the usual solvent for this reaction, in our case, its use generally yielded 
a mixture of three compounds, as illustrated in Scheme II-12. It was evident that ligand 
scrambling was occurring, resulting in a statistical mixture of titanocene derivatives
.
 
 
Scheme II-12: ligand scrambling during the synthesis of CpCpNTiCl2 derivatives 
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A mixture of toluene/THF was found to be the best choice to synthesize complexes 9-
13 in moderate yield without ligand scrambling (54-80% - Scheme II-13). These complexes 
were characterized by NMR (1H 13C, 15N, and 2D correlations) and IR spectroscopies, positive 
mode ESI HRMS and elemental analysis. The 1H NMR spectra of complexes 9-13 show 
downfield signals for the CpN and bridging CH2 protons compared to ligands 1-5-K (∆δ = 0.2-
1.25 ppm) (cf Table II-1). The unsubstituted Cp ring is in the 6.57-6.00 ppm range. 
 
 
 
Scheme II-13: synthesis of CpNCpTiCl2 complexes. a: only toluene was used for this procedure 
 
 
  
d (ppm) 
 
b (ppm) 
 
a (ppm) 
 
Cp (ppm) 
1-Ka 3.30 5.47 5.45 x 
9b 3.74 6.26 5.68 5.98 
2-Kc 3.34 5.27 5.22 x 
10d 3.67 6.52 6.46 6.57 
3-Kc 3.40 5.42 5.32 x 
11d 3.60 6.52 6.43 6.38 
4-Kc 3.41 5.28 5.22 x 
12d 3.71 6.52 6.44 6.54 
5-Ka 3.55 5.46 5.38 x 
13d 4.02 6.26-6.20 5.73-5.67 6.01 
Table II-1: relevant 1H NMR signals (600 MHz, 300 K): NMR spectra recorded in a THF-d8, b C6D6, c DMSO-d6, 
d
 CD2Cl2  
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The 13C{1H} NMR spectra of these compounds showed that the chemical shift of the 
bridging CH2 (d) was almost unaffected by the coordination to titanium, whilst the signals for 
the functionalized Cp (c,b,a) were shifted downfield (∆δ = 10-23.4 ppm) with respect to the 
anionic ligands 1-5-K (cf Table II-2). The chemical shift for the unsubstituted Cp ring remained 
around 120.0 ppm. 
  
d (ppm) 
 
c (ppm) 
 
b (ppm) 
 
a (ppm) 
 
Cp (ppm) 
1-Ka 59.8 117.6 106.5 104.9 x 
9b 57.7 133.2 124.6 115.1 119.7 
2-Kc 57.2 115.4 104.5 102.3 x 
10d 55.8 133.9 124.7 116.8 120.6 
3-Kc 55.1 114.0 105.6 103.3 x 
11d 53.6 133.5 124.5 117.6 120.5 
4-Kc 44.6 116.8 104.0 102.2 x 
12d 45.6 140.4 124.1 117.2 120.3 
5-Ka 45.0 123.5 105.6 104.1 x 
13d 45.6 146.2 121.9 115.6 119.1 
Table II-2: Relevant 13C{1H} NMR signals (600 MHz, 300 K): NMR spectra recorded on 600 MHz, 300 K, in a 
THF-d8, b C6D6, c DMSO-d6, d CD2Cl2 
 
The 15N NMR spectra of 6-10 display a single resonance between δ = -339 and δ = -
309 ppm in a range comparable to that observed for other amino-functionalized group 4 
organometallic complexes, consistent with the non-coordinating state of the amino group.7 
Suitable crystals for X-ray diffraction analysis were obtained by slow diffusion of 
pentane into saturated CH2Cl2 solutions of 11 and 13. For 13 two independent molecules were 
found in the asymmetric unit, only one is depicted for clarity in Figure II-1 (see experimental 
part, numbering up to C21 belongs to the second omitted molecule). The CpCpNTiCl2 
fragments adopt a typically pseudo tetrahedral geometry in both structures with similar 
structural parameters. These two titanocene moieties show a difference in the position of the 
substituent held by the cyclopentadienyl ring. In order to illustrate this characteristic, torsions 
angles have been calculated as illustrated in Scheme II-14. Clm is the centroid of Cl1/Cl2.  
 
Scheme II-14: top view of a dicloro(aminomethyl)titanocene and illustration of the torsion angle defined in 
this series 
                                               
7
 Kotov, V. V.; Fröhlich, R.; Kehr, G.; Erker, G. J. Organomet. Chem. 2003, 676, 1 
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According to this illustration, the value of the torsion angle φ indicates the relative position of 
the amino arm compared to the bisecting plane of the dichlorotitanocene moiety comprising 
Ct1, Ti and Clm. If φ is far from 0 or 180°, the amino group is not located in this bisecting plane 
otherwise it is. In 11, the latter situation is observed: the CH2 bridge is located to the open side 
of the bent metallocene and lies above the TiCl2 fragment (φ = C11-Ct1-Ti-Clm = -5.35(7)°), 
the lone pair of nitrogen is oriented to the opposite side of titanium (torsion angle C5-C1-C11-
N = 88.14(26)°). 
 
 
In contrast for compound 13, the bulky (tetramethylpiperidino)methyl substituent is 
rotated from the bisecting position leading to torsion angles (φ) C11-Ct1-Ti-Clm equal to -
81.25(12)° and -71.04(13)° for both independent molecules. The position of the nitrogen is 
particularly noteworthy with regard to complex 11 and the other complexes described in this 
manuscript. Indeed this atom is in the same plane as the Cp ring in 13 (torsion angles C2-C1-
C11-N1 = -22.85(67)° and C23-C22-C32-N2 = -31.86(64)°), whereas the C11-N bond is more 
or less orthogonal to the Cp ring in 11 (as a reminder torsion angle C5-C1-C11-N = 88.14(26)°). 
These parameters will be used for comparison in all other tetramethylpiperidine-based 
structures. 
Figure II-1: ORTEP view of complex 11 (left) and 13 (right) (ellipsoids drawn at the 30% probability level, 
hydrogen atoms removed for clarity). Selected bond lengths (Å) and angles(°) Ct1 and Ct2 are centroids of 
both Cp rings as illustrated above. 11: Ct1-Ti = 2.0606(11), Ct2-Ti = 2.0598(12), Cl1-Ti = 2.3615(6), Cl2-Ti = 
2.3768(6), C1-C11 = 1.494(3), C11-N = 1.481(3), Cl1-Ti-Cl2 = 93.89(2), Ct1-Ti-Ct2 = 131.12(5), C1-C11-N = 
112.06(17). 13: Ct1-Ti = 2.074(2) / 2.069(2), Ct2-Ti = 2.061(2) / 2.064(2), Cl1-Ti = 2.3613(14) / 2.3539(14), Cl2-Ti 
= 2.3790(13) / 2.3718(13), C1-C11 = 1.509(6) / 1.508(6), C11-N = 1.468(5) / 1.470(5), Cl1-Ti-Cl2 = 94.05(5) / 
94.26(5), Ct1-Ti-Ct2 = 131.39(9) / 131.73 (10), C1-C11-N = 113.9(4) / 112.3(4). 
 
Ti 
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It has been shown previously that the instability of amino titanocenes towards moisture 
could be attenuated by protonating the amine function.8 This was particularly observed for 12 
and 13. The protonation of complexes 9-13 in hydrochloric acid-saturated solutions of toluene 
was conducted and yielded the corresponding ammonium salts 14-18 in 52-73% yield 
(Scheme II-15).  
 
Scheme II-15: synthesis of titanocenyl ammonium chloride salts 
 
These ammonium salts turned out to be air and moisture-stable, and even water-
soluble. They were characterized by NMR (1H 13C, 15N, and 2D correlations) and IR 
spectroscopies, positive mode ESI HRMS and elemental analysis. The protonation of the 
amine function affected deeply the shape of the 1H NMR spectra of these complexes. Indeed, 
the nitrogen atom becomes prochiral (or chiral for 14) and, as a result, changes  the stereotopic 
relationships between atoms and/or groups. The 1H NMR spectrum of 14 was shown to 
illustrate this diastereotopy (Spectrum II-2). The acidic proton responsible for the chirality is at 
12.83 ppm. The aromatic CH signals appear in the 7.62 – 7.43 ppm range as two multiplets, 
whilst a set of four apparent quartets is observed for the signals of the protons from the CpN 
ring (7.07, 6.97, 6.60, 6.57, ppm). The signal of the unsubstituted Cp resonates as a singlet at 
6.69 ppm, whilst diastereotopy is observed for the methylenic protons signals, which appear 
as four doublet of doublets at 4.39, 4.36, 4.13, 4.04 ppm (see appendix for details).  
                                               
8
 Jutzi, P.; Redeker, T.; Neumann, B.; Stammler, H.-G. Organometallics. 1996, 15, 4153 
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Spectrum II-2: 1H NMR of 14 (600 MHz, 300K, CDCl3) 
 
Splitting of the signals is also observed for the methylenic protons of the pyrrolidine ring 
in 15, for the methylenic protons of the benzyl groups in 16, for the methylic protons of the 
isopropyl groups in 17 and for both methylic and methylenic protons of the 
tetramethylpiperidine in 18 (due in these cases to the prochirality of the nitrogen). X-ray 
diffraction analysis of monocrystals of 15, 17 and 18 allowed the determination of their solid-
state structures. The pyrrolidinium methyl and diisopropylammonium methyl substituents, 
depicted in Figure II-3 (15 and 17 respectively), adopt the same bisecting position as the 
neutral dibenzylamine group in 11 (φ = C11-Ct1-Ti-Clm = 0.90(22)° and C11-Ct1-Ti-Clm = 
8.55(3)° respectively). The protonation does not change significantly the steric hindrance of 
the pendant group attached to the Cp ring. Both structures are comparable with respect to the 
position of the ammonium groups away, from the titanium atom (C7-C6-C11-N = 85.11(57)° 
for 15, C5-C1-C11-N = 123.46(12)° for 17). 
Hh +Hi+Hg                  Hb Hb’ Ha Ha’ 
Hk 
Hf Hd                      Hd’         Hf’         He 
water 
NH 
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Figure II-2: ORTEP view of 15 (left) and 17 (right) (ellipsoids drawn at the 30% probability level, hydrogen 
atoms removed for clarity except NH as well as counter anion and solvent). Selected bond lengths (Å) and 
angles(°): 15: Ct1-Ti = 2.0606(11), Ct2-Ti = 2.0598(12), Cl1-Ti = 2.3477(17), Cl2-Ti = 2.3645(16), C1-C11 = 
1.485(8), C11-N = 1.494(7), Cl1-Ti-Cl2 = 92.43(6), Ct1-Ti-Ct2 = 131.94(17), C1-C11-N = 111.2(5). 17: Ct1-Ti = 
2.0617(6), Ct2-Ti = 2.0549(6), Cl1-Ti = 2.3660(4), Cl2-Ti = 2.3637(4), C1-C11 = 1.4988(15), C11-N = 1.5164(14), 
Cl1-Ti-Cl2 = 92.920(13), Ct1-Ti-Ct2 = 130.97(3), C1-C11-N = 113.72(9). 
 
 
 
In the IR spectra, a characteristic middle intensity band was observed in the range of 
2352-2588 cm-1 for -N-H compared to spectra from 9-13. This is illustrated by the IR spectra 
superposition of 9 and 14 (Spectrum II-3). 
 
Spectrum II-3: superposition of the IR spectra of 9 and 14 
 
Chapter I 
 
68 
 
To evaluate the coordination potential of our new ligands, other titanium complexes 
were synthesized. An electron-enriched titanocene was synthesized by reacting Cp*TiCl3 with 
4-K, forming 19 in 46% yield. This synthesis was realised by Cédric Balan (Scheme II-16). 
 
Scheme II-16: Synthesis of Cp*CpNTiCl2 19 
 
As its Cp analogue, this compound was characterized by NMR and IR spectroscopies, 
positive mode ESI HRMS, elemental and X-ray diffraction anaylses. The 1H NMR spectrum of 
this compound exhibits a set of two apparent triplets (6.19 and 5.99 ppm) for the signals of the 
monosubstituted Cp ring, and a singlet for the signal of the methyl groups of the Cp* ring at 
2.01 ppm. Whilst a singlet at 3.69 ppm is observed for the signal of the bridging CH2, a set of 
two signals appearing as an heptet and a doublet (2.97 and 1.00 ppm respectively) is observed 
for the two equivalent isopropyl groups (Spectrum II-4). 
 
 
Spectrum II-4: 1H NMR of 19 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Ha                        Hb He Hf 
Hd 
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This compound was shown to undergo ligand scrambling in solution as illustrated in 
Scheme II-12. Nevertheless, it was easily purified by layering a dichloromethane solution with 
pentane at -15°C, eventually forming block-shaped crystals (Figure II-3).  
 
Figure II-3: ORTEP view of 19 (ellipsoids drawn at the 50% probability level, hydrogen atoms removed for 
clarity as well as the second molecule in the cell). Selected bond lengths (Å) and angles(°): Ti-Ct1 = 2.0743 
/ 2.0936, Ti-Ct2 = 2.0932(10) / 2.0690(11), Ti-Cl1 = 2.3527(6) / 2.361(6), Ti-Cl2 2.3602(6) / 2.3705(6), C1-C16 = 
1.503(3) / 1.509(3), C16-N = 1.468(13) / 1.463(3), Ct1-Ti-Ct2 = 132.66(4) / 131.78(4), Cl1-Ti-Cl2 = 94.14(12) / 
93.61(02), C1-C16-N = 109.94(16) / 111.97(16). 
 
The structure is analogous to the one from 11 with respect to the calculated torsion 
angles (φ = C16-Ct1-Ti-Clm = -1.51(6)° / 1.94(6)° and C5-C1-C16-N = 56.26(3)° / 53.67(3)°) 
These parameters indicate that the amino substituent is almost in the bisecting plane of the 
metallocene. 
Attempts at synthesizing bis(aminomethyl)titanocenes were also made, but was 
tedious and hardly reproducible. One of them was randomly obtained once and characterized 
with the 80 mg isolated (15 % yield). 3-K was reacted in Et2O with half an equivalent of 
TiCl4(THF)2 at 0°C. The mixture was briefly brought to room temperature before workup. The 
resulting brown oil was further purified by recrystallization from a dichloromethane solution 
layered with pentane. This workup eventually yielded 20 as orange prism-shaped crystals 
(Scheme II-17).  
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Scheme II-17:synthesis of 20 
 
This compound was characterized as usual but elemental analysis and IR spectroscopy were 
not obtained due to a lack of compound. 
The 1H NMR spectrum of 20 shows one doublet at 7.36 ppm and two triplets at 7.32 
and 7.24 ppm for the signals of the aromatic protons, two apparent triplets for the signal of the 
protons of the monofunctionalized Cp ring at 6.35 and 6.25 
ppm and two overlapping singlets at 3.53 ppm corresponding 
to the signal of the twelve methylenic protons which fortuitously 
resonate at the same chemical shift (see appendix for details). 
The 15N NMR spectrum of 20 displays a single resonance at 
almost the same chemical shift as the one observed for 11 (-
328 ppm vs -327 ppm). 
The X-ray structure of 20 is presented in Figure II-4 and 
shows a C2 symmetric conformation in the solid state (half a 
molecule was present in the asymmetric unit). The two amino 
methyl groups are located close to the bisecting plane of the 
bent metallocene (φ = C6-Ct1-Ti-Clm = 0.93(4)°) and oriented 
away from each other in an antiperiplanar conformation (C2-
C1-C6-N = 80.04(17)°). 
  
Figure II-4: ORTEP view of 20 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed 
for clarity). Selected bond lengths (Å) and angles(°): Ti-Cl = 2.3586(4), Ti-Ct = 2.3586(4), C1-C6 = 
1.5006(18), C6-N = 1.4793(17), Cl-Ti-Cl = 94.38(2), Ct-Ti-Ct = 133.01(3), N-C6-C1 = 112.00(11). 
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A piano stool series was also envisioned. All attempt at forming such complexes failed 
except for the synthesis starting from 5-K (Scheme II-18). 
 
Scheme II-18: Synthesis of 21 
 
Silylation of this compound was smoothly performed in THF with distilled Me3SiCl. 5-
SiMe3 was directly treated after purification with TiCl4 in toluene at -30°C. The resulting brown 
solution yielded 21 as a dark brown powder. An amber solution in pentane was left to crystallize 
at -15°C, forming brown plates. This compound was fully characterized by standard techniques 
(NMR and IR spectrosocpies, HRMS, elemental and X-ray diffraction analyses). The 1H NMR 
spectrum has roughly the same aspect as the one from 5-K depicted in Spectrum II-2. The Cp 
signals are shifted downfield to 6.40 and 6.15 ppm (Spectrum II-5).  
 
Spectrum II-5: 1H NMR of 21 (600.23 MHz, 300K, benzene-d6) 
 
The signal of the bridging CH2 appears as a singlet at 3.75 ppm. The signals of the 
tetramethylpiperidine ring are in the 1.39-1.25 ppm range and 0.82 ppm for the methylene and 
methyl groups, respectively. The electronic equivalence of the methylic signals from the 
tetramethylpiperidine moiety argues against the presence of the Ti-N interaction in solution. 
Hh                                   Hg            
Hf 
Hd 
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Indeed, quaternisation of the N atom could block the conformation of the piperidine ring, which 
would translate in the 1H NMR spectrum as a non-equivalence of the methyl groups as 
observed in 18. The 15N NMR signal of 21 resonates at -308 ppm (very close to the value of 
13: -309 ppm).The X-ray diffraction structure of 21 (Figure II-5) shows a typical pseudo 
tetrahedral geometry for the titanium centre (piano stool-like structure), and corroborated the 
absence of Ti-N interaction previously deduced from 1H NMR spectroscopy in solution. 
 
Figure II-5: ORTEP view of 21 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed for 
clarity). Selected bond lengths (Å) and angles(°): Ct-Ti = 2.0162(10), Cl1-Ti = 2.2360(6), Cl2-Ti = 2.2308(6), 
Cl3-Ti =2.2425(6) , C1-C6 = 1.519(3), C6-N = 1.461(2), Ct-Ti-Cl1 = 116.78(3), Ct-Ti-Cl2 = 115.36(3), Ct-Ti-Cl3 = 
113.27(3), Cl1-Ti-Cl2 = 100.32(3), Cl1-Ti-Cl3 = 102.32(3), Cl2-Ti-Cl3 = 106.94(3)  
 
The relevant torsion angles of 21 (Ti-Ct-C6- = 107.03(11)° and C5-C1-C6-N = 15.12(3)°) 
indicate that the tetramethylpiperidine moiety remains slightly tilted from the Cp ring as in the 
structure of 13.  
Several (aminomethyl)titanocenes and related compounds were synthesized and 
characterized. Before exploring their potential as OmFLPs, the synthesis of zirconium 
analogues was envisioned in collaboration with Pr. Nadine Pirio (ICMUB, Dijon). 
2. Zirconium chemistry 
The synthesis of bis(aminomethyl)zirconocene derivatives was first attempted. By 
using half an equivalent of [ZrCl4(THF)2], with one equivalent of 3-4-K in THF, two new 
zirconocenes 22 and 23 were obtained (Scheme II-19), whilst the last with 5-K failed.  
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Scheme II-19: synthesis of bis(aminomethyl)zirconocenes 
 
Even if the corresponding bis(aminomethyl)zirconocene was formed according to 1H NMR, it 
could not be purified satisfactorily. All attempt at purification failed. Based on the observed 
behaviour with titanium compounds, one can assume that this complex is highly moisture 
sensitive and repeated workup only increased the extent of hydrolysis. Complexes 22 and 23 
were characterized by NMR (1H 13C 15N and 2D correlations) and IR spectroscopies and 
positive mode ESI HRMS. The elemental analyses were not satisfactory most probably due to 
the presence of remaining ZrCl4 or residual inorganic salts. The 1H NMR spectrum of 23 is 
presented on Spectrum II-6.  
 
Spectrum II-6: 1H NMR of 23 (600.23 MHz, 300 K, dichloromethane-d2) 
Ha                Hb                                                He Hf 
Hd 
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The signals of the protons from the Cp ring appears as two multiplets at 6.35 and 6.33 ppm, 
whilst the bridging CH2 shows a singlet at 3.66 ppm. The four equivalent isopropyl groups 
exhibit a set of two signals at 2.97 and 1.01 ppm as an heptet and a doublet respectively.The 
solid-state structure of compound 22 was obtained by X-ray diffraction. 
It adopts the same C2 symmetric conformation as 11 (Figure 
II-1) with similar parameters (C6-Ct1-Zr-Clm = -9.91(5)°), C5-
-C1C6-N = -68.89(22)°).  
The synthesis of the monosubstituted zirconocene 24 was 
also attempted with 5-K and succeeded in one instance, but 
then after yielded a 90:10 mixture of the desired compound 
with the corresponding bis(aminomethyl)zirconocene 
(Scheme II-20). The commercial CpZrCl3 most probably 
contained residual ZrCl4, which was not completely removed 
even after sublimation. The best batch obtained at first was fully characterized by standard 
techniques, but never reproduced. 
 
Scheme II-20: Synthesis of 24 
 
The 13C{1H} NMR chemical shifts of 13 are recalled in the following Table II-3. The nature of 
the metal in the metallocene does not change fundamentally the observed 13C{1H} NMR 
chemical shifts: ∆δ = 4.3-1.7 ppm for the signal of the carbons from the Cp rings and ∆δ = 0.3-
0.8 ppm for the signals of the bridging CH2 and the tetramethylpiperidine moiety. Suitable 
crystals for X-ray diffraction analysis were obtained by diffusion of pentane into a 
dichloromethane solution as colourless shaped needle at -15°C (Figure II-7). 
  
Figure II-6: ORTEP view of 20 (ellipsoids drawn at the 30% 
probability level, hydrogen atoms removed for clarity). Selected 
bond lengths (Å) and angles(°): Zr-Cl = 2.4468(4), Zr-Ct = 2.2057(8), 
C1-C6 = 1.504 (2), C6-N = 1.475 (2), Cl-Zr-Cl = 94.42(2), Ct-Zr-Ct = 
133.08(3), N-C6-C1 = 109.68(15). 
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M = Ti (13)a 
(δ in ppm) 
 
 
M = Zr (24)b 
(δ in ppm) 
c  142.6 146.2 
b 117.6 121.9 
I  116.6 119.1 
a 113.9 115.6 
e 56.2 55.6 
d 45.9 45.6 
g 42.7 41.9 
h 28.9-28.2 28.6-27.9 
f 18.9 18.2 
Table II-3: 13C{1H} NMR (600 MHz, 300 K) chemical shifts of 13 and 24, NMR recorded in a: CD2Cl2, b:THF-d8 
 
 
A structural comparison of both structures of 24 and 13, showed only one difference 
between the lengths of M-X bonds. These latter are longer for zirconium than titanium (∆length 
= 0.15-0.08 Å) due to the difference in their respective covalent radii (Ti = 1.60 ± 0.08 Å, Zr = 
1.75 ± 0.07 Å).9 
 
Figure II-7: ORTEP View of 24 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed for 
clarity). Selected bond lengths (Å) and angles(°): Zr-Cl1 = 24498(7), Zr-Cl2 = 2.4549(7), Zr-Ct1 = 2.2123(12), 
Zr-Ct2 = 2.2100(13), C1-C11 = 1.519(4), C11-N = 1.465(4), Cl1-Zr-Cl2 = 96.15(3), Ct1-Zr-Ct2 = 130.76(5), C1-
C11-N = 113.1(2). 
 
                                               
9
 Cordero, B.; Gómez, V.; Platero-Prats, A. E.; Revés, M.; Echeverría, J.; Cremades, E.; Barragán, F.; Alvarez, S. Dalton Trans. 
2008, 2832 
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All synthesized zirconocenes were too impure to be used as OmFLPs precursors. 
Therefore none of them will appear in the following chapter II. 
In conclusion to this chapter, a new series of (aminomethyl)cyclopentadienides and a 
new series of N-functionalized titanocenes was achieved in good yield and purity. 
(Aminomethyl)cyclopentadienides were coordinated to zirconium but the purity of the resulting 
complexes could not be improved. 
With these complexes in hand, a cationic titanocene has to be generated to finally 
obtain the targeted complexes of type C1 (Scheme II-2). This will be the topic of the following 
chapter II. 
D. Experimental part: 
3. Synthesis of 1-K: 
 
To a suspension of CpNa (2.6 g, 0.024 mol, 1.2 eq) in 50 mL of Et2O, was added dropwise by 
cannulation at -15°C, an etheral solution of N-benzotriazolylmethyl-N-methyl-1-
phenylmethanamine (5 g, 0.02 mol, 1 eq). The resulting solution was left to warm up to room 
temperature and then refluxed overnight. Reaction progress was monitored by TLC (1: 1 Et2O: 
pentane + several drops of methanol as eluent; mobile phase: silica). The white precipitate 
formed during the reaction was filtered off and extracted with 15 mL of Et2O. The yellow filtrate 
was washed twice with 30 mL of deionized water. The combined organic phases were washed 
with a solution of saturated brine (30 mL) and dried over MgSO4. After filtration and careful 
evaporation of the solvent, the yellow oil was dissolved in pentane (40 mL) and left 10 min 
during which time the residual starting material precipitated. After filtration and careful (25°C, 
middle depression) evaporation the corresponding diene was obtained as yellow oil (3.0 g, 
yield: 74 %). This unstable compound was directly used after dissolving in 50 mL of Et2O. The 
resulting solution was cooled down to 0°C, and a freshly-prepared solution in toluene of 
KHMDS (2.7 g, 0.014 mol, 0.9 eq, 20 mL) was added dropwise. The cold bath was left to warm 
to room temperature over 5 h. The light brown precipitate formed during this time was filtered 
off, washed with 10 mL of cold Et2O, 2 x 15 mL of pentane and resulted in a beige powder after 
drying (1.83 g, yield: 52 % overall yield: 39 %).10 
                                               
10
 Elemental analysis was not obtained good enough due to residual presence of solvent, and their unpredictable distribution in 
the solid.  
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1H NMR (600.23 MHz, 300 K, tetrahydrofuran-d8): δ1H: 7.31 (d, 3JHH = 7.4 Hz, 2H, Hh), 7.23 (t, 
3JHH = 7.4 Hz, 2H, Hi), 7.13 (t, 3JHH = 7.4 Hz, 1H, Hj) 5.47 (m, 2H, Hb), 5.45 (2H, Ha), 3.46 (s, 
2H, Hf), 3.30 (s, 2H, Hd), 2.09 (s, 3H, He).
 
13C{1H} NMR (150.94 MHz, 300 K, tetrahydrofuran-d8): δ13C: 142.2 (Cg), 129.8 (Ch), 128.8 (Ci), 
127.1 (Cj), 117.6 (Cc), 106.5 (Cb), 104.9 (Ca), 63.5 (Cf), 59.8 (Cd), 43.0 (Ce). 
1H 1H COSY (600.23 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ1H: 7.31 / 7.23 (CHh / CHi), 7.23 
/ 7.31, 7.13 (CHi / CHh, CHj), 7.13 / 7.23 (CHj / CHi) 5.47 / 5.45 (CHb / CHa), 5.45 / 5.47 (CHa / 
CHb). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ13C: 7.31 / 129.8 
(CHh), 7.23 / 128.8 (CHi), 7.13 / 127.1 (CHj) 5.47 / 106.5 (CHb), 5.45 / 104.9 (CHa), 3.46 / 63.5 
(CH2f), 3.30 / 59.8 (CH2d), 2.09 / 43.0 (CH3e).  
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ13C: 7.31 / 129.8, 
127.1, 63.5 (CHh / CHh, CHj, CH2f ), 7.23 / 142.2, 128.8 (CHi / Cg, CHi), 7.13 / 129.8 (CHj / CHh), 
5.46 / 117.6, 104.9, 59.8 (CHb / Cc, CHa, CH2d), 5.45 / 117.6, 106.5, (CHa / Cc, CHb), 3.46 / 
142.2, 129.8, 59.8, 43.1 (CH2f / Cg, CHh, CH2d, CH3e), 3.30 / 117.6, 106.5, 63.5, 43.0 (CH2d / 
Cc, CHb, CH2f, CH3e), 2.09 / 63.5, 59.8 (CH3e / CH2f, CH2d). 
HMRS (ESI negative mode, dimethylsulfoxide): calcd. for C14H16N [M-K]- 198.12869; found 
198.12773 (Rel ab: 100%, -0.7 ppm) 
4. Synthesis of 2-K: 
 
To a suspension of CpNa (0.06 mol, 1.2 eq) in 30 mL of Et2O, was added dropwise by 
cannulation at -15°C an etheral solution of N-benzotriazolylmethyl-pyrrolidine (10.0 g, 0.05 
mol, 1 eq). The resulting solution was stirred for 1 h at - 30°C and then brought to completion 
by an additional stirring of 3 h at room temperature. The resulting solution was left to warm up 
to room temperature and then refluxed overnight. Reaction progress was monitored by TLC 
(1: 1 Et2O: pentane + several drops of methanol as eluent; mobile phase: silica). The white 
precipitate formed during the reaction was filtered off and extracted with 3x40mL mL of Et2O. 
The yellow filtrate was washed twice with 50 mL of deionized water. The combined organic 
phases were washed with a solution of saturated brine (40 mL) and dried over MgSO4. After 
filtration and careful evaporation (25°C, middle depression) of the solvent, the yellow oil was 
dissolved in pentane (40 mL) and left 10 min during which time the residual starting material 
precipitated. After filtration and careful evaporation the corresponding diene was obtained as 
yellow oil (5.8 g, yield: 78 %). This unstable compound was directly used after dissolving in 50 
mL of Et2O. The resulting solution was cooled down to 0°C, and a freshly-prepared solution in 
Chapter I 
 
78 
 
toluene of KHMDS (7.6 g, 0.038 mol, 0.98 eq, 80 mL) was added dropwise. The cold bath was 
left to warm to room temperature overnight. The light brown precipitate formed during this time 
was filtered off, washed with 2 x 20 mL of cold Et2O, 2 x 30 mL of pentane and resulted in a 
beige powder after drying (4.58 g, yield: 96 % overall yield: 74 %).10  
1H NMR (600.23 MHz, 300 K, dimethylsulfoxide-d6): δ1H: 5.27 (apparent t, 3JHH = 4JHH = 2.5 Hz, 
2H, Hb), 5.22 (m, 2H, Ha), 3.34 (s, 2H, Hd), 2.40-2.33 (bs, 4H, He), 1.61-1.53 (bs, 4H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, dimethylsulfoxide-d6): δ13C: 115.4 (Cc), 104.5 (Cb), 102.3 
(Ca), 57.2 (Cd), 53.2 (Ce), 23.1 (Cf). 
1H 1H COSY (600.23 MHz, 300 K, dimethylsulfoxide-d6): δ1H / δ1H: 5.27 / 5.22 (CHb / CHa), 
5.22 / 5.27 (CHa/ CHb), 2.40-2.33 / 1.61-1.53 (CHe/ CHf) , 1.61-1.53 / 2.40-2.33 (CHf/ CHe). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dimethylsulfoxide-d6): δ1H / δ13C: 5.27 / 104.5 
(CHb), 5.22 / 102.3 (CHa), 3.34 / 57.2 (CH2d), 2.40-2.33 / 53.2 (CH2e), 1.61-1.53 / 23.1 (CH2f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dimethylsulfoxide-d6): δ1H / δ13C: 5.27 / 115.4, 
104.5, 102.3, 57.2 (CHb / Cc, CHb, CHa, CH2d), 5.22 / 115.4, 104.5, (CHa / Cc, CHb), 3.34 / 115.4, 
104.5, 53.2 (CH2d / Cc, CHb, CH2e), 2.40-2.33 / 53.2, 23.1 (CH2e / CH2e, CH2f), 1.61-1.53 / 53.2, 
23.1 (CH2f / CH2e, CH2f).  
HMRS (ESI negative mode, dimethylsulfoxide): calcd. For C10H14N [M-K]- 148.11325; found 
148.11323 (Rel ab: 100%, 0.5 ppm). 
5. Synthesis of 3-K: 
 
To a solid mixture of CpNa (0.055 mol, 1.2 eq) and N-benzotriazolylmethyl-N-benzyl-1-
phenylmethanamine (10 g, 0.030 mol, 1 eq) was added dropwise by cannulation at -15°C 500 
mL of Et2O. at -15°C. The resulting solution was left to warm up to room temperature and then 
refluxed overnight. TLC plate (1: 1 Et2O: pentane as eluent+ several drops of MeOH as eluent) 
was done in order to check the completion of the reaction. The white precipitate formed during 
the reaction was filtered off and extracted with 2x100 mL of Et2O. The yellow filtrate was 
washed twice with 50 mL of deionized water. The combined organic phases were washed with 
a solution of saturated brine (30 mL) and dried over MgSO4. After filtration and careful 
evaporation of the solvent, the yellow oil was dissolved in pentane (40 mL) and left 10 min 
during which time the residual starting material precipitated. After filtration and careful 
evaporation (25°C, middle depression), the corresponding diene was obtained as yellow oil 
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(8.86 g, yield: 70 %). This unstable compound was directly used after dissolving in 50 mL of 
Et2O. The resulting solution was cooled down to 0°C, and a freshly-prepared solution in toluene 
of KHMDS (5.77 g, 0.029 mol, 0.9 eq, 45 mL) was added dropwise. The cold bath was left to 
warm to room temperature overnight. A dark brown solution was obtained. After efficient 
evaporation, the sticky brown oil was triturated with 60 mL of Et2O and 20 mL of pentane to 
form a white precipitate. The supernatant was cannulated, the precipitate was washed twice 
with 20 mL of pentane before drying in vacuo to remove residual traces of solvent. The light 
brown foam formed during this process was reduced in a thin powder in the Glove Box (8.52 
g, yield: 84 %, overall yield: 60%).10  
1H NMR (500.13 MHz, 300 K, dimethylsulfoxide-d6): δ1H: 7.41 (d, 3JHH = 7.5 Hz, 4H, Hg), 7.29 
(t, 3JHH = 7.5 Hz, 4H, Hh), 7.17 (t, 3JHH = 7.5 Hz, 2H, Hi) 5.42 (t, 3JHH = 4JHH = 2.5 Hz, 2H, Hb), 
5.32 (apparent t, 3JHH = 4JHH = 2.5 Hz, 2H, Ha), 3.53 (s, 4H, He), 3.40 (s, 2H, Hd). 
13C{1H} NMR (125.77 MHz, 300 K dimethylsulfoxide-d6): δ13C: 142.0 (Cf), 128.8 (Cg), 128.2 
(Ch), 126.4 (Ci), 114.0 (Cc), 105.6 (Cb), 103.3 (Ca), 57.0 (Ce), 55.1 (Cd).  
1H 1H COSY (500.13 MHz, 300 K, dimethylsulfoxide-d6): δ1H / δ1H: 7.41 / 7.29, 7.17, 3.53 (CHg 
/ CHh, CHi, CH2e), 7.29 / 7.41, 7.17 (CHh / CHg, CHi), 7.17 / 7.41, 7.29 (CHi / CHg, CHh) 5.42 / 
5.32 (CHb / CHa), 5.32 / 5.42 (CHa/ CHb), 3.53 / 7.41 (CH2e / CHg). 
1H 13C HMQC (500.13 MHz / 125.77 MHz, 300 K, dimethylsulfoxide-d6): δ1H / δ13C: 7.41 / 128.8 
(CHg), 7.29 / 128.2 (CHh), 7.17 / 126.4 (CHi), 5.42 / 105.6 (CHb), 5.32 / 103.3 (CHa), 3.53 / 57.0 
(CH2f), 3.40 / 55.1 (CH2d). 
1H 13C HMBC (500.13 MHz / 125.77 MHz, 300 K, dimethylsulfoxide-d6): δ1H / δ13C: 7.41 / 128.8, 
128.2, 126.4, 57.0 (CHg / CHg, CHh, CHi, CH2f ), 7.29 / 142.0, 128.2 (CHh / Cf, CHg), 7.17 / 142.0, 
128.3 (CHi / Cf, CHg), 5.42 / 114.0, 103.3, 55.1 (CHb / Cc, CHb, CH2d), 5.32 / 114.0, 105.6 (CHa 
/ Cc, CHb), 3.53 / 142.0, 128.8, 57.0, 55.1 (CH2e/ Cf, CHg, CH2e, CH2d), 3.40 / 114.0, 105.6, 57.0 
(CH2d / Cc, CHb, CH2e). 
HMRS (ESI negative mode, dimethylsulfoxide): calcd. For C20H20N [M-K]- 274.15903; found 
274.15967 (Rel. ab: 5%, -1.7 ppm). 
6. Synthesis of 4-K: 
 
To a suspension of CpNa (0.043 mol, 1.3 eq) in 100 mL of Et2O, was added dropwise via a 
syringe N-benzotriazolylmethyl-N,N-diisopropylamine (7.7 g, 0.033 mol, 1 eq). The resulting 
solution was left to warm up to room temperature over 2h and then stirred for 2 additional 
hours. The resulting solution was left to warm up to room temperature and then refluxed 
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overnight. Reaction progress was monitored by TLC (1: 1 Et2O: pentane + several drops of 
methanol as eluent; mobile phase: silica). The white precipitate formed during the reaction was 
filtered off and extracted with 15 mL of Et2O. The combined organic phases were washed with 
deionized water (50 mL) and a solution of saturated brine (30 mL) and dried over MgSO4. After 
filtration and careful evaporation of the solvent (25°C, middle depression), the yellow oil was 
dissolved in pentane (40 mL) and left 10 min during which time the residual starting material 
precipitated After filtration and careful evaporation, the corresponding diene was obtained as 
yellow oil (4.43 g, yield: 75 %). This unstable compound was directly used after dissolution in 
50 mL of Et2O. The resulting solution was cooled down to 0°C, and a freshly-prepared solution 
in toluene of KHMDS (4.8 g, 0.024 mol, 0.98 eq, 40 mL) was added dropwise. The cold bath 
was left to warm to room temperature overnight. A dark brown solution was obtained with 
eventually a white precipitate. After efficient evaporation, the sticky brown oil was triturated 
with 50 mL of Et2O and 50 mL of pentane to form a white precipitate. The supernatant was 
cannulated; the precipitate was washed twice with 20 mL of pentane before drying in vacuo to 
remove residual traces of solvent. The desired compound was obtained as a beige powder 
(4.8 g, yield: 90%, overall yield 67%).10  
1H NMR (600.23 MHz, 300 K, dimethylsulfoxyde-d6): δ1H: 5.28 (apparent t, 3JHH= 4JHH = 2.5 Hz, 
2H, Hb), 5.22 (apparent t, 3JHH= 4JHH = 2.5 Hz, 2H, Ha), 3.41 (s, 2H, Hd), 3.21 (hept, 3JHH = 6.5 
Hz, 2H, He), 0.94 (s, 12H, 3JHH = 6.5 Hz, Hf). traces of toluene observed. 
13C{1H} NMR (150.94 MHz, 300 K, dimethylsulfoxyde-d6): δ13C: 116.8 (Cc), 104.0 (Cb), 102.2 
(Ca), 44.9 (Ce), 44.6 (Cd), 20.7 (Cf). traces of toluene observed. 
1H 1H COSY (600.23 MHz / 600 MHz, 300 K, dimethylsulfoxyde-d6): δ1H / δ1H: 5.28 / 5.22 (CHb 
/ CHa), 5.22 / 5.28 (CHa/ CHb), 3.21 / 0.94 (CHe/ CH3f), 0.94 / 3.21 (CH3f/ CHe).  
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dimethylsulfoxyde-d6): δ1H / δ13C: 5.28 / 
104.0 (CHb), 5.22 / 102.2 (CHa), 3.41 / 44.6 (CH2d), 3.21 / 44.9 (CHe), 0.94 / 20.7 (CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dimethylsulfoxyde-d6): δ1H / δ13C: 5.28 / 
116.8, 104.0, 102.2, 44.6 (CHb / Cc, CHb, CHa, CH2d), 5.22 / 116.8, 104.0 (CHa / Cc, CHb), 3.41 
/ 116.8, 104.0, 44.9 (CHd / Cc, CHb, CHe), 3.21 / 44.9, 20.7 (CHe / CHe, CH3f), 0.94 / 44.9, 20.7 
(CH3f / CHe, CH3f). 
HMRS (ESI negative mode, dimethylsulfoxide): calcd. For C12H16N [M-K]- 178.15903; found 
178.16042 (Rel. ab: 30%, 1.7 ppm). 
7. Synthesis of 5-K: 
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To a solid mixture of CpNa (0.068 mol, 1.4 eq) and N-benzotriazolylmethyl-2,2,6,6-
tetramethylpiperidine (13.8 g, 0.050 mol, 1 eq) was added dropwise by cannulation at -15°C 
500 mL of Et2O. at -15°C. The resulting solution was stirred for 1 h at -15°C and then brought 
to completion by an additional stirring of 3 h at room temperature. The resulting solution was 
left to warm up to room temperature and then refluxed overnight. Reaction progress was 
monitored by TLC (1: 1 Et2O: pentane + several drops of methanol as eluent; mobile phase: 
silica). The white precipitate formed during the reaction was filtered off and extracted with 40 
mL of Et2O twice. The combined organic phases were washed with a solution of saturated 
brine (30 mL) and dried over MgSO4. After filtration and careful evaporation of the solvent, the 
corresponding diene was dissolved in 15 mL of pentane to precipitate the remaining Bt-
derivative, filtered off and evaporated to yield a dark orange oil (9.83 g, yield: 90 %). This 
unstable compound was directly used after dissolving in 30 mL of Et2O. The resulting solution 
was cooled down to 0°C, and a freshly-prepared solution in toluene of KHMDS (8.85 g, 0.044 
mol, 0.98 eq, 80 mL) was added dropwise. The cold bath was left to warm to room temperature 
overnight. A dark brown solution was obtained. The solvent was first removed by vacuum 
pumping to yield a light brown precipitate. It was then dissolved in 20 mL of Et2O 80 mL of 
pentane was added to yield a biphasic system. First layer was removed by cannulation and 
the remaining phase was dried under vacuum. The sticky oil was washed with pentane (2x20 
mL) to yield a beige precipitate after drying (12.0 g, yield: 97%, overall yield 86%).10  
1H NMR (600.23 MHz, 300 K, tetrahydrofuran-d8): δ1H: 5.46 (apparent t, 3JHH = 4JHH = 2.5 Hz, 
2H, Hb), 5.38 (apparent t, 3JHH= 4JHH = 2.5 Hz, 2H, Ha), 3.55 (s, 2H, Hd), 1.60-1.54 (m, 2H, Hh), 
1.45-1.41 (m, 4H, Hg), 1.12 (s, 12H, CH3f).  
13C{1H} NMR (150.94 MHz, 300 K, tetrahydrofuran-d8): δ13C: 123.5 (Cc), 105.6 (Cb), 104.1 (Ca), 
55.6 (Ce), 45.0 (Cd), 42.9 (Cg), 29.0 (Cf), 19.2 (Ch). 
1H 1H COSY (600.23 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ1H: 5.46 / 5.38 (CHb / CHa), 5.38 
/ 5.46 (CHa/ CHb), 1.60-1.54 / 1.43 (CH2h/ CH2g) , 1.45-1.41 / 1.57 (CH2g/ CH2h). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ13C: 5.46 / 105.6 
(CHb), 5.38 / 104.1 (CHa), 3.55 / 45.0 (CH2d), 1.60-1.54 / 19.2 (CH2h), 1.45-1.41 / 42.9 (CH2g), 
1.12 / 29.0 (CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ13C 5.46 / 123.5, 
105.6, 104.2, 45.0 (CHb / Cc, CHb, CHa, CH2d), 5.38 / 123.5, 105.6 (CHa / Cc, CHb), 3.55 / 123.5, 
105.6, 55.6 (CH2d / Cc, CHb, Ce), 1.57 / 55.6, 42.9 (CH2h / Ce, CH2g), 1.43 / 55.6, 42.9, 29.0, 19.2 
(CH2g / Ce, CH2g, CH3f, CH2h), 1.12 / 55.6, 42.9, 29.0 (CH3f / Ce, CH2g, CH3f). 
HMRS (ESI negative mode, dimethylsulfoxide): calcd. For C10H14N [M-K]- 218.19033; found 
218.19111 (Rel. ab: 100%, -1.4 ppm). 
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8. Synthesis of 9: 
 
 
A solution of 1-K (818 mg, 3.4 mmol, 1.05 eq) in 25 mL of THF was added to a solution of 
CpTiCl3 (718 mg, 3.2 mmol, 1 eq) in 20 mL of toluene, by cannulation at -30°C. The resulting 
solution was left to warm up to room temperature and then stirred overnight. The crude red 
solution was first evaporated. The deep red oil obtained was dissolved in 20 mL of CH2Cl2, 
filtered through diatomaceous earth, which was then washed by 2 x 5 mL of CH2Cl2. The deep 
red extracts obtained were concentrated by evaporation of 3/4 of the solvent and the compound 
was precipitate by addition of pentane with vigorous stirring. The orange-red precipitate was 
filtered off, and dried to yield the desired compound. (680 mg, yield = 54 %). 
1H NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 7.29 (d, 3JHH = 7.4 Hz, 2H, Hh), 7.18 (t, 3JHH = 
7.4 Hz, 2H, Hi), 7.10 (t, 3JHH = 7.4 Hz, 1H, Hj) 6.26 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 
5.98 (s, 5H, Hk), 5.68 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Ha), 3.74 (s, 2H, Hd), 3.33 (s, 2H, 
Hf), 2.02 (s, 3H, He).  
13C{1H} NMR (125.77 MHz, 300 K, benzene-d6): δ13C: 139.6 (Cg), 133.2 (Cc), 129.3 (Ch), 128.6 
(Ci), 127.4 (Cj), 124.6 (Cb), 119.5 (Ck), 115.1 (Ca), 62.1 (Cf), 57.7 (Cd), 42.2 (Ce). 
1H 1H COSY (600.23 MHz, 300 K, benzene-d6): δ1H / δ1H: 7.28 / 7.18 (CHh / CHi), 7.18 / 7.28, 
7.10 (CHi / CHh, CHj), 7.10 / 7.18 (CHj / CHi), 6.26 / 5.67 (CHb / CHa), 5.68 / 6.26 (CHa / CHb). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.28 / 129.3 (CHh), 
7.18 / 128.6 (CHi), 7.10 / 127.4 (Hj) 6.26 / 124.6 (CHb), 5.98 / 119.5 (CHk), 5.68 / 115.1 (CHa), 
3.74 / 57.7 (CH2d), 3.33 / 62.1 (CH2f), 2.02 / 42.2 (CH3e). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.28 / 129.3, 128.6, 
62.1 (CHh / CHh, CHj, CH2f), 7.18 / 139.6, 128.6 (CHi / Cg, CHi), 7.10 / 129.3, 128.6 (CHj / CHh, 
CHi) 6.26 / 124.6, 115.1 (CHb / CHb, CHa), 5.98 / 119.5 (CHk / CHk), 5.68 / 133.2, 124.6, 115.1 
(CHa / Cc, CHb, CHa), 3.74 / 133.2, 124.6, 62.1, 42.2 (CH2d / Cc, CHb, CH2f, CH3e), 3.33 / 139.6, 
129.3, 57.7, 42.2 (CH2f / Cg, CHh, CH2d, CH3e), 2.02 / 62.1, 57.7 (CH3e / CH2f, CH2d). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 2.02 / -339 (He 
/ N). 
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C19H21NClTi [M-Cl]+ 
346.08388; found 346.08446 (Rel. ab: 90%, 2.3 ppm). 
IR (ATR) ν [cm-1]  
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MIR: 3110; 2780; 1452; 1024; 824; 696. 
FIR: 696; 610; 593; 465; 396; 361; 302; 256. 
Elemental Analysis: % calcd for C19H19NCl2Ti: C, 59.72; H, 5.54; N, 3.67; Found: C, 58.93; 
H, 5.50; N, 3.58. 
9. Synthesis of 10: 
 
A solution of 2-K (2.25 g, 0.012 mol, 1 eq) in 150 mL of THF was added to a solution of CpTiCl3 
(2.60 g, 0.012 mol, 1 eq) dissolved in 180 mL of toluene, by cannulation at -30°C. The resulting 
red solution was left to warm up to room temperature and then stirred overnight. The crude 
dark-red solution was first evaporated. The deep red oil obtained was dissolved in 50 mL of 
CH2Cl2, filtered through diatomaceous earth which was then washed by 2 x 2 mL of CH2Cl2. 
The deep-red extracts obtained were concentrated by evaporation of 3/4 of the solvent and the 
compound was precipitate by addition of pentane under vigorous stirring. The orange-red 
precipitate was filtered off, and dried to yield the desired compound. (2.74 g, yield = 69 %). 
1H NMR (600 MHz, 300 K, dichloromethane-d2): δ1H: 6.57 (s, 5H, Hg), 6.52 (m, 2H, Hb), 6.46 
(apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Ha), 3.67 (s, 2H, Hd), 2.61-2.49 (s, 4H, He), 1.83-1.70 (s, 
4H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, dichloromethane-d2): δ13C: 133.9 (Cc), 124.7 (Cb), 120.6 
(Cg), 116.8 (Ca), 55.8 (Cd), 54.7 (Ce), 24.1 (Cf). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H 6.52 / 6.46 (CHb / CHa), 6.46 
/ 6.52 (CHa / CHb), 2.61-2.49 / 1.83-1.70 (CH2e / CH2f), 1.83-1.70 / 2.61-2.49 (CH2f / CH2e). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.57 / 120.6 
(CHg), 6.52 / 124.7 (CHb), 6.46 / 116.8 (CHa), 3.67 / 55.8 (CH2d), 2.61-2.49 / 54.7 (CH2e), 1.83-
1.70 / 24.1 (CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.57 / 120.6 
(CHg / CHg), 6.52 / 124.8, 116.8 (CHi / Cg, CHh, CHj), 6.46 / 133.9, 124.7, 116.8 (CHj / CHh, CHi) 
3.67 / 133.9, 124.7, 54.7 (CH2d / Cc, CHb, CH2e), 2.61-2.49 / 54.7, 24.1 (CH2e / CH2e, CH2f), 
1.83-1.70 / 54.7, 24.1 (CH2f / CH2e, CH2f).  
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 1.83-1.70 / -
322 (Hf / N).  
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HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C15H19NClTi [M-Cl]+ 
296.06717; found 296.06819 (Rel. ab: 50%, -2.8 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3107; 2952; 2778; 2342; 1440; 1014; 828. 
FIR: 640; 620; 587; 405; 362; 303; 252. 
Elemental Analysis: % calcd for C15H19NCl2Ti: C, 54.25; H, 5.77; N, 4.22; Found: C, 54.66; 
H, 5.51; N, 4.26. 
10. Synthesis of 11: 
 
A solution of 3-K (3.76 g, 0.012 mol, 1.05 eq) in 100 mL of THF was added to a solution of 
CpTiCl3 (2.5 g, 0.011 mol, 1 eq) in 140 mL of toluene, by cannulation at -30°C. The resulting 
solution was left to warm up to room temperature and then stirred overnight. The crude red 
solution was first evaporated. The deep red oil obtained was dissolved in 50 mL of CH2Cl2, 
filtered through diatomaceous earth which was then washed by 2 x 15 mL of CH2Cl2. The deep-
red extracts obtained were concentrated by evaporation of 3/4 of the solvent and the compound 
was precipitated by addition of pentane (70 mL) with vigorous stirring. The orange-red 
precipitate was filtered off, and dried to yield the desired compound. (4.0 g, yield = 80 %). 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 7.38 (d, 3JHH = 7.4 Hz, 4H, Hg), 7.33 
(t, 3JHH = 7.4 Hz, 4H, Hh), 7.25 (t, 3JHH = 7.4 Hz, 2H, Hi), 6.52 (apparent t, 3JHH = 4JHH = 2.6 Hz, 
2H, Hb), 6.43 (t, 3JHH = 4JHH = 2.6 Hz, 2H, Ha), 6.38 (s, 5H, Hj), 3.60 (s, 2H, Hd), 3.57 (s, 4H, He). 
13C{1H} NMR (150.94 MHz, 300 K, dichloromethane-d2): δ13C: 139.9 (Cf), 133.5 (Cc), 129.5 
(Cg), 128.8 (Ch), 127.6 (Ci), 124.5 (Cb), 120.5 (Cj), 117.6 (Ca), 58.8 (Ce), 53.6 (Cd). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 7.38 / 7.33 (CHg / CHh), 7.33 
/ 7.38, 7.25 (CHh / CHg, CHi), 7.25 / 7.33 (CHi / CHg), 6.52 / 6.43 (CHb / CHa), 6.43 / 6.52 (CHa 
/ CHb). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.38 / 129.5 
(CHg), 7.33 / 128.8 (CHh), 7.25 / 127.6 (Hi), 6.52 / 124.5 (CHb), 6.43 / 117.6 (CHa), 6.38 / 120.5 
(CHj), 3.60 / 53.6 (CH2d), 3.57 / 58.8 (CH2e). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.38 / 129.5, 
127.6, 58.8 (CHg / CHg, CHi, CHe), 7.33 / 139.9, 128.8 (CHh / Cf, CHh), 7.25 / 129.5 (CHi / CHg) 
Chapter I 
85 
   
6.52 / 117.6 (CHb / CHa), 6.43 / 133.5, 124.5 (CHa / Cc, CHb), 6.38 / 120.5 (CHj / CHj), 3.60 / 
133.5, 124.5, 58.8 (CH2d / Cc, CHb, CH2e), 3.57 / 139.9, 129.5, 58.8, 53.6 (CH2e / Cf, CHg, CH2d, 
CH2e).  
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 3.60 / -327 (Hd 
/ N). 
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C25H26NCl2Ti [M+H]+ 
458.09196; found 458.09393 (Rel. ab: 100%, 5.0 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3098; 3061; 2784; 1493; 1117; 1029; 856; 821; 738; 729. 
FIR: 698; 612; 491; 473; 391; 375; 365; 306; 264. 
Elemental Analysis: % calcd: C, 65.53; H, 5.50; N, 3.06; Found: C, 66.52; H, 5.57; N, 3.20. 
 
XRD:  
 
Experimental. Single red prism-shaped crystals of (q2) were obtained by 
recrystallisation from diffusion of pentane into a concentrated 
dichloromethane solution at room temperature. A suitable crystal 
(0.30×0.25×0.20) mm3 was selected and mounted on a mylar loop with oil 
on a Nonius Kappa Apex II diffractometer. The crystal was kept at T = 
115 K during data collection. Using Olex2 (Dolomanov et al., 2009), the 
structure was solved with the SIR2004 (Burla et al., 2007) structure 
solution program, using the Direct Methods solution method. The model 
was refined with version 2014/7 of XL (Sheldrick, 2008) using Least 
Squares minimisation. 
Crystal Data. C25H25Cl2NTi, Mr = 458.26, triclinic, P-1 (No. 2), a = 
6.5681(2) Å, b = 12.8473(4) Å, c = 13.7963(3) Å, α = 73.684(2)°, β = 
79.294(2)°, γ = 86.2190(10)°, V = 1097.72(5) Å3, T = 115 K, Z = 2, Z' = 1, 
µ(MoKα) = 0.645, 15014 reflections measured, 4976 unique (Rint = 
0.0202) which were used in all calculations. The final wR2 was 0.1146 (all 
data) and R1 was 0.0452 (I > 2(I)). 
Compound  q2  
    
Formula  C25H25Cl2NTi  
Dcalc./ g cm-3  1.386  
µ/mm-1  0.645  
Formula Weight  458.26  
Colour  red  
Shape  prism  
Size/mm3  0.30×0.25×0.20 
T/K  115  
Crystal System  triclinic  
Space Group  P-1  
a/Å  6.5681(2)  
b/Å  12.8473(4)  
c/Å  13.7963(3)  
α/°  73.684(2)  
β/°  79.294(2)  
γ/°  86.2190(10)  
V/Å3  1097.72(5)  
Z  2  
Z'  1  
Wavelength/Å  0.71073  
Radiation type  MoKα  
Θmin/°  1.652  
Θmax/°  27.492  
Measured Refl.  15014  
Independent Refl. 4976  
Reflections Used  4646  
Rint  0.0202  
Parameters  262  
Restraints  0  
Largest Peak  1.479  
Deepest Hole  -0.550  
GooF  1.057  
wR2 (all data)  0.1146  
wR2  0.1121  
R1 (all data)  0.0481  
R1  0.0452  
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11. Synthesis of 12: 
 
A solution of 4-K (1.19 g, 5.5 mmol, 1 eq) in 25 mL of THF was added to a solution of CpTiCl3 
(1.2 g, 5.5 mmol, 1 eq) in 25 mL of toluene, by cannulation at -30°C. The resulting solution was 
left to warm up to room temperature and then stirred overnight. The crude red solution was 
first evaporated. The deep-red oil obtained was dissolved in 30 mL of CH2Cl2 and stirred 1h 
inside the glovebox to facilitate the following filtration. This solution was filtered through 
diatomaceous earth which was then washed by 2 x 5 mL of CH2Cl2. The deep red extracts 
obtained were concentrated by evaporation of 3/4 of the solvent and the compound was 
precipitated by addition of pentane (40) with vigorous stirring. The orange-red precipitate was 
filtered off, washed with pentane twice (15 mL) and dried to yield the desired compound. (1.61 
g, yield = 80 %). 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 6.54 (s, 5H, Hg), 6.52 (apparent t, 3JHH 
= 
4JHH = 2.6 Hz, 2H, Hb), 6.44 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Ha), 3.71 (s, 2H, Hd), 2.97 
(hept, 3JHH = 6.6 Hz, 2H, He), 1.01 (d, 3JHH = 6.6 Hz, 12H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, dichloromethane-d2): δ13C: 140.4 (Cc), 124.1 (Cb), 120.3 
(Cg), 117.2 (Ca), 49.2 (Ce), 45.6 (Cd), 21.3 (Cf). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 6.52 / 6.44 (CHb / CHa), 6.44 
/ 6.52 (CHa / CHb), 2.97 / 1.01 (CH2e / CH3f), 1.01 / 2.97 (CH3f / CH2e). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.54 / 120.3 
(CHg), 6.52 / 124.1 (CHb), 6.44 / 117.2 (CHa), 3.71 / 45.6 (CH2d), 2.97 / 49.1 (CHe), 1.01 / 21.3 
(CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.54 / 120.3 
(CHg / CHg), 6.52 / 140.4, 124.1, 117.2 (CHb / Cc, CHb, CHa), 6.44 / 140.4, 124.1 (CHa / Cc, 
CHb), 3.71 / 140.4, 124.1, 49.1 (CH2d / Cc, CHb, CHe), 2.97 / 49.1, 45.6, 21.3 (CHe / CHe, CH2d, 
CH3f), 1.01 / 49.1, 21.3 (CH3f / CHe, CH3f). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 1.01 / -322 (Hf 
/ N). 
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C17H26NClTi [M+H]+ 
362.09189; found 362.09285 (Rel. ab: 100%, 3.4 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3109; 2962; 1385; 1202; 1170; 859; 825. 
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FIR: 694; 619; 610; 522; 413; 387; 362; 302; 255. 
Elemental Analysis: % calcd for C17H25Cl2NTi: C, 56.38; H, 6.96; N, 3.87; Found: C, 55.99; 
H, 6.96; N, 3.88. 
12. Synthesis of 13:  
 
 
A solution of 5-K (693 mg, 3.17 mmol, 1.0 eq) in 20 mL of toluene was added to a solution of 
CpTiCl3 (800 mg, 3.17 mmol, 1 eq) in 20 mL of toluene. Both solutions were cooled down at -
15°C in the glovebox where the reaction was launched. The resulting solution was left to warm 
up to room temperature and then stirred overnight. Toluene was then evaporated and the red 
residue was dissolved in dichloromethane and filtered through diatomaceous earth in the 
glovebox. All volatiles were evaporated and the red precipitate was washed twice with pentane 
(20mL). An orange powder was obtained after drying in vacuo. (870 mg, yield = 68 %). 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 6.26-6.20 (bs, 2H, Hb), 6.01 (s, 5H, 
Hi), 5.73-5.67 (bs, 2H, Ha), 4.02 (s, 2H, Hd), 1.45-1.40 (m, 2H, Hh), 1.39-1.36 (m, 4H, Hg), 1.01 
(s, 12H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, dichloromethane-d2): δ13C: 146.2 (Cc), 121.9 (Cb), 119.1 
(Ci), 115.6 (Ca), 55.6 (Ce), 45.6 (Cd), 41.9 (Cg), 28.6-27.9 (bs, Cf), 18.2 (Ch). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 6.26-6.20 / 5.73-5.67 (CHa 
/ CHb), 5.73-5.67 / 6.26-6.20 (CHb / CHa), 1.45-1.40 / 1.39-1.36 (CH2h / CH2g), 1.39-1.36 / 1.45-
1.40 (CH2g / CH2h). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.26-6.20 / 
121.9 (CHa), 6.01 / 119.1 (CHi), 5.70 / 115.6 (CHb), 4.02 / 45.6 (CH2d), 1.45-1.40 / 18.2 (CH2h), 
1.39-1.36 / 41.9 (CH2g), 1.01 / 28.6-27.9 (CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.26-6.20 / 
146.1, 121.9, 115.6 (CHa / Cc, CHa, CHb), 6.01 / 119.1 (CHi / CHi), 5.70 / 146.1, 121.9 (CHb / 
Cc, CHa), 4.02 / 146.1, 121.1, 55.6 (CH2d / Cc, CHa, Ce), 1.45-1.40 / 55.6, 41.9 (CHh / Ce, CH2g), 
1.39-1.36 / 55.6, 41.9, 18.2 (CH2h / Ce, CH2g, CH2h), 1.01 / 55.6, 41.9, 28.26-27.9 (CH3f / Ce, 
CH2h, CH3f). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 1.01 / -309 (Hf 
/ N). 
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HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C20H30NCl2Ti [M+H]+ 
402.12322; found 402.12089 (Rel. ab: 90%, -5.1 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3105; 2927; 1460; 1174; 1024; 816. 
FIR: 694; 621; 631; 392; 332; 276; 144. 
Elemental Analysis: % calcd for C20H29NCl2Ti: C, 59.72; H, 7.27; N, 3.48; Found: C, 59.88; 
H, 7.71; N, 3.44. 
XRD:0 
 
Experimental. Single light yellow needle-shaped crystals of (ad10) 
were obtained by slow diffusion of pentane into a concentrated 
dichloromethane solution at room temperature. A suitable crystal 
(0.17×0.05×0.02) mm3 was selected and mounted on a mylar loop 
with oil on a Nonius Kappa Apex II diffractometer. The crystal was 
kept at T = 115 K during data collection. The structure was solved 
with the SIR2004 (Burla et al., 2007) structure solution program, 
using the Direct Methods solution method. Using Olex2 (Dolomanov 
et al., 2009), the model was refined with version 2014/7 of XL 
(Sheldrick, 2008) using Least Squares minimisation. 
Crystal Data. C20H29Cl2NTi, Mr = 402.24, triclinic, P-1 (No. 2), a = 
7.7334(2) Å, b = 12.1253(4) Å, c = 20.8289(8) Å, α = 85.756(2)°, 
β = 85.836(2)°, γ = 78.471(2)°, V = 1905.12(11) Å3, T = 115 K, Z = 4, 
Z' = 2, µ(MoKα) = 0.731, 24737 reflections measured, 8484 unique 
(Rint = 0.0789) which were used in all calculations. The final wR2 was 
0.1361 (all data) and R1 was 0.0726 (I > 2(I)). 
 
Compound  ad10  
    
Formula  C20H29Cl2NTi  
Dcalc./ g cm-3  1.402  
µ/mm-1  0.731  
Formula Weight  402.24  
Colour  light yellow  
Shape  needle  
Size/mm3  0.17×0.05×0.02 
T/K  115  
Crystal System  triclinic  
Space Group  P-1  
a/Å  7.7334(2)  
b/Å  12.1253(4)  
c/Å  20.8289(8)  
α/°  85.756(2)  
β/°  85.836(2)  
γ/°  78.471(2)  
V/Å3  1905.12(11)  
Z  4  
Z'  2  
Wavelength/Å  0.71073  
Radiation type  MoKα  
Θmin/°  2.030  
Θmax/°  27.453  
Measured Refl.  24737  
Independent Refl. 8484  
Reflections Used  5551  
Rint  0.0789  
Parameters  433  
Restraints  0  
Largest Peak  0.610  
Deepest Hole  -0.471  
GooF  1.166  
wR2 (all data)  0.1361  
wR2  0.1154  
R1 (all data)  0.1294  
R1  0.0726  
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13. Synthesis of 14: 
 
To a solution of 9 (100 mg, 0.26 mmol, 1 eq, 5 mL toluene) was added dropwise a freshly-
prepared HCl solution (5 mL of toluene). A red precipitate was directly formed. The reaction 
mixture was left to stir for 15 min. The precipitate was then filtered off and washed with 3 x 5 
mL of pentane under aerobic conditions, yielding the desired precipitate as an orange solid (74 
mg, yield: 67 %). 
1H NMR (600 MHz, 300 K, chloroform-d1): δ1H: 12.83 (s, 1H, 7.28, Hl), 7.62-7.58 (m, 2H, Hh), 
7.48-7.43 (m, 3H, Hi / Hj), 7.07 (apparent q, 3JHH = 4JHH = 2.6 Hz, 1H, Hb), 6.97 (apparent q, 3JHH 
= 
4JHH = 2.6 Hz,, 1H, Hb’), 6.69 (s, 5H, Hk), 6.60 (apparent q, 3JHH = 4JHH = 2.6 Hz, 1H, Ha), 6.57 
(apparent q, 3JHH = 4JHH = 2.6 Hz, 1H, Ha’), 4.38 (overlapping dd with Hd, 2JHH = 13.2 Hz  3JHH = 
3.6 Hz, 1H, Hf), 4.37 (overlapping dd with Hf, 2JHH = 13.7 Hz  3JHH = 4.6 Hz, 1H, Hd), 4.13 (dd, 
2JHH = 13.7 Hz, 3JHdHl = 6.0 Hz, 1H, Hd’), 4.04 (dd, 2JHH = 13.2 Hz, 3JHH = 6.6 Hz, 1H, Hf’), 2.60 
(d, 3JHH = 2.6 Hz, 3H, He).11 
13C{1H} NMR (150.94 MHz, 300 K, chloroform-d1): δ13C: 131.5 (Ch), 130.5 (Ci), 129.7 (Cj), 
128.2 (Cg), 125.9 (Cb’), 124.8 (Cb), 122.0 (Cc), 121.3 (Ck), 117.0 (Ca’), 116.4 (Ca), 60.0 (Cf), 
55.4 (Cd), 39.2 (Ce). 
1H 1H COSY (500.13 MHz, 300 K, chloroform-d1): δ1H / δ1H: 7.62-7.58 / 7.48-7.43 (CHh / CHi, 
CHj), 7.48-7.43 / 7.62-7.58 (CHi, CHj / CHh,), 7.07 / 6.60 (CHb / CHa), 6.97 / 6.57 (CHb / CHa), 
6.60 / 7.07 (CHa / CHb), 6.57 / 6.97 (CHa / CHb), 4.39 / 4.04 (CH2f), 4.36 / 4.13 (CH2d), 4.13 / 
4.36 (CH2d), 4.04 / 4.39 (CH2f). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 7.62-7.68 / 131.5 
(CHh), 7.48-7.43 / 130.5, 129.7 (CHi, CHj), 7.07 / 124.8 (CHb) 6.96 / 125.9 (CHb’), 6.69 / 121.3 
(CHk), 6.60 / 116.4 (CHa), 6.57 / 117.0 (CHa’), 4.39 / 60.0 (CH2f), 4.36 / 55.4 (CH2d), 4.13 / 55.4 
(CH2d), 4.04 / 60.0 (CH2f), 2.60 / 39.2 (CH3e). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 7.62-7.68 / 131.5, 
130.5, 129.7, 60.0 (CHh / CHh, CHj, CHi, CH2d), 7.48-7.43 / 131.5, 130.5, 129.7, 128.2 (CHi, CHj 
/ CHh, Chj/i, CHi/j, Cg), 7.07 / 125.9, 117.0 (CHb / CHb’, CHa’) 6.97 / 124.8, 116.4 (CHb’ / CHb, 
CHa), 6.69 / 121.3 (CHk / CHk), 6.60 / 125.9, 122.0, 117.0 (CHa / CHb’, Cc, CHa’), 6.57 / 124.8, 
122.0, 116.4 (CHa’ / CHb, Cc, CHa), 4.39 / 131.5, 128.2 (CH2f / CHh, Cg), 4.36 / 125.9, 122.0, 
                                               
11
 As the molecule is chiral, exact position of diastereotopic protons (x/x’) on CH2 groups was not determined, and noted. 
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39.2 (CH2d / CHb, Cc, CH3e), 4.13 / 124.8, 122.0, 60.0, 39.2 (CH2d / CHb, Cc, CH2f, CH3e), 4.04 / 
131.6, 128.2, 55.4, 39.2 (CH2f / CHh, Cg, CH2d, CH3e), 2.60 / 60.0, 55.4 (CH3e / CH2f, CH2d). 
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C19H22NCl2Ti [M]+ 382.06060; 
found 382.05935 (Rel. ab: 10%, -2.6 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3111; 2953; 2352 (N-H); 1461; 1434; 834; 696. 
FIR: 696; 611; 497; 367; 304; 267.  
Elemental Analysis: % calcd for C19H22Cl3NTi: C, 54.51; H, 5.30; N, 3.35; Found: C, 54.50; 
H, 5.44; N, 3.69. 
14. Synthesis of 15: 
 
To a solution of 10 (3.08 g, 0.008 mol, 1 eq, 20 mL dichloromethane) was added dropwise a 
freshly-prepared HCl solution (20 mL of toluene). The reaction mixture was left to stir for 15 
min and the red precipitate was obtained by adding 20 mL of pentane. It was then filtered off 
and washed with 3 x 5 mL of pentane. (1.6 g, yield: 52 %). 
1H NMR (600 MHz, 300 K, chloroform-d1): δ1H: 12.77 (bs, 1H, Hh), 6.92 (apparent t, 3JHH = 4JHH 
= 2.6 Hz, 2H, Hb), 6.67 (s, 5H, Hg), 6.56 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Ha), 4.27 (d, 3JHH 
= 6.0 Hz, 2H, Hd), 3.72-3.63 (m, 2H, He), 2.94-2.83 (m, 2H, He), 2.29-2.18 (m, 2H, Hf), 2.14-
2.05 (m, 2H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, chloroform-d1): δ13C: 125.0 (Cb), 123.1 (Cc), 121.1 (Cg), 
116.2 (Ca), 54.3 (Cd), 53.8 (Ce), 23.5 (Cf). 
1H 1H COSY (600.23 MHz, 300 K, chloroform-d1): δ1H / δ1H: 6.92 / 6.56 (CHb / CHa), 6.56 / 6.92 
(CHa / CHb), 3.72-3.63 / 2.94-2.83, 2.29-2.18 (CH2e / CH2e, CH2f), 2.94-2.83 / 3.72-3.63, 2.29-
2.18, 2.14-2.05 (CH2e / CH2e, CH2f, CH2f), 2.29-2.18 / 3.72-3.63, 2.94-2.83, 2.12 (CH2f / CH2e, 
CH2e, CH2f), 2.14-2.05 / 3.72-3.63, 2.94-2.83, 2.29-2.18 (CH2f / CH2e, CH2e, CH2f). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 6.92 / 125.0 (CHb), 
6.67 / 121.1 (CHg), 6.56 / 116.2 (CHa), 4.27 / 54.3 (CH2d), 3.72-3.63 / 53.8 (CH2e), 2.94-2.83 / 
53.8 (CH2e), 2.29-2.18 / 23.5 (CH2f), 2.14-2.05 / 23.5 (CH2f).  
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 6.92 / 125.0, 
123.1, 116.2 (CHa / CHb, Cc, CHa), 6.67 / 121.1 (CHg / CHg), 6.56 / 125.0, 123.1 (CHb / CHa, Cc) 
4.27 / 125.0, 123.1, 53.8 (CH2d / CHb, Cc,CH2e), 3.72-3.63 / 54.3, 53.8, 23.5 (CH2e / CH2d, CH2e, 
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CH2f), 2.94-2.83 / 54.3, 53.8, 23.5 (CH2e / CH2d CH2e, CH2f), 2.29-2.18 / 53.8, 23.5 (CH2f / CH2e, 
CH2f), 2.14-2.05 / 53.8, 23.5 (CH2f / CH2e, CH2f).  
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C15H20NCl2Ti [M-Cl+H]+ 
332.04492; found 332.04335 (Rel. ab: 100%, -4.0 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3111; 2954; 2357 (N-H); 1433; 1015; 823. 
FIR: 697; 642; 607; 597; 448; 401; 365; 303; 263; 257. 
Elemental Analysis: % calcd for C15H20Cl3NTi: C, 48.88; H, 5.44; N, 3.69; Found: C, 49.14; 
H, 5.82; N, 3.89. 
XRD: 
 
Experimental. Single orange plate-shaped crystals of (quent1) were 
obtained by slow diffusion of pentane into a chloroform solution at room 
temperature. A suitable crystal (0.25×0.10×0.05) mm3 was selected and 
mounted on a mylar loop with oil on a Nonius Kappa Apex II 
diffractometer. The crystal was kept at T = 115 K during data collection., 
The structure was solved with the SIR2004 (Burla et al., 2007) structure 
solution program, using the Direct Methods solution method. Using Olex2 
(Dolomanov et al., 2009) the model was refined with version 2014/7 of 
XL (Sheldrick, 2008) using Least Squares minimisation. 
Crystal Data. C16H21Cl6NTi, Mr = 487.94, triclinic, P-1 (No. 2), a = 
6.3551(2) Å, b = 11.2920(4) Å, c = 15.2516(4) Å, α = 73.396(2)°, β = 
79.317(2)°, γ = 78.9870(10)°, V = 1019.53(6) Å3, T = 115 K, Z = 2, Z' = 1, 
µ(MoKα) = 1.205, 14702 reflections measured, 4602 unique (Rint = 
0.0312) which were used in all calculations. The final wR2 was 0.1911 (all 
data) and R1 was 0.0798 (I > 2(I)). 
 
  
Compound  quent1  
    
Formula  C16H21Cl6NTi  
Dcalc./ g cm-3  1.589  
µ/mm-1  1.205  
Formula Weight  487.94  
Colour  orange  
Shape  plate  
Size/mm3  0.25×0.10×0.05 
T/K  115  
Crystal System  triclinic  
Space Group  P-1  
a/Å  6.3551(2)  
b/Å  11.2920(4)  
c/Å  15.2516(4)  
α/°  73.396(2)  
β/°  79.317(2)  
γ/°  78.9870(10)  
V/Å3  1019.53(6)  
Z  2  
Z'  1  
Wavelength/Å  0.71073  
Radiation type  MoKα  
Θmin/°  1.902  
Θmax/°  27.505  
Measured Refl.  14702  
Independent Refl. 4602  
Reflections Used  4354  
Rint  0.0312  
Parameters  300  
Restraints  456  
Largest Peak  0.851  
Deepest Hole  -0.791  
GooF  1.240  
wR2 (all data)  0.1911  
wR2  0.1894  
R1 (all data)  0.0832  
R1  0.0798  
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15. Synthesis of 16: 
 
To a solution of 11 (150 mg, 0.45 mmol, 1 eq, 5 mL toluene) was added dropwise a freshly-
prepared HCl solution (5 mL). A red precipitate appeared from the red starting solution. The 
reaction mixture was left to stir for 15 min and the red precipitate was then filtered off and 
washed with 2 mL of toluene and 3 x 5 mL of pentane. (100 mg, yield: 60 %). 
1H NMR (600.23 MHz, 300 K, chloroform-d1): δ1H: 12.90 (s, 1H, Hk), 7.63-7.59 (m, 4H, Hg), 
7.46-7.43 (m, 6H, Hh, Hi), 6.96 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Ha), 6.61 (s, 5H, Hj), 6.47 
(apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 4.25 (dd, 2JHH = 13.3 Hz, 3JHNlH = 4.5 Hz, 2H, He), 
4.18-4.15 (m overlapping with He, 2H, Hd), 4.15 (dd overlapping with Hd, 2JHH = 13.3 Hz, 3JHNH 
= 4.5 Hz, 2H, He). 
13C{1H} NMR (150.94 MHz, 300 K, chloroform-d1): δ13C: 131.7 (Cg), 130.4 (Ci), 129.7 (Ch), 
128.4 (Cf), 124.9 (Ca), 122.5 (Cc), 121.2 (Cj), 117.3 (Cb), 57.5 (Ce), 52.5 (Cd). 
1H 1H COSY (600.23 MHz, 300 K, chloroform-d1): δ1H / δ1H: 7.63-7.59 / 7.46-7.43 (CHg / CHh, 
CHi), 7.46-7.43 / 7.63-7.59 (CHh, CHi / CHg), 6.96 / 6.47 (CHa / CHb), 6.47 / 6.96 (CHb / CHa), 
4.25 / 4.14 (CHe / CHe), 4.14 / 4.25 (CHe / CHe). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 7.63-7.59 / 131.7 
(CHg), 7.46-7.43 / 130.4, 129.7 (CHi, CHh), 6.96 / 124.9 (CHb), 6.61 / 121.2 (CHj), 6.47 / 117.3 
(CHb), 4.25 / 57.5 (CHe), 4.18-4.15 / 52.5 (CH2d), 4.14 / 57.5 (CH2e). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 7.63-7.59 / 131.7, 
130.4, 129.7 (CHg / CHg, CHi, CHh), 7.46-7.43 / 131.7, 129.7, 128.4 (CHh, CHi / CHg, CHh/i, Cf), 
6.96 / 124.9, 122.5, 117.3 (CHa / CHa, Cc, CHb), 6.61 / 121.2 (CHj / CHj), 6.47 / 124.9, 122.5, 
117.3 (CHb / CHa , Cc, CHb), 4.25 / 131.7, 128.4 (CH2e / CHg, Cf), 4.18-4.15 / 124.9, 122.5, 57.5 
(CH2d / CHa, Cc, CH2d, CH2e), 4.14 / 131.7, 128.4 (CH2e / CHg, Cf). 
HMRS (Positive mode ESI, dichloromethane-methanol): m/z calcd. for C25H26NCl2Ti [M-
Cl]+ 458.09196; found 458.09056 (Rel. ab: 15%, -2.3 ppm) 
IR (ATR) ν [cm-1]  
MIR: 3108; 2423 (N-H); 2354; 1445; 824. 
FIR: 696; 615; 601; 506; 488; 363; 304; 256. 
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Elemental Analysis: % calcd for C25H26Cl3NTi: C, 60.70; H, 5.30; N, 2.83; Found: C, 60.54; 
H, 5.13; N, 2.92.  
16. Synthesis of 17: 
 
 
To a solution of 12 (725 mg, 1.82 mmol, 1 eq, 5 mL toluene) was added dropwise a freshly-
prepared HCl solution (5 mL). A red precipitate appeared from the red starting solution. The 
reaction mixture was left to stir for 15 min and the red precipitate was then filtered off and 
washed with 2 mL of toluene and 3 x 5 mL of pentane. (490 mg, yield: 66 %). 
1H NMR (600.23 MHz, 300 K, chloroform-d1): δ1H: 11.62 (s, 1H, Hh), 7.00 (bs, 2H, Ha), 6.68 (s, 
5H, Hg), 6.57 (bs, 2H, Hb), 4.35 (d, 3JHNH = 5.2 Hz, 2H, Hd), 3.71 (dhept, 3JHH = 6.7 Hz, 3JHNH = 
3.4 Hz, 2H, He), 1.56 (d, 3JHH = 6.7 Hz, 6H, Hf), 1.51 (d, 3JHH = 6.7 Hz, 6H, Hf).12 
13C{1H} NMR (150.94 MHz, 300 K, chloroform-d1): δ13C: 127.0 (CHa), 122.8 (Cc), 120.9 (Cg), 
115.0 (Cb), 55.2 (Ce), 46.6 (Cd), 19.3 (Cf), 18.1 (Cf). 
1H 1H COSY (600.23 MHz, 300 K, chloroform-d1): δ1H / δ1H: 7.00 / 6.57 (CHa / CHb), 6.57 / 7.00 
(CHb / CHa), 3.71 / 1.56, 1.51 (CH2e / CH3f, CH3f), 1.56 / 3.71 (CH3f / CH2e), 1.51 / 3.71 (CH3f / 
CH2e). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 7.00 / 127.0 (CHa), 
6.68 / 120.9 (CHg), 6.57 / 115.0 (CHb), 4.35 / 46.6 (CH2d), 3.71 / 55.2 (CHe), 1.56 / 19.3 (CH3f), 
1.56 / 19.3 (CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 7.00 / 127.0, 122.8 
115.0 (CHa / Cc, CHa, CHb), 6.68 / 120.9 (CHg / CHg), 6.57 / 127.0, 122.8, 55.2 (CHb / CHa, Cc, 
CH2e), 4.35 / 127.0, 122.8, 55.2 (CH2d / CHa, Cc, CHe), 1.56 / 55.2, 18.1 (CHf / CH2d, CH3f), 1.51 
/ 55.2, 19.3 (CH3f / CH2d, CH3f). 
HMRS (Positive mode ESI, dichloromethane-methanol): m/z calcd. for C19H21NClTi [M-Cl]+ 
362.09189; found 362.09282 (Rel. ab: 85%, 3.3 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3109; 3051; 2483 (N-H); 1423; 819. 
FIR: 631; 611; 554; 497; 402; 362; 304; 255. 
                                               
12
 Methyl groups are diastereotopics, that’s why, two different signals are observed. 
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Elemental Analysis: % calcd for C25H26Cl3NTi: C, 51.22; H, 6.57; N, 3.51; Found: C, 50.95; 
H, 7.64; N, 3.52. 
XRD: 
 
Experimental. Single red plate-shaped crystals of (quentin7_0m) were 
obtained by recrystallisation from slow diffusion of pentane into a 
chloroform solution at -15°C. A suitable crystal (0.17×0.17×0.05) mm3 
was selected and mounted on a mylar loop with oil on a Nonius Kappa 
APEX II diffractometer. The crystal was kept at T = 115 K during data 
collection. Using Olex2 (Dolomanov et al., 2009), the structure was solved 
with the SIR2004 (Burla et al., 2007) structure solution program, using the 
Direct Methods solution method. The model was refined with version 
2014/7 of XL (Sheldrick, 2008) using Least Squares minimisation. 
Crystal Data. C17H26Cl3TiN, Mr = 398.64, monoclinic, P21/n (No. 14), a = 
11.0641(6) Å, b = 10.2866(6) Å, c = 16.7645(9) Å, β = 107.559(2)°, α = 
γ = 90°, V = 1819.10(18) Å3, T = 115 K, Z = 4, Z' = 1, µ(MoKα) = 0.907, 
48780 reflections measured, 8183 unique (Rint = 0.0459) which were used 
in all calculations. The final wR2 was 0.0912 (all data) and R1 was 0.0361 (I > 2(I)). 
17. Synthesis of 18: 
Chemical Formula: C20H30Cl3NTi
Molecular Weight: 438,7
f
e
h
g
i
b
a
d
c
Ti ClCl
N
H
Cl
 
To a solution of 13 (2.55 g, 5.81 mmol, 1 eq, 5 mL toluene) was added dropwise a freshly-
prepared HCl solution (5 mL). A red precipitate appeared from the red starting solution. The 
Compound  quentin7_0m  
    
Formula  C17H26Cl3TiN  
Dcalc./ g cm-3  1.456  
µ/mm-1  0.907  
Formula Weight  398.64  
Colour  red  
Shape  plate  
Size/mm3  0.17×0.17×0.05 
T/K  115  
Crystal System  monoclinic  
Space Group  P21/n  
a/Å  11.0641(6)  
b/Å  10.2866(6)  
c/Å  16.7645(9)  
α/°  90  
β/°  107.559(2)  
γ/°  90  
V/Å3  1819.10(18)  
Z  4  
Z'  1  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  2.549  
Θmax/°  35.359  
Measured Refl.  48780  
Independent Refl. 8183  
Reflections Used  6370  
Rint  0.0459  
Parameters  203  
Restraints  0  
Largest Peak  0.675  
Deepest Hole  -0.343  
GooF  1.060  
wR2 (all data)  0.0912  
wR2  0.0834  
R1 (all data)  0.0538  
R1  0.0361  
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reaction mixture was left to stir for 15 min and the red precipitate was then filtered off and 
washed with 2 mL of CHCl3. The compound was made precipitated by adding pentane on a 
concentrated CHCl3 solution. (1.86 g, yield: 73 %). 
1H NMR (600.23 MHz, 300 K, chloroform-d1): δ1H: 10.77 (s, 1H, Hj), 6.75 (apparent t, 3JHH = 
4JHH = 2.6 Hz, 2H, Ha), 6.65 (s, 5H, Hi), 6.63 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 4.58 (d, 
3JHdHj = 3.5, 2H, Hd), 2.81-2.73 (apparent td, 2H, Hg), 1.79 (s, 6H, Hf), 1.75-1.67 (m, 2H, Hh), 
1.60-1.53 (m, 2H, Hg), 1.46 (s, 6H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, chloroform-d1): δ13C: 129.9 (Ca), 122.9 (Ci), 120.6 (Cb), 
112.6 (Cc), 66.9 (Ce), 46.1 (Cd), 36.8 (Cg), 30.2 (Cf), 22.1 (Cf), 16.2 (Ch). 
1H 1H COSY (600.23 MHz, 300 K, chloroform-d1): δ1H / δ1H: 10.77 / 4.58 (NHj / CH2d), 6.75 / 
6.63 (CHa / CHb), 6.63 / 6.75 (CHb / CHa), 4.58 / 10.77 (CH2d / NHj), 2.81-2.73 / 1.75-1.67, 1.60-
1.53 (CH2g / CH2h, CH2g), 1.75-1.67 / 2.81-2.73, 1.60-1.53 (CH2h / CH2g, CH2g), 1.60-1.53 / 2.81-
2.73, 1.75-1.67 (CH2g / CH2g, CH2h). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 6.75 / 129.9 (CHa), 
6.65 / 122.9 (CHi), 6.63 / 120.6 (CHb), 4.58 / 46.1 (CH2d), 2.81-2.73 / 36.8 (CH2g), 1.79 / 30.2 
(CH3f), 1.75-1.67 / 16.2 (CH2h), 1.60-1.53 / 36.8 (CH2g), 1.46 / 22.1 (CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1): δ1H / δ13C: 6.75 / 129.9, 
122.9, 112.6 (CHa / Cc, CHa, CHb), 6.65 / 120.6 (CHi / CHi), 6.63 / 129.9, 122.9, 112.6 (CHb / 
Cc, CHa, CHb), 4.58 / 129.9, 122.9, 66.9 (CH2d / Cc, CHa, Ce), 2.81-2.73 / 66.9, 22.1 (CHg / Ce, 
CH3f), 1.79 / 66.9, 36.8, 22.1 (CH3f / Ce, CH2g, CH3f), 1.60-1.53 / 36.8 (CH2g / CH2g), 1.46 / 66.9, 
36.8, 30.2 (CH3f / Ce, CH2g, CH3f). 
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C20H30NCl2Ti [M+H]+ 
402.12322; found 402.12149 (Rel. ab: 85%, -3.6 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3092; 3976; 2588(N-H); 2468; 1459; 1391; 820; 696. 
FIR: 632; 601; 594; 484; 399; 363; 300; 255; 114. 
Elemental Analysis: % calcd for C20H30Cl3NTi: C, 54.76; H, 6.89; N, 3.19; Found: C, 54.57; 
H, 6.60; N, 2.87. 
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XRD: 
 
Experimental. Single red plate-shaped crystals of 
(quentin21102013_0m) were obtained by recrystallisation from 
slow diffusion of pentane into a chloroform solution at room 
temperature. A suitable crystal (0.17×0.07×0.03) mm3 was 
selected and mounted on a mylar loop with oil on a Nonius Kappa 
APEX II diffractometer. The crystal was kept at T = 115 K during 
data collection. Using Olex2 (Dolomanov et al., 2009), the 
structure was solved with the ShelXS (Sheldrick, 2008) structure 
solution program, using the Direct Methods solution method. The 
model was refined with version 2014/7 of XL (Sheldrick, 2008) 
using Least Squares minimisation. 
Crystal Data. C20H30Cl3NTi, Mr = 438.70, monoclinic, C2/c 
(No. 15), a = 33.057(3) Å, b = 7.0951(4) Å, c = 21.3626(15) Å, 
β = 123.711(2)°, α = γ = 90°, V = 4167.9(5) Å3, T = 115 K, Z = 8, 
Z' = 1, µ(MoKα) = 0.799, 29692 reflections measured, 3369 
unique (Rint = 0.0447) which were used in all calculations. The 
final wR2 was 0.0821 (all data) and R1 was 0.0332 (I > 2(I)). 
18. Synthesis of 19: 
Chemical Formula: C22H35Cl2NTi
Molecular Weight: 432,3
e f
g
b
a
d
c
Ti Cl
Cl
N
h
 
A solution of 4-K (1.0 g, 4.6 mmol, 1 eq) in 70 mL of toluene was added to a solution of Cp*TiCl3 
(1.33 g, 4.6 mmol, 1 eq) in 50 mL of toluene, by cannulation at -30°C. The resulting solution 
was left to warm up to room temperature and then stirred overnight. The crude red solution 
Compound  quentin21102013_0
m  
    
Formula  C20H30Cl3NTi  
Dcalc./ g cm-3  1.398  
µ/mm-1  0.799  
Formula Weight  438.70  
Colour  red  
Shape  plate  
Size/mm3  0.17×0.07×0.03  
T/K  115  
Crystal System  monoclinic  
Space Group  C2/c  
a/Å  33.057(3)  
b/Å  7.0951(4)  
c/Å  21.3626(15)  
α/°  90  
β/°  123.711(2)  
γ/°  90  
V/Å3  4167.9(5)  
Z  8  
Z'  1  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  3.027  
Θmax/°  24.266  
Measured Refl.  29692  
Independent Refl.  3369  
Reflections Used  2659  
Rint  0.0447  
Parameters  293  
Restraints  60  
Largest Peak  0.279  
Deepest Hole  -0.218  
GooF  1.038  
wR2 (all data)  0.0821  
wR2  0.0745  
R1 (all data)  0.0497  
R1  0.0332  
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was first evaporated. The deep red oil obtained was dissolved in 10 mL of CH2Cl2, filtered 
through diatomaceous earth, which was then washed by 2 x 2 mL of CH2Cl2. The compound 
was concentrated and layered with pentane (15: 45 mL) to favored precipitation or 
crystallization at -15°C. The red precipitate was then filtered and dried in vacuo. (923 mg, yield 
= 46 %). 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 6.19 (apparent t, 3JHH = 4JHH = 2.6 Hz, 
2H, Ha), 5.99 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 3.69 (s, 2H, Hd), 2.97 (hept, 3JHH = 6.7 
Hz, 2H, He), 2.01 (s, 15H, Hh), 1.00 (d, 3JHH = 6.7 Hz, 12H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, dichloromethane-d2): δ13C: 139.5 (Cc), 130.0 (Cg), 124.4 
(Ca), 115.9 (Cb), 49.1 (Ce), 45.4 (Cd), 21.3 (Cf), 13.8 (Ch). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 6.19 / 5.99 (CHa / CHb), 5.99 
/ 6.19 (CHb / CHa), 2.97 / 1.00 (CH2e / CH3f), 1.00 / 2.97 (CH3f / CH2e). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.19 / 124.4 
(CHa), 5.99 / 115.9 (CHb), 3.69 / 45.4 (CH2d), 2.97 / 49.1 (CHe), 2.01 / 13.8 (CH3h), 1.00 / 21.3 
(CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.19 / 124.4, 
115.9 (CHa / Cc, CHa, CHb), 5.99 / 139.5, 124.4 (CHb / Cc, CHa), 3.69 / 139.5, 124.4, 49.1 (CH2d 
/ Cc, CHa, CHe), 2.97 / 49.1, 45.4, 21.3 (CHe / CHe, CH2d, CH3f), 2.01 / 130.0 (CH3h / Cg), 1.00 / 
49.1, 21.3 (CH3f / CHe, CH3f). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 1.00 / -322.1 
(Hf / N). 
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C22H36NCl2Ti [M+H]+ 
432.17019; found 432.16878 (Rel. ab. 100%, -2.5 ppm). 
IR (ATR) ν [cm-1]  
MIR: 2963; 1431; 1377; 1201; 1171; 1119; 1020; 895; 829; 789; 618. 
FIR: 620; 614; 379; 348; 310; 274; 186; 126. 
Elemental Analysis: % calcd for C22H35NCl2Ti: C, 61.12; H, 8.16; N, 3.24; Found: C, 61.13; 
H, 8.26; N, 3.40. 
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XRD: 
 
Experimental. Single red block-shaped crystals of 
(pierre090414bis_0m) were obtained by recrystallisation from 
diffusion of pentane in a concentrated dichloromethane solution at -
15°C. A suitable crystal (0.45×0.37×0.17) mm3 was selected and 
mounted on a mylar loop with oil on a Nonius Kappa Apex II 
diffractometer. The crystal was kept at T = 115 K during data 
collection. Using Olex2 (Dolomanov et al., 2009), the structure was 
solved with the ShelXT (Sheldrick, 2015) structure solution 
program, using the Intrinsic Phasing solution method. The model was 
refined with version 2014/7 of XL (Sheldrick, 2008) using Least 
Squares minimisation. 
Crystal Data. C22H35Cl2NTi, Mr = 432.31, monoclinic, P21/c (No. 
14), a = 11.9003(7) Å, b = 24.9058(15) Å, c = 16.1960(10) Å, β = 
111.552(2)°, α = γ = 90°, V = 4464.7(5) Å3, T = 115 K, Z = 8, Z' = 2, 
µ(MoKα) = 0.629, 65479 reflections measured, 10353 unique (Rint = 
0.0360) which were used in all calculations. The final wR2 was 
0.0746 (all data) and R1 was 0.0291 (I > 2(I)). 
 
19. Synthesis of 20: 
 
TiCl4(THF)2 (268 mg, 0.8 mmol, 1 eq) dissolved in 5 mL of Et2O was added dropwise at 0°C 
by cannulation on 3-K (500 mg, 1.6 mmol, 2.0 eq) dissolved in 10 mL of Et2O The resulting 
Compound  pierre090414bis_0m 
    
Formula  C22H35Cl2NTi  
Dcalc./ g cm-3  1.286  
µ/mm-1  0.629  
Formula Weight  432.31  
Colour  red  
Shape  block  
Size/mm3  0.45×0.37×0.17  
T/K  115  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  11.9003(7)  
b/Å  24.9058(15)  
c/Å  16.1960(10)  
α/°  90  
β/°  111.552(2)  
γ/°  90  
V/Å3  4464.7(5)  
Z  8  
Z'  2  
Wavelength/Å  0.71073  
Radiation type  MoKα  
Θmin/°  0.818  
Θmax/°  27.509  
Measured Refl.  65479  
Independent Refl. 10353  
Reflections Used  9880  
Rint  0.0360  
Parameters  488  
Restraints  0  
Largest Peak  0.407  
Deepest Hole  -0.321  
GooF  1.118  
wR2 (all data)  0.0746  
wR2  0.0692  
R1 (all data)  0.0322  
R1  0.0291  
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solution was left to warm up to room temperature and then stirred 30 min. The crude red/brown 
solution was filtered through diatomaceous earth which was then washed 2 x 5 mL of Et2O and 
residual starting material. The brown solution was then evaporated to yield a dark brown oil. 
The compound was purified by crystallization thanks to a biphasic (Dichloromethane: Pentane 
1: 3) in the Glove box. After removing the mother liquor, red crystals were obtained after 
washing with pentane and drying (80 mg, yield = 15 %).13 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 7.36 (d, 3JHH = 7.4 Hz, 8H, Hg), 7.32 
(t, 3JHH/I = 7.4 Hz, 8H, Hh), 7.24 (t, 3JHH = 7.4 Hz, 4H, Hi), 6.35 (apparent t, 3JHH = 4JHH = 2.6 Hz, 
2H, Ha), 6.25 (apparent t, 3JHH= 4JHH = 2.6 Hz, 2H, Hb), 3.53 (s overlapping with Hd, 8H, He), 
3.52 (s overlapping with He, 4H, Hd). 
13C{1H} NMR (150.94 MHz, 300 K, dichloromethane-d2): δ13C: 139.9 (Cf), 132.2 (Cc), 129.4 
(Cg), 128.8 (Ch), 127.6 (Ci), 124.5 (Ca), 117.1 (Cb), 58.7 (Ce), 53.6 (Cd). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 7.36 / 7.32 (CHg / CHh), 7.32 
/ 7.36, 7.24 (CHh / CHg, CHi), 7.24 / 7.32 (CHi / CHg), 6.35 / 6.25 (CHa / CHb), 6.25 / 6.35 (CHb 
/ CHa). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.36 / 129.4 
(CHg), 7.32 / 128.8 (CHh), 7.24 / 127.6 (Hi), 6.35 / 124.5 (CHa), 6.25 / 117.1 (CHb), 3.53 / 58.7 
(CH2e), 3.52 / 53.6 (CH2d). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.36 / 129.4, 
127.6, 58.7 (CHg / CHg, CHi, CHe), 7.32 / 139.9, 128.8 (CHh / Cf, CHh), 7.24 / 129.4 (CHi / CHg), 
6.35 / 124.5, 117.7 (CHa / CHa, CHb), 6.25 / 132.2, 124.5 (CHb / Cc, CHa), 3.53 / 132.2, 124.5, 
53.6 (CH2e / Cc, CHa, CH2d), 3.52 / 139.9, 129.4, 58.7 (CH2d / Cf, CHg, CH2e).  
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, benzene-d6): δ1H / δ15N: 3.52 / -328 (Hd / N). 
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C40H41N2Cl2Ti [M+H]+ 
667.21258; found 667.21217 (Rel. ab: 35%, 0.137 ppm), C40H40N2ClTi [M-Cl]+ 631.23586; 
found 631.23645 (Rel. ab: 5%, 1.7 ppm). 
 
 
 
 
 
 
 
 
                                               
13
 IR spectroscopy and elemental analysis were not performed due to a lack of compound and the non-reproducible character of 
its synthesis 
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XRD:  
 
 
Experimental. Single orange prism-shaped crystals of (q3) 
were obtained by recrystallisation from diffusion of pentane 
into a concentrated dichloromethane solution at room 
temperature. A suitable crystal (0.27×0.22×0.17) mm3 was 
selected and mounted on a mylar loop with oil on a Bruker 
APEX-II CCD diffractometer. The crystal was kept at T = 
115 K during data collection. Using Olex2 (Dolomanov et al., 
2009), the structure was solved with the SIR2004 (Burla et al., 
2007) structure solution program, using the Direct Methods 
solution method. The model was refined with version 2014/7 
of XL (Sheldrick, 2008) using Least Squares minimisation. 
Crystal Data. C40H40Cl2TiN2, Mr = 667.54, monoclinic, P2/c 
(No. 13), a = 13.2491(4) Å, b = 6.5269(2) Å, c = 20.2691(7) Å, 
β = 107.0590(10)°, α = γ = 90°, V = 1675.66(9) Å3, T = 115 K, 
Z = 2, Z' = 0.5, µ(MoKα) = 0.446, 6022 reflections measured, 
3813 unique (Rint = 0.0135) which were used in all calculations. The final wR2 was 0.0725 (all data) and R1 
was 0.0316 (I > 2(I)). 
 
20. Synthesis of 21: 
 
TiCl
Cl Cl
N
a
b c
d e
f
g
h
Chemical Formula: C15H24Cl3NTi
Molecular Weight: 372,6
 
A solution of 5-K (1.0 g, 3.9 mmol, 1.0 eq) in 30 mL of THF was cooled down at -70°C. 
Trimethylsilyl chloride (0.55 mL, 4.3mmol, 1.1 eq) was added dropwise to the solution and the 
Compound   quentin21102013_0m 
    
Formula   C20H30Cl3NTi  
Dcalc./ g cm-3   1.398  
µ/mm-1   0.799  
Formula Weight   438.70  
Colour   red  
Shape   plate  
Size/mm3   0.17×0.07×0.03  
T/K   115  
Crystal System   monoclinic  
Space Group   C2/c  
a/Å   33.057(3)  
b/Å   7.0951(4)  
c/Å   21.3626(15)  
α/°   90  
β/°   123.711(2)  
γ/°   90  
V/Å3   4167.9(5)  
Z   8  
Z'   1  
Wavelength/Å   0.710730  
Radiation type   MoKα  
Θmin/°   3.027  
Θmax/°   24.266  
Measured Refl.   29692  
Independent Refl. 3369  
Reflections Used  2659  
Rint   0.0447  
Parameters   293  
Restraints   60  
Largest Peak   0.279  
Deepest Hole   -0.218  
GooF   1.038  
wR2 (all data)   0.0821  
wR2   0.0745  
R1 (all data)   0.0497  
R1   0.0332  
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resulting solution was warmed up to room temperature and stirred for 3h. All volatiles were 
removed by evaporation to yield a yellow sticky solid. Dissolution of the solid in 30 mL of 
pentane and filtration through diatomaceous earth were used to remove KCl salts. Pentane 
was evaporated to yield the corresponding silylated amino cyclopentadiene (970 mg, 3.33 
mmol, 85 %) as a yellow solid. It was dissolved in 40 mL of toluene, and added at - 30°C to a 
toluenic solution of TiCl4 (0.36 mL, 3.33 mmol, 1eq). The resulting brown solution was left to 
warm up to room temperature and stirred overnight. A dark brown solution with a black 
precipitate was obtained. The heterogeneous solution was dried in vacuo. The brownish 
residue was triturated in pentane (30 mL) and dried in vacuo. The sticky residue was triturated 
in cold pentane (10 mL) and filtered to yield a dark brown precipitate (1.08g, 87% step yield, 
74% global yield). 
1H NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 6.40 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Ha), 
6.15 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 3.75 (s, 2H, Hd), 1.39-1.34 (m, 2H, Hh), 1.28-
1.25 (m, 4H, Hg), 0.82 (s, 12H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, benzene-d6): δ13C: 151.0 (Cc), 123.9 (Ca), 123.5 (Cb), 55.3 
(Ce), 45.5 (Cd), 41.2 (Cg), 29.0-27.2 (Cf), 17.8 (Ch). 
1H 1H COSY (600.23 MHz, 300 K, benzene-d6): δ1H / δ1H: 6.40 / 6.15 (CHa / CHb), 6.15 / 6.40 
(CHb / CHa), 1.39-1.34 / 1.28-1.25 (CH2h / CH2g), 1.28-1.25 / 1.39-1.34 (CH2g / CH2h). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C: 6.40 / 123.9 (CHa), 
6.15 / 123.5 (CHb), 3.75 / 45.5 (CH2d), 1.39-1.34 / 17.8 (CH2h), 1.28-1.25 / 41.2 (CH2g), 0.82 / 
29.0-27.2 (CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C: 6.40 / 123.5 (CHa / 
CHb), 6.15 / 151.0, 123.9 (CHb / Cc, CHa), 3.75 / 151.0, 124.0, 55.3 (CH2d / Cc, CHa, Ce), 1.39-
1.34 / 55.3, 41.3 (CHh / Ce, CH2g), 1.28-1.25 / 55.3, 41.2, 17.8 (CH2g / Ce, CH2g, CH2h), 0.82 / 
55.3, 41.3, 29.0-27.2 (CH3f / Ce, CH2h, CH3f). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, benzene-d6): δ1H / δ15N: 0.82 / -308 (Hf / N). 
HMRS (Positive mode ESI, dichloromethane / MeOH): m/z calcd. for C16H28NCl2TiO [M-
Cl+OCH3+H]+ 368.10244; found 368.1074 (Rel. ab: 100%, 2.3 ppm). 
IR (ATR) ν [cm-1]  
MIR:2942; 2586; 1409; 1224; 1115; 797. 
FIR: 624; 535; 404; 287; 159; 121. 
Elemental Analysis: % calcd for C15H24NCl3Ti: C, 48.35; H, 6.49; N, 3.76; Found: C, 48.67; 
H, 6.69; N, 3.63. 
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XRD:  
 
Experimental. Single brown plate-shaped crystals of 
(mo_q110914_0m_a) were obtained by introducing the filtrate 
at -15°C for several days. A suitable crystal 
(0.50×0.36×0.03) mm3 was selected and mounted on a mylar 
loop with oil on a Bruker D8 Mo diffractometer. The crystal was 
kept at T = 100 K during data collection. Using Olex2 
(Dolomanov et al., 2009), the structure was solved with the 
ShelXS (Sheldrick, 2008) structure solution program, using the 
Direct Methods solution method. The model was refined with 
version 2014/7 of XL (Sheldrick, 2008) using Least Squares 
minimisation. 
Crystal Data. C15H24Cl3NTi, Mr = 372.60, monoclinic, P21/c 
(No. 14), a = 7.8807(5) Å, b = 14.9295(9) Å, c = 14.8251(9) Å, 
β = 92.5190(19)°, α = γ = 90°, V = 1742.56(19) Å3, T = 100 K, 
Z = 4, Z' = 1, µ(MoKα) = 0.941, 37843 reflections measured, 
4005 unique (Rint = 0.0348) which were used in all calculations. 
The final wR2 was 0.0858 (all data) and R1 was 0.0362 (I > 2(I)). 
 
Compound  mo_q110914_0m_a  
    
Formula  C15H24Cl3NTi  
Dcalc./ g cm-3  1.420  
µ/mm-1  0.941  
Formula Weight  372.60  
Colour  brown  
Shape  plate  
Size/mm3  0.50×0.36×0.03  
T/K  100  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  7.8807(5)  
b/Å  14.9295(9)  
c/Å  14.8251(9)  
α/°  90  
β/°  92.5190(19)  
γ/°  90  
V/Å3  1742.56(19)  
Z  4  
Z'  1  
Wavelength/Å  0.710760  
Radiation type  MoKα  
Θmin/°  3.056  
Θmax/°  27.571  
Measured Refl.  37843  
Independent Refl.  4005  
Reflections Used  3395  
Rint  0.0348  
Parameters  185  
Restraints  0  
Largest Peak  0.472  
Deepest Hole  -0.272  
GooF  1.064  
wR2 (all data)  0.0858  
wR2  0.0777  
R1 (all data)  0.0472  
R1  0.0362  
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21. Synthesis of 22: 
 
A solution of 3-K (1.2 g, 3.83 mmol, 2.1 eq) in 15 mL of THF was added to a freshly prepared 
solution of ZrCl4(THF)2 (425 mg of ZrCl4 in 7 mL of THF, 1.83 mmol, 1 eq), by cannulation at -
10°C. The resulting solution was left to warm up to room temperature and then stirred 
overnight. The crude brown solution was first evaporated. The brown oil obtained was 
dissolved in 25 mL of toluene, filtered through diatomaceous earth which was then washed by 
4 x 10 mL of toluene
 
and residual starting material. The yellow solution was then evaporated 
to form a brown sticky oil which was stirred overnight in a mixture of Dichloromethane: pentane 
(1: 3) to yield a white precipitate. The precipitate was filtered off, washed with pentane (2 x 10 
mL) and dried to yield the desired compound. (400 mg, yield = 31 %).14 
1H NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 7.32 (d, 3JHH = 7.4 Hz, 8H, Hg), 7.20 (t, 3JHH = 
7.4 Hz, 8H, Hh), 7.10 (t, 3JHH = 7.4 Hz, 4H, Hi), 6.06 (apparent t, 3JHH = 4JHH = 2.6 Hz, 4H, Ha), 
5.72 (t, 3JHH = 4JHH = 2.6 Hz, 4H, Hb), 3.62 (s, 4H, Hd), 3.38 (s, 8H, He). 
13C{1H} NMR (150.94 MHz, 300 K, benzene-d6): δ13C: 139.6 (Cf), 129.2 (Cg), 128.7 (Ch), 128.6 
(Cc), 127.4 (Ci), 118.4 (Ca), 113.2 (Cb), 58.1 (Ce), 52.7 (Cd). 
1H 1H COSY (600.23 MHz, 300 K, benzene-d6): δ1H / δ1H: 7.32 / 7.20 (CHg / CHh), 7.20 / 7.32, 
7.10 (CHh / CHg, CHi), 7.10 / 7.20 (CHi / CHg), 6.06 / 5.72 (CHa / CHb), 5.72 / 6.06 (CHb / CHa). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.32 / 129.2 (CHg), 
7.20 / 128.7 (CHh), 7.10 / 127.4 (CHi), 6.06 / 118.4 (CHa), 5.72 / 113.2 (CHb), 3.62 / 52.7 (CH2d), 
3.38 / 58.1 (CH2e). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.32 / 129.2, 128.7, 
127.4, 58.1 (CHg / CHg, CHh, CHi, CHe), 7.20 / 139.6, 128.7 (CHh / Cf, CHh), 7.10 / 129.2, 128.7 
(CHi / CHg, CHh) 6.06 / 128.6, 118.4, 113.2 (CHa / Cc, CHa, CHb), 5.72 / 128.6, 118.4 (CHb / Cc, 
CHa), 3.62 / 128.6, 118.4, 58.1 (CH2d / Cc, CHa, CH2e), 3.38 / 139.6, 129.2, 58.1, 52.7 (CH2e / 
Cf, CHg, CH2d, CH2e).  
                                               
14
 A satisfactory elemental analysis could not be obtained (low C) due to remaining KCl salts or ZrCl4 
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1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, benzene-d6): δ1H / δ15N: 3.62 / -328 (Hd / N). 
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C40H41N2Cl2Zr [M+H]+ 
709.16884; found 709.16653 (Rel. ab: 15%, -3.3 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3062, 3061, 2825, 1494, 1243, 1029, 834 , 747. 
FIR: 698, 696, 638, 625, 504, 336, 278, 116. 
XRD: 
11-x,+y,1/2-z 
Experimental. Single colourless plate-shaped crystals of (shelx) 
were obtained by recrystallisation from diffusion of pentane into 
a dichloromethane solution at -15°C. A suitable crystal 
(0.37×0.22×0.10) mm3 was selected and mounted on a mylar 
loop with oil on a Bruker APEX-II CCD diffractometer. The 
crystal was kept at T = 115(2) K during data collection. Using 
Olex2 (Dolomanov et al., 2009), the structure was solved with 
the SIR2004 (Burla et al., 2007) structure solution program, 
using the Direct Methods solution method. The model was 
refined with version 2014/7 of XL (Sheldrick, 2008) using Least 
Squares minimisation. 
Crystal Data. C40H40Cl2N2Zr, Mr = 710.86, monoclinic, C2/c 
(No. 15), a = 26.4156(7) Å, b = 6.6533(2) Å, c = 20.1035(6) Å, 
β = 93.798(2)°, α = γ = 90°, V = 3525.45(18) Å3, T = 115(2) K, 
Z = 4, Z' = 0.5, µ(MoKα) = 0.494, 7508 reflections measured, 
4016 unique (Rint = 0.0199) which were used in all calculations. 
The final wR2 was 0.0678 (all data) and R1 was 0.0300 (I > 2(I)). 
  
Compound  shelx  
    
Formula  C40H40Cl2N2Zr  
Dcalc./ g cm-3  1.339  
µ/mm-1  0.494  
Formula Weight  710.86  
Colour  colourless  
Shape  plate  
Size/mm3  0.37×0.22×0.10  
T/K  115(2)  
Crystal System  monoclinic  
Space Group  C2/c  
a/Å  26.4156(7)  
b/Å  6.6533(2)  
c/Å  20.1035(6)  
α/°  90  
β/°  93.798(2)  
γ/°  90  
V/Å3  3525.45(18)  
Z  4  
Z'  0.5  
Wavelength/Å  0.71073  
Radiation type  MoKα  
Θmin/°  3.091  
Θmax/°  27.493  
Measured Refl.  7508  
Independent Refl.  4016  
Reflections Used  3663  
Rint  0.0199  
Parameters  204  
Restraints  0  
Largest Peak  0.335  
Deepest Hole  -0.266  
GooF  1.094  
wR2 (all data)  0.0678  
wR2  0.0644  
R1 (all data)  0.0355  
R1  0.0300  
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22. Synthesis of 23: 
 
 
A solution of 2-K (3 g, 13.8 mmol, 2.0 eq) in 70 mL of THF was added to a freshly prepared 
solution of ZrCl4(THF)2 (1.77 g of ZrCl4 in 30 mL of THF, 7.6 mmol, 1.1 eq), by cannulation at -
10°C. The resulting solution was left to warm up to room temperature and then stirred 
overnight. The crude brown solution was filtered through diatomaceous earth to remove KCl 
salts. Solvent was removed by vacuum pumping and the white precipitate obtained was wash 
with pentane (2 x 20 mL) to afford the desired compound in good yield .(2.75g, yield = 76 %).14 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 6.35 (m, 4H, Ha), 6.33 (m, 4H, Hb), 
3.66 (s, 4H, Hd), 2.97 (hept, 3JHH = 6.5 Hz, 4H, He), 1.01 (d, 3JHH = 6.5 Hz, 24H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, dichloromethane-d2): δ13C: 136.0 (Cc), 118.4 (Ca), 113.0 
(Cb), 48.8 (Ce), 44.8 (Cd), 21.2 (Cf). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 6.35 / 6.33 (CHa / CHb), 6.33 
/ 6.35 (CHb / CHa), 2.97 / 1.01 (CHe / CH3f), 1.01 / 2.97 (CH3f / CHe). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.35 / 118.4 
(CHa), 6.33 / 113.0 (CHb), 3.66 / 44.8 (CH2d), 2.97 / 48.8 (CH2e), 1.01 / 21.2 (CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.35 / 113.0 
(CHa / CHb), 6.33 / 136.0, 118.4 (CHb / Cc, CHa), 3.66 / 136.0, 118.4, 48.8 (CH2d / Cc, CHa, CHe), 
2.97 / 48.8, 44.8, 21.2 (CH2e / Ce, CH2d, CH3e), 1.01 / 48.8, 21.2 (CH3f / CHe, CH3f).  
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 1.01 / -322 (Hf 
/ N). 
HMRS (Positive mode ESI, dichloromethane): not detected. 
IR (ATR) ν [cm-1]  
MIR: 2931; 1458; 1360; 1199; 1017; 848; 739. 
FIR: 523; 359; 309; 277; 162; 105. 
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23. Synthesis of 24: 
 
A solution of 5-K (586 mg, 2.66 mmol, 1.0 eq) in 35 mL of THF was added to a solution of 
CpZrCl3 (700 mg, 2.66 mmol, 1 eq) in 35 mL of THF cooled down to -30°C. The resulting 
solution was left to warm up to room temperature and then stirred overnight. The crude solution 
was evaporated and the residue was treated with 30 mL of dichloromethane. After filtration 
through diatomaceous earth, the filtrate was evaporated and the residue triturated with 15 mL 
of pentane in order to form a white powder. The supernatant was removed and the precipitate 
washed twice with 5 mL of pentane. The desired compound was obtained after removal of all 
volatiles as a white powder. (640 mg, 54%).15 
 1H NMR (600.23 MHz, 300 K, tetrahydrofuran-d8): δ1H: 6.45 (s, 5H, Hi), 6.38 (apparent t, 3JHH 
= 
4JHH = 2.6 Hz, 2H, Ha), 6.31 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 3.82 (s, 2H, Hd), 1.59-
1.53 (m, 2H, Hh), 1.44-1.39 (m, 4H, Hg), 1.03 (s, 12H, Hf). 
13C{1H} NMR (150.94 MHz, 300 K, tetrahydrofuran-d8): δ13C: 142.6 (Cc), 117.6 (Cb), 116.6 (Ci), 
113.9 (Ca), 56.2 (Ce), 45.4 (Cd), 42.7 (Cg), 28.9-28.2 (Cf), 18.9 (Ch). 
1H 1H COSY (600.23 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ1H: 6.38 / 6.31 (CHa / CHb), 6.31 
/ 6.38 (CHb / CHa), 1.59-1.53 / 1.44-1.39 (CH2h / CH2g), 1.44-1.39 / 1.59-1.53 (CH2g / CH2h). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ13C: 6.45 / 116.6 
(CHi), 6.38 / 113.9 (CHa), , 6.31 / 117.6 (CHb), 3.82 / 45.4 (CH2d), 1.59-1.53 / 18.9 (CH2h), 1.44-
1.39 / 42.7 (CH2g), 1.03 / 28.9-28.2 (CH3f). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ13C: 6.45 / 116.6 
(CHi / CHi), 6.38 / 142.6, 117.6 (CHa / Cc, CHb), 6.31 / 113.9 (CHb / CHa), 3.82 / 142.6, 117.6, 
56.2 (CH2d / Cc, CHb, Ce), 1.44-1.39 / 56.2, 42.7, 28.9-28.2, 18.9 (CH2h / Ce, CH2g, CH2h, CH3f), 
1.03 / 56.2, 42.7, 28.9-28.2 (CH3f / Ce, CH2g, CH3f). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, tetrahydrofuran-d8): δ1H / δ15N: 1.44-1.39, 1.03 
/ -311 (Hg, Hf / N). 
HMRS (Positive mode ESI, dichloromethane): m/z calcd. for C20H30NCl2Zr [M+H]+ 
444.07969; found 444.07893 (Rel. ab: 10%, -1.701 ppm), C15H26N [M-CpZrCl2+H]+ 220.20652 
found 220.20539 (Rel. ab: 100%, -5.1 ppm). 
IR (ATR) ν [cm-1]  
                                               
15
 A satisfactory elemental analysis could not be obtained du to the remaining presence of bis-24 
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MIR: 3100, 2926, 2869, 1460, 1376, 1261, 1131, 1022, 771, 737. 
FIR: 627, 597, 535, 360, 309, 267, 153, 125. 
XRD:  
 
Experimental. Single colourless needle-shaped crystals of 
(mo_q160714_0ma) were obtained by recrystallisation from diffusion 
of pentane into a concentrated dichloromethane solution at -15°C. A 
suitable crystal (0.50×0.07×0.07) mm3 was selected and mounted on a 
mylar loop with grease on a Bruker D8 Mo diffractometer. The crystal 
was kept at T = 100 K during data collection. Using Olex2 (Dolomanov 
et al., 2009), the structure was solved with the ShelXS (Sheldrick, 
2008) structure solution program, using the Direct Methods solution 
method. The model was refined with version 2014/7 of XL (Sheldrick, 
2008) using Least Squares minimisation. 
Crystal Data. C20H29Cl2NZr, Mr = 445.56, orthorhombic, Pna21 (No. 
33), a = 21.2992(9) Å, b = 14.3145(7) Å, c = 6.5295(3) Å, α = β = γ = 
90°, V = 1990.76(16) Å3, T = 100 K, Z = 4, Z' = 1, µ(MoKα) = 0.823, 
19980 reflections measured, 4387 unique (Rint = 0.0351) which were 
used in all calculations. The final wR2 was 0.0422 (all data) and R1 was 
0.0222 (I > 2(I)). 
Compound  mo_q160714_0ma 
    
Formula  C20H29Cl2NZr  
Dcalc./ g cm-3  1.487  
µ/mm-1  0.823  
Formula Weight  445.56  
Colour  colourless  
Shape  needle  
Size/mm3  0.50×0.07×0.07  
T/K  100  
Crystal System  orthorhombic  
Flack Parameter  -0.017(19)  
Hooft Parameter  0.011(18)  
Space Group  Pna21  
a/Å  21.2992(9)  
b/Å  14.3145(7)  
c/Å  6.5295(3)  
α/°  90  
β/°  90  
γ/°  90  
V/Å3  1990.76(16)  
Z  4  
Z'  1  
Wavelength/Å  0.710760  
Radiation type  MoKα  
Θmin/°  3.002  
Θmax/°  27.508  
Measured Refl.  19980  
Independent Refl. 4387  
Reflections Used  4026  
Rint  0.0351  
Parameters  221  
Restraints  1  
Largest Peak  0.330  
Deepest Hole  -0.263  
GooF  1.065  
wR2 (all data)  0.0422  
wR2  0.0406  
R1 (all data)  0.0286  
R1  0.0222  
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III. Chapter II: Generation of cationic species and study of their reactivity 
 
Several methods for cationic group 4 metals generation have been developed in the 
literature. This chapter will be composed of two parts: the first will present a preliminary 
overview of the reagents traditionally used for ligand abstraction; a second part will then be 
developed on the synthesis of cationic (aminomethyl)titanocenes and the study of their 
reactivity. 
A. Survey of the literature on X-ligand abstractors 
The heterolytic cleavage of the M-X bond is usually called abstraction. Considering a 
group 4 metallocene fragment, one can abstract easily a chloride or a methide, as developed 
in this chapter. The first abstractor commonly used in catalysis was the organometallic 
aluminium-based polymer methylaluminoxane, usually called MAO. MAO was often used in 
Ziegler-Natta catalysis as both chloride and alkide abstractor. The two main drawbacks of MAO 
are its use in approximately hundredfold to ten-thousandfold excess due to its polymeric 
structure of type [Al(CH3)xO]n; and its ill-defined action mechanism. As a result, numerous 
compounds with well-defined structures were further designed and used, in order to better 
understand the mechanisms involved in such reactions. These compounds are usually based 
on non-coordinating anions in order to prevent any coordination to the newly formed cationic 
species.1 
1. Chloride abstraction 
The first category of compounds described in the literature, are inorganic salts based 
on alkali metals with a non-coordinating, or at least weakly-coordinating counter anion. A highly 
valuable compound of this type was designed by Lapointe and Klosin in 2000,2 and used on a 
dichloroziroconocene by Erker two years later (Scheme III-1).3 The imidazolate A- showed no 
interaction with the cationic zirconocene. Tetrasubstituted borates BPh4 and B(C6F5)4- have 
also been used in conjunction with alkali metal cations.4 The driving force for these reactions 
is the precipitation of MCl salts (M = Li, Na, K,…). It generally requires the use of an adapted 
solvent (e.g. dichloromethane) in which the inorganic salt will precipitate. Such reactivity has 
already been described in Scheme I-42 with the use of [Li][BuB(C6F5)3].5 
                                               
1
 See for example Focante, F.; Mercandelli, P.; Sironi, A.; Resconi, L. Coord. Chem. Rev. 2006, 250, 170 and publications herein 
2
 LaPointe, R. E.; Roof, G. R.; Abboud, K. A.; Klosin, J. J. Am. Chem. Soc. 2000, 122, 9560 
3
 Vagedes, D.; Erker, G.; Fröhlich, R. J. Organomet. Chem. 2002, 641, 148 
4
 Döring, S.; Kotov, V. V.; Erker, G.; Kehr, G.; Bergander, K.; Kataeva, O.; Fröhlich, R. Eur. J. Inorg. Chem. 2003, 1599 
5
 Hüerländer, D.; Fröhlich, R.; Erker, G. J. Chem. Soc. Dalton Trans. 2002,7, 1513 
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Scheme III-1: chloride abstraction from L240 by the alkali metal salt [Li][A] 
 
An alternative reduction-oxidation process has been used for titanium complexes. By 
using an alkali metal with a reductive anion (PR2- or C8-), chloride abstraction is achieved 
concomitantly with reduction to Ti(III). Oxidation with a cationic oxidant containing a non-
coordinating anion (e.g. [Cp2Fe][BPh4]) results in net chloride abstraction. An example of this 
type has already been described in Scheme I-74. 
Furthermore, silver (I) salts have also been used to effect chloride abstraction. In that 
case, the high affinity of silver (I) for the chloride anion is the driving force of the abstraction 
reaction. Various salts are commercially available. One example with a zirconocene is depicted 
in Scheme III-2. The triflate ligand was shown to be substituted by water molecules due to the 
low basicity of the triflate ligand.6 The same reactivity was also observed with titanium by 
Thewalt and Klein.7 
 
Scheme III-2: synthesis of a ditriflate zirconocene with a silver-based abstractor 
 
Noteworthy, the use of [Ag][B(C6F5)4] on L211 by Wass led to the formation of the water 
addition compound L245, due to traces of water in the silver abstractor. In 1994, a new 
triethylsilyl cation was designed by Lambert,8 and then used later by Wass to overcome the 
problem met with the silver derivative. A chloride from the chloro titanocene L211 previously 
described (Scheme I-68) was successfully abstracted.9 The use of the triphenylsilyl analogue 
was also found to effect chloride abstraction (Scheme III-3).10  
                                               
6
 Thewalt, U.; Wiltraud, L. Z Naturforsch. 1983, 38b, 1501 
7
 Thewalt, U.; Klein, H.-P. Z. Für Krist. - Cryst. Mater. 1980, 153 
8
 Lambert, J. B.; Zhang, S.; Ciro, S. M. Organometallics. 1994, 13, 2430 
9
 Chapman, A. M.; Haddow, M. F.; Wass, D. F. Eur. J. Inorg. Chem. 2012, 2012, 1546 
10
 Chapman, A. M.; Wass, D. F. Dalton Trans. 2012, 41, 9067 
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Scheme III-3: formation of cationic titanocene derivatives by silyl- or silver-based abstractors 
 
The last category of compounds cited in this section are the Lewis acids based on 
group 13 elements. The most commonly used reagent in this category is MAO, as already 
been mentioned in the introduction. More recently, the perfluorinated borane B(C6F5)3 was 
shown to be as competent chloride or methide abstractor.11 The main disadvantage of its use 
is the reversibility of the abstraction. Indeed, several cationic transition metal complexes were 
isolated with the formation of a tight ion-pair between the cationic metal centre and the R-
B(C6F5)3- anion (R = Cl, or Me depending on the nature of the abstraction).12 An example of 
this type of interaction was reported by Le Gendre and Erker on a titanocene complex. The 
use of B(C6F5)3 on L237-PCy2 led to the formation of the desired cationic species in equilibrium 
with a tight ion-pair exhibiting a Cl between the cationic titanocene and the borane (L246-PCy2 
Scheme III-4).  
 
Scheme III-4: an example of chloride abstraction with B(C6F5)3 
                                               
11
 See for example: Bosch, B. E.; Erker, G.; Fröhlich, R.; Meyer, O. Organometallics. 1997, 16, 5449 
12
 For R=Me, see for example: Yang, X.; Stern, C.; Marks, T. J. Organometallics. 1991, 10, 840 
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This equilibrium was inferred on the basis of NMR spectroscopic data. Addition of CD3CN to 
the mixture led to the regeneration of the starting titanocene L237-PCy2 with the formation of 
the Lewis adduct of CD3CN → B(C6F5)3 (Scheme III-4).13 
The chloride abstraction was the first strategy envisioned in this project. The second 
was based on the abstraction of methide. This requires the synthesis of the corresponding 
methylated titanocenes, the synthesis of which will be presented in due course. 
2. Methide abstraction 
As mentioned above, group 13-based Lewis acids have been used for both methide 
and chloride abstractions. The principle being the same as for the chloride abstraction, it will 
not be developed in more detail. 
Trityl (or triphenylmethylcarbenium) derivatives have often been used alternatively to 
B(C6F5)3. These compounds have the advantage of eliciting irreversible methide abstraction 
by forming 1,1,1-triphenylethane as a byproduct. This abstractor was shown to be compatible 
with group 4 dimethyl metallocenes. As illustrated in Scheme III-5, an OmFLP could be 
obtained in this way from L221-b. 
 
Scheme III-5: synthesis of an OmFLP with a trityl borate 
 
A cationic group 4 metallocene was also generated by protonolysis of the M-Me bond 
with a Brønsted acid. This was done by using the super acid H(Et2O)2+ or various ammonium 
salts combined with a non- or wealky-coordinating anion. The use of H(Et2O)2+ entails the 
presence of Et2O. In some cases, one molecule of diethyl ether was shown to coordinate to 
the cationic metallocenes as described by Erker with L248.3 
 
Scheme III-6: protonolysis of L247 with [H(Et2O)2][A] 
 
                                               
13
 Normand, A. T.; Richard, P.; Balan, C.; Daniliuc, C. G.; Kehr, G.; Erker, G.; Le Gendre, P. Organometallics. 2015, 34, 2000 
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In the case of ammonium or pyridinium abstractors, the use of a bulky cation such as 2,6-di-
tertbutylpyridinium prevents the coordination of the free N-base, such as in the example 
depicted in Scheme III-7.9  
 
Scheme III-7: protonolysis of L249 by an ammonium borate salt 
 
Most of these abstractors can be synthesized according to literature procedures, or 
purchased commercially in some cases (see general remarks). Their use to try to generate 
various cationic titanocenes will be illustrated in the following part. 
B. Abstraction from (aminomethyl)titanocenes 
In this section, the generation of some cationic species, (starting from the 
(aminomethyl)titanocenes described in section II.A.3.a.), will be discussed. The first part will 
deal with chloride abstraction, whilst the second will be focused on the synthesis of methylated 
(aminomethyl)titanocenes and methide abstraction therefrom. 
3. Chloride abstraction 
As illustrated in the first part of this chapter, various reagents can be used for chloride 
abstraction. The first procedure envisioned was based on the use of alkali metal-based 
abstractors: [Na][BPh4] and [Li][B(C6F5)4] were used on the dichloro series 9-13 and 19 (section 
II.C.1), in various solvent conditions, in a 1: 1 ratio but did not effect the chloride abstraction. 
In one case however, we observed the formation of a new species upon reaction of 19 with 
[Li][B(C6F5)4] (Spectrum III-1). Indeed, the signals of the monosubstituted Cp ring were splitted, 
whilst the signals relative to the bridging CH2 and the isopropyl groups were shifted downfield. 
In addition, a diastereotopic relationship appeared for the bridging CH2, and the methyl groups 
of the isopropyl moieties. These observations were at first presumed to be a consequence of 
chloride abstraction from 19, but the X-ray diffraction analysis rapidly contradicted this 
presumption. 
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Spectrum III-1: superposition of the 1H NMR spectra of 19 (bottom) and after reaction with [Li][BC6F5)4] 
(top) (600.23 MHz, 300 K, dichloromethane-d2) 
 
In fact a lithium adduct via µ-chloro bonds was obtained as illustrated in Scheme III-8.  
 
Scheme III-8: synthesis of the Li adduct 25  
 
This compound was additionally characterized by NMR spectroscopy (1H, 11B, 13C, 15N, 
19F and 2D correlations), positive mode ESI HRMS and as mentioned before, X-ray diffraction 
analysis. The molecule crystallizes in a centrosymmetric space group (P-1) because of the 
presence of both enantiomers in the cell; only one is depicted in Figure III-1 for clarity. This 
unexpected heterotrimetallic complex exhibits an apparent tetrahedral geometry around both 
Ti centres and the Li atom. This concatenation gives to the molecule a spiranic-like structure, 
in which both titanocenes are orthogonal to each other (torsion angle Ct1-Ti1-Ti2-Ct3 = 
83.94(6)°), responsible for the diastereotopy observed by NMR for 25. Noteworthy, both 
nitrogens do not coordinate to Li, either intramolecularly or intermolecularly. This type of adduct 
could be formed in other reactions run with 9-13 as evidenced by 1H NMR spectroscopy; but 
the corresponding adducts were not characterized further. 
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Figure III-1: ORTEP view of 25. (ellipsoids drawn at the 30% probability level, hydrogen atoms removed for 
clarity as well as the counter anion). Selected bond lengths (Å) and angles(°): Ti1-Ct1 = 2.0594(13), Ti1-Ct2 
= 2.0720(11), Ti2-Ct3 = 2.0641(14), Ti2-Ct4 = 2.0714(13), Ti1-Cl1 = 2.3923, Ti1-Cl2 = 2.3862(7), Ti2-Cl3 = 
2.3771(8), Ti2-Cl4 = 2.3990(8), C1-C6 = 1.507(4), C23-C28 = 1.506(4), C6-N1 = 1.457(3), C28-N2 = 1.456(3), Li-
Cl1 = 2.348(5), Li-Cl2 = 2.323(5), Li-Cl3 = 2.301(5), Li-Cl4 = 2.357(5), Ct1-Ti1-Ct2 = 133.66(5), Ct3-Ti2-Ct4 = 
133.41(5), Cl1-Ti1-Cl2 = 90.45(2), Cl3-Ti2-Cl4 = 89.79(3), C1-C6-N1 = 110.5(2), C23-C28-N2 = 110.0(2), Cl1-Li-
Cl2 = 93.17(16), Cl3-Li-Cl4 = 92.72(16), Cl1-Li-Cl3 = 114.3(2), Cl1-Li-Cl4 = 126.3(2), Cl2-Li-Cl3 = 116.7(2), Cl2-
Li-Cl4 = 115.7(2), Ct1-Ti1-Ti2-Ct3 = 83.94(6). 
 
Two other examples of Li adduct formation by µ-chloro bonds have been also described 
in the literature with a Pd-based and a Co-based complex by Jordan and Roesky 
respectively.14,15 The preparation of 25 with the correct stoichiometry (1 eq of [Li][B(C6F5)4] for 
2 eq of 19), yielded 25 in 56% yield in 90% purity after multiple recrystallization steps. 
Remaining unidentified by-products were still observed even after this workup (see 
experimental part).  
Despite our efforts, all attempts to generate cationic titanocenes from 9-13 failed 
whatever the choice of the chloride abstractor ([Ag][BPh4], [Ag][NTf2], B(C6F5)3 or 
[Et3Si][B(C6F5)4]. The synthesis of electron-enriched titanocenes was then envisioned by 
substituting a chloride ligand by an aryloxy ligand. According to the results previously obtained 
in our group,16 a 2,6-dimethylphenoxy ligand was chosen. A new series was thus synthesized 
according to the same procedure, yielding 26-29 in 42-73% yield (Scheme III-9). 
                                               
14
 Shen, H.; Steele, I. M.; Jordan, R. F. Acta Crystallogr. C. 2003, 59, m 405 
15
 Mondal, K. C.; Samuel, P. P.; Roesky, H. W.; Carl, E.; Herbst-Irmer, R.; Stalke, D.; Schwederski, B.; Kaim, W.; Ungur, L.; 
Chibotaru, L. F.; Hermann, M.; Frenking, G. J. Am. Chem. Soc. 2014, 136, 1770 
16
 Normand, A. T.; Richard, P.; Balan, C.; Daniliuc, C. G.; Kehr, G.; Erker, G.; Le Gendre, P. Organometallics. 2015, 34, 2000 
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Scheme III-9: synthesis of 26-29 
 
Stoichiometry was carefully controlled in order to avoid disubstitution of the titanocene. 
However, the chosen aryloxy ligand is quite bulky, which might prevent disubstitution due to 
steric hindrance. All these complexes were characterized at least by NMR spectroscopy, 
positive mode ESI HRMS and IR spectroscopy, except 26.17 Four different substituents of the 
titanium centre make these complexes chiral, which translates into diastereotopic relationships 
in the NMR spectra. For the protons on the monosubstituted Cp ring, a set of four apparent 
quartets is observed, whilst the signal of the bridging CH2 exhibits an AB pattern. Methyl groups 
on 28 and 29 are also diastereotopic. The 1H NMR of 29 is depicted in Spectrum III-2. The 
signals of the 2,6-dimethylphenoxy ligand appear as a set of one doublet and one triplet at 
6.93 and 6.66 ppm respectively for aromatic signals, and one singlet for the methyl groups at 
2.09 ppm. As explained above, a set of four apparent quartets (6.43, 6.36, 6.11 and 6.06 ppm) 
is observed for the signals of the monofunctionalized Cp ring, whilst the signal of the 
unsubstituted Cp appears as a singlet at 6.19 ppm. The signal of the bridging CH2 exhibits a 
marked AB pattern (3.74 and 3.69 ppm, 2JHH = 15.2 Hz). Finally, whilst the methyl groups from 
the tetramethylpiperidine moiety are diastereotopics (two singlets at 0.99 and 0.87 ppm), the 
signals for the methylene groups show two multiplets at 1.54-1.48 and 1.37-1.35 ppm. 
 
                                               
17
 26 was isolated as a sticky oil which prevented satisfactory IR measurement 
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Spectrum III-2: 1H NMR of 29 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Suitable crystals for X-ray diffraction analysis were obtained by diffusion of pentane 
into a dichloromethane solution of 29. These crystals belong to the P21/c space group. Even if 
both enantiomers are present in the cell, the space group is chiral. Indeed, as illustrated in 
Figure III-2, both enantiomers do not adopt the same conformation. Whilst the 
tetramethylpiperidine moiety is located far away from both X ligand of the titanocene in the first 
enantiomer (left: C11-Ct1-Ti-Cl = -20.66(06), C11Ct1TiO = -122.70(07)); it is located almost 
above the oxygen atom in the second one (right: C11A-Ct1A-TiA-ClA = -94.33(06), C11A-
Ct1A-TiA-OA = 7.37(08)). In both structures, the tetramethylpiperidine is located almost as in 
other tetramethylpiperidine-based structures described in chapter II (torsion angles φ: C5-C1-
C11-N = -22.25(3)°, C5A-C1A-C11A-NA = 32.76°).  
Hm                 Hn                Hb  Ha’ Hb’ Ha                  Hd Hd’                 Hh                        Hg  
Hi 
Hl 
Hf Hf’ 
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Figure III-2: ORTEP view of 29 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed for 
clarity). Selected bond lengths (Å) and angles(°): Ct1-Ti 2.0951(11) / 2.1053(9), Ct2-Ti = 2.0924(11) / 
2.0721(10), Cl-Ti = 2.3864(7) / 2.3945(7), O-Ti = 1.8620(14) / 1.8835(15), C1-C11 = 1505(3), C11-N = 1.470(2) / 
1.475(3), Ct1-Ti-Ct2 = 130.47(4) / 130.79(5), Cl-Ti-O = 96.17(5) / 96.94(5), C1-C11-N = 113.17(17) / 113.87(17) 
 
For this series, the standard chloride abstractors were used to form the cationic 
titanocenes. Some of them did not react, and the starting titanocene was still observed in the 
1H NMR spectrum ([Li][B(C6F5)4], [Ag][BPh4]); or the cationic species formed was not stable, 
yielding only decomposition of the titanocene fragment according to NMR analyses (AgNTf2, 
[Et3Si][B(C6F5)4]). However, the use of AgOTf was effective on 29 yielding 30 in moderate yield, 
with the presence of a side product. Indeed, the commercially available silver complex 
contained remaining triflic acid forming 31 (reaction of TfOH with 30). Fortunately, purification 
by recrystallization was efficient (see experimental part) affording 30 in very good purity.  
Ti ClO
29
N
AgOTf
(remaining TfOH)
-AgCl
Ti OTfO
30
N
Ti OTfO
31
N
H TfO
+
removed by crystallization
110 mg, 47%
 
Scheme III-10: synthesis of 30 
 
The compound was then characterized by the standard set of techniques (NMR, IR, 
HRMS, elemental and X-ray diffraction analyses). The 1H NMR spectrum of 30 is similar to 
that of 29 (Spectrum III-2), the most noticeable change is that of the chemical shift of Cp rings. 
The signals of Hb and the unsubstituted Cp ring are shifted downfield, whilst the signals of Ha 
are shifted upfield.  
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Spectrum III-3: Superposition of the 1H NMR spectra of 29 (bottom) and 30 (top) (600.23 MHz, 300K, 
dichloromethane-d2) 
 
Red plate-shaped crystals for X-ray measurement were obtained by cooling a concentrated 
pentane solution at -15°C over several days (Figure III-3).  
 
Figure III-3: ORTEP view of 30 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed for 
clarity, enantiomer omitted for clarity). Selected bond lengths (Å) and angles(°): Ti-Ct1 = 2.0931(14) / 
2.0849(12), Ti-Ct2 = 2.0658(14) / 2.0585(12), Ti-O1 = 1.8748(17) / 1.8754(16), Ti-O2 = 2.0931(14) / 2.0887(17), 
C1-C11 = 1.514(4) / 1.503(3), C11-N 1.462(3) / 1.460(3), Ct1-Ti-Ct2 = 131.31(6) / 130.62(5), O1-Ti-O2 93.97(7) / 
93.76(5), C1-C11-N = 113.0(2) / 112.7(2). 
 
The elongated Ti-triflate bond observed for 30 (Ti-O2 = 2.0931(14) Å) suggests some 
degree of lability of the triflate. Indeed, complex Cp2Ti(OTf)2 (Ti-O = 2.003(7) and 2.000(7)Å) 
Hb Hb Ha Ha 
Hb Ha Hb Ha 
Hi 
Hi 
p-H 
p-H m-H 
m-H 
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reported by Thewalt,18 was shown to be labile in presence of coordinating solvents (DMF, 
H2O).19 This suggest that the titanocene triflate is a deguised cationic titanocene and could act 
as an OmFLP. Several attempts were made at activating small molecules (H2, CO2, 
phenylacetylene, acetophenone or benzophenone), but none of them succeeded, as 
evidenced by the unchanged 1H NMR spectra of the reaction mixture. In fact, this complex 
turned out to be quite robust. This lack of reactivity prompted us to give up the triflate route. 
Since silver-based and alkali-based abstractors failed, an alternative redox route was 
attempted. By using a phosphide as previously done in our group, all attempt to purify the Ti(III) 
species failed due to their high solubility even in apolar solvents and the resulting impossibility 
to separate them from the diphosphine byproduct. KC8 was alternatively used to effect the 
reduction (Scheme III-11).  
 
Scheme III-11: synthesis of Ti(III) species. a: crude yield determined by comparing the mass of isolated oil 
with the expected mass. 
 
After evaporation of the crude solution, trituration in pentane helped removal of KCl salts and 
graphite easily from the product by filtration. Both Ti(III) species were obtained after 
evaporation of pentane as green sticky oils. They were characterized only by EPR and 1H NMR 
spectroscopies (see Spectrum III-4 for the former, and the appendix for the latter). 
  
                                               
18
 Thewalt, U.; Klein, H.-P. Z. Für Krist. - Cryst. Mater. 1980, 153 
19
 Honold, B.; Thewalt, U. J. Organomet. Chem. 1986, 316, 291 
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Spectrum III-4: EPR spectra of 27-III and 29-III (9.437952 and 9.437703 GHz, 295 K, pentane) 
 
Both exhibits one peak at the same Lande factor (g = 1.9781) with no multiplicity. It 
does not indicate coordination of the nitrogen to the Ti centre. Nevertheless, N coupling are 
not always observed by EPR, even in cases where coordination is established by X-ray 
analysis.20 The 1H NMR spectra only showed traces of pentane and very broad signals, 
consistent with the paramagnetic nature of these species. These two Ti (III) species were 
engaged in an oxidation reaction with [Cp2Fe][BPh4] with (Scheme III-12) or without 
phenylacetylene (to trap the putative OmFLPs). These reactions only led to decomposition 
products. The reduction/oxidation process was then given up. 
Ti O
27-III and 29-III
NR2
[Cp2Fe][BPh4] (Phenylacetylene)
THF, -70°C, 5 min
-Cp2Fe
Ti O
27+ and 29+
NR2
(III) (IV)
NPh NR2N
27 29
BPh4-
 
Scheme III-12: attempt at OmFLPs formation via a two steps reduction/oxidation process 
 
In summary of this first part focused on chloride abstraction, all attempts at cationic 
titanocene generation failed with mild (alkali metals) or strong (silyl cation) chloride abstractors. 
Whilst the use of AgOTf (on a mono chlorotitanocene), yielded the stable neutral complex 30, 
the apparent successful reduction of 27 and 29 unfortunately did not lead to the clean formation 
                                               
20
 Helten, H.; Dutta, B.; Vance, J. R.; Sloan, M. E.; Haddow, M. F.; Sproules, S.; Collison, D.; Whittell, G. R.; Lloyd-Jones, G. C.; 
Manners, I. Angew. Chem. Int. Ed. 2013, 52, 437 
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of a cationic species after oxidation. These results prompted us to envision an alternative route 
for cationic titanocene generation, by using methide abstractors.  
4. Methide abstraction 
a. Synthesis of dimethyl (aminomethyl)titanocenes  
The first step required for this route was the formation of methylated titanocenes. For 
this purpose, the dimethyl titanocenes 32-35 were synthesized, first by using 2.0 equivalents 
of MeLi on complexes 10-13. Complexes 32-35 were easily obtained in this manner in 
moderate yield as yellow light-, temperature- and moisture- sensitive solids (Scheme III-13).  
 
Ti Me
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Ti Cl
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Cl
R
R
H
Ti Cl
Cl
NR2
R2N K
2 MeLi
3 MeLi
1) CpTiCl3
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N N NN
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32 353433
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x
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Scheme III-13: the three procedures used for the synthesis of dimethyltitanocenes 
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These compounds were stored at -15°C inside the glovebox to avoid their decomposition. The 
moisture sensitivity of the dichloro series (9-13) and the sensitivity of their dimethyl analogues 
(32-35) prompted us to find out a procedure for the generation of dimethyl titanocenes via the 
moisture stable ammonium complexes previously described in Scheme II-15. Indeed, the first 
FLP reactivity assays were conducted in Münster (Germany) in the group of Pr. Erker. The 
compounds had to be stable enough for a safe shipment. Thus, an alternative synthesis of 
complexes 34 and 35 was envisioned, starting from 17 and 18 by using 3.05 equivalents of 
MeLi. A third procedure was also developed, based on a one-pot synthesis starting from 2-K, 
4-K and 5-K, in order to increase the scale of dimethyl titanocene isolated. These complexes 
were characterized by NMR spectroscopy (1H, 13C, 15N and 2D correlations) and positive mode 
ESI HRMS. Complexes 34 and 35, isolated as yellow powders, were also characterized by IR 
spectroscopy. The 1H NMR spectra of these species are similar to those of their dichloro 
analogues. Noteworthy, a new signal appears at -0.21 ppm, characteristic of the two equivalent 
methyl groups bound to a Ti centre. The 15N chemical shit remained unchanged after 
methylation, as expected (e.g. -308 ppm vs -309 ppm for 13). 
In our hands, all attempts to synthesize mono methylated titanocenes failed. Only the 
dimethyl titanocenes described above could be isolated in sufficient purity and quantity. 
b. Preliminary methide abstraction: en route to rearrangements 
With complexes 17 and 18, and the procedure B described in the previous section in 
hands, potential OmFLPs precursors were generated by forming 34 and 35 respectively. After 
achieving the synthesis of B(C6F5)3, preliminary methide abstractions with this chemical were 
tried on 34 and 35. Whilst the abstraction from 34 yielded a complex mixture of three 
titanocenes, the reaction of 35 led to an immediate gas release and a colour change from 
yellow to dark-red. A complete NMR study of this new molecule indicated that only one species 
had formed during this process (only one set of signals for a monosubstituted titanocene was 
observed) but that the TMP moiety had vanished. According to 2D NMR experiment (1H 13C 
HMQC NMR), a characteristic resonance was observed between a new carbon atom at 110.5 
ppm (in the ethylenic region) with two different signals from the 1H NMR spectrum at 4.83 and 
4.73 ppm. 
 
Spectrum III-5: 1H 13C HMQC of 36 (500.03 / 125.75 MHz, 300 K, bromobenzene-d5) 
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This strongly suggests the presence of a terminal alkene. Unfortunately, all crystallization 
attempts made at this compound failed. This lack of crystallinity might be a consequence of 
the Me-B(C6F5)3- anion.21 
 
Compound 36 was fully characterized by standard techniques (NMR spectroscopy, 
HRMS, and elemental analysis). The proposed structure for 36, depicted in Scheme III-14 will 
be unambiguously proved below. 
 
Scheme III-14: discovery of a new cationic titanocene 
 
Considering this structure, all signals from the 1H NMR spectrum (Spectrum III-6) can 
be assigned: the titanocene fragment appears as a set of two apparent triplets (5.90 and 5.66 
ppm) for the monosubstituted Cp ring, and a singlet for the non-substituted Cp ring. 
 
Spectrum III-6: 1H NMR spectrum of 36 (500.03 MHz, 300 K, bromobenzene-d5; counter anion omitted for 
clarity) 
 
                                               
21
 A. Normand, personal communication 
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The bridging CH2 resonates at 4.42 ppm, whilst two new multiplets are found at 4.82 
and 4.75 ppm corresponding to the signals of the protons of the terminal akene. The signals 
of the aliphatic chain appear as one triplet and two multiplets (1.92, 1.38-1.23 and 1.15-1.02 
ppm), and finally one can found two singlets in a 3 : 6 ratio for the two methyl groups (1.70 and 
1.09 ppm respectively). Again, in the 1H 13C HMQC spectrum, a noteworthy correlation is found 
for the ethylenic protons with a carbon atom located at 111.0 ppm (see appendix). Both protons 
correlate to the same carbon atom.  
In addition, the 15N chemical shift was observed at -363 ppm, which represents a 
significant upfiled shift compared to 35 (-309 ppm ∆δ = 54 ppm), indicating a change of the 
electronic and / or geometric environment of the nitrogen atom. Furthermore, a careful analysis 
of the ESI-MS spectrum showed the presence of two clusters of peaks with the molecular 
formula of C20H28NTi and C20H30ONTi corresponding to [M]+ and [M+H2O]+ cations respectively 
(Spectrum III-7). 
 
Spectrum III-7: HRMS spectrum of 36 (positive mode ESI, bromobenzene) 
 
Nevertheless, these data do not prove the proposed structure, although they are in 
agreement with it. No crystals of 36 could be obtained. However, a OPEt3-stabilised derivative 
(37) could be synthesized by trapping 36 in situ, and suitable crystals for X-ray diffraction were 
obtained by layering a dichloromethane solution with pentane at room temperature (Figure 
III-4). Due to the coordination of the phosphine oxide, the titanium centre is chiral. As a result, 
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new diastereotopic relationships were observed by 1H NMR spectroscopy between the signals 
of the protons of the monofunctionalized Cp ring, and those of the methylene and methyl 
groups along the aliphatic chain (see experimental part).  
 
Figure III-4: ORTEP view of 37 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed for 
clarity except those from C19, enantiomer and counter anion omitted for clarity). Selected bond lengths (Å) 
and angles(°): Ti-Ct1 = 2.064(4), Ti-Ct2 = 2.078(4), O1-Ti = 2.023(4), N-Ti = 1.996(7), C1-C11 = 1.469(11), C18-
C19 = 1.323(17), C18-C17 = 1.523(15), Ct1-Ti-Ct2 = 130.07(16), N1-Ti-O = 100.0(3), C1-C11-N = 99.3(6), C11-N-
Ti = 104.9(5), Ti-N-C12 = 112.3(6), C11-N-C12 = 142.6(5), C-19-C18-C20 = 120.8(12), C19-C18-C17 = 121.8(12), 
C17-C18-C20 = 113.7(12), C18-C19-H19b = 120.01(11), C18-C19-H19a = 120.0(2), H19a-C19-H19b = 
119.99(18). 
 
The space group is achiral meaning that both enantiomers are present in the cell. The second 
molecule is omitted due to high disorder. It even confers a low-resolution factor to the global 
molecule. Nevertheless, the crystallographic analysis confirms the structure of the molecule. 
The Ti-N bond is relatively short (1.996(7) Å) and the nitrogen is planar (Σα(N) = 359.8(9)°) 
indicating sp2 hybridation. In addition, the calculated torsion angles (Ct1-Ti-N-C11 = 1.05(5)°, 
Ct2-Ti-N-C12 = 37.1(1)°) indicate that the orientation of the lone pair of the nitrogen is suitable 
for pi-interaction with titanium. Moreover, the same hybridation is observed for C18 and C19 
(Σα(C18) = 359.8(2)°, Σα(C19) = 360.0(2)° respectively), and the C18-C19 bond is also 
relatively short (1.323(17) Å vs 1.523(15) Å for C18-C17), which is in agreement with a terminal 
carbon-carbon double bond.  
To the best of our knowledge, only one example of such rearrangement was observed 
by O’Hara by refluxing for 12h L251, forming the magnesium complex L252 the structure of 
which was elucidated by X-ray diffraction analysis (Scheme III-15).22 
 
                                               
22
 Kennedy, A. R.; Klett, J.; McGrath, G.; Mulvey, R. E.; Robertson, G. M.; Robertson, S. D.; O’Hara, C. T. Inorganica Chim. Acta. 
2014, 411, 1 
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Scheme III-15: ring opening of TMP by a magnesium complex 
 
This unexpected rearrangement was a consequence of the high reactivity and low 
stability of the cationic intermediate formed upon methide abstraction. Two mechanisms could 
be envisioned: complex [38] is presumed to be intermediately formed after methide 
abstraction, and then N-coordination of TMP is able to occur (Scheme III-16). 
 
Scheme III-16: alternative strategy for the OmFLP concept with 35 
 
This confers some degree of ammonium character to the nitrogen atom, which then 
undergoes intramolecular deprotonation by the remaining methide on titanium in a process 
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akin to the Hofmann elimination in a concerted manner. Alternatively, a non-concerted 
mechanism can also be proposed: activation of one methyl of the TMP moiety could occur, 
forming [38]’ intermediately. Considering that cationic amido titanocene can promote 
intramolecular hydroamination via a carbon-carbon double bond insertion into a Ti-N bond,23 
one might envisage the reverse desinsertion step as illustrated in Scheme III-16. A 
consequence of the mechanisms depicted in Scheme III-16 is that intermediate [38] could be 
trapped with a suitable reagent, e.g. an unsaturated substrate (X=Y).  When 35 was reacted 
with [Ph3C][B(C6F5)4] in the presence of nitriles or phenylacetylene, only 36 stabilized by the 
reagent (acting as L-Ligand) was observed. However, the same reaction in the presence of 
benzophenone prevented the rearrangement (presumably due to the high affinity of the 
titanocenium cation for oxygen) and adduct 38-B was obtained (Scheme III-17). 
 
Scheme III-17: synthesis of 38 
 
This new compound was fully characterized by NMR spectroscopy (1H, 11B, 13C, 15N, 
19F and 2D correlations), HRMS and elemental analysis.24 Red prism-shaped crystals were 
obtained by slow diffusion of heptane into a chlorobenzene solution at -15°C. The X-ray 
diffraction study definitely established its structure (Figure III-5). As previously observed for 
other structures, the space group is achiral (P-1), both enantiomers are present in the cell but 
only one is presented for clarity. The structure exhibits a relatively short Ti-O bond (2.0008(13) 
Å vs 2.26 ± 0.10 Å for the empirical covalent bond length),25 and the oxygen atom adopts a 
slight bent geometry (Ti-O-C22: 160.44(13) Å), whilst C22 retains a planar geometry (Σα(C22) 
= 359.98(3)°). 
                                               
23
 Gribkov, D. V.; Hultzsch, K. C. Angew. Chem. Int. Ed. 2004, 43, 5542 
24
 IR analysis did not show characteristic C=O absorptions due to the overwhelming bands of the borate anion. 
25
 Cordero, B.; Gómez, V.; Platero-Prats, A. E.; Revés, M.; Echeverría, J.; Cremades, E.; Barragán, F.; Alvarez, S. Dalton Trans. 
2008, 2832 
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Figure III-5: ORTEP view of 38-B (ellipsoids drawn at the 30% probability level, hydrogen atoms removed 
for clarity, enantiomer, solvent and counter anion omitted for clarity). Selected bond lengths (Å) and 
angles(°): Ti-Ct1 = 2.0542(10), Ti-Ct2 = 2.0510(10), Ti-C21 = 2.1686(19), Ti-O = 2.0008(13), C1-C11 = 1.514(3), 
C11-N = 1.463(2), O-C22 = 1.252(2), Ct1-Ti-Ct2 = 134.78(4), O-Ti-C21 = 93.21(7), C1-C11-N = 114.73(16), Ti-O-
C22 = 160.44(13), O-C22-C23 = 160.44(13), O-C22-C29 = 118.95(13), C23-C22-C29 = 121.75(17). 
 
Additionnaly, the TMP arm is located between C21 and O but closer to the oxygen atom 
(torsion angles: C11-Ct1-Ti-O = 25.94(7)° and C11-Ct1-Ti-C21 -71.93(8)°). 
The coordination of benzophenone to titanium entails diastereotopic relationships in the 1H 
NMR spectrum (Spectrum III-8). The 1H NMR spectrum in bromobenzene-d5 is presented in 
Spectrum III-8. In this particular case, residual non-deuterated chlorobenzene was still 
observed. One can observe the three signals of the phenyl rings of benzophenone as two 
triplets and one doublet in a 2 : 4 : 4 ratio at 7.50, 7.32 (overlapping with a signal of the 
deuterated solvent) and 7.22 ppm (for para-, meta- and ortho-H respectively). Then a 
characteristic set, for a chiral titanocene, of four apparent quartets with one singlet, are 
observed for the Cp rings, at 6.32, 6.01, 5.83 and 5.48 ppm and 5.85 ppm (monosubstituted 
and non-substituted Cp ring respectively). Diastereotopy is also observed at the bridging CH2 
and at the TMP moiety, with an AB pattern for the former (2JHH = 16.4 Hz) at 3.21 and 3.12 
ppm and a set of two multiplets and two singlets for the signals of the methylene and the methyl 
groups of the latter respectively (1.39-1.29, 1.27-1.19, 0.72 and 0.63 ppm). Lastly, the signal 
of the remaining methide on the titanium centre is observed at a rather downfield shift for a Ti-
Me group (1.24 vs -0.21 ppm for the methide of 35 in benzene-d6), indicative of the formation 
of a titanocenium cation. 
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Spectrum III-8: 1H NMR of 38-B (500.03 MHz, 263 K, bromobenzene-d5) 
 
It has to be noted that compound 38-B was isolated at low temperature, and 
characterized at 263 K. Indeed, a solution of 38-B kept at room temperature, slowly turned into 
36 with coordination of benzophenone in the course of several hours. The rearrangement 
occurred but in this case, unidentified side products were observed. The benzophenone-
stabilized analogue of 36 was not characterized. In retrospect, one can conclude that 35 might 
not be the best precursor for OmFLP chemistry, due to the reactive nature of the TMP 
fragment.  
With this new amidotitanocene in hand, the reactivity of the Ti-N bond in 36 was finally 
investigated. Several alkenes or alkynes were tested but none of them led to clean formation 
of a new species. Nevertheless, this species was able to react with CO2, forming a new 
species, which we tentatively propose to be the dimeric complex 39 (Scheme III-18). A red 
solution of 36 in bromobenzene was stirred under 1 bar of CO2 for 1h. Rapidly, a red oil had 
decanted from the organic layer. After workup, an orange precipitate was formed and was not 
soluble in bromobenzene anymore. This compound was characterized by NMR spectroscopy 
(1H 11B 13C 15N 19F and 2D correlation), positive mode ESI HRMS and elemental analysis.  
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Scheme III-18: CO2 activation with 36 
 
Even if no suitable crystals for X-ray diffraction analysis were obtained, several pieces of 
evidence corroborate the dimeric structure. Indeed, similar examples for CO2 activation by 
cationic amidozirconocenes have been reported in the literature, with 15N chemical shifts 
around -363 ppm (vs -254 ppm for 39). The mass spectrum of 39 is also consistent with the 
proposed dimeric structure, with a cluster of peaks at 374.16042 Da corresponding to [2M]2+. 
Finally, the solubility profile of 39 is similar to its Zr analogues (L254-a-b Scheme III-19).26  
 
Scheme III-19: CO2 activation with amidozirconocenes25 
 
The discovery of the unexpected rearrangement leading to 39 prompted further 
investigations into the reactivity of the pendant amine moiety in complexes 32-34. Another 
consequence was the realisation that N/Ti+ OmFLPs are probably elusive targets due to the 
reactivity of the amine moiety in the presence of the titanocenium fragment. Before further 
developing the results of these investigations, this chapter will present a short survey of the 
literature on CH activation of amines. Particular attention will be devoted to group 4 metal 
examples. 
c. CH activation of amines in the literature 
One of the earlier example in this category was described in 1960 by Meerwein,27 who 
used the trityl cation to activate tribenzylamine. In this case, CH activation in the α position of 
the nitrogen atom occurred, yielding the L256 iminium salt selectively (Scheme III-20). This 
                                               
26
 Normand, A. T.; Daniliuc, C. G.; Wibbeling, B.; Kehr, G.; Le Gendre, P.; Erker, G. J. Am. Chem. Soc. 2015, 137, 10796 
27
 Meerwein, H.; Hederich, V.; Morschel, H.; Wunderlich, K. Justus Liebigs Ann. Chem. 1960, 635, 1 
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reaction highlights one of the typical reactivity pattern of Ph3C+, i.e. hydride abstraction. The 
use of the trityl cation was further extended to β-H containing amines by Damico and 
Broaddus,28 but they showed that another reaction occurred in their case. Indeed, the 
ammonium borate L258 and triphenymethane were isolated in more than 60% yield, as if 
hydrogen activation had occurred, and no iminium salt was observed. A mechanism was 
proposed in which α-H abstraction by Ph3C+ yielded the iminium salt L259, which was 
deprotonated by the starting amine to yield L258 and an enamine byproduct. This mechanism 
implies that some of the starting amine (~ 30%) is used as a sacrificial hydrogen source.  
 
Scheme III-20: reactivity of amines with the trityl cation 
 
Almost forty years later, a similar abstraction reaction was developed by Periasamy 
and Basset, using TiCl4 or B(C6F5)3 (Scheme III-21 and Scheme III-22).29,30  
 
Scheme III-21: simplified mechanism of the CH activation of triethylamine with TiCl4 
 
                                               
28
 Damico, R.; Broaddus, C. D. J. Org. Chem. 1966, 31, 1607 
29
 Bharathi, P.; Periasamy, M. Org. Lett. 1999, 1, 857 
30
 Millot, N.; Santini, C. C.; Fenet, B.; Basset, J. M. Eur. J. Inorg. Chem. 2002, 2002, 3328 
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Starting from dimethylaniline and B(C6F5)3, equilibrium (1) was established, in which an 
iminium salt and a Lewis adduct are formed. In the case of diethylaniline, in which β-hydrogens 
are present, the iminium formed first, which was rapidly deprotonated by diethylaniline, to form 
the corresponding enamine, along with hydridoborate salt L267. The enamine reacted with 
B(C6F5)3 to form a zwitterionic species (L266, Scheme III-22).  
 
Scheme III-22: CH activation on tertiary amines by B(C6F5)3 
 
By using a borane, Basset showed that these reactions were in equilibrium, contrary to the 
reaction previously shown with the trityl cation. Nevertheless, a parallel can be established 
between both reactions, highlighting the reactivity of β-hydrogen-containing amines towards 
hydride abstraction. The formation of enamine is a key event in this type of reactivity. This 
feature was used by Stephan, to catalytically racemize amines with B(C6F5)3 via the enamine 
form.31 
Numerous publications reported the potential of methylamine derivatives to undergo 
CH activation. The hydroaminoalkylation, first described by Hartwig in 2007 with thallium 
complexes,32 enters in this category and was then developed with titanium by Doye. The 
mechanism of this reaction was investigated by D-labelling NMR spectroscopy experiments.33. 
The mechanism, depicted in Scheme III-23, suggests a rate-determining CH activation step to 
form L270, the active catalyst. 
 
                                               
31
 Farrell, J. M.; Heiden, Z. M.; Stephan, D. W. Organometallics. 2011, 30, 4497 
32
 Herzon, S. B.; Hartwig, J. F. J. Am. Chem. Soc. 2007, 129, 6690 
33
 Prochnow, I.; Zark, P.; Müller, T.; Doye, S. Angew. Chem. Int. Ed. 2011, 50, 6401 
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Scheme III-23: proposed mechanism of Ti-catalysed hydroaminoalkylation  
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Erker reported CH activation processes in zirconocene complexes containing a 
pendant NMe2 moiety.34,35 Reaction of complex L273 with B(C6F5)3 rapidly yielded compound 
L276. Intermediate L274, in which the nitrogen atom coordinates to the zirconocenium cation, 
was proposed as the key species from which the final product evolved (Scheme III-24). The 
authors suggested three mechanisms to explain the formation of L276: i/ β-H elimination 
leading to the species L275, followed by reductive elimination of methane, and ii/ concerted 
deprotonation of the NMe2 moiety by the methide ligand. In both cases, intermediate L277 is 
formed, in which the metal is in the +II oxidation state. The last proposed mechanism would 
be a concerted σ-bond metathesis mechanism (β-H abstraction - L278) in which Zr remains in 
the +IV oxidation state.35  
 
Scheme III-24: CH activation on a zirconocenyl amine, counter anion omitted for clarity 
 
Krut’ko also observed analogous reactivity on a dichlorozirconocene. In reductive conditions 
(Mg/Hg) the zirconocene was shown to yield the same type of azametallacycle. In this case, a 
Zr(II) intermediate was probably involved in CH activation.36  
                                               
34
 Bertuleit, A.; Fritze, C.; Erker, G.; Fröhlich, R. Organometallics. 1997, 16, 2891 
35
 Pflug, J.; Bertuleit, A.; Kehr, G.; Fröhlich, R.; Erker, G. Organometallics. 1999, 18, 3818 
36
 Krut’ko, D. P.; Borzov, M. V.; Kirsanov, R. S.; Churakov, A. V.; Kuz’mina, L. G. J. Organomet. Chem. 2005, 690, 3243 
Chapter II 
135 
   
The last example of this survey is that of the reaction of complex L229 with the trityl 
cation (Scheme III-25). The product of this reaction L230, was shown to activate various 
substratres following typical OmFLP reactivity, as illustrated in the bibliographic introduction 
(Scheme I-72). However, L230 has limited stability in solution. When treated in bromobenzene 
at 60°C for 36h, it underwent β-H elimination to give iminium salt L279-[1]. The iminium 
enaminium tautomerization then yields L279-[2], followed by H2 loss and double bond 
isomerisation to give L280 (identified by X-ray diffraction analysis). Dyson recently reported 
analogous reactivity in a diisopropylamine-containing ionic liquid. (Scheme I-59).37  
 
Scheme III-25: formation of azametallacycle L280 by intramolecular CH activation, counter anion omitted 
for clarity 
 
A well-documented review has already been published by Resconi, discussing other 
examples not described above. Particular interest was devoted to the choice of methide 
abstractor and to the problems commonly faced with amine-based abstractors.1 In the light of 
these results, CH activation of amines is not a rare occurence. Numerous examples have been 
reported, especially with tertiary amines. The dimethyl (aminomethyl)titanocenes 32-35 are 
good candidates for such reactivity, as previously observed for the rearrangement of 35+. 
These observations will help the comprehension of the reactivity of 32-34 described in the 
following section.  
                                               
37
 Perrin, F. G.; Bobbink, F. D.; Păunescu, E.; Fei, Z.; Scopelliti, R.; Laurenczy, G.; Katsyuba, S.; Dyson, P. J. Inorganica Chim. 
Acta. 2018, 470, 270 
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d. CH activation with cationic dimethyl (aminomethyl)titanocenes 
 
 
Scheme III-26: nomenclature used with amines 
 
For this section, a general nomenclature will be used, as illustrated in Scheme III-26. 
The Greek symbols refer to the position of carbon atoms relative to the nitrogen atom (unless 
explicit noted otherwise). The bridging CH2 of the titanocenes remained untouched in every 
reaction where CH activation was observed. As a result, the TMP moiety only possesses β-
hydrogens whilst diphenylamine only has α-hydrogens. In the case of pyrrolidine and 
diisopropylamine, both α- and β-hydrogens are present. 
(1) α−H activation 
Since the case of TMP led to rearrangement via β-H activation, we were wondering if 
α-H activation would occur in the case of (dibenzylaminomethyl)titanocene. Indeed, after the 
formation of the cationic titanocene, gas evolution was observed and a deep green precipitate 
was obtained, identified as being 40 by spectroscopic analyses (NMR spectroscopy, positive 
mode ESI HRMS) and elemental analysis (Scheme III-27).  
 
Scheme III-27: CH activation on 33 
 
This compound is composed of 3 chiral centres (Ti, N, C), as a results, two diastereoisomers 
could have been formed (2 chirality centres, N and Ti are not independent). Nevertheless, 
according to the 1H NMR spectrum (Spectrum III-9), only one diastereoisomer is formed. In 
this spectrum, two sets of signals are observed for the inequivalent phenyl rings (7.30-7.24, 
7.18 and 6.77 ppm and 6.94-6.89 and 5.43 ppm respectively). The 1H NMR spectrum shows 
several diastereotopic relationships. A set of four multiplets is observed for the 
monosubstituted Cp ring (6.87-6.81, 6.18-6.13, 5.08-5.02 and 4.41-4.36 ppm), and one singlet 
for the non-substituted Cp ring. The two remaining CH2 groups exhibit an AB pattern (5.08 and 
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4.25 ppm, 2JHH = 12.0 Hz for the bridging CH2, and 3.34 and 2.96 ppm, 2JHH = 13.0 Hz, for the 
benzylic CH2), whilst a singlet appears at 5.00 ppm corresponding to the new CH group bound 
to titanium. This latter signal correlated with a shielded carbon signal at 92.3 ppm in the 1H 13C 
HMQC NMR spectrum, consistent with coordination to titanium. 
 
Spectrum III-9: 1H NMR of 40 (500.03 MHz, 300 K, bromobenzene-d5). i: unidentified impurities 
 
The coordination of the nitrogen atom to the titanium can be inferred from the 15N 
chemical shift observed for 40 compared to the one observed with 33 (-310 ppm, vs -328 ppm). 
It clearly indicates a change in electronic and / or geometric properties of the N atom, 
corresponding to the coordination to titanium. The last evidence of formation of this species 
was given by the HRMS analysis with a cluster of peaks at 386.13870 Da, characteristic of the 
cation (see experimental part). 
Since both α- and β-CH activations can be observed in two different complexes in which 
only one type of CH activation can occur, we wondered what kind of CH activation would occur 
if both α and β hydrogens were present in the amine moiety. 
(2) α- and β-H activation 
For this purpose, methide abstraction on the pirrolidinyl 32 and the diisopropylaminyl 
(34) dimethyltitanocene was performed with [Ph3C][B(C6F5)4]. Whilst in the case of pyrrolidine 
(32) only decomposition was observed, with the disappearance of any Cp signals in the 1H 
NMR spectrum, two interesting, albeit complicated reactions occurred with the 
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(diisopropylamino)titanocene 34. Firstly, when benzophenone was used (in order to trap the 
potential cationic species generated by methide abstraction from 34 by [Ph3C][B(C6F5)4]), gas 
evolution was observed. A reaction mixture carried out in a J-Young NMR tube was directly 
brought to the spectrometer for NMR measurement. The following 1H NMR spectrum was 
obtained (Spectrum III-10).  
 
Spectrum III-10: crude 1H NMR spectrum of the methide abstraction of 34 in presence of benzophenone 
 
Careful analysis of the signals present in the crude 1H NMR spectrum helped to understand 
the mechanism involved in this reaction, and as a result, to identify the product formed. 
Triphenylethane was observed as previously (30H in the aromatic region, signals overlapping 
with both solvent and benzophenone, and a singlet at 2.04 ppm for the signal of the methyl 
group). Traces of methane were also observed at 0.14 ppm. Finally, a set of four signals was 
also present in this spectrum as a multiplet, two doublets of multiplets and an apparent doublet 
of triplets (5.77-5.66, 4.98, 4.91 and 1.59 ppm respectively), all attributed to propene. Whilst 
the stoichiometry between the triphenylethane and the new compound seems to be respected 
according to the integrations of the respective signals, both methane and propene showed 
Ph3CCH3 Ph3CCH3 CH4 
Zoom on propene signals 
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smaller integrations, probably because of their volatility. These observations suggest the 
formation of 41 (Scheme III-28).  
 
Scheme III-28: formation of 41 by β-CH activation 
 
This complex was isolated on a preparative scale, and its identity was unambiguously 
established by NMR experiments (multinuclear and 2D experiments), positive mode ESI 
HRMS, elemental and XRD analyses. The 1H NMR spectrum of this compound after workup 
is presented below.  
 
 
Spectrum III-11: 1H NMR spectrum of 41 (500.03 MHz, 300 K, bromobenzene-d5). i: unidentified impurities. 
  
A set of three signals is observed in the aromatic region for the protons of the benzophenone. 
In this structure, the titanium centre is also chiral; the protons of the monosubstituted Cp ring 
are diastereotopic, and appear as a set of four apparent quartets (one is overlapping with the 
Ha’             Hb’               He               Hd                                 Hf/f’ 
p-H m-H  o-H  
Hg + Hb 
Ha  
i  i  i  i  
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signal of the non-substituted Cp ring). The bridging CH2 resonates at 4.44 and 4.18 ppm with 
an AB pattern (2JHH = 15.4 Hz). For the isopropyl group, the CH group shows a heptet at 4.65 
ppm, whilst the two methyl groups are diastereotopics and exhibit an apparent triplet at 0.85 
ppm (a doublet of doublet was observed on the 600.23 MHz spectrometer). The mass 
spectrum showed a cluster of peaks at 248.09089 Da corresponding to the [M-benzophenone]+ 
cation. 
The structure was confirmed by X-ray diffraction analysis. The ORTEP view is 
presented in Figure III-6. 
 
Figure III-6: ORTEP view of 41 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed for 
clarity, enantiomer and counter anion omitted for clarity). Selected bond lengths (Å) and angles(°): Ti-Ct1 = 
2.037(2), Ti-Ct2 = 2.040(2), Ti-O = 2.078(2), Ti-N = 1.950(5) / 1.997(13), N-C11 = 1.463(9) / 1.463(15), C1-C11 = 
1.593(10) / 1.662(10), Ct1-Ti-Ct2 = 136.09(9), O-Ti-N = 99.80(18) / 103.8(4), C1-C11-N = 101.6(5) / 101.6(8), C11-
N-C12 = 113.7(5) / 115.7(10), C11-N-Ti = 104.3(5) / 103.9(8), C12-N-Ti = 140.6(5) / 140.0(9), Ti-O-C15 = 177.6(2). 
 
The titanocene adopts a bent geometry, with a short Ti-N bond (1.950(5) / 1.997(13) Å). In 
both enantiomers, the nitrogen atom is planar (Σα(N) = 358.6(2)° / 359.6(9)°). In addition, for 
this complex, Ti, O and C15 are almost aligned (Ti-O-C15 = 177.6(2)°). 
In the absence of benzophenone, the reaction of 34 with [Ph3C][B(C6F5)4] led to a 
completely different outcome. The formation of triphenylethane and methane was observed as 
previously, but triphenylmethane also appeared in the 1H and 13C NMR spectra. Besides these 
organic products, complex 43 was observed after ca 24h of reaction, whilst complex 42 was 
present initially (Scheme III-29). Interestingly, at no point during the reaction could we observe 
a well-defined stoichiometric ratio between organic and Ti-containing species. This is due to 
the parallel formation of paramagnetic Ti(III) species, which further complicates the analysis of 
reaction mixtures (vide infra). Although 42 and 43 are both unstable (all attempts at isolating 
them failed), we could characterize them in situ by NMR spectroscopy at 258 and 273 K, 
respectively. Complex 42 shows the common characteristics of a chiral titanium centre, with a 
Chapter II 
141 
   
set of four multiplets for the substituted Cp ring (6.66, 5.25, 5.02 and 4.97 ppm), an AB pattern 
for the signal of the bridging CH2 (4.12 and 3.27 ppm, 2JHH = 15.0 Hz), and two doublets at 
1.09 and 0.85 ppm for the two inequivalent methyl groups of the isopropyl moiety. Surprisingly, 
the methylene group bound to titanium resonates as a pronounced AB pattern (2.64, -0.86 
ppm) was observed with no evaluable coupling constant, but a characteristic correlation for the 
same carbon atom in the 1H 13C HMQC NMR spectrum (δ 13C = 67.8 ppm). In the 1H NMR 
spectrum, the formation of 43 is accompanied by a loss of diastereotopic relationships 
previously observed for 42. Indeed, only two broad signals are found for the substituted Cp 
ring (5.48-5.43 and 4.81-4.73 ppm), the bridging CH2 signal resonates as a singlet at 3.76 ppm, 
and both methyl groups from the isopropyl moiety resonate as a doublet at 1.00 ppm. The loss 
of the pronounced AB pattern for the methylenic group boud to titanium for 42 is accompanied 
by the appearance of a new downfield-shifted signal at 11.44 ppm consistent with a carbenic 
signal for 43 (for more details, see experimental part and appendix). Besides, the 15N chemical 
shift is notably modified during the process, as illustrated in Scheme III-29. 
 
Scheme III-29: in situ formation of 42 and 43 (counteranion omitted for clarity) 
 
Titanium carbene complexes have previously been reported in the literature. These 
compounds are rarely stable, and often used directly as catalysts (e.g. ring opening metathesis 
polymerization of diene),38 or stabilized with a phosphine for characterization purpose.39 An 
interesting review was published on these species in 2001.40 In addition to these reports, one 
can cite the studies published by Mindiola in the past six years (Scheme III-30).41,42,43 All of 
these carbenes were characterized by 1H and 13C NMR spectroscopy (Table III-1). 
Chemical shift L281a L282a L283 43c L284d L285c 
1H: δ (ppm) 8.30  14.20 11.82a 11.44 - - 
                                               
38
 Qian, Y.; Zhang, D.; Huang, J.; Ma, H.; Chan, A. S. C. J. Mol. Catal. Chem. 1998, 133, 135 
39
 Meinhart, J. D.; Anslyn, E. V.; Grubbs, R. H. Organometallics. 1989, 8, 583 
40
 Beckhaus, R.; Santamarıá, C. J. Organomet. Chem. 2001, 617–618, 81 
41
 Flores, J. A.; Cavaliere, V. N.; Buck, D.; Pintér, B.; Chen, G.; Crestani, M. G.; Baik, M.-H.; Mindiola, D. J. Chem. Sci. 2011, 2, 
1457 
42
 Grant, L. N.; Ahn, S.; Manor, B. C.; Baik, M.-H.; Mindiola, D. J. Chem. Commun. 2017, 53, 3415 
43
 Kurogi, T.; Carroll, P. J.; Mindiola, D. J. Chem. Commun. 2017, 53, 3412 
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13C{1H}: δ (ppm) 285.4 290.3 291.1b 266.2 254.3 220.6 
Table III-1: selected chemical shifts of carbenic or vinylic titanium complexes.aC6D6, btoluene-d8, cC6D5Br, 
dCD2Cl2 
The carbene CH reported by Mindiola, resonates between 8.30 and 14.18 ppm in the 
1H NMR spectrum depending on the carbon substituent, whilst the metal-bound carbon itself 
resonates between 285.4 and 291.1 ppm in the 13C{1H} NMR spectrum. The 1H NMR chemical 
shift of CH bound to titanium in 43 is consistent with those observed for carbenic species. 
However, the 13C NMR chemical shift observed for 43 is relatively more upfield shifted 
compared to those of the carbenic titanium complexes described by Mindiola (Scheme III-30). 
 
Scheme III-30: carbenic and vinylic titanocenium. Counter anion omitted for clarity 
 
Interestingly, 43 can be considered as two resonance forms; the carbenic form A, and the 
vinylic form B. 
 
Scheme III-31: the two limit forms of 43 
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Mindiola also reported a Ti-vinyl complex L284, the NMR spectroscopic signatures of which 
also appear in Table III-1. Additionnaly, we include the data for compound L285, a bona fide 
vinylic complex prepared by Dr. A. Normand.44 The 13C NMR chemical shift of 43 is relatively 
close to the one of the vinylic titanium complex L284 reported by Mindiola but remains relatively 
dowfield-shifted compared to the one of L285 (∆δ = 46 ppm). Therefore, it is difficult on the 
basis of the NMR spectroscopic evidence to ascribe form A or B to 43 with confidence. 
However, its reactivity is less ambiguous: metallacyclobutane formation, typical of Schrock 
carbenes, is observed upon reaction with olefins (vide infra), thus giving more credit to the 
carbenic form.  
 In order to obtain X-ray quality crystals of 43, the reaction mixtures containing this 
complex were quenched with phosphine oxide OPMe3 and OPEt3. Two new species (44 and 
45) were observed (Scheme III-32), which are more conducive to isolation. Nevertheless, they 
showed poor stability in dichloromethane, and consequently, isolated material always 
contained a large amount of bromo- or chlorobenzene. 
 
Scheme III-32: synthesis of new stabilized Ti-carbenes 
 
In the 1H NMR spectrum of 44 (Spectrum III-12), the first downfield signal at 9.07 ppm 
corresponds to the carbenic CH (vs 11.44 ppm in 43). The signal of the non-substituted Cp 
ring appears as a singlet at 5.80 ppm, whilst the chirality of the titanium centre entails 
diasterotopic relationships between the signals of the monosubstituted Cp ring, with four 
apparent quartets (5.80, 5.27, 5.17 and 4.53 ppm).The signal of the bridging CH2 exhibits a 
noteworthy AB pattern (4.20, 3.01 ppm 2JHH = 15.0 Hz). Then, only one isopropyl group is 
observed with a set of three signals due to the diastereotopy of the methyl groups showing an 
heptet and two doublets (3.82, 0.94 and 0.91 ppm respectively). Finally, a singlet (1.67 ppm) 
is observed for the isolated methyl group bound to the iminium carbon atom, whilst a doublet 
is found at 0.91 ppm for the three equivalents methyl groups bound to the phosphorus atom. 
Furthermore, the 1H 13C HMQC NMR spectrum shows a correlation between the signal at 9.70 
ppm in the 1H NMR spectrum with the signal of a CH carbon at δ = 221.9 ppm, consistent with 
a titanium-bound carbon atom. 
                                               
44
 Manuscript in preparation 
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Spectrum III-12: 1H NMR of 44 (600.23 MHz, 300 K, bromobenzene-d5) 
 
The 15N chemical shift was slightly downfield compared to the one observed for the free 
carbene (-268 vs -242 ppm). The large upfield shift of the 1H and 13C NMR signals of the Ti=CH 
moiety (1H: ∆δ = 2.4 ppm, 13C: ∆δ = 44.3 ppm) raises again the question of the appropriate 
resonance form of this compound (Scheme III-33). 
Ti
N
44 or 45-A
Ti
N
44 or 45-B
OPR3 OPR3R = Me, 44
R = Et, 45
 
Scheme III-33: resonance forms of 44 
 
Finally, the high-resolution ESI-MS spectrum of 44 showed a cluster of peaks corresponding 
to the cationic part at 380.16175 Da along with an H2O-addition product at 388.17229 Da.  
 
 Suitable crystals for X-ray diffraction were obtained by diffusion of heptane into a 
bromobenzene solution of 45 (Figure III-7). Surprisingly, the structure obtained was not the 
one expected on the basis of NMR spectroscopic analysis. Indeed, as illustrated in the ORTEP 
view of the brown crystals obtained, a Ti(III)-alkyl compound was obtained instead (46-OPEt3).  
Ha Ha’            Hb’     Hd      He                           Hd’ Hh                                      Hf        Hf’ Hk  
Hi 
Hj 
Hb 
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Figure III-7: ORTEP view of 46 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed for 
clarity except Ha and Hb, enantiomer and counter anion omitted for clarity). Selected bond lengths (Å) and 
angles(°): Ti-Ct1 = 2.0612(14), Ti-Ct2 = 2.0661(17), Ti-O = 2.106(2), Ti-C17 = 2.419(3), C1-C11 = 1.503(4), C11-
N = 1.470(4), N-C15 = 1.291(4), Ct1-Ti-Ct2 = 133.91(7), O-Ti-C17 = 81.00(11), O-Ti-C17 = 81.00(11), C1-C11-N 
= 110.8(2), P-O-Ti = 175.71, C11-N-C15 = 117.3(3), C11-N-C12 = 117.7(3), C12-N-C15 = 124.8(3). 
 
In accordance with this formulation, the Ti-C bond is relatively long (2.419(3) Å). On the other 
hand, a short distance is observed for N-C15 (1.291(4) Å vs 1.470(4) Å for N-C11), along with 
a trigonal-planar nitrogen atom (Σα(N) = 354.8(5)°), consistent with iminium formulation. 
Since the presence of paramagnetic Ti(III) species could realistically be envisaged, NMR 
spectroscopic titration of these mixtures was performed (using tetramethylsilane as a 
standard). In fact, 44 and 45 only represent about 45% of the total amount of Ti introduced in 
the tube. The formation of 43 was also followed by EPR spectroscopy, and several 
paramagnetic species were observed (see appendix for details). The formation of these 
species explains the presence of unidentified broad signals in some of the 1H NMR spectra 
recorded during the formation of 43. It also explains the non-trivial stoichiometry between 
organic and Ti-containing species. Noteworthy, the presence of the trityl radical was observed 
during the late stages of the formation of 43. The reaction sequence depicted below is an 
attempt at rationalizing the gathered spectroscopic and crystallographic evidence. 
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Scheme III-34: proposed mechanism of formation for 43, counter anion omitted for clarity 
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According to this mechanism, methide abstraction yields amine-coordinated 
methyltitanocenium intermediate I and triphenylethane. This reaction initiates the autocatalytic 
decomposition of 34: intramolecular hydride abstraction of the α-H atom in I yields iminium salt 
II, which is deprotonated by 34 to give enamine complex IV. Ammonium salt III is also 
generated and converted into methane and intermediate I, thus closing the autocatalytic cycle. 
Intermediate IV competes with Ph3C+ for hydride abstraction, giving triphenylmethane and 
complex V. The iminium form of V is the observed species 42, which undergoes methane 
extrusion to yield carbene 43. This complex is then subject to decomposition, e.g. H• 
abstraction from triphenylmethane to generate 46 and the trityl radical. 
A consequence of this mechanism is that the presence of an excess of H• donor should 
promote the formation of 46 by displacing the Ti(IV) carbene / Ti(III) alkyl equilibrium towards 
the right. Indeed, reacting 34 with [Ph3C][B(C6F5)4] in the presence of an excess of cyclohexa-
1,4-diene completely suppressed the formation of 43 and trityl radical (Scheme III-35). On the 
other hand, a signal at g = 1.9858 was observed by EPR spectroscopy (see appendix for 
details). Addition of OPEt3 to the reaction mixture followed by workup afforded a new complex, 
which was characterized by EPR spectroscopy. Crystallization of the batch thus obtained 
yielded crystals with identical cell parameters as 46-OPEt3,45 therefore we conclude that both 
compounds are identical and that 46 originates from reaction of 43 from an H• donor. 
  
Scheme III-35: preparative scale synthesis of 46-OPEt3 
 
In the light of these findings, we also tried to prepare 45 and 43 from 46-OPEt3 and 
(freshly generated) 46, respectively but to no avail (Scheme III-36).   
As mentioned above, the formulation of 43 as a Ti-carbene species rather than a 
titanocenium enamine cannot be grounded in spectroscopic evidence. In order to highlight the 
carbenic character of this compound, we reacted 34 with [Ph3C][B(C6F5)4] in the presence of 3 
eq of 3,3-dimethylbut-1-ene in the hope of generating a titanacyclobutane complex as 
illustrated in Scheme III-37. 
                                               
45
 Other crystals formed as well, which could be due to hydrolysis, or other decomposition reactions which commonly occur with 
Ti(III) species. 
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Scheme III-36: H. abstraction attempts 
 
 Indeed, the expected metallacycle 47 was observed and characterized 
spectroscopically. 
 
Scheme III-37: formation of a Ti-metallacyclobutane complex 
 
The first feature of the 1H NMR spectrum, is the absence of a carbenic signal in the highfield 
region. According to 2D NMR experiments, all signals were assigned to 47 and the side 
products formed during the reaction. Four products were observed: triphenylethane (aromatic 
region and a singlet at 2.05 ppm), triphenylmethane (aromatic region and a singlet at 5.46 
ppm), methane (s, 0.16 ppm) and excess 3-3-dimethylbut-1-ene, with three doublet of doublets 
and one singlet in a 1: 1: 1: 3 ratio (5.79, 4.91, 4.88 and 0.96 ppm respectively). Only one 
titanocene species is observed, exhibiting chirality as evidenced by the four apparent quartets 
observed for the monosubstituted Cp ring (6.63, 5.47, 4.80 and 4.55 ppm). A singlet is 
observed at 5.86 ppm for the non-substituted Cp ring. Diastereotopy is also observed at both 
the bridging CH2 and the methyl groups of the isopropyl moeity; exhibiting an AB pattern at 
4.23 and 4.12 ppm (2JHH = 15.5 Hz), and two multiplets respectively (0.93-0.95 and 0.85-0.82). 
The methylene group of the isopropyl moiety shows an expected heptet at 3.63 ppm and the 
methyl group bound to the iminium shows a singlet at 1.60 ppm. The metallacycle exhibits a 
specific set of four signals: two triplets for the protons bound to Ck, a doublet for Hi and a 
quartet for Hj all in a 1: 1: 1: 1 ratio (2.82, 2.33, 2.66 and 1.33 ppm respectively). 
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The comparison of the signals observed in the 13C{1H} NMR spectrum for the carbon 
atom involved in the metallacyclobutane with those of the starting diene (Ck = 77.1 ppm and Cl 
= 36.4 ppm vs CH2diene = 149.6 ppm and CHdiene = 109.5 ppm) provides further evidence for 
47. In addition, the carbenic CH (Ci = 266.2 ppm for 43) appears at 82.5 ppm in the newly 
formed metallacycle. These combined data are in agreement with the formation of a 
metallacyclobutane, according to the values observed in the literature.39 
 
Spectrum III-13: 1H NMR of 47 [7.5-3.9 ppm] (600.23 MHz, 300 K, bromobenzene-d5). i: unidentified 
impurities 
 
In the present case, the activation of the diene is regioselective, probably due to the steric 
hindrance of the tert-butyl group. Nevertheless, two diastereoisomers (cis / trans) would have 
been expected with this reaction, depending on which faces of 3,3-dimethylbutene and 
carbene react with each other preferentially. However, only one titanocene was observed by 
NMR spectroscopy, meaning that only one set of enantiomers was formed. A NOESY 
experiment was realised, to determine the relative position of the hydrogen atoms along the 
metallacyclobutane. With the two correlations described on the following Spectrum III-15, 
between Hd and Hj on the one hand, and Hi and tBu on the other hand, the selective formation 
of 47.  
 
Ph3CCH3 + Ph3CH Ph3CH 
Hn 
Ha Ha’     Hb’ Hb 
Hd 
CH2CHtBu CH2CHtBu 
i i i i 
C6D5Br 
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Spectrum III-14: 1H NMR of 47 [3.9-0.0 ppm] (600.23 MHz, 300 K, bromobenzene-d5) 
 
 
Spectrum III-15: 1H 1H NOESY of 47 (600.23 MHz, 273 K, bromobenzene-d5) 
 
Since attempts at isolating 47 failed, we surmised that this compound might be in 
equilibrium with the free alkene and carbene 43. Others have successfully highlighted similar 
Hf Hf’ 
CH2CHtBu 
Ph3CCH3  
Hh He 
CH4  Hk                  Hk’  Hm 
 
Hj 
Hi 
Hj 
Hk Hi Hk’  Hk  Hd 
Hn 
Hb 
i i i 
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equilibria by adding PMe3 to titanacyclobutanes.39 Indeed, when PMe3 was added to a mixture 
of 47 and 3,3-dimethylbut-1-ene, analysis of the reaction mixture by 31P{1H} NMR spectroscopy 
indicated the presence of two species in addition to excess PMe3 (Spectrum III-16). A possible 
explanation for this observation would be the nucleophilic addition of PMe3 to the iminium 
moiety (signal at 36.7 ppm), besides the expected formation of a PMe3-stabilized carbene 
species Scheme III-38. 
 
Scheme III-38: putative species formed by reaction of 47 with PMe3 
 
Spectrum III-16: 31P{1H} NMR of crude 48 (600.23 MHz, 300 K, bromobenzene-d5) 
 
The 1H NMR spectrum (Spectrum III-17) shows the disappearance of titanacyclobutane 
signals, along with the appearance of a characteristic downfield singlet at 9.84 ppm, which was 
ascribed to 48. Therefore, the reversible nature of the cycloaddition of 3,3-dimethylbut-1-ene 
to Ti-carbene 43 is established. 
? 
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Spectrum III-17: superposition of the 1H NMR spectra of 48 (bottom) and 47 (top) (600.23 MHz, 300 K, 
bromobenzene-d5) 
 
This spectrum will not be completely assigned since two species were present. This 
superposition just illustrates the complete and quick consumption of the previous 
titanacyclobutane (disappearance of the signals from the metallacycle) and formation of a 
major product with a downfield shifted signal (9.84 ppm) identified as 48, by addition of PMe3. 
This experiment is another proof of the formation of the metallacycle. 
To resume this part on methide abstraction, the targeted OmFLPs were not obtained 
due to the high reactivity and activity of the titanocenium fragment, leading to novel unexpected 
species via CH activation pathways of the pendant amine arm. 
In conclusion to this chapter, the synthetic approach towards N/Ti+ based OmFLPs led 
us to shift our focus into new fields of investigations. Indeed, as previously described in the 
literature but rarely observed on titanium, new CH-activation of the tertiary amine moiety were 
highlighted and enabled us to synthesize two new cationic amidotitanocenes and an 
unexpected titanium carbene species. Their mechanisms of formation were also investigated. 
This work could help to understand the behaviour of cationic group 4 metallocenes towards N-
based substrate in catalytic reaction, and could be used to synthesize new Ti-carbene species. 
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C. Experimental part: 
1. Synthesis of 25: 
 
   
A solution of 19 (150 mg, 0.35 mmol, 2 eq), and LiB(C6F5)4 (121.6 mg, 0.17 mol, 1 eq) was 
prepared in dichloromethane for 5 minutes. The solution was then filtered through 
diatomaceous earth, and the compound was purified by fractional crystallization from diffusion 
of pentane in a concentrated dichloromethane solution at -15°C. The compound was dried in 
vacuo after the third time to afford the desired compound as a crystalline red solid with a 90% 
purity determined by NMR (140 mg, 56%).46,47 
1H NMR (500.03 MHz, 260 K, dichloromethane-d2): δ1H: 6.21-6.18 (apparent q, 3JHH = 4JHH = 
2.6 Hz, 4H, Ha), 6.18-6.15 (apparent q, 3JHH = 4JHH = 2.6 Hz, 4H, Hb), 4.49 (s, 4H, 2JHH Hd/d’), 
4.00 (hept, 3JHH = 6.7 Hz, 4H, He), 2.05 (s, 30H, Hh), 1.48 (d, 3JHH = 6.7 Hz, 12H, Hf), 1.41 (d, 
3JHH = 6.7 Hz, 12H, Hf). Traces of pentane: 1.32-1.19 (m), 0.85 (t), and unidentified compound: 
6.33-6.21 (bm), 3.68-3.54 (bm), 3.16-2.90 (bm), 1.10-0.91 (bm). 
13C{1H} NMR (125.75 MHz, 260 K, dichloromethane-d2): δ13C: 148.2 (dm, 1JFC = 243 Hz, o-
CF), 138.3 (dm, 1JFC = 243 Hz, p-CF), 136.5 (dm, 1JFC = 243 Hz, m-CF), 133.1 (Cg), 126.4 (Cb), 
116.0 (Cc), 113.1 (Ca), 56.9 (Ce), 46.7 (Cd), 18.6 (Cf), 18.4 (Cf’), 13.9 (Ch). Pentane: 34.5, 22.8, 
14.3 
1H 1H COSY (500.03 MHz, 260 K, dichloromethane-d2): δ1H / δ1H: 6.21-6.18 / 6.18-6.15 (CHa 
/ CHb), 6.18-6.15 / 6.21-6.18 (CHb / CHa), 4.00 / 1.48, 1.41 (CH2e / CH3f/f’), 1.48 / 4.00 (CH3f / 
CH2e), 1.41 / 4.00 (CH3f’ / CH2e). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 260 K, dichloromethane-d2): δ1H / δ13C: 6.21-6.18 / 
113.1 (CHa), 6.18-6.15 / 126.4 (CHb), 4.49 / 46.7 (CH2d), 4.00 / 56.9 (CHe), 2.05 / 13.9 (CH3h), 
1.48 / 18.6 (CH3f), 1.41 / 18.4 (CH3f’). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 260 K, dichloromethane-d2): δ1H / δ13C: 6.21-6.18 / 
126.4 (CHa / CHb), 6.18-6.15 / 116.0, 113.1 (CHb / Cc, CHa), 4.49 / 126.4, 116.0, 56.9 (CH2d / 
                                               
46
 A satisfactory elemental analysis could not be obtained (low C) due to remaining [Li][B(C6F5)4 salts 
47
 IR spectroscopy was not measured due to the presence of the counter anion, hiding all structural parameters of the titanocene 
fragment. 
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CHb, Cc, CHe), 4.00 / 56.9, 46.7, 18.6, 18.4 (CHe / CHe, CH2d, CH3f/f’), 2.05 / 133.1 (CH3h / Cg), 
1.48 / 56.9, 18.4 (CH3f / CHe, CH3f’), 1.41 / 56.9, 18.6 (CH3f’ / CHe, CH3f). 
11B{1H} NMR (160.42 MHz, 300 K, dichloromethane-d2): δ11B: -16.8 (ν1/2 = 21 Hz). 
11B NMR (160.42 MHz, 300 K, dichloromethane-d2): δ11B: -16.8 (ν1/2 = 21 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -133.2 (apparent d, 3JFF = 15 Hz, 
8F, o-F), -163.3 (t, 3JFF = 19 Hz, 8F, p-F), -167.2 (apparent t, 3JFF = 17 Hz, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -133.2 (apparent d, 3JFF = 15 Hz, 8F, 
o-F), -163.3 (t, 3JFF = 19 Hz, 8F, p-F), -167.2 (apparent t, 3JFF = 17 Hz, 8F, m-F). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 1.48, 1.41 / -
309.0 (Hf / N). 
HRMS (Positive mode ESI, dichloromethane) m/z: C22H36Cl2NTi [M-CpNCpTiCl2-
LiB(C6F5)4+H]+ 432.16988, found 432.17088 (Rel. Ab: 100%, 2.3 ppm). 
XRD: 
 
Experimental. Single black block-shaped crystals of 
(q28102015_0m_a) were obtained by recrystallisation from .. A 
suitable crystal (0.50×0.50×0.50) mm3 was selected and mounted on 
a mylar loop with oil on a Nonius Kappa APEX II diffractometer. 
The crystal was kept at T = 115 K during data collection. Using 
Olex2 (Dolomanov et al., 2009), the structure was solved with the 
ShelXT (Sheldrick, 2015) structure solution program, using the 
Direct Methods solution method. The model was refined with 
version 2017/1 of XL (Sheldrick, 2008) using Least Squares 
minimisation. 
Crystal Data. C68H70BCl4F20LiN2Ti2, Mr = 1550.61, triclinic, P-1 
(No. 2), a = 11.2304(6) Å, b = 17.2668(10) Å, c = 19.7419(11) Å, 
α = 83.951(2)°, β = 89.789(2)°, γ = 88.199(2)°, V = 3805.0(4) Å3, T 
= 115 K, Z = 2, Z' = 1, µ(MoKα) = 0.438, 120519 reflections 
measured, 17612 unique (Rint = 0.0366) which were used in all 
calculations. The final wR2 was 0.1425 (all data) and R1 was 0.0501 
Compound  q28102015_0m_a  
    
Formula  C68H70BCl4F20LiN2Ti2 
Dcalc./ g cm-3  1.353  
µ/mm-1  0.438  
Formula Weight  1550.61  
Colour  black  
Shape  block  
Size/mm3  0.50×0.50×0.50  
T/K  115  
Crystal System  triclinic  
Space Group  P-1  
a/Å  11.2304(6)  
b/Å  17.2668(10)  
c/Å  19.7419(11)  
α/°  83.951(2)  
β/°  89.789(2)  
γ/°  88.199(2)  
V/Å3  3805.0(4)  
Z  2  
Z'  1  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  1.037  
Θmax/°  27.610  
Measured Refl.  120519  
Independent Refl. 17612  
Reflections Used  13200  
Rint  0.0366  
Parameters  892  
Restraints  30  
Largest Peak  1.182  
Deepest Hole  -0.654  
GooF  1.047  
wR2 (all data)  0.1425  
wR2  0.1229  
R1 (all data)  0.0735  
R1  0.0501  
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(I > 2(I)). 
 
2. Synthesis of 26: 
 
A solution of 9 (1.0 g, 2.6 mmol, 1.0 eq) and sodium 2,6-dimethylphenolate (430 mg, 2.6 mmol, 
1.0 eq) in 40 mL of dichloromethane were stirred for 12h. The resulting red solution was filtered 
through diatomaceous earth to remove LiCl salts and all volatiles were removed. The red oil 
obtained was dissolved in Et2O (30 mL), supernatant was syringed to remove insoluble 
impurities. After removal of all volatiles, the red oil was stirred in pentane. The desired 
compound was obtained as a red oil after removal of the supernatant and drying in vacuo. (510 
mg, yield = 42 %).(Since grease can not be removed from this oily compound soluble in 
pentane, it was not characterized by elemental analysis and grease is observed in NMR 
spectra).48 
1H NMR (500.03 MHz, 300 K, dichloromethane-d2): δ1H: 7.29-7.18 (m, 5H, Hh,I,j), 6.93 (d, 3JHH 
= 6.9 Hz, 2H, Ho), 6.67 (t, 3JHH = 6.9 Hz, 1H, Hp), 6.46 (apparent q, 3JHH = 4JHH’ = 2.8 Hz, 1H, 
Hb), 6.43 (apparent q, 3JHH = 4JHH’ = 2.8 Hz, 1H, Ha), 6.23 (apparent q overlapping with Hk, 3JHH 
= 
4JHH’ = 2.8 Hz, 1H, Hb’), 6.22 (s overlapping with Hb’, 5H, Hk), 6.12 (apparent q, 3JHH = 4JHH = 
2.8 Hz, 1H, Ha’), 3.58 (d, 2JHH = 14.9 Hz, 1H, Hd), 3.51 (d, 2JHH = 14.9 Hz, 1H, Hd’), 3.47 (s, 2H, 
Hf’), 2.12 (s, 3H, He), 2.06 (bs, 6H, Hn). 
13C{1H} NMR (125.77 MHz, 300 K, dichloromethane-d2): δ13C: 169.4 (Cl), 139.8 (Cg), 132.2 
(Cc), 129.4 (h/i/j), 129.0 (Co), 128.7 (CHh/i/j), 127.5 (Ch/i/j), 123.3 (Cb), 123.2 (Cb’), 120.3 (Cp), 
118.4 (Cm), 118.1 (Ck), 116.6 (Ca), 109.6 (Ca’), 62.3 (Cf), 57.2 (Cd), 42.6 (Ce), 19.3-18.5 (bs, 
Cn). 
1H 1H COSY (500.03 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 7.29-7.18 / 7.29-7.18 
(CHh,I,j), 6.93 / 6.67 (CHo / CHp), 6.67 / 6.93 (CHp / CHo), 6.46 / 6.43, 6.23, 6.12 (CHb / CHa, 
CHb’, CHa’), 6.43 / 6.46, 6.23, 6.12 (CHa / CHb, CHb’, CHa’), 6.23 / 6.46, 6.43, 6.12 (CHb’ / CHb, 
CHa, CHa’), 6.12 / 6.46, 6.43, 6.23 (CHa’ / CHb, CHa, CHb’), 3.58 / 3.51 (CH2d/d’), 3.51 / 3.58 
(CH2d/d’). 
                                               
48
 IR spectroscopy and elemental analysis were not performed due to the oily character of this compound. 
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1H 13C HMQC (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.29-7.18 / 
129.4, 128.7, 127.5 (CHh,I,j), 6.93 / 129.0 (CHo), 6.67 / 120.3 (CHp), 6.47 / 123.3 (CHb), 6.43 / 
116.6, (CHa), 6.23 / 123.2 (CHb’), 6.22 / 118.1 (CHk), 6.12 / 109.6 (CHa’), 3.58, 3.51 / 57.2 
(CH2d/d’), 3.47 / 62.3,1 2.12 / 42.6 (CH3e), 2.06 / 19.3-18.5 (CH3n). 
1H 13C HMBC (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.29-7.18 / 
139.8, 129.4, 128.7, 127.5 (CHi,j,k / Cg, CHi,j,k), 6.93 / 169.4, 129.0, 19.3-18.5 (CHo / Cm, CHo, 
CH3n), 6.67 / 169.4, 129.0 (CHp / Cm, CHo), 6.47 / 132.2, 123.2, 116.6, 109.6 (CHb / Cc, CHb’, 
CHa, CHa’), 6.43 / 132.2, 123.3, 123.2, 109.6 (CHa / Cc, CHb, CHb’, CHa’, CH), 6.23 / 132.2, 
123.3, 123.2, 116.6, 109.6 (CHb’ / Cc, CH, CH, CH), 6.22 / 118.1 (CHk / CHk), 6.12 / 132.2, 
123.3, 123.2, 116.6 (CHa’ / Cc, CHb, CHb’, CHa), 3.58, 3.51 / 132.2, 123.3, 123.2, 62.3, 42.6 
(CH2d / Cc, CHb, CHb’, CH2f, CH3e), 3.47 / 139.8, 129.4, 57.2, 42.6 (CH2f / Cg, CHh, CH2d, CH3e) 
2.12 / 62.3, 57.2 (CH3e / CH2f, CH2d), 2.06 / 169.4, 129.0 (CH3n / Cm, CHo). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 2.12 / -340 (He 
/ N). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C27H31ClNOTi [M+H]+ 
468.15682; found 468.15620 (Rel. ab: 100%, -1.3 ppm). 
3. Synthesis of 27: 
 
A solution of 11 (810 mg, 1.8 mmol, 1.0 eq) and sodium 2,6-dimethylphenolate (290 mg, 1.8 
mmol, 1.0 eq) in 15 mL of dichloromethane were stirred for 12h. The resulting red solution was 
filtered through diatomaceous earth to remove LiCl salts and all volatiles were removed. The 
red oil obtained was suspended in pentane (10 mL), and supernatant was removed at - 40 °C. 
The desired compound was obtained as a red sticky solid after drying in vacuo. (590 mg, yield 
= 61 %).48  
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 7.32 (d, 3JHH = 7.3 Hz, 4H, Hg), 7.25 
(t, 3JHH = 3JHH = 7.3 Hz 4H, Hh), 7.18 (t, 3JHH = 7.3 Hz, 2H, Hi), 6.89 (d, 3JHnHo = 7.4 Hz, 2H, Hn), 
6.65 (t, 3JHH = 7.4 Hz, 1H, Ho), 6.44 (apparent q, 3JHH = 4JHH = 2.2 Hz, 1H, Hb), 6.38 (apparent 
q, 3JHH = 4JHH = 2.2 Hz, 1H, Hb’), 6.22 (apparent q, 3JHH = 4JHH = 2.2 Hz, 1H, Ha), 6.12 (s, 5H, Hj), 
6.08 (apparent q, 3JHH = 4JHH = 2.2 Hz, 1H, Ha’), 3.56 (apparent d, 2JHH = 14.4 Hz, 2H, Hd+d’), 
3.54 (d, 2JHH = 14.4 Hz, 2H, He), 3.48 (d, 2JHH = 14.4 Hz, 2H, He’), 1.96 (bs, 6H, Hl). 
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13C{1H} NMR (125.77 MHz, 300 K, dichloromethane-d2): δ13C: 169.4 (Ck), 140.1 (Cf), 131.8 
(Cc), 129.3 (g), 129.1 (Cn), 128.7 (Ch), 127.4 (Ci), 123.6 (Cb’), 123.0 (Cb), 120.7 (Cl), 120.3 (Co), 
118.5 (Cl), 118.1 (Cj), 117.5 (Ca), 109.4 (Ca’), 58.7 (Ce), 53.3 (Cd), 19.0-18.6 (Cm). 
1H 1H COSY (500.03 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 7.32 / 7.25, 7.18 (Hg / Hh, 
Hi), 7.25 / 7.32, 7.18 (Hh / Hg, Hi), 7.18 / 7.32, 7.25 (Hi / Hg, Hh), 6.89 / 6.65 (Hn / Ho), 6.65 / 6.89 
(Ho / Hn), 6.44 / 6.38, 6.22, 6.08 (Hb / Hb’, Ha, Ha’), 6.38 / 6.44, 6.22, 6.08 (Hb’ / Hb, Ha , Ha’), 6.22 
/ 6.44, 3.38, 6.08 (Ha / Hb, Hb’, Ha’), 6.08 / 6.44, 6.38, 6.22 (Ha’ / Hb, Hb’, Ha), 3.56 / 3.56 (Hd/d’), 
3.54 / 3.48 (He/e’), 3.48 / 3.54 (He/e’). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.32 / 129.3 
(CHg), 7.25 / 128.7 (CHh), 7.18 / 127.4 (CHi), 6.89 / 129.1 (CHn), 6.65 / 120.3 (CHo), 6.44 / 
123.0 (CHb), 6.38 / 123.6 (CHb’), 6.22 / 117.5 (CHa), 6.12 / 118.1 (CHj), 6.08 / 109.4 (CHa’), 
3.56 / 53.3 (CH2d/d’), 3.54, 3.48 / 58.7 (CH2e/e’), 1.96 / 19.0-18.6 (CH3m). 
1H 13C HMBC (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.32 / 127.4, 
58.7 (CHg / CHi, CH2e), 7.25 / 140.1, 128.7 (CHh / Cf, CHh), 7.18 / 129.3 (CHi / CHg), 6.89 / 
169.4, 129.1, 19.0-18.6 (CHn / Ck, CHn, CH3m), 6.65 / 129.1 (CHo / CHn), 6.44 / 131.8, 123.6, 
117.5, 109.4 (CHb / Cc, CHb’, CHa, CHa’), 6.38 / 131.8, 117.5, 109.4 (CHb’ / Cc, CHa, CHa’), 6.22 
/ 131.8, 123.6, 123.0, 109.4 (CHa / Cc, CHb’, CHb, CHa’), 6.22 / 118.1 (CHk / CHk), 6.08 / 131.8, 
123.6 (CHa’ / Cc, CHb’), 3.56 / 131.8, 123.6, 123.0, 58.7 (CH2d / Cc, CHb’, CHb, CH2e), 3.54, 3.48 
/ 140.0, 129.3, 58.7, 53.3 (CH2e / Cf, CHg, CH2d, CH2e), 1.96 / 169.4, 129.1, 120.3 (CH3m / Ck, 
CHn, CHo). 
1H 15N HMBC (600.23 MHz / 60.83 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 3.56 / -329 
(He / N) 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C33H35ClNOTi [M+H]+ 
544.18812; found 544.18842 (Rel. ab: 100%, 0.6 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3025; 2917; 1587; 1453; 1369; 1263; 1218; 1091; 1022; 873; 812; 732; 695. 
FIR: 565; 545; 488; 386; 363; 241; 195, 128; 100. 
Elemental Analysis: % calcd for C33H34ClNOTi: C, 72.87; H, 6.30; N, 2.58; Found: C, 71.68; 
H, 6.48; N, 2.89. 
4. Synthesis of 28: 
O
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l
Chemical Formula: C25H34ClNOTi
MolecularWeight: 447,9
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A solution of 12 (200 mg, 0.55 mmol, 1.0 eq) and sodium 2,6-dimethylphenolate (97.5 mg, 
0.55 mmol, 1.0 eq) in 5 mL of dichloromethane were stirred for 12h. The resulting red solution 
was filtered through diatomaceous earth to remove NaCl salts and all volatiles were removed. 
The red oil obtained was dissolved in Et2O and left in the freezer (-30°C) for overnight 
crystallization. The desired compound was obtained as an orange microcrystalline solid after 
removal of the supernatant and drying in vacuo. (140 mg, yield = 57 %). 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 6.93 (d, 3JHH = 7.4, 2H, CHj), 6.66 (t, 
3JHH = 7.4, 1H, Hk), 6.44 (apparent q, 3JHH = 4JHH = 2.3 Hz, 1H, Hb), 6.38 (apparent q, 3JHH = 4JHH 
= 2.3 Hz, 1H, Ha’), 6.23 (s, 5H, Hg), 6.17 (apparent q, 3JHH = 4JHH = 2.3 Hz, 1H, Hb’), 6.09 
(apparent q, 3JHH = 4JHH = 2.3 Hz, 1H, Ha), 3.68 (d, 2JHH = 15.7 Hz, 1H, Hd), 3.59 (d, 2JHH = 15.7 
Hz, 1H,Hd’), 2.94 (hept, 3JHH = 6.6 Hz, 2H, He), 2.10 (bs, 6H, Hj), 0.96 (d, 3JHH = 6.6 Hz, 6H, Hf), 
0.91 (d, 3JHH = 6.6 Hz, 6H, Hf’). 
13C{1H} NMR (150.94 MHz, 300 K, dichloromethane-d2): δ13C: 169.3(Ch), 138.3 (Cc), 129.0 
(Ck), 122.9 (Cb), 122.8 (Cb’), 120.1 (Cl), 118.4 (Ci), 117.8 (Cg), 116.6 (Ca’), 109.0 (Ca), 49.0 (Ce), 
45.0 (Cd), 21.5 (Cf), 20.8 (Cf’), 19.0-18.7 (Cj). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 6.93 / 6.66 (CHk / CHl), 6.66 
/ 6.92 (CHl / CHk), 6.44 / 6.09 (CHb / CHa), 6.38 / 6.17 (CHa’ / CHb’), 6.17 / 6.38, 6.09 (CHb’ / 
CHa’, CHa), 6.09 / 6.44, 6.17 (CHa / CHb, CHb’), 3.68 / 3.59 (CH2d/d’), 3.59 / 3.68 (CH2d/d’), 2.94 / 
0.96, 0.91 (CHe / CH3f, CH3f’), 0.96 / 2.94 (CH3f / CHe), 0.91 / 2.97 (CH3f’ / CHe). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.93 / 129.0 
(CHk), 6.66 / 120.2 (CHl), 6.44 / 122.9 (CHb), 6.38 / 116.6 (CHa’), 6.23 / 117.8 (CHg), 6.17 / 
122.8 (CHb’), 6.09 / 109.0 (CHa), 3.68, 3.59 / 45.0 (CH2d/d’), 2.94 / 49.0 (CHe), 2.10 / 19.0-18.7 
(CH3j), 0.96 / 21.5 (CH3f), 0.91 / 20.8 (CH3f’). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.93 / 169.3, 
129.0, 120.2, 19.0-18.7 (CHk / Ci, CHk, CHl, CH3j), 6.66 / 169.3, 129.0 (CHl / Ci, CHk), 6.44 / 
138.3, 116.6, 109.0 (CHb / Cc, CHa’, CHa), 6.38 / 138.3, 122.8, 109.0 (CHa’ / Cc, CHb’, CHa), 
6.23 / 117.8 (CHg / CHg), 6.17 / 138.3, 116.6, 109.0 (CHb’ / Cc, CHa’, CHa), 6.09 / 138.3, 122.9, 
122.8 (CHa / Cc, CHb, CHb’), 3.68, 3.59 / 138.3, 122.9, 122.8, 49.0 (CH2d / Cc, CHb, CHb’, CHe), 
2.94 / 49.0, 45.0, 21.5, 20.8 (CHe / CHe, CH2d, CH3f, CH3f’), 2.10 / 169.3, 129.0 (CH3j / Ci, CHk) 
0.96 / 49.0, 20.8 (CH3f / CHe, CH3f’), 0.91 / 49.0, 21.5 (CH3f’ / CHe, CH3f). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 0.96 / -324 (Hf 
/ N). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C25H35ClNOTi [M+H]+ 
448.18841; found 448.18899 (Rel. ab: 100%, 2.0 ppm). 
IR (ATR) ν [cm-1]  
MIR: 2954; 1589; 1463; 1267; 1225; 1200; 1178; 1019; 876; 814; 753; 734; 716. 
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FIR: 716; 624; 563; 545; 392, 363, 270; 233; 189; 137. 
Elemental Analysis: % calcd for C25H35ClNOTi: C, 67.05; H, 7.65; N, 3.13; Found: C, 66.15; 
H, 7.79; N, 3.12. 
5. Synthesis of 29: 
 
A solution of 13 (300 mg, 0.75 mmol, 1.0 eq) and sodium 2,6-dimethylphenolate (131.7 mg, 
0.75 mmol, 1.0 eq) in 5 mL of dichloromethane were stirred for 12h. The resulting red solution 
was filtered through diatomaceous earth to remove LiCl salts and all volatiles were removed. 
The red oil obtained was dissolved in dichloromethane and left in the freezer (-30°C) for 
crystallization by pentane diffusion. The desired compound was obtained as an orange 
microcrystalline solid after removal of the supernatant and drying in vacuo. (224 mg, yield = 58 
%). 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 6.93 (d, 3JHH = 7.4, 2H, CHm), 6.66 (t, 
3JHH = 7.4, 1H, Hn), 6.43 (apparent q, 3JHH = 4JHH = 2.3 Hz, 1H, Hb), 6.36 (apparent q, 3JHH = 4JHH 
= 2.3 Hz, 1H, Ha’), 6.19 (s, 5H, Hi), 6.11 (apparent q, 3JHH = 4JHH = 2.3 Hz, 1H, Hb’), 6.06 
(apparent q, 3JHH = 4JHH = 2.3 Hz, 1H, Ha), 3.79 (d, 2JHH = 15.2 Hz, 1H, Hd), 3.74 (d, 2JHH = 15.2 
Hz, 1H,Hd’), 2.09 (bs, 6H, Hl),1.54-1.48 (m, 2H, CH2h), 1.39-1.35 (m, 4H, CH2g), 0.99 (s, 6H, 
Hf), 0.87 (s, 6H, Hf’). 
13C{1H} NMR (150.94 MHz, 300 K, dichloromethane-d2): δ13C: 169.3 (Cj), 144.6 (Cc), 129.1 
(Cm), 122.5 (Cb), 120.1 (Cn), 120.1 (Ca), 118.4 (Ck), 117.6 (Ci), 115.3 (Ca’), 109.7 (Cb’), 55.6 
(Ce), 44.9 (Cd), 41.9 (Cg), 28.7-27.6 (Cf), 18.9-18.8 (Cl), 18.4 (Ch). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 6.93 / 6.66 (CHm / CHn), 6.66 
/ 6.93 (CHn / CHm), 6.43 / 6.36, 6.11, 6.06 (CHb / CHa’, CHb’, CHa), 6.36 / 6.43, 6.11, 6.06 (CHa’ 
/ CHb, CHb’, CHa), 6.11 / 6.43, 6.36, 6.06 (CHb’ / CHb, CHa’, CHa), 6.06 / 6.43, 6.36, 6.11 (CHa / 
CHb, CHa’, CHb’), 3.79 / 3.74 (CH2d/d’), 3.74 / 3.79 (CH2d’/d), 1.54-1.48 / 1.39-1.35 (CH2h / CH2g), 
1.39-1.35 / 1.54-1.48 (CH2g / CH2h). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.93 / 129.1 
(CHm), 6.66 / 120.2 (CHn), 6.43 / 122.5 (CHb), 6.36 / 115.3 (CHa’), 6.19 / 117.6 (CHi), 6.11 / 
109.7 (CHb’), 6.06 / 120.1 (CHa), 3.79, 3.74 / 44.9 (CH2d/d’), 2.09 / 18.9-18.8 (CHl), 1.54-1.48 / 
18.4 (CH2h), 1.39-1.35 / 41.9 (CH2g), 0.99 / 28.3 (CH3f), 0.87 / 28.7-27.6 (CH3f’). 
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1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.93 / 169.3, 
129.1, 18.4 (CHm / Ck, CHm, CH2h), 6.19 / 117.6 (CHi / CHi), 3.79, 3.74 / 144.6, 120.1, 115.3, 
44.9 (CH2d / Cc, CHa, CHa’, CH2d), 2.09 / 169.3, 129.1 (CH3l / Ck, CHm) 1.54-1.48 / 55.6, 41.9 
(CH2h / Ce, CH2g), 1.39-1.35 / 55.6, 41.9, 28.7-27.6, 18.4 (CH2g / Ce, CH2g, CH3f, CH2h), 0.99 / 
55.6, 41.9, 28.7-27.6 (CH3f / Ce, CH2g, CH3f’), 0.87 / 55.6, 41.9, 28.7-27.6 (CH3f’ / Ce, CH2g, 
CH3f). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 0.99, 0.87 / -
311 (Hf / N) 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C28H39ClNOTi [M+H]+ 
488.21974; found 488.21917 (Rel. ab: 100%, -0.5 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3089; 2956; 1589; 1463; 1382; 1260; 1221; 1091; 1048; 870; 812; 739; 710. 
FIR: 710; 620, 568, 542, 366, 280, 242, 195. 
Elemental Analysis: % calcd for C28H38ClNOTi: C, 68.92; H, 7.85; N, 2.87; Found: C, 68.07; 
H, 7.56; N, 2.72. 
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XRD: 
 
Experimental. Single red plate-shaped crystals of (q060116_0ma_a) 
were obtained by slow diffusion of pentane into a concentrated 
dichloromethane solution. A suitable crystal (0.20×0.20×0.02) mm3 was 
selected and mounted on a mylar loop with oil on a Nonius Kappa APEX 
II diffractometer. The crystal was kept at T = 115 K during data 
collection. Using Olex2 (Dolomanov et al., 2009), the structure was 
solved with the ShelXT (Sheldrick, 2015) structure solution program, 
using the Direct Methods solution method. The model was refined with 
version 2014/7 of XL (Sheldrick, 2008) using Least Squares 
minimisation. 
Crystal Data. C28H38ClNOTi, Mr = 487.94, monoclinic, P21/c (No. 14), 
a = 28.570(3) Å, b = 11.7824(11) Å, c = 14.9004(14) Å, β = 94.977(2)°, 
α = γ = 90°, V = 4997.0(8) Å3, T = 115 K, Z = 8, Z' = 2, µ(MoKα) = 0.470, 
64922 reflections measured, 11454 unique (Rint = 0.1148) which were 
used in all calculations. The final wR2 was 0.0732 (all data) and R1 was 
0.0427 (I > 2(I)). 
6. Synthesis of 30: 
g
d
e
f
c
h
j
k
l
n
m
o
Chemical Formula: C29H39F3NO4STi
Molecular Weight: 602,6
O
i
b
a
Ti OTf
N
30
 
A mixture of 29 (190 mg, 0.39 mmol, 1.0 eq) and silver triflate (98.3 mg, 0.38 mmol, 0.98 eq) 
was dissolved in 2 mL of THF for 12h. The resulting red solution was filtered over borosilicate 
to remove AgCl salts and all volatiles were removed. The red oil obtained was dissolved in 
Compound  q060116_0ma_a
    
Formula  C28H38ClNOTi  
Dcalc./ g cm-3  1.297  
µ/mm-1  0.470  
Formula Weight  487.94  
Colour  red  
Shape  plate  
Size/mm3  0.20×0.20×0.02  
T/K  115  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  28.570(3)  
b/Å  11.7824(11)  
c/Å  14.9004(14)  
α/°  90  
β/°  94.977(2)  
γ/°  90  
V/Å3  4997.0(8)  
Z  8  
Z'  2  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  2.565  
Θmax/°  27.512  
Measured Refl.  64922  
Independent Refl. 11454  
Reflections Used  6203  
Rint  0.1148  
Parameters  589  
Restraints  0  
Largest Peak  0.367  
Deepest Hole  -0.473  
GooF  0.858  
wR2 (all data)  0.0732  
wR2  0.0616  
R1 (all data)  0.1135  
R1  0.0427  
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dichloromethane (2 mL) and pentane (10 mL) and left in the freezer (-15°C) in order to 
crystalize the impurity. The desired compound was obtained by evaporation of the filtrate as a 
red solid. (110 mg, yield = 47 %). 
1H NMR (500.03 MHz, 300 K, dichloromethane-d2): δ1H: 7.02 (d, 3JHH = 7.4, 2H, CHm), 6.94 
(apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb’), 6.85 (apparent q, 3JH/H = 4JHH = 2.5 Hz, 1H, Hb), 6.76 
(t, 3JHH = 7.4, 1H, Hn), 6.36 (s, 5H, Hi), 6.29 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Ha), 5.94 
(apparent q, 3JHH = 4JHH = 2.3 Hz, 1H, Ha’), 3.61 (d, 2JHH = 17.4 Hz, 1H, Hd), 3.52 (d, 2JHH = 17.4 
Hz, 1H, Hd’), 2.04 (bs, 6H, Hl),1.53-1.45 (m, 2H, CH2h), 1.40-1.34 (m, 4H, CH2g), 0.96 (s, 6H, 
Hf), 0.77 (s, 6H, Hf’). 
13C{1H} NMR (125.77 MHz, 300 K, dichloromethane-d2): δ13C: 169.8 (Cj), 149.5 (Cc), 129.3 
(Cm), 126.4 (Cb), 121.4 (Cn), 120.6 (Cn), 119.8 (q, 1JCF = 317.5 Hz, Co), 118.8 (Ci), 116.1 (Ca’), 
115.6 (Cb’), 111.5 (Ca), 55.5 (Ce), 44.4 (Cd), 41.8 (Cg), 28.6-28.0 (Cf’), 28.0-27.4 (Cf), 18.3 (Ch), 
18.2-18.0 (Cl). 
1H 1H COSY (500.03 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 7.02 / 6.76 (CHm / CHn, 6.94 
/ 6.85, 6.29, 5.94 (CHb’ / CHb, CHa, CHa’), 6.85 / 6.94, 6.29, 5.94 (CHb / CHb’, CHa , CHa’), 6.76 
/ 7.02 (CHn / CHm), 6.29 / 6.94, 6.85, 5.94 (CHa / CHb, CHb’, CHa’), 5.94 / 6.94, 6.85, 6.29 (CHa’ 
/ CHb’, CHb, CHa), 3.61 / 3.52 (CH2d/d’), 3.52 / 3.61 (CH2d/d’), 1.53-1.45 / 1.40-1.34 (CH2h / CH2g), 
1.40-1.34 / 1.53-1.45 (CH2g / CH2h). 
1H 13C HMQC (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.02 / 129.3 
(CHm), 6.94 / 115.6 (CHb’), 6.85 / 126.4 (CHb), 6.76 / 121.4 (CHn), 6.36 / 118.8 (CHi), 6.29 / 
111.5 (CHa), 5.94 / 116.1 (CHa’), 3.61, 3.52 / 44.4 (CH2d/d’), 2.04 / 18.2-18.0 (CHl), 1.53-1.45 / 
18.3 (CH2h), 1.40-1.34 / 41.8 (CH2g), 0.96 / 28.0-27.4 (CH3f), 0.77 / 28.6-28.0 (CH3f’). 
1H 13C HMBC (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.02 / 169.8, 
129.3, 18.2-18.0 (CHm / Ck, CHm, CH3l), 6.94 / 149.5, (CHb’ / Cc), 6.85 / 149.5, 115.6, 111.5 
(CHb / Cc, CHb’, CHa),, 6.76 / 129.3 (CHh / CHm), 6.36 / 118.8 (CHi / CHi), 6.29 / 115.6 (CHa / 
CHb’), 5.94 / 126.5, 115.6, 111.5 (CHa’ / CHb, CHb’, CHa), 3.61, 3.52 / 149.5, 126.4, 115.6, 55.5 
(CH2d / Cc, CHb, CHb’, CH2d), 2.04 / 169.8, 129.3 (CH3l / Ck, CHm) 1.53-1.45 / 55.5, 41.8 (CH2h / 
Ce, CH2g), 1.40-1.34 / 55.5, 41.8, 28.6-28.0, 28.0-27.4, 18.3 (CH2g / Ce, CH2g, CH3f’, CH3f’, 
CH2h), 0.96 / 55.5, 41.8, 28.6-28.0 (CH3f / Ce, CH2g, CH3f’), 0.77 / 55.5, 41.8, 28.0-27.4 (CH3f’ / 
Ce, CH2g, CH3f). 
19F{1H} NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -77.9. 
19F NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -77.9. 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 0.96, 0.77 / -
311 (Hf / N).  
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HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C29H39NF3SO4Ti [M+H]+ 
602.20259 found 602.20082 (Rel. ab: 100%, -2.9 ppm), C28H38NOTi [M-OTf]+ 452.24274 found 
452.24105 (Rel. ab: 5%, -3.7 ppm). 
Elemental Analysis: % calcd for C29H39F3NO4STi: C, 57.90; H, 6.37; N, 2.33; S, 5.33; Found: 
C, 57.95; H, 6.74; N, 2.85; S, 4.73. 
XRD: 
  
Experimental. Single red plate-shaped crystals of (q220616_0m) were 
obtained by recrystallisation from a saturated solution in pentane at -
15°C. A suitable crystal (0.35×0.12×0.07) mm3 was selected and 
mounted on a mylar loop with oil on a Nonius Kappa APEX II 
diffractometer. The crystal was kept at T = 115 K during data collection. 
Using Olex2 (Dolomanov et al., 2009), the structure was solved with the 
ShelXT (Sheldrick, 2015) structure solution program, using the Direct 
Methods solution method. The model was refined with version 2014/7 of 
XL (Sheldrick, 2008) using Least Squares minimisation. 
Crystal Data. C29H38F3NO4STi, Mr = 601.56, triclinic, P-1 (No. 2), a = 
11.8444(13) Å, b = 15.3636(17) Å, c = 17.702(2) Å, α = 76.761(2)°, β = 
84.699(3)°, γ = 69.316(3)°, V = 2933.4(6) Å3, T = 115 K, Z = 4, Z' = 2, 
µ(MoKα) = 0.416, 63699 reflections measured, 12796 unique (Rint = 
0.0707) which were used in all calculations. The final wR2 was 0.1054 
(all data) and R1 was 0.0477 (I > 2(I)). 
 
7. Synthesis of 32: 
Ti Me
Me
b
a
d
e
f
g
c
h
Chemical Formula: C17H25NTi
Molecular Weight: 291,3
N
 
Compound  q220616_0m  
    
Formula  C29H38F3NO4STi 
Dcalc./ g cm-3  1.362  
µ/mm-1  0.416  
Formula Weight  601.56  
Colour  red  
Shape  plate  
Size/mm3  0.35×0.12×0.07  
T/K  115  
Crystal System  triclinic  
Space Group  P-1  
a/Å  11.8444(13)  
b/Å  15.3636(17)  
c/Å  17.702(2)  
α/°  76.761(2)  
β/°  84.699(3)  
γ/°  69.316(3)  
V/Å3  2933.4(6)  
Z  4  
Z'  2  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  1.182  
Θmax/°  27.642  
Measured Refl.  63699  
Independent Refl. 12796  
Reflections Used  7968  
Rint  0.0707  
Parameters  715  
Restraints  0  
Largest Peak  0.424  
Deepest Hole  -0.460  
GooF  1.009  
wR2 (all data)  0.1054  
wR2  0.0882  
R1 (all data)  0.1057  
R1  0.0477  
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A solution of 2-K (0.85 g, 4.6 mmol, 1.1 eq) in 20 mL of toluene was added to a solution of 
CpTiCl3 (1.0 g, 4.6 mmol, 1 eq) in 40 mL of toluene, by canulation at -30°C. The resulting 
solution was left to warm up to room temperature and then stirred overnight. The crude red 
solution was first evaporated. The deep red oil obtained was triturated in pentane (20 mL), and 
the yellowish supernatant was removed. After drying in vacuo, the red residue was suspended 
in 60 mL of Et2O. MeLi (1.1 mL, 1.6 M, 2.05 eq) was added dropwise to the etheral suspension 
cooled down to -70°C. After warming up to room temperature, the initial crude red suspension 
turned into a yellow solution with a white precipitate after 1h of stirring. The solvent was then 
removed and the residue was dissolved in 20 mL of pentane. LiCl salts were removed by 
filtration through diatomaceous earth. The desired compound was obtained after evaporation 
of all volatiles as a yellow sticky oil. (620 mg, yield = 47 %).49,50 
1H NMR (500.03 MHz, 300 K, benzene-d6): δ1H: 5.92 (br s, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 5.75 
(s, 5H, Hg), 5.37 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Ha), 3.40 (s, 2H, Hd), 2.56-5.44 (m, 4H, 
He), 1.69-1.59 (m, 4H, Hf), 0.07 (s, 6H, Hh). 
13C{1H} NMR (125.75 MHz, 300 K, benzene-d6): δ13C: 126.1 (Cc), 115.6 (Cb), 113.4 (Cg), 110.9 
(Ca), 56.0 (Cd), 54.4 (Ce), 45.3 (Ch), 24.0 (Cf). 
1H 1H GCOSY (500.03 MHz, 300 K, benzene-d6): δ1H / δ1H 5.92 / 5.37 (CHb / CHa), 5.37 / 5.92 
(CHa / CHb), 2.56-5.44 / 1.69-1.59 (CH2e / CH2f), 1.69-1.59 / 2.56-5.44 (CH2f / CH2e). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 5.92 / 115.6 (CHg), 
5.75 / 113.4 (CHb), 5.37 / 110.9 (CHa), 3.40 / 56.0 (CH2d), 2.56-5.44 / 54.4 (CH2e), 1.69-1.59 / 
24.0 (CH3f), 0.07 / 45.3 (CH3h). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 5.92 / 126.1, 115.6, 
110.9 (CHb / Cc, CHb, CHa), 5.75 / 113.4, 45.3 (CHg / CHg, CH3h), 5.37 / 126.1, 115.6 (CHa / Cc, 
CHb) 3.40 / 126.1, 115.6, 54.4 (CH2d / Cc, CHb, CH2e), 2.56-5.44 / 54.4, 24.0 (CH2e / CH2e, CH2f), 
1.69-1.59 / 54.4, 24.0 (CH2f / CH2e, CH2f), 0.07 / 113.4 (CH3h / CHg). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, benzene-d6): δ1H / δ15N: 1.78 / -322 (Hf / N). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C16H22ONlTi [M-CH4+CH3OH]+ 
292.11754 (Rel. ab: 65%, -2.0 ppm); found 292.11693, C15H18NTi, [M-CH3-CH4]+ 260.09132; 
found 260.09106 (Rel. ab: 100%, -1.0 ppm). 
                                               
49
 A satisfactory elemental analysis could not be obtained (low C) due to remaining LiCl salts. 
50
 Ir spectroscopy was not measured due to the oily character of the compound. 
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8. Synthesis of 33: 
 
An etheral solution of MeLi (1.1 mL, 1.6 M, 2.05 eq) was added dropwise to an etheral 
suspension of 11 (400 mg, 0.87 mmol, 1.0 eq) cooled down to -70°C. After warming up to room 
temperature, the initial crude red suspension turned into a yellow solution with a white 
precipitate after 1h of stirring. The solvent was then removed and the residue was dissolved in 
20 mL of pentane. LiCl salts were removed by filtration through diatomaceous earth. The 
desired compound was obtained after evaporation of all volatiles as a yellow sticky oil. (228 
mg, yield = 63 %).49,50  
 
1H NMR (500.03 MHz, 300 K, benzene-d6): δ1H: 7.41 (d, 3JHH = 7.2 Hz, 4H, Hg), 7.20 (t, 3JHH = 
7.2 Hz, 4H, Hh), 7.10 (t, 3JHH = 7.2 Hz, 2H, Hi), 5.89 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 
5.63 (s, 5H, Hj), 5.53 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 3.58 (s, 4H, He), 3.30 (s, 4H, 
Hd), -0.06 (s, 6H, Hk). Traces of grease 0.29 (s) and pentane 1.31-1.14 (m), 0.87 (t). 
13C{1H} NMR (125.75 MHz, 300 K, benzene-d6): δ13C: 140.0 (Cf), 129.2 (Cg), 128.6 (Ch), 127.3 
(Ci), 124.0 (Cc), 115.6 (Cba), 113.4 (Cj), 111.9 (Ca), 58.2 (Ce), 52.9 (Cd), 45.6 (Ck). Traces of 
grease 1.4 (s) and pentane 34.4, 22.7, 14.3. 
1H 1H COSY (500.03 MHz, 300 K, benzene-d6): δ1H / δ1H: 7.41 / 7.20 (CHg / CHh),7.20 / 7.41, 
7.10 (CHh / CHg, CHi), 7.10 / 7.20 (CHi / CHg), 5.89 / 5.53 (CHb / CHa), 5.53 / 5.89 (CHa / CHb). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.41 / 129.2 (CHg), 
7.20 / 128.6 (CHh), 7.10 / 127.3 (CHi), 5.89 / 115.6 (CHb), 5.63 / 113.4 (CHj), 5.53 / 111.9 (CHa), 
3.58 / 58.2 (CH2e), 3.30 / 52.9 (CH2d), -0.06 / 45.6 (CH3k). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.41 / 128.6, 58.2 
(CHg / CHh, CHe), 7.20 / 140.0, 129.2 (CHh / Cf, CHg), 7.10 / 129.2 (CHi / CHg) 5.89 / 124.0, 
115.6, 111.9 (CHb / Cc, CHb, CHa), 5.63 / 113.4, 45.6 (CHj / CHj, CH3k), 5.53 / 124.0, 115.6, 
111.9 (CHa/ Cc, CHb CHa), 3.58 / 140.0, 129.2, 128.6, 58.2, 52.9 (CH2e / Cc, CHg, CHh, CH2e, 
CH2d), 3.30 / 124.0, 115.6, 58.2 (CH2d / Cc, CHb, CH2e), -0.06 / 113.4 (CH3f / CHj).  
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, benzene-d6): δ1H / δ15N: 3.30 / -328 (Hd / N). 
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HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C27H32ONTi [M-
CH4+CH3OH+H]+ 434.19579; found 434.19598 (Rel. ab: 20%, 0.4 ppm); C25H24NTi [M-2CH4]+ 
386.13827, found 386.13899 (Rel. ab: 100%, 1.9 ppm). 
9. Synthesis of 34: 
 
Procedure A: An etheral solution of MeLi (1.8 mL, 1.53 M, 2 eq) was added dropwise to an 
etheral suspension of 12 (415 mg, 1.14 mmol, 1.0 eq) cooled down to -70°C. The crude red 
suspension turned into a yellow solution with a white precipitate after 1h of stirring at room 
temperature. The solvent was then removed and the residue was dissolved in 20 mL of 
pentane. LiCl salts were removed by filtration through diatomaceous earth. The desired 
compound was obtained after evaporation of all volatiles as a yellow precipitate. (250 mg, yield 
= 68 %). 
Procedure B: An etheral solution of MeLi (1.0 mL, 1.67 M, 3.05 eq) was added dropwise to an 
etheral suspension 17 (218 mg, 0.5 mmol, 1 eq) cooled down to -70°C. The crude red 
suspension turned into a yellow solution with a white precipitate after 1h of stirring at room 
temperature. The solvent was then removed and the residue was dissolved in 20 mL of 
pentane. LiCl salts were removed by filtration through diatomaceous earth. Volatiles were 
removed in vacuo, yielding the 34 as a yellow precipitate. (120 mg, yield = 62 %). 
Procedure C: A solution of 4-K (840 mg, 3.86 mmol, 1 eq) in 25 mL of THF was added to a 
solution of CpTiCl3 (840 mg, 3.86 mmol, 1 eq) in 25 mL of toluene, by cannulation at -30°C. 
The resulting solution was left to warm up to room temperature and then stirred overnight. The 
crude red solution was first evaporated. The deep-red oil obtained was dissolved in Et2O, and 
MeLi (5.8 mL, 1.60 M, 2.4 eq) was added dropwise at -70°C. The crude red suspension turned 
into a yellow solution with a white precipitate after 1h of stirring at room temperature. The 
solvent was then removed and the residue was dissolved in 20 mL of pentane. LiCl salts were 
removed by filtration through diatomaceous earth. The desired compound was obtained after 
evaporation of all volatiles as a yellow precipitate. (830 mg, yield = 67 %).49 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 6.09 (apparent t, 3JHH = 4JHH = 2.6 Hz, 
2H, Ha), 6.05 (s, 5H, Hg), 5.76 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 3.38 (s, 2H, Hd), 3.11 
(hept, 3JHH = 6.6 Hz, 2H, He), 1.03 (d, 3JHH = 6.6 Hz, 12H, Hf), -0.21 (s, 6H, Hh). 
13C{1H} NMR (150.9 MHz, 300 K, dichloromethane-d2): δ13C: 129.5 (Cc), 116.1 (Ca), 113.7 (Cg), 
111.5 (Cb), 48.3 (Ce), 44.9 (Cd), 44.4 (Ch), 21.2 (Cf). 
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1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 6.09 / 5.76 (CHa / CHb), 5.76 
/ 6.09 (CHb / CHa), 3.11 / 1.03 (CH2e / CH3f), 1.03 / 3.11 (CH3f / CH2e). 
1H 13C HMQC (600.23 MHz / 150.9 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.09 / 116.1 
(CHa), 6.05 / 113.7 (CHg), 5.76 / 111.5 (CHb), 3.38 / 44.9 (CH2d), 3.11 / 48.3 (CHe), 1.03 / 21.2 
(CH3f), -0.21 / 44.4 (CH3h). 
1H 13C HMBC (600.23 MHz / 150.9 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.09 / 116.1, 
111.5 (CHa / CHa, CHb), 6.05 / 113.7 (CHg / CHg), 5.76 / 129.5, 116.1 (CHb / Cc, CHa), 3.38 / 
129.5, 116.1, 48.3 (CH2d / Cc, CHa, CHe), 3.11 / 21.2 (CHe / CH3f), 1.03 / 48.3, 21.2 (CH3f / CHe, 
CH3f), -0.21 / 44.4 (CH3h / CH3h). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 1.03 / -322 (Hf 
/ N). 
HRMS (Positive mode ESI, dichloromethane + methanol): m/z calcd. for C19H32NTi [M - Me 
+ MeOH]+ 338.19578; found 338.19578 (Rel. ab: 40%, 0.02 ppm). 
IR (ATR) ν [cm-1]  
MIR: 2965; 2884; 1379; 1199; 1034; 813; 475. 
FIR: 620; 566; 476; 399; 236; 165. 
10. Synthesis of 35: 
 
Procedure A: An etheral solution of MeLi (1.6 mL, 1.25 M, 2 eq) was added dropwise to an 
etheral suspension of 13 (400 mg, 1.0 mmol, 1 eq) cooled down to -70°C. The crude red 
suspension turned into a yellow solution with a white precipitate after 1h of stirring at room 
temperature. The solvent was then removed and the residue was dissolved in 20 mL of 
pentane. LiCl salts were removed by filtration through diatomaceous earth. The desired 
compound was obtained after evaporation of all volatiles as a yellow precipitate. (260 mg, yield 
= 72 %). 
Procedure B: An etheral solution of MeLi (1.0 mL, 1.67 M, 3.05 eq) was added dropwise to an 
etheral suspension of 18 (240 mg, 0.54 mmol, 1.0 eq) cooled down to -70°C. The crude red 
suspension turned into a yellow solution with a white precipitate after 1h of stirring at room 
temperature. The solvent was then removed and the residue was dissolved in 20 mL of 
pentane. LiCl salts were removed by filtration through diatomaceous earth. The desired 
compound was obtained after evaporation of all volatiles as a yellow precipitate. (115 mg, yield 
= 63 %). 
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Procedure C: An etheral solution of 5-K (1.53 g, 5.51 mmol, 1.0 eq) dissolved in 20 mL of 
toluene was added to a solution of CpTiCl3 (1.2 g, 3.17 mmol, 1 eq) in 20 mL of toluene. Both 
solutions were cooled down at -15°C in the glovebox where the reaction was launched. The 
resulting solution was left to warm up to room temperature and then stirred overnight. Toluene 
was then evaporated and the red residue was dissolved in Et2O, and MeLi (7.2 mL, 1.61 M, 
2.1 eq) was added dropwise at -70°C. The crude red suspension turned into a yellow solution 
with a white precipitate after 1h of stirring at room temperature. The solvent was then removed 
and the residue was dissolved in 40 mL of pentane. LiCl salts were removed by filtration 
through diatomaceous earth. The desired compound was obtained after evaporation of all 
volatiles as a yellow precipitate. (1.1 g, overall yield = 57 %).49 
 
1H NMR (600.23 MHz, 300 K, dichloromethane-d2): δ1H: 6.10 (apparent t, 3JHH = 4JHH = 2.6 Hz, 
2H, Ha), 6.05 (s, 5H, Hi), 5.76 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 3.43 (s, 2H, Hd), 1.60-
1.52 (m, 2H, Hh), 1.48-1.40 (m, 4H, Hg), 1.07 (s, 12H, Hf), -0.21 (s, 6H, Hj). 
13C{1H} NMR (150.9 MHz, 300 K, dichloromethane-d2): δ13C: 134.6 (Cc), 115.1 (Ca), 113.6 (Ci), 
112.2 (Cb), 55.7 (Ce), 44.8 (Cd), 44.5 (Cg), 42.1 (Cf), 25.7-28.1 (Cj), 18.4 (Ch). 
1H 1H COSY (600.23 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 6.10 / 5.76 (CHa / CHb), 5.76 
/ 6.10 (CHb / CHa), 1.60-1.52 / 1.48-1.40 (CH2h / CH2g), 1.48-1.40 / 1.60-1.52 (CH2g / CH2h). 
1H 13C HMQC (600.23 MHz / 150.9 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.10 / 115.1 
(CHa), 6.05 / 113.6 (CHi), 5.76 / 112.2 (CHb), 3.43 / 44.5 (CH2d), 1.60-1.52 / 18.4 (CH2h), 1.48-
1.40 / 42.1 (CH2g), 1.07: 25.7-28.1 (CH3f), -0.21 / 44.8 (CH3j). 
1H 13C HMBC (600.23 MHz / 150.9 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.10 / 134.6, 
115.1, 112.2 (CHa / Cc, CHa, CHb), 6.05 / 113.6 (CHi / CHi), 5.76 / 134.6, 115.1 (CHb / Cc, CHa), 
3.43 / 134.6, 115.1, 55.7 (CH2d / Cc, CHa, Ce), 1.60-1.52 / 55.7, 44.5 (CHh / Ce, CH2g), 1.48-1.40 
/ 55.7, 44.5, 25.7-28.1, 18.4 (CH2h / Ce, CH2g, CH2h), 1.07 / 55.7, 44.5, 25.7-28.1 (CH3f / Ce, 
CH2h, CH3f), -0.21 / 44.8 (CH3j). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 1.07 / -308 (Hf 
/ N). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C22H36NTi [M+H]+ 362.23238; 
found 362.23152 (Rel. ab: 65%, -1.8 ppm). 
IR (ATR) ν [cm-1]  
MIR: 2965; 1492; 1259; 1130; 1022; 810; 392. 
FIR: 471; 403; 254; 187. 
Elemental Analysis: % calcd. For C22H35NTi: C, 73.12; H, 9.76; N, 3.88; Found: C, 70.84; H, 
9.50; N, 3.42.  
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11. Synthesis of 36: 
 
A solution of 35 (200 mg, 0.56 mmol, 1 eq) and [Ph3C][B(C6F5)4] (511 mg, 0.56 mmol, 1 eq) 
was prepared in 2 mL of C6H5Br. The yellow solid mixture turned deep black-red in solution. 
After 5 min of stirring the solution was tried to precipitate in a vigorously stirred pentane solution 
(8 mL) but a red oil was formed instead. Precipitation attempt via C6H5Cl failed and a red oil 
was obtained again. A sticky red-brown precipitate was obtained after drying in vacuo (510 
mg, 90 %).47 
1H NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 5.90 (apparent t, 3JHH = 4JHH = 2.5 Hz, 
2H, Ha), 5.85 (s, 5H, Hm), 5.66 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 4.82 (bs, 1H, Hl’), 4.75 
(bs, 1H, Hl), 4.42 (s, 2H, Hd), 1.92 (t, 3JHH = 7.1 Hz, 2H, Hi), 1.70 (s, 3H, Hk), 1.38-1.23 (m, 2H, 
Hg), 1.15-1.02 (m overlapping with Hf, 2H, Hh) 1.09 (s overlapping with Hh, 6H, Hf). 
13C{1H} NMR (125.75 MHz, 300 K, bromobenzene-d5): δ13C: 148.8 (dm, 1JCF = 240 Hz, o-CF), 
144.8 (Cj), 138.5 (dm, 1JCF = 240 Hz, p-CF), 136.9 (dm, 1JCF = 240 Hz, m-CF), 125.6-123.6 (bs, 
ipso-CB), 118.8 (Cb), 116.2 (Ca), 114.3 (Cm) 112.4 (Cc), 111.0 (Cl), 74.7 (Ce), 52.1 (Cd), 42.2 
(Cg), 37.9 (Ci), 28.7 (Cf), 22.7 (Ch), 22.6 (Ck). (131.6, 130.2, 127.0, 122.7 belong to residual 
C6H5Cl). 
1H 1H COSY (500.03 MHz, 300 K, bromobenzene-d5): δ1H / δ1H: 5.90 / 5.66 (CHa / CHb), 5.66 
/ 5.90 (CHb / CHa), 4.82 / 4.75, 1.70 (Hl’ / Hl, CH3k), 4.75 / 4.82, 1.92 (Hl / Hl’, CH2i), 1.92 / 1.15-
1.02, 4.75 (CH2i / CH2h, Hl), 1.70 / 4.82 (CH3k / Hl’), 1.38-1.23 / 1.15-1.02 (CH2g/ CH2h), 1.15-
1.02 / 1.92, 1.38-1.23 (CH2h / CH2i, CH2g). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 5.90 / 116.2 
(CHa), 5.85 / 114.3 (CHm), 5.66 / 118.8 (CHb), 4.82, 4.75 / 111.0 (CH2l), 4.42 / 52.1 (CH2d), 1.92 
/ 37.9 (CH2i), 1.70 / 22.6 (CH3k), 1.38-1.23 / 42.2 (CH2g), 1.15-1.02 / 22.7 (CH2h), 1.09 / 28.7 
(CH3f). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 4.82, 4.42 / 
37.9, 22.7, 22.6 (Hl, Hl’ / CH2i, CH2h, CH3k), 4.42 / 118.8, 112.4, 74.7 (CH2d / CHa, Cc, Ce), 1.92 
/ 144.8, 111.0, 42.2, 22.6 (CH2i / Cj, CH2l, CH2g, CH3k), 1.70 / 144.8, 111.0, 37.9 (CH3k / Cj, CH2l, 
CH2i), 1.38-1.23 / 74.7, 28.7 (CH2g / Ce, CH3f), 1.15-1.02 / 74.7, 42.2, 28.7 (CH2h/ Ce, CH2g, 
CH3f), 1.09 / 74.7, 42.2, 28.7 (CH3f / Ce, CH2g, CH3f). 
11B{1H} NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -16.2 (ν1/2 = 21 Hz). 
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11B NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -16.2 (ν1/2 = 21 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.8 (m, 8F, o-F), -161.8 (t, 3JFF 
= 21 Hz, 8F, p-F), -165.7 (m, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.8 (d, 3JFF = 11 Hz, 8F, o-F), -
161.8 (t, 3JFF = 21 Hz, 8F, p-F), -165.7 (m, 8F, m-F). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 1.09 / -363 (Hf 
/ N). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C20H28NTi [M]+ 330.16957; 
found 330.16940 (Rel. ab: 100%, -6.2 ppm); for C20H30ONTi [M+H2O]+ 348.18014; found 
348.17798 (Rel. ab: 95%, -0.5 ppm). 
Elemental Analysis: % calcd for C28H38NClOTi: C, 68.92; H, 7.85; N, 2.87; Found: C, 68.07; 
H, 7.56; N, 2.72. 
12. Synthesis of 37: 
 
A solution of 35 (60 mg, 0.16 mmol, 1 eq) and [Ph3C][B(C6F5)4] (153.3 mg, 0.16 mmol, 1 eq) 
was prepared in 1 mL of C6H5Br. The yellow solid mixture turned deep black-red in solution. 
After 10 min of stirring OPEt3 (22.3 mg, 0.16 mmol, 1eq) was added to the solution which was 
stirred for additional 30 min. The lighter red resulting solution was added in a vigorously stirred 
pentane solution (8 mL) and yield to a red oil. The whole solution was stored in the freezer (-
15°C) for two days. The resulting red oil was isolated and dried after removing the yellow 
filtrate. The red precipitate obtained was dissolved in dichloromethane (1 mL) and layered with 
pentane (4 mL) and stored overnight in the freezer (-15°C). The microcrystalline red solid was 
isolated and dried in vacuo (160 mg, 84 %).47 
1H NMR (500.03 MHz, 300 K, dichloromethane-d2): δ1H: 6.75 (apparent q, 3JHH = 4JHH = 2.5 Hz, 
1H, Ha), 6.34 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb), 6.16 (s, 5H, Hm), 5.98 (apparent q, 3JHH 
= 
4JHH = 2.5 Hz, 1H, Ha’), 5.48 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb’), 4.88 (d, 2JHH = 14.7 
Hz , 1H, Hd), 4.76 (m, 1H, Hl’), 4.71 (m, 1H, Hl), 4.52 (d, 2JHH = 14.7 Hz , 1H, Hd’), 2.05 (t, 3JHH 
= 7.0 Hz, 2H, Hi), 1.83 (dq, 2JHP = 11.9 Hz, 3JHH = 7.7 Hz, 6H, Hn), 1.74 (s, 3H, Hk), 1.72-1.62 
(m, 1H, CHg), 1.45-1.26 (m overlapping with Hf and Hf’, 3H, Hg/h), 1.33 (s overlapping with Hg/h, 
3H, Hf/f’), 1.30 (s overlapping with Hg/h, 3H, Hf’/f), 1.17 (dt, 3JHP = 17.8 Hz, 3JHH = 7.0 Hz, 9H, 
Ho). 
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1H{31P} NMR (500.03 MHz, 300 K, dichloromethane-d2): δ1H: 6.75 (apparent q, 3JHH = 4JHH = 
2.5 Hz, 1H, Ha), 6.34 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb), 6.16 (s, 5H, Hm), 5.98 (apparent 
q, 3JHH = 4JHH = 2.5 Hz, 1H, Ha’), 5.48 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb’), 4.88 (d, 2JHH = 
14.7 Hz , 1H, Hd), 4.76 (br s, 1H, Hl’), 4.71 (br s, 1H, Hl), 4.52 (d, 2JHH = 14.7 Hz , 1H, Hd’), 2.05 
(t, 3JHH = 7.0 Hz, 2H, Hi), 1.83 (bq, 3JHH = 7.7 Hz, 6H, Hn), 1.74 (s, 3H, Hk), 1.72-1.62 (m, 1H, 
CHg), 1.45-1.26 (m overlapping with Hf and Hf’, 3H, Hg/h), 1.33 (s overlapping with Hg/h, 3H, Hf/f’), 
1.30 (s overlapping with Hg/h, 3H, Hf’/f), 1.17 (bt, 3JHH = 7.0 Hz, 9H, Ho). 
13C{1H} NMR (125.75 MHz, 300 K, dichloromethane-d2): δ13C: 148.7 (dm, 1JCF = 250 Hz, o-CF), 
146.2 (Cj), 138.8 (dm, 1JCF = 250 Hz, p-CF), 136.9 (dm, 1JCF = 250 Hz, m-CF), 125.3-124.1 (bs 
overlapping with Cb, ipso-CB), 124.3 (overlapping with ipso-CB, Cb), 119.8 (Ca), 113.8 (Cm), 
113.5 (Ca’), 112.0 (Cc), 110.8 (Cl), 110.5 (Cb’), 70.9 (Ce), 50.8 (Cd), 42.5 (Cg), 38.7 (Ci), 28.9 
(Cf), 28.7 (Cf’), 23.6 (Ch), 22.6 (Ck), 18.9 (d, 2JCP = 67.1 Hz, Cn), 6.1 (d, 3JCP = 4.7 Hz, Co). 
Pentane: 34.7, 22.9, 14.4. 
1H 1H COSY (500.03 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 6.75 / 6.34, 5.98, 5.48 (CHa 
/ CHb, CHa’, CHb’), 6.34 / 6.75, 5.98, 5.48 (CHb / CHa, CHa’, CHb’), 6.16 / 113.8 (CHm), 5.98 / 
6.75, 6.34, 5.48 (CHa’ / CHa, CHb, CHb’), 5.48 / 6.75, 6.34, 5.98 (CHb’ / CHa, CHb, CHa’), 4.88 / 
4.52 (CH2d/d’), 4.76 / 4.71, 1.74 (Hl’ / Hl, CH3k), 4.71 / 4.76 (Hl / Hl’), 4.52 / 4.88 (CH2d’/d), 2.05 / 
4.71, 1.45-1.26 (Hi / Hl, CH2h/g), 1.83 / 1.17 (CH2n / CH3o), 1.74 / 4.76 (CH3k / Hl’), 1.72-1.62 / 
1.45-1.26 (CH2g / CH2h/g), 1.45-1.26 / 1.72-1.62, 1.45-1.26 (CH2g/ CH2h/g), 1.17 / 1.83 (CH3o / 
CH2n). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.75 / 119.8 
(CHa), 6.34 / 124.3 (CHb), 6.16 / 113.8 (CHm), 5.98 / 113.5 (CHa’), 5.48 / 110.5 (CHb’), 4.88, 
4.52 / 50.8 (CH2d), 4.76, 4.71 / 110.8 (CH2l), 2.05 / 38.7 (CH2i), 1.83 / 18.9 (CH2n), 1.74 / 22.6 
(CH3k), 1.72-1.62 / 42.5 (CH2g), 1.45-1.26 / 42.5, 23.6 (CH2g/h), 1.33 / 23.6 (CH3f), 1.30 / 28.7 
(CH3f’), 1.17 / 6.06 (CH3o). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.75 / 124.3, 
113.5, 112.0, 110.5 (CHa / CHb, CHa’, Cc, CHb’), 6.34 / 119.8, 113.5, 112.0, (CHb / CHa, CHa’, 
Cc), 6.16 / 113.8 (CHm / CHm), 5.98 / 112.0, 110.5 (CHa’ / Cc, CHb’), 5.48 / 113.5, 112.0, 110.5 
(CHb’ / CHa’, Cc, CHb’), 4.88 / 124.3, 112.0, 110.5, 70.9 (CH2d / CHb, Cc, CHb’, Ce), 4.76, 4.71 / 
38.7, 22.6 (Hl, Hl’ / CH2i, CH3k), 4.52 / 124.3, 112.0, 110.5, 70.9 (CH2d / CHb, Cc, CHb’, Ce), 2.05 
/ 146.2, 110.8, 42.5, 23.6, 22.6 (CH2i / Cj, CH2l, CH2g, CH3k), 1.83 / 6.06 (CH2n / CH3o), 1.74 / 
146.2, 110.8, 42.5, 23.6 (CH3k / Cj, CH2l, CH2g, CH2h), 1.72-1.62 / 70.9, 28.9, 28.7 (CH2g / Ce, 
CH3f, CH3f’), 1.45-1.26 / 70.9, 28.9, 28.7, 22.6 (CH2g/h / Ce, CH3f, CH3f’, CH3k), 1.33 / 70.9, 42.5, 
28.7 (CH3f/ Ce, CH2g, CH3f’), 1.30 / 70.9, 42.5, 28.9 (CH3f’ / Ce, CH2g, CH3f), 1.17 / 18.9 (CH3o / 
CH2n). 
31P{1H} NMR (202.46 MHz, 300 K, dichloromethane-d2): δ31P: s 79.5 (ν1/2 = 2.5 Hz) 
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31P NMR (202.46 MHz, 300 K, dichloromethane-d2): δ31P: m 79.5 (ν1/2 = 74.5 Hz) 
11B{1H} NMR (160.42 MHz, 300 K, dichloromethane-d2): δ11B: -16.6 (ν1/2 = 21 Hz). 
11B NMR (160.42 MHz, 300 K, dichloromethane-d2): δ11B: -16.6 (ν1/2 = 21 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -133.1 (apparent d, 3JFF = 11 Hz, 
8F, o-F), -163.7 (t, 3JFF = 21 Hz, 4F, p-F), -167.6 (apparent t, 3JFF = 21 Hz, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -133.1 (apparent d, 3JFF = 11 Hz, 8F, 
o-F), -163.7 (t, 3JFF = 21 Hz, 4F, p-F), -167.6 (apparent t, 3JFF = 21 Hz, 8F, m-F). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 4.88, 4.52, 
1.33, 1.30 / -23.3 (Hd, Hd’, Hf, Hf’ / N). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C26H43NOPTi [M]+ 464.25563; 
found 464.25493 (Rel. ab 65%, 1.8 ppm); for C20H37NOPTi [M-C6H6]+ 386.20867; found 
386.20797 (Rel. ab 100%, -1.5 ppm). 
Elemental Analysis: % calcd for C50H43BF20NOPTi + (C5H12)0.2: C, 52.88; H, 3.94; N, 1.21; 
Found: C, 52.50; H, 4.15; N, 1.29. 
XRD: 
 
Crystal Data. C50H41BF20NOPTi, Mr = 1140.01, triclinic, P-1 (No. 2), a = 16.747 Å, b = 17.135 Å, c = 
19.906 Å, α = 71.61°, β = 66.61°, γ = 82.42°, V = 4975.0 Å3, T = 115 K, Z = 4, Z' = 2, µ(MoKα) = 0.318, 
68495 reflections measured, 17489 unique (Rint = 0.0735) which were used in all calculations. The final wR2 
was 0.3090 (all data) and R1 was 0.0928 (I > 2(I)). 
13. Synthesis of 38-B: 
Ti
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O
i
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Ph
Ph
Chemical Formula: C58H42BF20NOTi
Molecular Weight: 1207,6
B(C6F5)4
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A solution of benzophenone (50.5 mg, 0.28 mmol, 1 eq) and 35 (100 mg, 0.28 mmol, 1 eq), 
was prepared in 1 mL of C6H5Br. Then, [Ph3C][B(C6F5)4] was added to the yellow solution which 
turned red rapidly. After 5 mn of stirring, the compound was crystalized by slow diffusion of 
heptane at -15°C for two weeks. Crystals were isolated, washed twice with 2 mL of pentane 
and finally dried in vacuo to yield to a microcrystalline red powder (233 mg, 70%). Suitable 
crystals for XRD analysis were obtained by this process.47 
 1H NMR (500.03 MHz, 263 K, bromobenzene-d5): δ1H: 7.50 (t, 3JHH = 7.2 Hz, 2H, p-CHbenzo), 
7.32 (t overlapping with solvent signal, 3JHH = 7.2 Hz, 4H, m-CHbenzo), 7.22 (d, 3JHH = 7.2 Hz, 
4H, o-CHbenzo), 6.32 (apparent q, 3JHH = 4JHH = 2.6 Hz, 1H, Hb’), 6.01 (apparent q, 3JHH = 4JHH = 
2.6 Hz, 1H, Hb), 5.85 (s, 5H, Hi), 5.83 (apparent q, 3JHH = 4JHH = 2.6 Hz, 1H, Ha), 5.48 (apparent 
q, 3JHH= 4JHH = 2.6 Hz, 1H, Ha’), 3.21 (d, 2JHH = 16.4 Hz, 1H, Hd), 3.12 (d, 2JHH = 16.4 Hz, 1H, 
Hd’), 1.39-1.29 (m, 2H, Hh), 1.27-1.19 (m overlapping with Hj, 4H, Hg), 1.24 (s overlapping with 
Hg, 3H, Hj), 0.72 (s, 6H, Hf), 0.63 (s, 6H, Hf). 
13C{1H} NMR (125.75 MHz, 263 K, bromobenzene-d5): δ13C: 211.0 (C=O), 148.8 (br d, 1JCF = 
240 Hz, o-CF), 141.9 (Cc), 138.7 (br d, 1JCF = 240 Hz, p-CF), 137.7 (p-CHbenzo), 136.8 (br d, 1JCF 
= 240 Hz, m-CF), 133.2 (ipso-Cbenzo), 132.6 (o-CHbenzo), 129.7 (m-CHbenzo), 125.6-123.9 (bs, 
ipso-CB), 121.8 (CHb’), 118.4 (CHb), 116.0 (Ci), 112.7 (CHa), 111.2 (CHa’), 55.3 (Ce), 54.3 (Cj), 
43.4 (Cd), 41.2 (Cg), 29.1-26.6 (Cf), 17.9 (Ch). C6H5Br 131.7, 130.4, 127.2, 122.8. 
1H 1H COSY (500.03 MHz, 263 K, bromobenzene-d5): δ1H / δ1H: 7.50 / 7.32 (p-CHbenzo / m-
CHbenzo), 7.32 / 7.50, 7.22 (m-CHbenzo / p-CHbenzo, (o-CHbenzo), 7.22 / 7.32 (o-CHbenzo / m-CHbenzo), 
6.32 / 5.48 (CHb’ / CHa’), 6.01 / 5.83 (CHb / CHa), 5.83 / 6.01 (CHa / CHb), 5.48 / 6.32 (CHa’/ 
CHb’), 3.21 / 3.12 (CH2d/d’), 3.12 / 3.21 (CH2d’/d), 1.39-1.29 / 1.27-1.19 (CH2h / CH2g), 1.27-1.19 
/ 1.39-1.29 (CH2g / CH2h). 
1H 13C HMQC (500.03 MHz / 125.03 MHz, 263 K, bromobenzene-d5): δ1H / δ13C: 7.50 / 137.7 
(p-CHbenzo), 7.32 / 129.7 (m-CHbenzo), 7.22 / 132.6 (o-CHbenzo), 6.32 / 121.8 (CHb’), 6.01 / 118.4 
(CHb), 5.85 / 116.0 (CHi), 5.83 / 112.7 (CHa), 5.48 / 111.2 (CHa’), 3.21, 3.17 / 43.4 (CH2d), 1.39-
1.29 / 17.9 (CH2h), 1.27-1.19 / 41.2 (CH2g), 1.24 / 54.3 (CH3j), 0.72 / 29.1-26.6 (CH3f), 0.63 / 
29.1-26.6 (CH3f).  
1H 13C HMBC (500.03 MHz / 125.03 MHz, 263 K, bromobenzene-d5): δ1H / δ13C: 7.50 / 132.6 
129.7 (p-CHbenzo / o-CHbenzo,, m-CHbenzo), 7.32 / 137.7, 132.2, 129.7 (m-CHbenzo / p-CHbenzo,, 
ipso-Cbenzo, m-CHbenzo), 7.22 / 211.0, 137.7, 132.6 (o-CHbenzo / C=O, p-Cbenzo, o-CHbenzo), 6.32 / 
141.9, 118.4, 112.7, 111.2 (CHb’ / Cc, CHb, CHa, CHa’), 6.01 / 141.9, 121.8, 112.7, 111.2 (CHb 
/ Cc, CHb’, CHa), 5.85 / 116.0 (CHi / CHi), 5.83 / 141.9, 121.8, 111.2 (CHa / Cc, CHb’, CHa’), 5.48 
/ 141.9, 121.8, 118.5, 112.7 (CHb’ / Cc, CHb’, CHb, CHa), 3.21, 3.17 / 141.9, 121.8, 118.5, 55.3 
(CH2d / Cc, CHb, CHb’, Ce), 1.39-1.29 / 55.3, 41.2 (CH2h / Ce, CH2g), 1.27-1.19 / 55.3, 41.2, 17.3 
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(CH2g / Ce, CH2g, CH2h), 1.24 / 121.8, 116.0 (CH3f / CHb, CHi), 0.72, 0.63 / 55.3, 41.2, 29.1-26.6 
(CH3f/f’ / Ce, CH2g, CH3f’/f).  
1H 15N HMBC (600.23 MHz / 43.3 MHz, 263 K, bromobenzene-d5): δ1H / δ15N: 0.72, 0.63 / -
306 (Hf, Hf’ / N). 
11B{1H} NMR (160.42 MHz, 263 K, bromobenzene-d5): δ11B: -16.0 (ν1/2 = 24 Hz). 
11B NMR (160.42 MHz, 263 K, bromobenzene-d5): δ11B: -16.0 (ν1/2 = 24 Hz). 
19F{1H} NMR (470.45 MHz, 263 K, bromobenzene-d5): δ19F: -131.5 (d, 3JFF = 15 Hz, 8F, o-F), 
-161.3 (t, 3JFF = 19 Hz, 8F, p-F), -165.2 (m, 8F, m-F). 
19F NMR (470.45 MHz, 263 K, bromobenzene-d5): δ19F: -131.5 (d, 3JFF = 15 Hz, 8F, o-F), -
161.3 (t, 3JFF = 19 Hz, 8F, p-F), -165.2 (m, 8F, m-F). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C20H30ONTi [M-
benzophenone-CH4+H2O]+ 348.18014; found 348.17798 (Rel. ab: 75%, -2.6 ppm). 
Elemental Analysis: % calcd for C20H29Cl2NTi: C, 57.59; H, 3.51; N, 1.16; Found: C, 57.58; 
H, 3.58; N, 1.00.  
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XRD: 
 
Experimental. Single red prism-shaped crystals of 
(q121515_0m) were obtained by recrystallisation from diffusion 
of heptane in a bromobenzene solution at -15°C. A suitable 
crystal (0.12×0.12×0.07) mm3 was selected and mounted on a 
mylar loop with oil on a Nonius Kappa Apex II diffractometer. 
The crystal was kept at T = 115 K during data collection. Using 
Olex2 (Dolomanov et al., 2009), the structure was solved with 
the ShelXT (Sheldrick, 2015) structure solution program, using 
the Direct Methods solution method. The model was refined with 
version 2017/1 of XL (Sheldrick, 2008) using Least Squares 
minimisation. 
Crystal Data. C61H44.5BCl0.5F20NOTi, Mr = 1263.91, triclinic, P-
1 (No. 2), a = 11.6624(6) Å, b = 12.6758(7) Å, c = 
18.7399(12) Å, α = 75.383(3)°, β = 83.631(3)°, γ = 87.410(3)°, 
V = 2663.7(3) Å3, T = 115 K, Z = 2, Z' = 1, µ(MoKα) = 0.302, 
86538 reflections measured, 12289 unique (Rint = 0.0732) which 
were used in all calculations. The final wR2 was 0.0871 (all data) 
and R1 was 0.0385 (I > 2(I)). 
14. Synthesis of 39: 
i
b
a
d
e
f
c
g
h j
k
l
m
Ti
N
OO
Ti
N
O O
n
H
H
H
l'
Chemical Formula: C90H56BF40N2O4Ti2
Molecular Weight: 2095,9
B(C6F5)42
 
A solution of 36 (200 mg, 0.56 mmol, 1 eq) and [Ph3C][B(C6F5)4] (511 mg, 0.56 mmol, 1 eq) 
was prepared in 2 mL of C6H5Br in a 15 mL Schlenk flask. The yellow solid mixture turned 
Compound  q121515_0m  
    
Formula  C61H44.5BCl0.5F20NO
Ti  
Dcalc./ g cm-3  1.576  
µ/mm-1  0.302  
Formula Weight  1263.91  
Colour  red  
Shape  prism  
Size/mm3  0.12×0.12×0.07  
T/K  115  
Crystal System  triclinic  
Space Group  P-1  
a/Å  11.6624(6)  
b/Å  12.6758(7)  
c/Å  18.7399(12)  
α/°  75.383(3)  
β/°  83.631(3)  
γ/°  87.410(3)  
V/Å3  2663.7(3)  
Z  2  
Z'  1  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  2.589  
Θmax/°  27.659  
Measured Refl.  86538  
Independent Refl.  12289  
Reflections Used  6785  
Rint  0.0732  
Parameters  807  
Restraints  36  
Largest Peak  0.384  
Deepest Hole  -0.394  
GooF  0.880  
wR2 (all data)  0.0871  
wR2  0.0750  
R1 (all data)  0.0936  
R1  0.0385  
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deep black-red in solution. After 5 mn of stirring the solution was degassed, 1 bar of dry CO2 
was introduced in the Schlenk tube and the solution was stirred at room temperature for 5 mn 
until a red oil was formed. Yellow supernatant was removed in the Glovebox, and the remaining 
oil was washed with 2 mL of C6H5Br and then twice with 5 mL of pentane. Traces of C6H5Br 
were removed by solubilisation of the residue in 2 mL of dichloromethane and precipitation 
with pentane (10 mL). 1h of decantation was required before removal of the supernatant. The 
red oil was finally dried in vacuo to yield a light-orange powder (200 mg, 66%).47 
1H NMR (500.03 MHz, 300 K, dichloromethane-d2): δ1H: 7.50 (apparent q, 3JHaHb = 3JHaHa’ = 
4JHaHb' = 2.5 Hz, 2H, Ha), 6.92 (apparent q, 3JHbHa = 4JHbHb’ = 4JHbHa’ = 2.5 Hz, 2H, Hb), 6.80 (s, 
10H, Hm), 6.07 (apparent q, 3JHa’Hb’ = 3JHa’Ha = 4JHa’Hb = 2.6 Hz, 2H, Ha’), 5.83 (apparent q, 3JHb’Ha’ 
= 
4JHb’Ha = 4JHb’Hb = 2.5 Hz, 2H, Hb’), 4.74 (br s, 2H, Hl’), 4.66 (br s, 2H, Hl), 4.62 (d, 2JHdHd’ = 
16Hz, 2H, Hd), 3.94 (d, 2JHdHd’ = 16 Hz, 2H, Hd’), 2.10-1.95 (m, 4H, Hi), 1.78-1.62 (m, 4H, Hg), 
1.69 (s overlapping with Hg, 6H, Hk), 1.53-1.44 (m overlapping with Hf/f’, 4H, Hh) 1.47 (s 
overlapping with Hh, 6H, Hf), 1.44 (s overlapping with Hh, 6H, Hf’). Remaining pentane: 1.35-
1.21 (m), 0.88 (t). 
13C{1H} NMR (125.75 MHz, 300 K, dichloromethane-d2): δ13C: 166.8 (Cn), 148.6 (br d, 1JCF = 
240 Hz, o-CF), 145.8 (Cc), 145.2 (Cj) 138.6 (br d, 1JCF = 240 Hz, p-CF), 136.8 (br d, 1JCF = 240 
Hz, m-CF), 126.7 (Ca’), 125.2-123.1 (ipso-CB), 122.0 (Cm), 117.6 (Ca), 114.9 (Cb’), 111.9 (Cb), 
111.0 (Cl), 63.6 (Ce), 45.4 (Cd), 40.8 (Cg), 37.9 (Ci), 27.7 (Cf), 27.6 (Cf’), 22.7 (Ch) 22.3 (Ck). 
C6H5Br: 131.9, 130.5, 128.7, 122.8; pentane: 34.6, 22.8, 14.2 belong to pentane. 
1H 1H COSY (500.03 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 7.50 / 6.92, 6.07, 5.83 (CHa 
/ CHb, CHa’, CHb’), 6.92 / 7.50, 6.07, 5.83 (CHb / CHa, CHa’, CHb’), 6.07 / 7.50, 6.92, 5.83 (CHa’ 
/ CHa, CHb, CHb’), 5.83 / 7.50, 6.92, 6.07 (CHb’ / CHa, CHb, CHa’), 4.74 / 4.66, 1.69 (Hl’ / Hl, 
CH3k), 4.66 / 4.74, 2.10-1.95, 1.69 (Hl / Hl’, CH2i, CH3k), 4.62 / 3.94 (Hd / Hd’), 3.94 / 4.62 (Hd’ / 
Hd), 2.10-1.95 / 4.74, 1.53-1.44 (CH2i / Hl’, CH2h), 1.78-1.62 / 4.74, 4.66, 1.53-1.44 (CH2g / Hl’, 
Hl, CH2h), 1.69 / 4.74, 4.66 (CH3h / Hl’, Hl), 1.53-1.44 / 2.10-1.95, 1.78-1.62 (CH2h / CH2i, CH2g). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.50 / 117.6 
(CHa), 6.92 / 111.9 (CHb), 6.80 / 122.0 (CHm), 6.07 / 126.7 (CHa’), 5.83 / 114.9 (CHb’), 4.74, 
4.66 /111.0 (CH2l), 4.62, 3.94 / 45.4 (CH2d), 2.10-1.95 / 37.9 (CH2i), 1.78-1.62 / 40.8 (CH2g), 
1.69 / 22.3 (CH3k), 1.47 / 27.7 (CH3f), 1.53-1.44 / 22.7 (CH2h), 1.44 / 27.6 (CH3f’). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.50 / 145.8, 
126.7, 114.9, 111.9 (CHa / Cc, CHa’, CHb’, CHb), 6.92 / 145.8, 126.7, 117.6, 114.9 (CHb / Cc, 
CHa’, CHa, CHb’), 6.80 / 122.0 (CHm / CHm), 6.07 / 145.8, 117.6, 114.9, 111.9 (CHa’ / Cc, CHa, 
CHb’, CHb), 5.83 / 145.8, 126.7, 117.6, 111.9 (CHb’ / Cc, CHa’, CHa, CHb), 4.74, 4.66 / 37.9, 22.3 
(CH2l’/l / CH2i, CH3k), 4.62 / 166.8, 145.8, 63.6 (Hd / Cn, Cc, Ce), 3.94 / 145.8, 114.9, 111.9 (Hd’ / 
Cc, CHb’, CHb), 2.10-1.95 / 145.2, 111.0, 40.8, 22.7 (CH2i / Cj, CH2l, CH2g, CH3k), 1.78-1.62 / 
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63.6, 27.7, 22.7 (CH2g / Ce, CH3f), 1.69 / 145.2, 111.0, 37.9 (CH3k / Cj, CH2l, CH2i), 1.47 / 145.2 
63.6, 40.8, 27.6 (CH3f / Cj, Ce, CH2g, CH3f’), 1.53-1.44 / 145.2, 40.8, 27.7, 27.6 (CH2h/ Ce, CH2g, 
CH3f, CH3f’), 1.44 / 145.2, 63.6, 40.8, 27.7 (CH3f’ / Cj, Ce, CH2g, CH3f). 
11B{1H} NMR (160.42 MHz, 300 K, dichloromethane-d2): δ11B: -16.6(ν1/2 = 21 Hz). 
11B NMR (160.42 MHz, 300 K, dichloromethane-d2): δ11B: -16.6 (ν1/2 = 21 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -132.8 (d, 3JFF = 11 Hz, 8F, o-F), 
-163.2 (t, 3JFF = 21 Hz, 8F, p-F), -167.1 (m, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -132.8 (d, 3JFF = 11 Hz, 8F, o-F), -
163.2 (t, 3JFF = 21 Hz, 8F, p-F), -167.1 (m, 8F, m-F). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2): δ1H / δ15N: 1.47, 1.44 / -
254 (Hf/f’ / N). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C42H56N2Ti2O4 [2M]2+ 
374.15940; found 374.16042 (Rel. ab: 10%, 2.7 ppm). 
Elemental Analysis: % calcd for C93.65H64.76N2F40O4Ti2 (with 73% pentane): C, 52.09; H, 3.02; 
N, 1.30; Found: C, 52.43; H, 2.89; N, 1.29. 
15. Synthesis of 40: 
 
A solid mixture of 33 (400 mg, 0.32 mmol, 1 eq) and [Ph3C][B(C6F5)4] (294.2 mg, 0.34 mmol, 
0.95 eq) was introduced in a Schlenk tube an dissolved in 5 mL of C6H5Br. The solution turned 
rapidly dark green and gas was released. After 1h of stirring, pentane (15 mL) was added to 
the solution and a green precipitate formed after 30 min of stirring. The supernatant was then 
removed and the green residue was washed with 5 mL of pentane. The green residue was 
dissolved in dichloromethane (3mL) and precipitated by pentane (5 mL). After removal of the 
supernatant, washing by pentane (5 mL), the desired compound was obtained after 
evaporation of all volatiles as a green powder. (295 mg, 0.28 mmol, yield = 87 %).47  
1H NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 7.30-7.24 (m, 1H, Hi), 7.18 (t, 3JHH = 7.2 
Hz, 2H, Hh), 6.94-6.89 (m, 3H, Hm+Hn), 6.87-6.81 (m, 1H, Ha), 6.77 (d, 3JHH = 7.5 Hz, 2H, Hg), 
6.48 (s, 5H, Ho), 6.18-6.13 (m, 1H, Hb), 5.43 (d, 3JHH = 7.5 Hz, 2H, Hl), 5.07 (d overlapping with 
Ha’, 2JHH = 12.0 Hz, 1H, Hd), 5.08-5.02 (m overlapping with Hd, 1H, Ha’), 5.00 (s, 1H, Hj), 4.25 
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(d, 2JHH = 12.0 Hz, 1H, Hd’), 4.41-4.36 (m, 1H, Hb’), 3.34 (d, 2JHH = 13.0 Hz, 1H, He), 2.96 (d, 
2JHH = 13.0 Hz, 1H, He’). Pentane: 1.27-1.00 (m), 0.85 (t). 
13C{1H} NMR (125.75 MHz, 300 K, bromobenzene-d5) correlated with dept135: δ13C: 148.8 (br 
d, 1JCF = 240 Hz, o-CF), 141.9 (Ck), 138.6 (br d, 1JCF = 240 Hz, p-CF), 136.9 (br d, 1JCF = 240 
Hz, m-CF), 132.8 (Cf), 130.4 (Ci), 129.8 (Ch), 129.5 (Cg), 129.0 (Cm/n), 127.6 (Cn/m), 127.2 (Cb), 
126.7 (Cl), 125.0 (Ca), 121.0 (Cb’), 119.8 (Co), 115.6 (Ca’), 111.1 (Cc), 92.3 (Cj), 68.0 (Ce), 49,1 
(Cd). ispo-CB n.o. (C6H5Br: 131.6, 130.0, 126.8 and 122.8).51 
1H 1H COSY (500.03 MHz, 300 K, bromobenzene-d5): δ1H / δ1H: 7.30-7.24 / 7.18 (CHi / CHh), 
7.18 / 7.30-7.24, 6.77 (CHh / CHi, CHg), 6.94-6.89 / 5.43 (CHm/n / CHl), 6.87-6.81 / 6.18-6.13, 
5.08-5.02, 4.41-4.36 (CHa / CHb, CHa’, CHb’), 6.18-6.13 / 6.87-6.81, 5.08-5.02, 4.41-4.36 (CHb 
/ CHa, CHa’, CHb’), 5.43 / 6.94-6.89 (CHl / CHm/n), 5.08-5.02 / 6.87-6.81, 6.18-6.13, 4.41-4.36 
(CHa’ / CHa, CHb, CHb’), 5.07 / 4.25 (CH2d/d’) 4.25 / 5.07 (CH2d’/d), 4.41-4.36 / 6.87-6.81, 6.18-
6.13, 5.08-5.02 (CHb’ / CHa, CHb, CHa’), 3.34 / 2.96 and 2.96 / 3.34 (CH2e/e’). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 7.30-7.24 / 
130.4 (CHi), 7.18 / 129.7 (CHh), 6.94-6.89 / 127.6, 129.0 (CHm/n), 6.87-6.81 / 125.0 (CHa), 6.77 
/ 129.5 (CHg), 6.48 / 119.8 (CHo), 6.18-6.13 / 127.6 (CHb), 5.43 / 126.7 (CHl), 5.07, 4.25 / 49.0 
(CH2d), 5.00 / 92.3 (CHj), 4.41-4.36 / 121.0 (CHb’), 3.34, 2.96 / 68.0 (CH2e/e’). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 7.30-7.24 / 
129.8, 129.5 (CHg / CHh, CHg), 7.18 / 132.8, 130.4 (CHh / Cf, CHi), 6.94-6.89 / 141.9 (CHm/n / 
Ck) 6.77 / 130.4, 129.8, 68.0 (CHg / CHi, CHh, CH2e), 6.48 / 119.8 (CHj / CHj), 6.18-6.13 / 125.0, 
121.0, 115.6, 111.1 (CHb / CHa, CHb’, CHa’ Cc), 5.43 / 127.6, 92.3 (CHl / CHm/n, CHj), 5.08-5.02 
/ 111.1 (CHa / Cc), 5.07, 4.25 / 127.2, 121.0, 111.1, 92.3, 68.0 (CH2d / CHb, CHb’, Cc, CHj, CH2e), 
5.00 / 141.8, 129.0, 126.7, 68.0, 49.0 (CHj / Ck, CHm/n, CH2e, CH2d), 4.41-4.36 / 127.2, 115.6 
(CHb’ / CHb, CHa’), 3.34, 2.96 / 132.8, 130.4, 129.8, 92.3, 49.0 (CHb / Cf, CHi, CHh, CHj, CH2d).  
1H 15N HMBC (600.13 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 5.00 / -309.8 (Hj 
/ N). 
11B{1H} NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 19 Hz). 
11B NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 19 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.3 (bs, 8F, o-F), -161.2 (bs, 
4F, p-F), -165.1 (bs, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.3 (bs, 8F, o-F), -161.2 (bs, 4F, p-
F), -165.1 (bs, 8F, m-F). 
HRMS (Positive mode ESI, bromobenzene): m/z calcd. for C25H24NTi [M]+ 386.13827 found 
386.13870 (Rel. ab: 100%, 1.105 ppm). 
                                               
51
 Satelite peaks were unfortunately observed. 
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Elemental Analysis: % calcd for C44H31BF20NOPTi: C, 55.24; H, 2.27; N, 1.31; Found: C, 
54.66; H, 2.51; N, 1.34. 
16. Synthesis of 41: 
 
A solution of benzophenone (57 mg, 0.31 mmol, 1 eq) and 34 (100 mg, 0.31 mmol, 1 eq), was 
prepared in 1 mL of C6H5Br. Then [Ph3C][B(C6F5)4] (237 mg, 0.31 mmol, 1 eq) was added to 
the yellow solution which turned red rapidly. After 30 min of stirring, the red solution was 
precipitated by transferring in a stirred pentane solution (10 mL). A sticky red oil was formed. 
The yellow supernatant was removed and the red residue was stirred in pentane (10 mL) for 
1h, until it was fully solidified. After removing supernatant, the red precipitate was dissolved in 
2 mL of CH2Cl2, and made precipitate by addition of 4 eq of pentane. The red solid was isolated 
and triturated in pentane to get an orange precipitate. The desired compound was isolated as 
a light orange powder after drying in vacuo. (195 mg, 57%).47  
1H NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 7.50 (t, 3JHH = 7.5 Hz, 2H, p-CHbenzo), 
7.32 (m overlapping with solvent, 4H, m-CHbenzo), 7.28 (d, 3JHH = 7.5 Hz, 4H, o-CHbenzo), 6.21 
(apparent q, 3JHH = 4JHH = 2.7 Hz, 1H, Ha), 5.82-5.77 (m overlapping with Hi, 1H, Hb), 5.79 (s 
overlapping with Hb, 5H, Hi), 5.45 (apparent q, 3JHHH = 4JHH = 2.7 Hz, 1H, Ha’), 5.01 (apparent q, 
3JHH = 4JHH = 2.7 Hz, 1H, Hb’), 4.65 (hept, 3JHH = 6.7 Hz, 1H, CHe), 4.44 (d, 2JHH = 15.4 Hz, 1H, 
Hd’), 4.18 (d, 2JHH = 15.4 Hz, 1H, Hd’), 0.89-0.81 (m, 6H, Hf/f’). 
13C{1H} NMR (125.75 MHz, 300 K, bromobenzene-d5) correlated with dept135: δ13C: 209.5 
(C=O), 148.8 (br d, 1JCF = 240 Hz, o-CF), 138.7 (br d, 1JCF = 240 Hz, p-CF), 136.8 (br d, 1JCF = 
240 Hz, m-CF), 136.3 (p-CHbenzo), 134.6 (ipso-Cbenzo), 131.3 (o-CHbenzo), 129.4 (m-CHbenzo), 
125.5-123.7 (ipso-CB), 123.5 (Cb), 117.4 (Ca), 113.1 (Cg), 112.4 (Ca’), 111.0 (Cc), 110.6 (Cb’), 
66.8 (Ce), 47.7 (Cd), 22.0 and 21.7 (Cf). ipso-CB n.o.(C6H5Br: 131.6, 130.0, 126.8 and 122.6; 
pentane: 34.4, 22.8, 14.5). 
1H 1H COSY (500.03 MHz, 300 K, 300 K, bromobenzene-d5): δ1H / δ1H: 7.50 / 7.32 (p-Hbenzo / 
m-Hbenzo), 7.32 / 7.50, 7.28 (m-Hbenzo / p-Hbenzo, (o-Hbenzo), 7.28 / 7.32 (o-Hbenzo / m-Hbenzo), 6.21 
/ 5.82-5.77, 5.45, 5.01 (Hb / Ha, CHa’, Hb’), 5.82-5.77 / 6.21, 5.45, 5.01 (Ha / Hb, Ha’, Hb’), 5.45 / 
6.21, 5.82-5.77, 5.01 (Ha’ / Hb, Ha, Hb’),5.01 / 6.21, 5.82-5.77, 5.45 (Hb’ / Hb, Ha, Ha’), 4.65 / 0.89-
0.81 (He / Hf), 4.44 / 4.18 (Hd/d’), 4.18 / 4.44 (Hd’/d), 0.89-0.81 / 4.65 (Hf / He). 
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1H 13C HMQC (500.03 MHz / 125.03 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 7.50 / 136.3 
(p-CHbenzo), 7.32 / 129.4 (m-CHbenzo), 7.28 / 131.3 (o-CHbenzo), 6.21 / 117.4 (CHa), 5.82-5.77 / 
123.5 (CHb), 5.79 / 113.1 (CHg), 5.45 / 112.4 (CHa’), 5.01 / 110.6 (CHb’), 4.65 / 66.8 (CHe), 4.44, 
4.18 / 47.7 (CH2d), 0.89-0.81 / 22.0, 21.7 (CH3f/f’).  
1H 13C HMBC (500.03 MHz / 125.03 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 7.50 / 131.3 
(p-CHbenzo / o-CHbenzo), 7.32 / 134.6, 129.4 (m-CHbenzo / ipso-Cbenzo,, m-Cbenzo), 7.28 / 209.5, 
136.3, 131.3 (o-CHbenzo / C=O, p-Cbenzo, o-CHbenzo), 6.21 / 123.5, 112.4, 111.0, 110.6 (CHa / 
CHb, CHa’, Cc, CHb’), 5.79 / 113.1 (CHg / CHg), 5.45 / 111.0, 110.6 (CHa’ / Cc, CHb’), 5.01 / 123.5, 
112.4, 117.4, 111.0 (CHb’ / CHb, CHa’, CHa, Cc), 4.65 / 47.7, 22.0, 21.7 (CHe / CH2d, CH3f/f’), 
4.44, 4.18 / 123.5, 111.0, 110.6, 66.8 (CH2d / CHb, Cc, CHb’, CHe), 0.89-0.82 / 66.8, 22.0, 21.7 
(CH3f/f’ / Ce, CH3f’/f).  
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 0.89-0.81 / -419 
(Hf, Hf’ / N). 
11B{1H} NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -16.2 (ν1/2 = 24 Hz). 
11B NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -16.2 (ν1/2 = 24 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.7 (dm, 3JFF = 15 Hz, 8F, o-
F), -161.9 (t, 3JFF = 19 Hz, 8F, p-F), -165.8 (m, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.7 (dm, 3JFF = 15 Hz, 8F, o-F), -
161.9 (t, 3JFF = 19 Hz, 8F, p-F), -165.8 (m, 8F, m-F). 
Elemental Analysis: % calcd for C51H28BF20NOTi: C, 55.21; H, 2.54; N, 1.26; Found: C, 55.10; 
H, 2.93; N, 1.28 
HRMS (Positive mode ESI, bromobenzene): m/z calcd. for C14H18NTi [M-benzophenone]+ 
248.09132 found 248.09089 (Rel. ab: 35%, -1.8 ppm). 
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XRD analysis:  
 
Experimental. Single plate-shaped crystals of 
(cu_q09262016_0m) were obtained by recrystallisation from 
diffusion of methylcyclohexane in a chlorobenzene solution at -
15°C. A suitable crystal (0.25×0.18×0.08) mm3 was selected and 
mounted on a mylar loop with oil on a Bruker D8 VENTURE 
diffractometer. The crystal was kept at T = 100 K during data 
collection. Using Olex2 (Dolomanov et al., 2009), the structure 
was solved with the XT (Sheldrick, 2015) structure solution 
program, using the Intrinsic Phasing solution method. The model 
was refined with version 2017/1 of XL (Sheldrick, 2008) using 
Least Squares minimisation. 
Crystal Data. C51H28BF20NOTi, Mr = 1109.45, monoclinic, 
P21/n (No. 14), a = 7.7585(2) Å, b = 29.6034(8) Å, c = 
19.1746(5) Å, β = 91.662(2)°, α = γ = 90°, V = 4402.1(2) Å3, T = 
100 K, Z = 4, Z' = 1, µ(CuKα) = 2.815, 29330 reflections 
measured, 7771 unique (Rint = 0.0554) which were used in all 
calculations. The final wR2 was 0.1124 (all data) and R1 was 
0.0478 (I > 2(I)). 
 
17. In situ characterization of 42: 
Ti
N
a
b c
d e
f
k
CH3
g h
i
j
Chemical Formula: C42H26BF20NTi
Molecular Weight: 983,3
B(C6F5)4
 
A J-Young NMR-tube was loaded with 34 (20 mg, 62.3 µmol, 1 eq) and [Ph3C][B(C6F5)4] (57.5, 
62.3 µmol, 1 eq) and stored in the freezer for 10 min (258 K). Cold C6D5Br was added (0.7 mL) 
in the Young-tube and tightly closed. The initial yellow solution turned rapidly dark red. The 
tube was brought then on the spectrometer and kept at 258 K for analysis. 
Compound  cu_q09262016_0m  
    
Formula  C51H28BF20NOTi  
Dcalc./ g cm-3  1.674  
µ/mm-1  2.815  
Formula Weight  1109.45  
Colour  None None None  
Shape  plate  
Size/mm3  0.25×0.18×0.08  
T/K  100  
Crystal System  monoclinic  
Space Group  P21/n  
a/Å  7.7585(2)  
b/Å  29.6034(8)  
c/Å  19.1746(5)  
α/°  90  
β/°  91.662(2)  
γ/°  90  
V/Å3  4402.1(2)  
Z  4  
Z'  1  
Wavelength/Å  1.541840  
Radiation type  CuKα  
Θmin/°  2.985  
Θmax/°  66.838  
Measured Refl.  29330  
Independent Refl.  7771  
Reflections Used  6116  
Rint  0.0554  
Parameters  701  
Restraints  750  
Largest Peak  0.562  
Deepest Hole  -0.402  
GooF  1.028  
wR2 (all data)  0.1124  
wR2  0.1034  
R1 (all data)  0.0665  
R1  0.0478  
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1H NMR (500.03 MHz, 258 K, bromobenzene-d5): δ1H: 7.24-7.01 (m, ~ 30H, CHPh3CH, Ph3CCH3), 
6.66 (m, 1H, Hb), 5.87 (s, 5H, Hk), 5.46 (s, ~ 1H, CHCHCPh3), 5.25 (m, 1H, Ha), 5.02 (m, 1H, Hb’), 
4.97 (m, 1H, Ha’), 4.12 (d, 2JHH = 15.0 Hz, 1H, Hd/d’), 3.27 (d, 2JHH = 15.0 Hz, 1H, Hd’/d), 3.69 (bs, 
1H, CHe), 2.03 (s, 3H, CH3CH3CPh3), 2.64 (s, 2JHH = not observed, 2H, Hi/i’), 1.25 (s, 3H, Hh), 1.09 
(d, 3JH’H = 6.5 Hz, 3H, Hf), 0.85 (d, 3JHH = 6.5 Hz, 3H, Hf’), 0.18 (s, methane), -0.04 (Hj), -0.86 
(s, 2JHH = not observed, 1H, Hi’/i). 
13C{1H} NMR (125.75 MHz, 258 K, bromobenzene-d5): δ13C: 192.3 (Cg), 148.4 (dm, 1JCF = 240 
Hz, o-CF), 146.2 (Cc), 138.3 (dm, 1JCF = 240 Hz, p-CF), 136.4 (dm, 1JCF = 240 Hz, m-CF), 125.2-
123.2 (bs, ipso-CB), 120.9 (Cb), 116.1 (Ck), 112.3 (Ca’), 110.5 (Ca), 108.5 (Cb’), 67.8 (Ci), 59.9 
(Cj), 52.8 (Ce), 43.7 (Cd), 21.1 (Ch), 20.5 (Cf’), 19.7(Cf).  
Side product of the crude: C6H5Br: 131.2, 129.8, 126.6; Ph3CCH3: 148.9 (ipso-C), 128.7, 127.9, 
126.0 (CHPh), 52.3 (Cq), 30.3 (CH3); Ph3CH: 143.8 (ipso-C), 129.5, 128.3, 126.3 (CHPh), 56.7 
(CH); CH4: -3.6. 
Side products are omitted for clarity on the following description. 
 
1H 1H COSY (500.03 MHz, 300 K, 258 K, bromobenzene-d5): δ1H / δ1H: 6.66 / 5.25, 5.02, 4.97 
(CHb / CHa, CHb’, CHa’), 5.25 / 6.66, 5.02, 4.97 (CHa / CHb, CHb’, CHa’), 5.02 / 6.66, 5.02, 4.97 
(CHb’ / CHb, CHa, CHa’),4.97 / 6.66, 5.25, 5.02 (CHa’ / CHb, CHa, CHb’), 4.12 / 3.27 (CH2d’ / CH2d), 
3.69 / 1.09, 0.85 (CHe / CH3f, CH3f’), 3.27 / 4.12 (CH2d / CH2d’), 2.64 / -0.86 (CH2i / CH2i’), 1.09, 
0.85 / 3.69 (CH3f,CH3f’ / CHe), -0.86 / 2.64 (CH2d’ / CH2d). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 258 K, bromobenzene-d5): δ1H / δ13C: 6.66 / 120.9 
(CHb), 5.87 / 116.1 (CHk), 5.25 / 110.5 (CHa), 5.02 / 108.5 (CHb’), 4.97 / 112.3 (CHa’), 4.12, 
3.27 / 43.7 (CH2d), 3.69 / 52.8 (CHe), 2.64 / 67.8 (CH2i), 1.25 / 21.1 (CH3h), 1.09 / 19.7 (CH3f), 
0.85 / 20.5 (CH3f’), -0.04 / 59.9 (CH3j), -0.86 / 67.8 (CH2i). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 258 K, bromobenzene-d5): δ1H / δ13C: 6.66 / 146.2, 
110.5, 108.5 (CHb / Cc, CHa, CHb’’), 5.87 / 116.1 (CHk/ CHk), 5.25 / 146.2, 120.9, 112.3, 110.5 
(CHa / Cc, CHb, CHa’, CHa), 5.02 / 146.2, 120.9, 112.3, 110.5 (CHb’ / Cc, CHb, CHa’, CHa), 4.97 
/ 146.2, 120.9, 110.5, 108.5 (CHa’ / Cc, CHb, CHa, CHb’), 4.12, 3.27 / 192.3, 146.2, 120.9, 108.5, 
52.8 (CH2d / Cg, Cc, CHb, CHb’, CHe), 2.64 / 21.1 (CH2i / CH3h), 1.25 / 192.2, 67.8 (CH3h / Cg, 
CH2i), 1.09 / 52.8, 20.5 (CH3f / CHe, CH3f’) 0.85 / 52.8, 19.7 (CH3f’ / Ce, CH3f), -0.04 / 120.9 (CH3j 
/ CHb), -0.86 / 21.1 (CH2i / CH3h). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 258 K, bromobenzene-d5): δ1H / δ15N: 1.25, 1.09, 0.85 
/ -197 (Hh, Hf, Hf’ / N). 
11B{1H} NMR (160.42 MHz, 258 K, bromobenzene-d5): δ11B: -16.3 (ν1/2 = 19 Hz). 
11B NMR (160.42 MHz, 258 K, bromobenzene-d5): δ11B: -16.3 (ν1/2 = 19 Hz). 
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19F{1H} NMR (470.45 MHz, 258 K, bromobenzene-d5): δ19F: -131.6 (bs, 8F, o-F), -161.2 (bs, 
8F, p-F), -164.6 (m, 8F, m-F). 
19F NMR (470.45 MHz, 258 K, bromobenzene-d5): δ19F: -131.6 (bs, 8F, o-F), -161.2 (bs, 8F, p-
F), -164.6 (bs, 8F, m-F). 
HRMS (Positive mode ESI, bromobenzene): m/z calcd. for C14H18NTi [M-propene]+ 
248.09132 found 248.09119 (Rel. ab: 60%, -0.5 ppm). 
18. In situ characterization of 43: 
 
The Young-type NMR-tube was left to warm up to room temperature and turned slowly dark 
green. The desired compound was completely formed after 24h and characterized by NMR at 
273 K in order to obtain a decent 13C{1H} NMR spectrum. 
1H NMR (500.03 MHz, 273 K, bromobenzene-d5): δ1H: 11.44 (s, 1H, CHi), 7.23-7.05 (m, ~ 40H, 
CHPh3CH, Ph3CCH3), 5.86 (s, 5H, Hk), 5.48-5.43 (br s, 2H, Ha), 5.43 (s, ~ 1.8H, CHCHCPh3), 4.81-
4.73 (br s, 2H, Hb), 3.84 (m, 1H, CHe), 3.76 (s, 2H, Hd), 2.05 (s, ~ 3.7H, CH3CH3CPh3), 1.55 (s, 
3H, Hh), 1.00 (d, 3JHH = 7.0 Hz, 6H, Hf), 0.16 (s, methane). 
13C{1H} NMR (125.75 MHz, 273 K, bromobenzene-d5): δ13C: 266.2 (Ci), 156.9 (Cg), 148.8 (dm, 
1JCF = 240 Hz, o-CF), , 138.7 (dm, 1JCF = 240 Hz, p-CF), 136.9 (dm, 1JCF = 240 Hz, m-CF), 125.6-
123.7 (bs, ipso-BC), 115.9 (Cc), 111.9 (Cb), 111.7 (Cj), 106.9 (Ca), 52.0 (Ce), 42.6 (Cd), 20.7(Cf), 
19.9 (Ch).  
Side product of the crude: C6H5Br: 131.6, 130.1, 127.0; Ph3CCH3: 149.3 (ipso-C), 129.1, 128.3, 
126.3 (CHPh), 52.7 (Cq), 30.7 (CH3); Ph3CH: 144.2 (ipso-C), 129.8, 128.7, 126.7 (CHPh), 57.2 
(CH); CH4: -3.4. 
Side products are omitted for clarity on the following description. 
1H 1H COSY (500.03 MHz, 300 K, 273 K, bromobenzene-d5): δ1H / δ1H: 5.86 / 4.81-4.73 (CHa 
/ CHb), 4.81-4.73 / 5.86 (CHb / CHa), 3.84 / 1.00 (CHe / CH3f’), 1.00 / 3.84 (CH3f / CHe). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 273 K, bromobenzene-d5): δ1H / δ13C: 11.44 / 266.2 
(CHi), 5.86 / 111.7 (CHj), 5.48-5.43 / 111.9 (CHa), 4.81-4.73 / 106.9 (CHb), 3.84 / 52.0 (CHe), 
3.76 / 42.6 (CH2d), 1.55 / 19.9 (CH3h), 1.00 / 20.7 (CH3f). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 273 K, bromobenzene-d5): δ1H / δ13C: 11.44 / 19.9 
(CHi / CH3h), 5.86 / 111.7 (CHj/ CHj), 5.48-5.43 / 115.9, 106.9 (CHa / Cc, CHb), 4.81-4.73 / 115.9, 
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111.9, 106.9 (CHb / Cc, CHa, CHb), 3.84 / 20.7 (CHe / CH3f), 3.76 / 156.9, 115.9, 106.9, 52.0 
(CH2d / Cg, Cc, CHb, CHe), 1.55 / 266.2, 156.9 (CH3h / CHi, Cg), 1.00 / 52.0, 20.7 (CH3f / CHe, 
CH3f). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 1.55, 1.00 / -
242.6 (Hh, Hf / N). 
11B{1H} NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -16.0 (ν1/2 = 20 Hz). 
11B NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -16.0 (ν1/2 = 20 Hz). 
19F{1H} NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.3 (br s, 8F, o-F), -160.9 (br 
s, 4F, p-F), -164.5 (br s, 8F, m-F). 
19F NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.3 (br s, 8F, o-F), --160.9 (br s, 
4F, p-F), -164.5 (m, 8F, m-F). 
HRMS (Positive mode ESI, bromobenzene): m/z calcd. for C17H22NTi [M]+ 288.12262 found 
288.12323 (Rel. ab: 65%, 2.1 ppm); C14H18NTi [M-propene]+ 248.09132 found 248.09150 (Rel. 
ab: 100%, 0.7 ppm). 
19. Attempted synthesis of 44: 
 
A solution of 34 (100 mg, 0.31 mmol, 1 eq) and [Ph3C][B(C6F5)4] (287.6, 0.31 mmol, 1 eq) in 3 
mL of C6H5Cl was prepared in a vial inside the glovebox. The solution turned rapidly red and 
gaz releasing was observed. The solution was stirred for 24h until the color turned to dark 
green, due to the formation of the carbene. OPMe3 (28.7 mg, 0.31 mmol, 1 eq) was 
incorporated to the solution which became dark purple. After 10 min of stirring, the solution 
was transferred in a Schlenk tubecontaining 25 mL of vigorously stirred pentane. A dark purple 
oil slowly decanted after freezing at -15°C overnight. Supernatant was removed and the dark 
purple oil was washed twice with pentane (2x5 mL). A dark purple precipitate (205 mg) was 
obtained in vacuo. EPR spectrum revealed that the material was contaminated with 
considerable amount of paramagnetic material. 
1H NMR (600.23 MHz, 300 K, bromobenzene-d5): δ1H: 9.07 (s, 1H, CHi), 5.80 (apparent q, 3JHH 
= 
4JHH = 2.5 Hz, 1H, Hb), 5.74 (s, 5H, Hj), 5.27 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Ha), 5.17 
(apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Ha’), 4.53 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb’), 3.82 
(hept 3JHH = 6.6 Hz, 1H, CHe), 4.20 (d, 2JHH = 15.0 Hz, 1H, Hd), 3.01 (d, 2JHH = 15.0 Hz, 1H, 
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Hd’), 1.67 (s, 3H, Hh), 1.13 (d, 3JHH = 6.6 Hz, 3H, Hf), 0.94 (d overlapping with Hk, 3JHH = 6.6 Hz, 
3H, Hf’), 0.91 (d overlapping with Hf’, 2JHP = 12.8 Hz, 9H, Hk). 
1H{31P} NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 9.07 (s, 1H, CHi), 5.80 (apparent 
q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb), 5.74 (s, 5H, Hj), 5.27 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Ha), 
5.17 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Ha’), 4.53 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb’), 
3.82 (hept 3JHH = 6.6 Hz, 1H, CHe), 4.20 (d, 2JHH = 15.0 Hz, 1H, Hd), 3.01 (d, 2JHH = 15.0 Hz, 
1H, Hd’), 1.67 (s, 3H, Hh), 1.13 (d, 3JHH = 6.6 Hz, 3H, Hf), 0.94 (d overlapping with Hk, 3JHH = 6.6 
Hz, 3H, Hf’), 0.91 (soverlapping with Hf’, 9H, Hk). 
13C{1H} NMR (125.75 MHz, 300 K, bromobenzene-d5): δ13C: 221.9 (Ci), 149.0 (Cg), 148.4 (dm, 
1JCF = 240 Hz, o-CF), 138.3 (dm, 1JCF = 240 Hz, p-CF), 136.3 (dm, 1JCF = 240 Hz, m-CF), 125.9-
123.3 (bs, ipso-CB), 118.8 (Ca’), 116.6 (Cc), 112.0 (Cj), 109.3 (Ca), 108.0 (Cb), 103.6 (Cb’), 49.8 
(Ce), 41.8 (Cd), 22.4 (Cf), 21.1 (Ch), 19.4 (Cf’), 14.1 (d, 1JPC = 72 Hz, Ck). C6H5Cl: 131.3, 129.9, 
126.8, 124.7 
1H 1H COSY (500.03 MHz, 300 K, 300 K, bromobenzene-d5): δ1H / δ1H: 5.80 / 5.27, 5.17, 4.53 
(CHb / CHa, CHa’, CHb’), 5.27 / 5.80, 5.17, 4.53 (CHa / CHb, CHa’, CHb’), 5.17 / 5.80, 5.27, 4.53 
(CHa’ / CHb, CHa, CHb’), 4.53 / 5.80, 5.27, 5.17 (CHb’ / CHb, CHa, CHa’), 4.20 / 3.01 (CH2d’/d), 
3.82 / 0.94, 0.91(CHe / CH3f/f’),3.01/ 4.20 (CH2d’/d), 1.13 / 3.82 (CH3f / CHe), 0.94 / 3.82 (CH3f’ / 
CHe). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 9.07 / 221.9 
(CHi), 5.80 / 108.0 (CHb), 5.74 / 112.0 (CHj), 5.27 / 109.3 (CHa), 5.17 / 118.8 (CHa’), 4.53 / 
103.6 (CHb’), 4.20 / 41.8 (CH2d), 3.82 / 49.8 (CHe), 3.01 / 41.8 (CH2d), 1.67 / 21.1 (CH3h), 1.13 
/ 22.4 (CH3f), 0.94 / 19.4 (CH3f’), 0.91 / 14.1 (CH3k). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 9.07 / 21.1 
(CHi / CH3h), 5.74 / 221.9, 112.0 (CHj/ CHi, CHj), 5.27 / 118.8, 116.6, 108.0, 103.6 (CHa / CHa’, 
Cc, CHb, CHb’), 5.17 / 116.6, 108.0, 103.6 (CHb’ / Cc, CHb, CHb’), 4.53 / 118.8, 116.6, 109.3 
(CHb’ / CHa’, Cc, CHa), 3.82 / 149.0, 41.8, 22.4, 19.4 (CHe / Cg, CH2d, CH3f, CH3f’), 4.20, 3.01 / 
221.9, 149.0, 116.6, 108.0, 103.6, (CH2d / CHi, Cg, Cc, CHb, CHb’), 1.67 / 221.9, 149.0, 49.8 
(CH3h / CHi, Cg, CHe), 1.13 / 49.8, 19.4 (CH3f / CHe, CH3f’), 0.94 / 49.8, 22,4 (CH3f’ / CHe, CH3f), 
0.91 / 14.1 (CH3k). 
31P{1H} NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: 63.5 (ν1/2 = 3.0 Hz) 
31P NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: apparent hex 63.5 (ν1/2 = 44.6 Hz) 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 9.07, 1.13, 0.94 
/ -268 (H’, Hf/f’ / N). 
11B{1H} NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -16.2 (ν1/2 = 22 Hz). 
11B NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -16.2 (ν1/2 = 22 Hz). 
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19F{1H} NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.6 (bs, 8F, o-F), -161.8 (t, 3JFF 
= 21 Hz, 4F, p-F), -165.6 (bs, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.6 (bs, 8F, o-F), -161.8 (t, 3JFF = 
21 Hz, 4F, p-F), -165.6 (bs, 8F, m-F). 
HRMS (Positive mode ESI, bromobenzene): m/z calcd. for C20H31NOPTi [M]+ 380.16172 
found 380.16175 (Re. ab: 100%, 0.07 ppm); C20H33NO2PTi [M+H2O] + 398.17229 found 
380.17230 (Rel. ab 48%, 0.03 ppm). 
Elemental Analysis: % calcd for C44H31BF20NOPTi: C, 49.31; H, 2.98; N, 1.34; Found: C, 
49.44; H, 3.25; N, 1.30. 
 
20. Attempted synthesis of 45: 
 
Asolution of 34 (100 mg, 0.31 mmol, 1 eq) and [Ph3C][B(C6F5)4] (287.6, 0.31 mmol, 1 eq) in 3 
mL of C6H5Br was prepared in a vial inside the glovebox. The solution turned rapidly red and 
gaz releasing was observed. The solution was stirred for 24h until the color turned to dark 
green, due to the formation of the carbene. OPet3 (42 mg, 0.31 mmol, 1 eq) was incorporated 
to the solution which became dark purple. After 10 min of stirring, the solution was transferred 
in a Schlenk tube containing 25 mL of vigorously stirred pentane. A dark purple oil slowly 
decanted after freezing at -15°C overnight. Supernatant was removed and the dark purple oil 
was washed twice with pentane (2x5 mL). A dark purple precipitate (210 mg) was obtained in 
vacuo. EPR spectrum revealed that the material was contaminated with considerable amount 
of paramagnetic material. 
1H NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 9.04 (s, 1H, CHi), 5.82 (apparent q, 3JHH 
= 
4JHH = 2.5 Hz, 1H, Ha), 5.76 (s, 5H, Hj), 5.35 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb), 5.18 
(apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Ha’), 4.55 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb’), 4.21 
(d, 2JHH = 15.0 Hz, 1H, Hd), 3.81 (hept 3JHH = 6.6 Hz, 1H, CHe), 3.03 (d, 2JHH = 15.0 Hz, 1H, 
Hd’), 1.66 (s, 3H, Hh), 1.21-1.13 (m overlapping with Hf, 6H, Hk), 1.13 (d overlapping with Hk, 
3JHH = 6.6 Hz, 3H, Hf), 0.95 (d, 3JHH = 6.6 Hz, 3H, Hf’), 0.66 (dt, 3JHP = 17.8 Hz, 3JHH = 7.7 Hz, 
9H, Hl). 
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1H{31P} NMR (600.23 MHz, 300 K, bromobenzene-d5): δ1H: 9.04 (s, 1H, CHi), 5.82 (apparent 
q, 3JHH = 4JHH = 2.5 Hz, 1H, Ha), 5.76 (s, 5H, Hj), 5.35 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb), 
5.18 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Ha’), 4.55 (apparent q, 3JHH = 4JHH = 2.5 Hz, 1H, Hb’), 
4.21 (d, 2JHH = 15.0 Hz, 1H, Hd), 3.81 (hept 3JHH = 6.6 Hz, 1H, CHe), 3.03 (d, 2JHH = 15.0 Hz, 
1H, Hd’), 1.66 (s, 3H, Hh), 1.21-1.13 (bm overlapping with Hf, 3JHH = 7.7 Hz, 6H, Hk), 1.13 (d 
overlapping with Hk, 3JHH = 6.6 Hz, 3H, Hf), 0.95 (d, 3JHH = 6.6 Hz, 3H, Hf’), 0.66 (bm, 3JHP = 
17.8 Hz, 3JHH = 7.7 Hz, 9H, Hl). 
13C{1H} NMR (125.75 MHz, 300 K, bromobenzene-d5): δ13C: 221.1 (Ci), 149.0 (Cg), 148.8 (dm, 
1JCF = 245 Hz, o-CF), 138.7 (dm 1JCF = 245 Hz, p-CF), 136.8 (dm, 1JCF = 245 Hz, m-CF), 125.8-
123.7 (bs, ipso-CB), 118.9 (Ca’), 117.1 (Cc), 112.3 (Cj), 109.7 (Cb), 108.0 (Ca), 104.4 (Cb’), 50.1 
(Ce), 42.1 (Cd), 22.8 (Cf), 21.5 (Ch), 19.8 (Cf’), 17.4 (d, 1JPC = 72 Hz, Ck), 5.2 (d, 1JPC = 4.7 Hz, 
Cl). 
1H 1H COSY (500.03 MHz, 300 K, 273 K, bromobenzene-d5): δ1H / δ1H: 4.21 / 3.03 (CH2d), 3.81 
/ 1.13, 0.95 (CHe / CH3f/f’), 3.03 / 4.21 (CH2d), 1.21-1.13 / 0.66 (CH3l / CH2k), 1.13 / 3.81 (CH3f / 
CHe), 0.95 / 3.81 (CH3f’ / CHe), 0.66 / 1.21-1.13 (CH2k / CH3l). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 9.04 / 221.1 
(CHi), 5.82 / 108.0 (CHa), 5.76 / 112.3 (CHj), 5.35 / 109.7 (CHb), 5.18 / 118.9 (CHa’), 4.55 / 
104.4 (CHb’), 4.21 / 42.1 (CH2d), 3.81 / 50.1 (CHe), 3.03 / 42.1 (CH2d), 1.66 / 21.5 (CH3h), 1.21-
1.13 / 17.4 (CH2k), 1.13 / 22.8 (CH3f), 0.95 / 19.8 (CH3f’), 0.95 / 14.1 (CH3l), 0.66 / 5.2 (CH2l). 
1H 13C HMBC (600.23 MHz / 150.86 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 9.04 / 21.5 
(CHi / CH3h), 5.82 / 117.1 (CHa/ Cc), 5.76 / 112.3 (CHj), 5.35 / 118.9, 117.1, 108.0, 104.4 (CHb 
/ CHa’, Cc, CHa, CHb’), 5.18 / 117.1, 104.4 (CHa’ / Cc, CHa’), 4.55 / 118.9, 117.1, 109.7 (CHb’ / 
CHa’, Cc, CHa), 4.21 / 149.0, 117.1, 109.7, 104.4, 50.1, 22.8, 19.8 (CH2d / Cg, Cc, CHb, CHb’, 
CHe, CH3f/f’) 3.81 / 149.0, 42.1 (CHe / Cg, CH2d), 3.03 / 149.0, 117.1, 109.7, 104.4, 50.1, 22.8, 
19.8 (CH2d’ / Cg, Cc, CHb, CHb’, CHe, CH3f/f’), 1.66 / 149.0, 50.1 (CH3h / Cg, CHe), 1.21-1.13 / 5.2 
(CH2k / CH3l), 1.13, 0.95 / 50.1, 22.8, 19.8 (CH3f/f’ / CHe, CH3f/f’), 0.66 / 17.4 (CH3l / CH2k). 
31P{1H} NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: 76.7 (ν1/2 = 2.8 Hz) 
31P NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: m 77.1-76.3 (ν1/2 = 70.0 Hz) 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 9.04, 1.66, 1.13, 
0.95 / -268 (Hi, Hh, Hf/f’ / N). 
11B{1H} NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 20 Hz). 
11B NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 20 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.2 (bm, 8F, o-F), -161.2 (bm, 
4F, p-F), -164.8 (bm, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.2 (bm, 8F, o-F), -161.2 (bm, 4F, 
p-F), -164.8 (bm, 8F, m-F). 
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HRMS (Positive mode ESI, bromobenzene): m/z calcd. for C23H37NOPTi [M]+ 422.20890 
found 422.20718 (Rel. ab: 20%, -3.5 ppm), C17H23NTi [M + H°- OPEt3] + 289.13060 found 
289.12712 (Rel. ab: 70%, -11.5 ppm); C17H22NTi [M - OPEt3] + 288.12278 found 288.12222 
(Rel. ab: 75%, -1.4 ppm); C14H18NTi [M - OPEt3 - propene]: 248.09145 found 248.09060 (Rel. 
ab: 45 %, -2.9 ppm) 
Elemental Analysis: % calcd for C47H37BF20NOPTi: C, 51.25; H, 3.39; N, 1.27; Found: C, 
51.13; H, 3.18; N, 1.15. 
 
21. Synthesis of 46-OPEt3: 
 
A solution of 34 (50 mg, 0.16 mmol, 1 eq) and [Ph3C][B(C6F5)4] (923.4, 0.16 mmol, 1 eq) in 3 
mL of C6H5Br was prepared in a vial inside the glovebox.The solution turned rapidly red and 
gaz releasing was observed. The solution was stirred for 8h until the color turned to dark green, 
due to the formation of the carbene. 1,4-cyclohexadiene (80 mg, 0.93 mmol, 6.4 eq), was 
added to the solution and stirred overnight. OPet3 (42 mg, 0.31 mmol, 1 eq) was incorporated 
to the maroon solution. After 10 min of stirring, the solution was transferred in a Schlenk tube 
containing 25 mL of vigorously stirred pentane. A dark purple oil slowly decanted after freezing 
at -15°C overnight. Supernatant was removed and the dark purple oil was washed twice with 
pentane (2x5 mL). The desired compound was obtained after evaporation of all volatiles in 
vacuo as a maroon precipitate (73 mg, 43%). Suitable crystals for X-ray diffraction were 
obtained by diffusion of heptane into a bromobenzene solution at -15°C. 
Positive mode ESI HRMS (Positive mode ESI, bromobenzene): m/z calcd. for C17H22NTi 
[M - OPEt3] + 289.13060 found 289.12895 (Rel. ab: 37%, -3.5 ppm); C14H18NTi [M - OPEt3 – 
propene-H°]: 248.09145 found 248.09055 (Rel. ab: 32%, -3.5 ppm). 
Elemental Analysis: % calcd for C47H38BF20NOPTi: C, 51.21; H, 3.47; N, 1.27; Found: C, 
51.13; H, 4.11; N, 1.15. 
EPR (9.439232 GHz, 295 K, bromobenzene): the spectrum was too compled to be simulated. 
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XRD:  
 
Experimental. Single brown plate-shaped crystals of 
(q060317_0m_a) were obtained by recrystallisation from 
diffusion of heptane in a chlorobenzene solution at -15°C. A 
suitable crystal (0.17×0.12×0.03) mm3 was selected and 
mounted on a mylar loop with oil on a Bruker APEX-II CCD 
diffractometer. The crystal was kept at T = 115 K during data 
collection. Using Olex2 (Dolomanov et al., 2009), the structure 
was solved with the ShelXT (Sheldrick, 2015) structure solution 
program, using the Intrinsic Phasing solution method. The model 
was refined with version 2017/1 of XL (Sheldrick, 2008) using 
Least Squares minimisation. 
Crystal Data. C47H38BF20NOPTi, Mr = 1102.46, triclinic, P-1 
(No. 2), a = 12.9659(13) Å, b = 13.1590(13) Å, c = 
15.5256(15) Å, α = 113.182(2)°, β = 107.789(2)°, γ = 90.732(3)°, 
V = 2291.7(4) Å3, T = 115 K, Z = 2, Z' = 1, µ(MoKα) = 0.342, 
58682 reflections measured, 10547 unique (Rint = 0.0497) which 
were used in all calculations. The final wR2 was 0.1296 (all data) and R1 was 0.0495 (I > 2(I)). 
 
22. In situ characterization of 47: 
Ti
Nb c
a
d e
f
g
h
i
j
k
l m
n
Chemical Formula: C47H34BF20NTi
Molecular Weight: 1051,4
H
H Hk'
B(C6F5)4
 
A solution of 34 (10 mg, 31.2 µmol, 1 eq) and 3,3-dimethylbut-1-ene (8 mg, 95.0 µmol, 3 eq) 
was prepared in 1 mL of cold C6D5Br. This yellow solution was added in a J-Young NMR tube 
Compound  q060317_0m_a  
    
Formula  C47H38BF20NOPTi  
Dcalc./ g cm-3  1.598  
µ/mm-1  0.342  
Formula Weight  1102.46  
Colour  brown  
Shape  plate  
Size/mm3  0.17×0.12×0.03  
T/K  115  
Crystal System  triclinic  
Space Group  P-1  
a/Å  12.9659(13)  
b/Å  13.1590(13)  
c/Å  15.5256(15)  
α/°  113.182(2)  
β/°  107.789(2)  
γ/°  90.732(3)  
V/Å3  2291.7(4)  
Z  2  
Z'  1  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  1.669  
Θmax/°  27.563  
Measured Refl.  58682  
Independent Refl.  10547  
Reflections Used  7282  
Rint  0.0497  
Parameters  655  
Restraints  0  
Largest Peak  0.831  
Deepest Hole  -0.540  
GooF  1.021  
wR2 (all data)  0.1296  
wR2  0.1125  
R1 (all data)  0.0845  
R1  0.0495  
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where [Ph3C][B(C6F5)4] (28.8 mg, 31.2 µmol, 1 eq) was introduced before. The initial yellow 
solution turned rapidly dark red. The tube was then brought to the spectrometer. After 12h, the 
reaction was completed, and the reaction mixture was characterized by NMR spectroscopy. 
 
1H NMR (600.23 MHz, 273 K, bromobenzene-d5): δ1H: 7.18 – 7.05 (m, ~ 30H, CHPh3CH, Ph3CCH3), 
6.63 (s, 1H, Hb/b’), 5.86 (s, 5H, Hn), 5.79 (dd, transJHH = 17.4 Hz, cisJHH = 10.6 Hz, ~ 3H, CHalkene), 
5.47 (bs, 1H, Ha/a’), 5.46 (s, ~ 1H, CHCHCPh3), 4.91 (dd, transJHH = 17.4 Hz, gemJHH = 1.4 Hz, ~ 3H, 
trans-HCH2alkene), 4.84 (dd, cisJHH = 10.6 Hz, gemJHH = 1.4 Hz, ~ 3H, cis-HCH2alkene), j 4.80 (bs, 1H, 
Ha’/a), 4.55 (bs, 1H, Hb’/b), 4.23 (d, 2JHH = 15.5 Hz, 1H, Hd), 4.12 (d, 2JHH = 15.5 Hz, 1H, Hd’), 
3.63 (hept, 3JHH = 7.4 Hz, 1H, He), 2.82 (t, 3JHH = 10.1 Hz, 1H, Hk), 2.66 (d, 3JHH = 10.1 Hz, 1H, 
Hi), 2.33 (t, 3JHH = 10.1 Hz, 1H, Hk’), 2.05 (s, ~ 2H, CH3CH3CPh3), 1.60 (s, 3H, Hh), 1.33 (q, 3JHH 
= 10.1 Hz, 1H, Hj), 0.96 (s, ~ 27iH, tBualkene), 0.93-0.95 (m, 3H, Hf/f’), 0.85-0.82 (m, 3H, Hf’/f), 
0.57 (m, 9H, Hm), 0.16 (s, methane). 
13C{1H} NMR (125.75 MHz, 273 K, bromobenzene-d5): δ13C: 185.9 (Cg), 148.8 (dm, 1JCF = 240 
Hz, o-CF), 138.7 (dm, 1JCF = 240 Hz, p-CF), 138.6 (Cc), 136.8 (dm, 1JCF = 240 Hz, m-CF), 127.0 
(Cb/b’), 125.6-123.5 (bs, ipso-CB), 115.3 (Cn), 113.1 (Ca/a’), 108.2 (Ca’/a), 105.2 (Cb’/b), 82.5 (Ci), 
77.1 (Ck), 53.7 (Ce), 44.8 (Cd), 36.4(Cl), 29.6 (Cj), 27.9 (Cm) 25.1 (Ch), 20.9 (Cf/f’), 18.7 (Cf’/f).  
Side product of the crude: C6H5Br: 131.6, 130.1, 126.9, 122.8; Ph3CCH3: 149.3 (ipso-C), 129.0, 
128.2, 126.3 (CHPh), 52.7 (Cq), 30.7 (CH3); Ph3CH: 144.2 (ipso-C), 129.8, 128.6, 126.6 (CHPh), 
57.1 (CH); CH4: -3.4. CH2CHC(CH3)3: 149.6 (CH2), 109.5 (CH), 33.8 (C), 29.4 (CH3). 
Side products are omitted for clarity on the following description. 
1H 1H COSY (500.03 MHz, 273 K, bromobenzene-d5): δ1H / δ1H: 6.63 / 5.47, 4.80, 4.55 (Hb/b’ / 
Ha/a’, Ha’/a, Hb’/b), 5.47 / 6.63, 4.80, 4.55 (Ha/a’ / Hb/b’, Ha’/a, Hb’/b), 4.80 / 6.63, 5.47, 4.55 (Ha’/a / 
Hb/b’, Ha/a’, Hb’/b), 4.55 / 6.63, 5.47, 4.80 (Hb’/b’ / Hb/b’, Ha/a’, Ha’/a), 4.23 / 4.12 (Hd), 4.12 / 4.23 
(Hd), 3.63 / 0.95-0.93, 0.85-0.82 (He/ Hf/f’), 2.82 / 2.33, 1.33 (Hk / Hk’, Hj), 2.66 / 1.33 (Hi / Hj), 
2.33 / 2.82, 1.33 (Hk’ / Hk, Hj), 1.33 / 2.82, 2.66, 2.33 (Hj / Hk, Hi, Hk’), 0.95-0.93 / 3.63 (Hf/f’ / He), 
0.85-0.82 / 3.63 (Hf’/f / He). 
1H 1H NOESY (600.23 MHz, 273 K, bromobenzene-d5): δ1H / δ1H: 4.17 / 1.33, 0.85-0.82 (Hd / 
Hj, Hf’/f), 3.63 / 1.60, 0.85-0.82 (He / Hh, Hf’/f), 2.82 / 5.86, 2.33, 0.5 (Hk / Hn, Hk’, Hm), 2.66 / 5.86, 
1.60, 0.57 (Hi / Hn, Hh, Hm), 2.33 / 6.63, 2.82, 0.57 (Hk’ / Hb/b’, Hk, Hm). 
 1H 13C HMQC (500.03 MHz / 125.75 MHz, 273 K, bromobenzene-d5): δ1H / δ13C: 6.59 / 127.0 
(CHb/b’), 5.86 / 115.2 (CHn), 5.43 / 113.1 (CHa/a’), 4.76 / 108.2 (CHa’/a), 4.51 / 105.2 (Cb’/b), 4.23, 
4.12 / 44.8 (Cd), 3.58 / 53.7 (Ce), 2.80 / 77.1 (Ck), 2.62 / 82.5 (Ci), 2.33 / 77.1 (Ck), 1.56 / 25.1 
(Ch), 1.33 / 29.6 (Cj), 0.90 / 18.7 (Cf/f’), 0.81 (Cf’/f), 0.56 / 27.9 (Cm). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 273 K, bromobenzene-d5): δ1H / δ13C: 6.59 / 138.6, 
113.1, 108.2, 105.2 (CHb/b’/ Cc, CHa/a’, CHa’/a, CHb’/b), 5.86 / 115.2 (CHn), 5.43 / 138.6, 127.0, 
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108.2, 105.2 (CHa/a’ / Cc, CHb/b’, CHa’/a, CHb’/b), 4.77 / 138.6, 127.0, 108.2, 105.2 (CHa’/a / Cc, 
CHb/b’, CHa/a’, CHb’/b), 4.52 / 138.6, 127.0, 113.1, 108.2 (CHb’/b / Cc, CHb/b’, CHa/a’, CHb’/b), 4.23, 
4.12 / 185.9, 138.6, 127.0, 105.2, 53.7 (CH2d / Cg, Cc, CHb/b’, CHb’/b, CHe), 3.63 / 185.9, 44.8, 
20.9, 18.7 (CHe / Cg, CH2d, CH3f/f’, CH3f’/f), 2.80 / 36.4, 29.6 (Hk / Cl, CHj), 2.62 / 36.4, 25.1 (CHi 
/ Cl, CH3f/f’), 2.33 / 82.5, 29.6 (Hk’ / CHi, CHj), 1.60 / 185.9, 82.5 (CH3h / Cg, CHi), 1.33 / 82.5, 
77.2, 36.4, 27.9 (CHj / CHi, CH2k, Cl, Cm), 0.90 / 53.7, 20.9 (CH3f/f’ / CHe, CH3f’/f), 0.80 / 53.7, 
18.6 (CH3f / CHe, CH3f’/f), 0.55 / 36.4, 27.9 (CH3m / Cl, CH3m). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 2.66, 1.60, 0.95-
0.93, 0.85-0.82 / -220 (Hi, Hg, Hf/f’/ N). 
11B{1H} NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -16.0 (ν1/2 = 23 Hz). 
11B NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -16.0 (ν1/2 = 23 Hz). 
19F{1H} NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.3 (bs, 8F, o-F), -161.1 (bs, 
8F, p-F), -164.8 (bs, 8F, m-F). 
19F NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.3 (bs, 8F, o-F), -161.1 (bs, 8F, p-
F), -164.8 (bs, 8F, m-F). 
HRMS (Positive mode ESI, bromobenzene): m/z calcd. for C23H36NOTi [M+H2O]+ 390.22709 
found 390.22726 (Rel. ab: 65%, 0.4 ppm), C14H18NTi [M-3,3-dimethylbutene-propene]+ 
248.09132 found 248.09148 (Rel. ab: 100%, -0.6 ppm). 
23. In situ characterization of 48: 
 
A solution of 34 (19.1 mg, 59.5 µmol, 1 eq) and 3,3-dimethylbut-1ene (13 mg, 154 µmol, 2.6 
eq) was prepared in 1 mL of cold C6D5Br. This yellow solution was added in a Young-type 
NMR-tube where [Ph3C][B(C6F5)4] (54.8 mg, 59.5 µmol, 1 eq) was introduced before. The initial 
yellow solution turned rapidly dark red. The tube was then brought on the spectrometer in order 
to check complete formation of the titanocyclobutane species. PMe3 (4.5 mg, 59.5 µmol, 1 eq) 
was added to the red solution inside the glovebox and a dark “blood” red solution was obtained. 
NMR measurements have been carried out on the tube. 
 
1H NMR (600.23 MHz, 300 K, bromobenzene-d5): δ1H: 9.84 (d, 3JPH = 4.5 Hz, 1H, Hi), 7.20 – 
7.05 (m, ~ 30H, CHPh3CH, Ph3CCH3), , 5.81 (dd, 3JHH = 17.4 Hz, 3JHH = 10.6 Hz, ~ 4H, CHalkene), 
5.54 (d, 3JPH = 2.5 Hz, 5H, Hj) 5.46 (s, ~ 1H, CHCHCPh3), 5.04 – 4.90 (m overlapping with 
CH2alkene, 4H, Ha/b) 4.91 (dd overlapping with Ha/b, 3JHH = 17.4 Hz, , 2JHH = 1.5 Hz, ~ 4H, 
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CH2alkene), 4.83 (dd, 3JHH = 3JHH = 10.6 Hz, 2JHH = 1.5 Hz, ~ 4H, CH2alkene), 4.29 (d, 2JHH = 15.3 
Hz, 1H, Hd), 3.79 (hept, 3JHH = 6.5 Hz, 1H, He), 3.16 (d, 2JHH = 15.3 Hz, 1H, Hd’), 2.05 (s, 1.7 H, 
CH3CH3CPh3), 1.50 (s, 3H, Hh), 1.08 (m, 3H, CH3f), 0.96 (s, ~ 36H, tBualkene), 0.92 (m, 3H, CH3f), 
0.87 (br s, 67H, free PMe3), 0.76 (d, 3JPHm = 7.6 Hz, 9H, Hm). 
1H {31P} NMR (600.23 MHz, 300 K, bromobenzene-d5): δ1H: 9.84 (s, 1H, Hi), 7.20 – 7.05 (m, ~ 
30H, CHPh3CH, Ph3CCH3), , 5.81 (dd, 3JHH = 17.4 Hz, 3JHH = 10.6 Hz, ~ 4H, CHalkene), 5.54 (s, 5H, 
Hj) 5.46 (s, ~ 1H, CHCHCPh3), 5.04 – 4.90 (m overlapping with CH2alkene, 4H, Ha/b) 4.91 (dd 
overlapping with Ha/b, 3JHH = 17.4 Hz, , 2JHH = 1.5 Hz, ~ 4H, CH2alkene), 4.83 (dd, 3JHH = 3JHH = 
10.6 Hz, 2JHH = 1.5 Hz, ~ 4H, CH2alkene), 4.29 (d, 2JHH = 15.3 Hz, 1H, Hd), 3.79 (hept, 3JHH = 6.5 
Hz, 1H, He), 3.16 (d, 2JHH = 15.3 Hz, 1H, Hd’), 2.05 (s, 1.7 H, CH3CH3CPh3), 1.50 (s, 3H, Hh), 1.08 
(m, 3H, CH3f), 0.96 (s, ~ 36H, tBualkene), 0.92 (m, 3H, CH3f), 0.87 (br s, 67H, free PMe3), 0.76 
(s, 9H, Hm). 
31P{1H} NMR (243.0 MHz, 300 K, bromobenzene-d5): δ31P: 36.7 (minor), -3.3 (major), 62.5 
(free PMe3).  
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IV. Chapter III: Cationic amido- and phosphidotitanocenes: exploring 
the frontier of the FLP concept 
 
As illustrated in the previous chapter, the intramolecular combination of a titanocenium 
cation with a tertiary amine is not a suitable target for FLP chemistry, due to the reactivity of 
CH bonds in the amine moiety with strong Lewis acids. However, since this reactivity leads to 
stable amidotitanocene cations such as 36 and 41 (Scheme IV-1), we spotted an opportunity 
for the development of cooperative systems based on the combination of a titanocenium cation 
with simple amido ligands. 
 
Scheme IV-1 illustration of the new approach 
 
In fact, this approach has already been explored successfully by Le Gendre and Erker with 
cationic amido- and phosphidozirconocene complexes.1 As a result, the synthesis of new 
titanocene analogues was envisioned. In the following chapter, a brief overview of cationic 
group 4 metals with amido or phosphido ligands will be described, before developing the 
results obtained with the new cationic titanocenes, synthesized during this thesis. 
A. Bibliographic introduction 
Numerous example of neutral group 4 amido- or phosphidometallocenes have been reported 
over the years,2,3,4 but only a few examples of cationic analogues have been described until 
now. Some of them will be presented in the following section. Early examples of 
amidozirconocene cations were described by Erker in 1995 (Scheme IV-2).5 These 
compounds were shown to be unstable. For example, the cationic (diethylamido)zirconocene 
L288-a, characterized by 1H NMR spectroscopy, was shown to be highly unstable in the course 
of several hours, yielding cationic (η2-iminoacyl)zirconocene L290-a. The proposed 
mechanism of formation of L290-a involves CH activation at the α-position of nitrogen, followed 
by methane elimination (by reaction with the methyl-borate anion) and hydride abstraction with 
                                               
1
 Normand, A. T.; Daniliuc, C. G.; Wibbeling, B.; Kehr, G.; Le Gendre, P.; Erker, G. J. Am. Chem. Soc. 2015, 137, 10796 
2
 Hey-Hawkins, E. Chem. Rev. 1994, 94, 1661 
3
 Stephan, D. W. Angew. Chem. Int. Ed. 2000, 39, 314 
4
 Rosenberg, L. Coord. Chem. Rev. 2012, 256, 606 
5
 Temme, B.; Erker, G. J. Organomet. Chem. 1995, 488, 177 
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B(C6F5)3 thus regenerated. This reactivity is in line with some processes described in the 
previous chapter (III.B.2.c). 
 
 
Scheme IV-2: synthesis of the (η2-iminoacyl)zirconocene via an amidozirconocene 
 
In 1999, another example was reported by Norton (Scheme IV-3).6 A neutral 
imidozirconocene was reacted with ethylene in order to form the azametallacycle L292 after 
[2+2] cycloaddition. Treatment of this compound with B(C6F5)3 afforded the cationic 
amidozirconocene L293 by alkide abstraction. Compound L293 was shown to be highly 
sensitive and was not characterized. Nevertheless, its formation was proved by further reaction 
with ethylene, forming L295 after H2 loss and ethylene insertion.  
 
Scheme IV-3: reactivity of an azazirconacycle with B(C6F5)3 
                                               
6
 Harlan, C. J.; Bridgewater, B. M.; Hascall, T.; Norton, J. R. Organometallics. 1999, 18, 3827 
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 Recently, Le Gendre and Erker reported the synthesis of cationic Zr amido and 
phosphido complexes as previously mentioned in the introduction (Scheme IV-4).1 Starting 
from chloro methyl zirconocene L286, the target compounds were synthesized in two steps 
(Scheme IV-4). In the case of amidozirconocenes, the cationic species were isolated and fully 
characterized, whilst the phospidozirconocenes were shown to be too reactive species to be 
isolated, and were used in situ. Furthermore, both series were shown to be active for small 
molecule activation. Both N and P atoms exhibited a marked nucleophilic character, conferring 
to these molecules the ability to react with dihydrogen, CO2, benzaldehyde.  
 
Scheme IV-4: synthesis of cationic amido and phosphido zirconocene complexes 
 
The insertion product of diphenylacetylene with L217-a was shown to act as an OmFLP (I.D.3: 
Scheme I-68),1 whilst L217-a was also used for the direct P-functionalization of azobenzene.7 
Additionnaly, these Zr phosphido and amido complexes were used for the catalytic 
hydrogenation of alkenes, alkynes, and enamines. Complexes L217-b and L288-d were 
shown to be the most active species in this series (Scheme IV-5). 
                                               
7
 Normand, A. T.; Daniliuc, C. G.; Kehr, G.; Gendre, P. L.; Erker, G. Dalton Trans. 2016, 45, 3711 
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Scheme IV-5: catalytic hydrogenation of various substrates 
 
To the best of my knowledge, no analogous titanocenes complexes have been reported 
in the literature. Nevertheless, one can cite the widely reported family of constrained geometry 
complex, with a M-bound nitrogen, mainly composed of Ti-based examples. These complexes 
have often been used in combination with an X-Ligand abstractor such as MAO to generate 
the cationic active species in situ in Ziegler-Natta polymerization. Three examples of neutral 
precursors from the work of Okuda,8 Teuben,9 and Erker,10 are illustrated in Scheme IV-6.  
 
Scheme IV-6: selected examples of CGC complexes 
 
Although these complexes have been mainly characterized under their neutral form, 
the activity of the cationic CGC complexes have been widely developed over the years and 
could not be avoided in this section. Their use in catalytic processes has already been 
reviewed elsewhere.11,12 Working on a metallocenic platform, we were interested in 
synthesizing cationic amido- and phosphido titanocenes, in order to study their reactivity, and 
extend the scope of cationic group 4 metallocenes of this category previously initiated in our 
group.1 
                                               
8
 Okuda, J. Chem. Ber. 1990, 123, 1649 
9
 van Leusen, D.; Beetstra, D. J.; Hessen, B.; Teuben, J. H. Organometallics. 2000, 19, 4084 
10
 Kunz, K.; Erker, G.; Döring, S.; Fröhlich, R.; Kehr, G. J. Am. Chem. Soc. 2001, 123, 6181 
11
 For example: Braunschweig, H.; Breitling, F. M. Coord. Chem. Rev. 2006, 250, 2691 and publications cited herein 
12
 Collins, R. A.; Russell, A. F.; Mountford, P. Appl. Petrochem. Res. 2015, 5, 153 
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B. Synthesis of cationic phosphidotitanocenes 
1. Preliminary results 
In the course of our studies on OmFLPs, we were interested in the reactivity of 
secondary phosphines with compound 38-B in order to form a species of type 38-PPh2. The 
nucleophilic attack of the carbonyl group envisioned initially did not occur. Indeed, protonation 
of the methide ligand was observed instead, as illustrated in Scheme IV-7. 
 
Scheme IV-7: unexpected formation of a cationic phosphido phosphine titanocene 
 
 According to a no lock 31P{1H} NMR spectrum, a new cationic phosphido titanocene was 
identified (Spectrum IV-1).  
 
Spectrum IV-1: no lock 31P{1H} NMR spectrum of 49 (202.46 MHz, 300 K, bromobenzene-d5) 
M-PPh2 M-PPh2H Free PPh2H 
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Indeed, two doublets (2JPP = 82.7 Hz: coupling through the titanium atom) are observed with 
one signal shifted strongly downfield (408.9 ppm), similar to the phosphidozirconocene cations 
(previously described in Scheme IV-4). The other doublet at δ = 17.2 ppm turns into a doublet 
of doublets in the 31P NMR spectrum, indicative of the presence of a secondary phosphine 
(1JPH = 340 Hz). The presumed structure of 49 is depicted in Scheme IV-7. This compound 
was not isolated, but this unexpected result was the starting point of new investigations. 
2. A straightforward route to phosphidotitanocenes 
A new procedure was developed according to the preliminary results described above. 
Starting from dimethyltitanocene, [Ph3C][B(C6F5)4] was used to abstract a methide from the 
titanium centre, forming [Cp2TiMe][B(C6F5)4] intermediately. Attempts at isolating this 
compound failed. As a result, this compound was always used in situ. Addition of a secondary 
phosphine yielded the corresponding cationic phosphido phosphine titanocene in very good 
yield as dark-red precipitates (Scheme IV-8). 
 
Scheme IV-8: one-pot synthesis of cationic phosphidotitanocenes 
 
The 1H NMR spectra of 50 shows several multiplet for the aromatic signals (7.30-7.28, 7.24, 
7.19-7.13, 7.09 and 6.95-6.92 ppm), and one doublet (3JPH = 2.4 Hz) for the signal of the Cp 
rings (5.49 ppm). The coupling observed for the signal of the Cp rings is indicative of the 
coordination of at least one phosphorous atom to the titanocenium fragment.  
A characteristic doublet with a large coupling (1JPH = 342 Hz) is observed at δ = 6.07 
ppm for the signal of the phosphorous-bound hydrogen. As previously shown for 49, a 
characteristic set of two doublets is observed in the 31P{1H} NMR. The upfield doublet 
corresponding to the secondary phosphine turns into a doublet of doublets in the 31P NMR 
(Spectrum IV-3).  
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Spectrum IV-2: 1H NMR of 50 (500.03 MHz, 300 K, bromobenzene-d5) 
 
 
Spectrum IV-3: superposition of the 31P{1H} (top) and 31P (bottom) NMR spectra of 50 (202.46 MHz, 300 K, 
bromobenzene-d5) 
 
In addition, both compounds were characterized by positive mode ESI HRMS, in which a 
characteristic cluster of peaks corresponding to [M-PR2H]+ was observed (at 363.07672 Da for 
50 and 375. 17001 Da for 51). Finally, suitable crystals for X-ray diffraction analysis were 
obtained for 50. The ORTEP view is depicted in Figure IV-1. 
Cp 
Pha and Phb 
PH 
pentane 
Pb  Pa  
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Figure IV-1: ORTEP view of 50 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed as 
the counter anion, except H2). Selected bond lengths (Å) and angles(°):Ct1-Ti = 2.051(3), Ct2-Ti = 2.042(3), 
P1-Ti = 2.3607(16), P2-Ti = 2.5864(16), P2-H2 = 1.36(5), P2-Ti-P1 = 88.85(5), Ct1-Ti-Ct2 = 134.85(12), Ti-P1-C11 
= 126.16(18), Ti-P1-C17 = 133.52(19), C1-P1-C17 = 100.3(2). 
 
The titanocene fragment adopts a classical bent geometry. Both Ti-P bonds are relatively short 
compared to the sum of covalent radii (Ti-PPh2 = 2.3607(16) Å and Ti-PPh2H = 2.5864(16) vs 
2.67 ± 0.11 Å).13 In addition, the phosphido ligand adopts an almost planar geometry according 
to the sum of angles around P1 (Σα(P1) = 359.9(3)°). The phosphido ligand is well oriented for 
pi-orbital overlap with Ti-based empty orbitals (Torsion angles: C17-P1-Ti-Ct2 = -2.26(3)° and 
C11-P1-Ti-Ct1 = 24.74(3)°).14 These results suggest a potential double bond character of the 
Ti-P1 bond.  
The reactivity of these compounds was then investigated. The presence of a lone 
electron pair on the phosphorus atom of the phosphido ligand, suggests that the formation of 
heterobimetallic complexes could be feasible. However, all attempts at preparing such 
compounds failed, whichever late-metal precursor was used: ([Pd-Cl2], [(COD)Rh-Cl]2, 
[Pd(PPh3)4], [Pt(allyl)PPh3)3]). The reactivity of the Ti-PR2 bond was then investigated: no 
reactivity towards CO2 or H2 (2 atm and 1 atm respectively) was observed at room temperature 
over 24h. Barely any change was observed according to 31P NMR experiments. Since no 
reactivity was observed with gaseous substrates, diphenylacetylene was tested on 50. When 
this complex was reacted with 1 eq of alkyne for 12h at room temperature, a new compound 
was observed (according to no lock 31P NMR spectroscopy). However, only 30% of conversion 
was observed. The reaction was then carried out with 4 equivalents of diphenylacetylene, and 
shown to be completed after 72h of stirring at room temperature (Scheme IV-9). 
                                               
13
 Cordero, B.; Gómez, V.; Platero-Prats, A. E.; Revés, M.; Echeverría, J.; Cremades, E.; Barragán, F.; Alvarez, S. Dalton Trans. 
2008, 2832 
14
 Lauher, J. W.; Hoffmann, R. J. Am. Chem. Soc. 1976, 98, 1729 
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Scheme IV-9: synthesis of 52 
 
The new cationic titanocene compound was identified as being 52, formed by insertion of the 
diphenylacetylene into the Ti-PPh2 bond. This compound was isolated and characterized by 
NMR (1H, 11B, 13C, 19F, 31P and 2D correlations) positive mode ESI HRMS and elemental 
analysis. The 1H 1H COSY NMR spectrum shows three different phenyl rings, as illustrated in 
Spectrum IV-4.  
 
Spectrum IV-4: 1H 1H COSY NMR spectrum of 52 (500.03 MHz, 300 K, dichloromethane-d2) 
 
Furthermore, the signal of the Cp rings resonates as a doublet (3JPH = 2.0 Hz), the coupling of 
which was attributed to the phosphorous atom according to 1H{31P} NMR spectroscopy (see 
Spectrum IV-5). 
Chapter III 
 
202 
 
 
Spectrum IV-5: superposition of 1H{31P} (top) and 1H (bottom) NMR of 52 
 
Lastly, the mass spectrum of 52 shows a cluster of peaks corresponding to the cationic 
species, at 541.15625 Da, as illustrated in Spectrum IV-6. 
 
Spectrum IV-6: HRMS spectrum of 52 (Positive mode ESI, dichloromethane) 
Cp 
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This compound was tested towards standard substrates for FLP reactivity, but turned 
out to be completely unreactive. The PCy2 analogue of 52 was not synthesized, since it had 
been prepared by Dr. Adrien Normand using a different synthetic route. Of note, the structure 
of this compound was elucidated by X-ray diffraction analysis, which gives further support to 
the proposed connectivity of 52.  
The successful synthesis of cationic phosphidotitanocenes led us to investigate the 
extension of this methodology to cationic amidotitanocenes by reacting [Cp2TiMe][B(C6F5)4] 
with secondary amines. 
C. Synthesis of cationic amidotitanocenes 
1. Synthesis 
By using the above described procedure, three new amidotitanocenes were obtained 
in very good yield and purity as illustrated in Scheme IV-10. With secondary amines, no amine 
coordination was observed, even in the presence of an excess of amine. The dark-red solution 
of [Cp2TiMe][B(C6F5)4]  turned rapidly dark-green after addition of the amine. 
 
Scheme IV-10: a one-pot synthesis for cationic amidotitanocenes 
 
Compounds 53-55 were characterized by NMR spectroscopy (1H, 11B, 13C, 15N, 19F and 2D 
correlations) and elemental analysis. Despite their ionic form, these compounds could not be 
characterized by mass spectrometry, presumably due to their high sensitivity, and rapid 
decomposition. The 1H NMR spectrum of 54 is depicted in Spectrum IV-7. 
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Spectrum IV-7: 1H NMR of 54 (600.23 MHz, 300 K, bromobenzene-d5) 
 
Two sets of aromatic signals are observed: one monosubstituted phenyl ring with a set of two 
triplets and one doublet (7.13, 6.99 and 5.63 ppm respectively), and one para-disubstituted 
phenyl ring with two doublets (one at 6.95-6.92 ppm overlapping with the solvent peak, and 
one at 5.61 ppm). Lastly, one can find one singlet for the signals of the Cp rings and one singlet 
for the methyl of the tolyl group (6.20 and 2.23 ppm respectively). The structure of this 
compound was elucidated by X-ray diffraction analysis of green needle-shaped crystals.  
 
Figure IV-2: ORTEP view of 54 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed as 
the counter anion). Selected bond lengths (Å) and angles(°): Ct1-Ti = 2.0308(12), Ct2-Ti = 2.0282(11), N-Ti = 
1.9791(19), N-C11 = 1.433(3), N-C18 = 1.432(3), Ct1-Ti-Ct2 = 135.41(6), Ct1-Ti-N = 111.56(6), Ct2-Ti-N = 
112.99(6), Ti-N-C18 = 127.01(14), Ti-N-C11 = 122.31(14), C11-N-C18 = 110.67(17). 
 
Ha 
Hd He Hh Hc Hg 
Hj 
pentane 
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In this structure, the titanocene adopts a bent geometry. The Ti-N bond is relatively short 
compared to the sum of covalent radii for Ti and N (1.9791(19) vs 2.31 ± 0.09 Å). Besides, the 
sum of angles around nitrogen indicates a planar geometry (Σα(N) = 359.9(3)°). The selected 
torsion angles calculated (C11-N-Ti-Ct2 = 43.82(18)°, C18-N-Ti-Ct1 = 41.46(19)°) show that 
the tolyl and phenyl groups bound to the amido ligand are neither in the bisecting plane of the 
titanocene moiety, nor orthogonal to it, but somewhere in between. Nevertheless partial pi-
orbitals overlap between the titanocenium fragment and the amido ligand may confer a certain 
degree of double bond character to the Ti-N interaction. This assumption should be 
investigated by theoretical calculations. 
This synthesis was also attempted on alkyl-substituted amines such as dibenzylamine, 
tetramethylpiperidine or tert-butyl-meta-dimethylaniline. The green color observed for the aryl 
analogues was also observed, but rapid decomposition occurred forming brownish solution 
containing unidentified compounds. As previously shown in chapter II, CH activation on the 
amine fragment might occur, yielding decomposition of the desired product. Nevertheless, an 
additional Ti amido complex was obtained by using benzotriazole. In this case, dimeric species 
56 was obtained with two bridging benzotriazolides, as a light-orange powder (Scheme IV-11). 
Scheme IV-11: synthesis of the homobimetallic complex 56 
 
This compound was characterized by NMR (1H, 11B, 13C, 19F and 2D correlation) and IR 
spectroscopies, positive mode ESI HRMS and elemental analysis. The positive mode ESI 
HRMS spectrum shows the cationic species derived from the splitting of the dimer as a cluster 
of peaks at 296.06660 Da (calculated for C16H14N3Ti+), and more surprisingly, another cluster 
of peaks is observed at 1271.11567 Da, corresponding to a monocationic adduct of the dimer 
with only one borate (calculated for C32H28N6Ti2BC24F20+). An additional dimeric mixed valence 
(Ti(III) and Ti(IV)) species was identified with a cluster of peaks at 592.13433 Da (calculated 
for C32H28N6Ti2+). The dimeric nature of 56 was definitely established by X-ray diffraction 
analysis (Figure IV-3). 
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Figure IV-3: ORTEP view of 56 (ellipsoids drawn at the 30% probability level, hydrogen atoms removed as 
the counter anion and the molecules of solvent for clarity). Selected bond lengths (Å) and angles(°): Ti-N1 
= 2.235(3), Ti-N2 = 2.086(3), Ti’-N3 = 2.236(3), N1-N2 = 1.303(4), N2-N3 = 1.326(4), Ct1-Ti = 2.061(2), Ct2-Ti = 
2.055(2), Ct1-Ti-Ct2 = 133.17(10), N3’-Ti-Cln = 95.49(10), N1-N2-N3 = 114.1(2), N2-N3-C12 = 104.8(2), N3-C12-
C11 = 107.3(3), C12-C11-N1 = 107.0(3), C11-N1-N2 = 106.8(3), Ti-N2-N3 = 166.8(2), Ti-N3’-N2’ = 115.54(18), 
N2-Ti-N3’ = 77.45(10). 
 
The molecule present a symmetric centre in the solid state. As a result, the numbering with the 
superscript prime was used to describe the whole structure. The geometry of the titanocene 
moiety remains pseudo tetrahedral as illustrated by the ORTEP view. This structure clearly 
shows that the benzotriazolide group acts as a bridging XL ligand. The geometry of the triazole 
pentagon remains planar in this structure (Σα(triazole) = 540.0(6)°). As a result, both 
benzotriazolide ligands lie in the bisecting plane of the titanocenes. 
This compound was shown to be highly stable, in various solvents (dichloromethane, 
tetrahydrofuran….) contrary to the cationic amidotitanocene analogues, only stable in bromo- 
or chlorobenzene. It has to be mentioned that these cationic amidotitanocenes are prone to 
decomposition if stored at room temperature and ambient light over several weeks. We 
suspected that decomposition might be a result of exposure to light, therefore we conducted a 
study to verify this assumption. 
2. Irradiation study 
These results were collected in collaboration with Dr. Adrien Normand, who had 
previously developed the general procedure for the reactivity studies of cationic phosphido 
titanocenes he designed.15 According to this procedure, complexes 50 and 51 on the one hand, 
and 53-54 on the other hand, were irradiated with an Heraeus TQ 150 UV lamp in THF (purple-
coloured solution). Reaction mixtures were analysed by EPR and NMR spectroscopies (and 
GCMS analysis for the amido series) and compared to the solution before irradiation. A 
                                               
15
 Manuscript in preparation 
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characteristic cation had been prepared separately as its BPh4- salt and characterized by EPR 
spectroscopy XRD analysis, and elemental analysis by Dr. Adrien Normand. This 
paramagnetic complex was used as reference for the following study. As a matter of fact, 
[Cp2Ti(THF)2][BPh4] can be made by decomposition of [Cp2Ti(PCy2)][BPh4] under ambient light 
(established by Dr. Adrien Normand). As a result for the phosphido series, a 20 min-period of 
irradiation was sufficient to obtain a blue-coloured solution, characteristic of the paramagnetic 
species Cp2Ti(THF)2+ (g = 1.9758), further confirmed by EPR spectroscopy and X-ray 
diffraction analysis. In addition, multinuclear NMR spectroscopy corroborates the formation of 
(PR2)2, the side product in such decomposition process (see appendix for more details). Of 
note, Ti-P bond homolysis has been previously observed by Stephan with neutral 
phosphidotitanocenes.16  
 
 
Scheme IV-12: homolytic cleavage of the Ti-N bond from cationic phosphidotitanocenes 
 
 On the other hand, for the amido series, whilst a 20-min-period of irradiation was 
sufficient to obtain a blue-coloured solution for 55, an additional period of 20 min was required 
for 53 and 54. The EPR spectra of 53 before and after irradiation are depicted in Spectrum 
IV-8, showing the presence of Cp2Ti(THF)2+ in both cases.  
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 Dick, D. G.; Stephan, D. W. Organometallics. 1991, 10, 2811 
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Spectrum IV-8: EPR spectra of 53 before (left) and after irradiation (right) (9.438876 GHz / 9.435437 GHz, 
295 K, THF) 
 
Note that the attenuation has been increased and the gain has been diminished in the 
spectrum recorded after irradiation, which indicates that the concentration of Cp2Ti(THF)2+ has 
increased. The calculated Lande factor (g = 1.9758) is consistent with that measured by Dr. A. 
Normand and to the literature value. 17 
For the amido series, no (NR2)2 coupling products were observed by NMR 
spectroscopy or by GCMS analysis. B(C6F5)4- was the only species identified by NMR 
spectroscopies, whilst secondary amines were identified by GCMS analysis (see experimental 
part). According to the literature, aminyl radicals do not dimerize like phosphanyl radicals, but 
tend to abstract H• (e.g. from solvent molecules),18 as illustrated in Scheme IV-13. 
Ti
B(C6F5)4-
53-55
NR2
irradiation
THF Ti
B(C6F5)4-
O
O
(IV) (III) NR2+
H from the reaction
mixture
HNR2
+ +
 
Scheme IV-13: homolytic cleavage of the Ti-N bond from cationic amidotitanocenes 
 
3. Reactivity study 
After this irradiation study, the reactivity of this amido series was also studied. Dimeric 
56 did not react towards CO2 or H2 under mild conditions. The starting product was recovered 
after these reactions. Similarly, all attempts to insert unsaturated substrates 
(diphenylacetylene, phenylacetylene, imines) also failed, highlighting the high stability of 56. 
Conversely, insertion reaction of the same unsaturated substrates with cationic 
amidotitanocenes 53-55 only yielded decomposition of the complexes. These compounds 
                                               
17
 Borkowsky, S. L.; Baenziger, N. C.; Jordan, R. F. Organometallics. 1993, 12, 486 
18
 Wang, Y.; Olankitwanit, A.; Rajca, S.; Rajca, A. J. Am. Chem. Soc. 2017, 139, 7144 
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were shown to react with CO2, but these reactions did not yield well-defined species, according 
to the recorded spectra, indicating a mixture of several products. The same observation was 
made with H2. These compounds were shown to be too reactive to form viable complexes 
whatever the type of reactivity attempted. Thus, these complexes were tested as catalysts for 
the hydrogenation of unsaturated substrates, due to their ability to react with H2. 
D. Catalytic hydrogenation of unsaturated molecules 
The previously described amido and phosphido Zr complexes reported by Erker and 
Le Gendre, showed good catalytic activity in the hydrogenation of unsaturated substrates 
(Scheme IV-5).1  
Thus, the activity of 50-51 and 53-56 was tested by reacting a range of substrate in an 
atmosphere of dry H2 (see the appendix for details), in bromobenzene over a period of 3h. 
Trimethoxybenzene (TMB) was used as internal standard, in order to quantify the conversion 
of the reaction by 1H NMR spectroscopy. The results obtained are summarized in Table IV-1.  
 
Entry Substrate Product conditions catalyst Loading (mol %) Conversion (%) 
1 
  
a x X 0 
2 
 
 
a 50 4 0 
3 
  
a 51 4 0 
4 
  
a 53 2 97 
5 
  
a 54 2 87 
6 
  
a 55 2 79 
7 
  
a 56 2 0 
8 
  
a x x 0 
9 
  
a 53 2 69 
10 
  
a 54 2 74 
11 
  
a 55 2 55 
12 
  
a 56 2 0 
13 
  
a x x 0 
14 
  
a 53 2 1 
15 
  
a 54 2 1.2 
16 
  
a 55 2 0 
17 
  
a x x 0 
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Entry Substrate Product conditions catalyst Loading (mol %) Conversion (%) 
18 
  
b 53 4 4.5 
19 
  
b 54 4 3.2 
20 
  
b 55 4 traces 
21 
  
b 56 4 0 
22  
 
b x x 0 
23  
 
b 53 4 95 
24  
 
b 54 4 53 
25  
 
b 55 4 14 
26  
 
b 56 4 0 
27 
 
 
b x x 0 
28 
 
 
b 53 4 12c 
29 
 
 
b 54 4 8c 
30 
 
 
b 55 4 4c 
31 
 
 
b 56 4 0 
 
Conversion to product (average of two runs) determined by integration versus trimethoxybenzene (TMB) standard 
a:
 960 µmol of substrate, 5 mol% TMB, 2 mol% catalyst ; b: 480 µmol of substrate, 5 mol% TMB, 4 mol% catalyst; c 
conversion determined by integration vs starting material. 
Table IV-1: results of the hydrogenation catalysis 
 
The first catalytic assays were conducted on alkenes with the cationic phosphido and 
amidotitanocenes. The Ti phosphido series (Table IV-1: entry 2-3) turned out to be completely 
inactive, contrary to the phosphido zirconocene complexes previously reported by Le Gendre 
and Erker (L217-a-b Scheme IV-4).1 This difference might be explained considering that the 
vacant site on L217-a-b is occupied by PR2H in 50-51, even if this phosphine was found to be 
labile in polar solvents (e.g. THF, see appendix). The benzotriazolido titanocenium was also 
completely inactive. Nevertheless, the Ti amido series was active against a range of 
substrates. Indeed, comparable conversions to those obtained with the zirconocene series 
described by Le Gendre and Erker, were observed for the cationic amidotitanocenes in the 
hydrogenation of styrene, 3,3-dimethybut-1-ene, and diphenylacetylene (Table IV-1 Entry 4-6, 
9-11 and 23-25 respectively). The best catalyst in this series is compound 53. However, the 
hydrogenation of an electron-deprived substrate such as the perfluorostyrene was completely 
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ineffective with this, even with higher loading and concentration (Table IV-1 Entry 14-20). The 
limitation of the system was also observed with benzalaniline (Table IV-1 Entry 28-30). For this 
substrate, complicated 1H NMR spectra were recorded. In some cases, the TMB signals were 
even almost vanished from the 1H NMR spectrum. Nevertheless, the starting imine and the 
corresponding hydrogenated product benzylaniline (corroborated with GCMS analysis for 
qualitative purpose) were observed and identified by 1H NMR spectra, showing very low 
conversion (entry 28-30). Catalyst poisoning by the imine substrate or by the amine product is 
likely the cause of this lack of catalytic activity. 
To summarize the results obtained in the titanocenium series, the phosphido series 
was completely inactive contrary to their Zr analogues in catalytic hydrogenation. More 
surprisingly for the amido Ti series, comparable activity to the most basic Zr analogues were 
observed. Indeed, the diphenylamido zirconocenium complex was relatively poorly active 
compared to the 3,5-dimethylphenyl-tert-butylamido zirconocenium complex and the amido Ti 
series reported in this manuscript. 
 
Scheme IV-14: comparison of the activity of cationic amido- and phosphido titanocenes in catalytic 
hydrogenation (counter anion B(C6F5)4- omitted for clarity) 
 
For this catalytic reaction, the following mechanisms are proposed based on a metal-
ligand cooperativity, but remain subject to debate without further experimental evidence, and / 
or DFT calculations. The first proposal is analogous to the mechanism proposed for the Zr-
based systems previously described by Le Gendre and Erker, in which the active species is a 
cationic amido Ti (IV) complex. For clarity, it has been exemplified with styrene but it could be 
extended to any substrates used in this catalytic reaction. The first step of this mechanism is 
the cooperative H2 activation by the cationic Ti amido complex, forming [C1-a]. The resulting 
formation of a labile secondary amine may favour the styrene approach in the coordination 
sphere of the titanium [C1-b], a requirement for the insertion step of the carbon-carbon double 
into the Ti-H bond. The cationic alkyl titanocene formed ([C1-c]) may then be able to undergo 
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protonolysis by the Ti-bound secondary amine via transition state [C1-d], liberating 
ethylbenzene, and regenerating the cationic amidotitanocene complex. 
 
 
Scheme IV-15: catalytic mechanism via a cationic Ti(IV) species: first proposal 
 
Alternatively, a mechanism based on Ti(III) species may be envisioned. Indeed, Ti(IV)-H 
species are known to undergo homolytic Ti-H cleavage, thus generating Ti(III) species along 
with H2.19 One can then draw the catalytic cycle depicted in Scheme IV-16. Starting from the 
cationic titanium hydride [C1-a], the second catalytically active species [C2-a] is generated by 
homolytic cleavage of the Ti-H bond forming [C2-a]. From this stage, an analogous mechanism 
to the one depicted in Scheme IV-15 may operate, except that the ammonium acts as an 
external Brønsted acid to protonate Ti-alkyl species. Of note, both mechanisms could operate 
simultaneously, or the formation of Ti(III) species could just be a catalyst decomposition 
pathway, if one step of the following mechanism is energetically unfavoured. 
                                               
19
 Chapman, A. M.; Wass, D. F. Dalton Trans. 2012, 41, 9067 
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Scheme IV-16: catalytic mechanism via a cationic Ti(III) species: second proposal 
 
A preliminary clue was obtained, by measuring an EPR spectrum during the catalytic 
hydrogenation of styrene with 53 (Spectrum IV-9). The presence of Ti(III) species was 
detected, but this is definitely not sufficient to demonstrate the second mechanism without a 
better characterization of the detected Ti(III) species. Indeed, Ti(IV) compounds often contain 
residual Ti(III) species.  
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Spectrum IV-9: EPR spectrum of the catalytic hydrogenation of diphenylacetylene with 53 (9.430654 GHz, 
295 K, bromobenzene) 
 
In conclusion to this chapter, a straightforward synthesis of cationic phosphido and 
amidotitanocenes was developed with commercially available starting material in a one-pot 
synthesis. The cationic phosphidotitanocenes series was shown to be poorly reactive 
compared to the amido series. The latter were used in catalytic hydrogenation (possibly 
following a mechanism involving metal ligand cooperativity) of unsaturated substrates in mild 
conditions and showed relatively good activity. 
E. Experimental part 
1. Synthesis of phosphido-titanocenes: 
Ti
Me
Me
Ti TiMe
[ Ph3C][B(C6F5)4] 2 PR2H
B(C6F5)4
B(C6F5)4
PR2
PR2
- Ph3CMe - CH4
 
General procedure: 
In an Ar glovebox, Cp2TiMe2 (200 mg, 0.96 mmol) and [Ph3C][B(C6F5)4] (888 mg, 0.96 mmol, 
1 eq) were mixed for 5 min in 2 mL of C6H5Br at room temperature. A solution of PR2H (376 
mg, 2.02 mmol) in C6H5Br was added dropwise to the reaction mixture. The resulting deep-red 
solution was stirred for 3h until a red precipitate was formed. The heterogeneous solution was 
added dropwise to 8 mL pf pentane under vigorous agitation to complete the precipitation of 
the desired red compound. The supernatant was removed and the red precipitate was washed 
325 330 335 340 345 350 355
Magnetic Field (mT)
Attenuation 30 dB
Gain 50 dB
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twice with 5 mL of pentane. After removal of traces of pentane in vacuo, the red precipitate 
was dissolved in CH2Cl2 and precipitated from pentane as described above (N.B.: compound 
50 and 51 slowly decompose in CH2Cl2, therefore this step must be performed quickly).  
a. PR2H = PPh2H 50: 
 
Yield: 0.98 g, 83% 
1H NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 7.30-7.28 (m overlapping with 
bromobenzene signal, 2H, p-Hb), 7.24 (tm, 3JHH = 7.0 Hz, 4H, o-Hb), 7.19-7.13 (m, 6H, m-Hb, 
p-Ha), 7.09 (apparent tm, 3JHH = 7.0 Hz, 4H, m-Hb, o-Ha), 6.95-6.92 (m, 4H, m-Hb, m-Ha), 6.07 
(d, 1JPH = 342 Hz, 1H, HP-H), 5.49 (d, 3JPH = 2.4 Hz, 10H, HCp). Residual pentane 1.29-1.14 (m), 
0.85 (t). 
1H{31P} NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 7.30-7.28 (m, 2H, p-Hb), 7.24 (t, 
3JHH = 7.0 Hz, 4H, o-Ha), 7.19-7.13 (m, 6H, m-Hb, p-Ha), 7.09 (t, 3JHH = 7.0 Hz, 4H, m-Hb, o-Hb), 
6.95-6.92 (m, 4H, m-Hb, m-Ha), 6.06 (s, 1H, HP-H), 5.49 (s, 10H, HCp). 
13C{1H} NMR (125.77 MHz, 300 K, bromobenzene-d5) correlated with dept 135: δ13C: 148.8 
(dm, 1JCF = 240 Hz, o-CF), 144.8 (dm, 1JCP = 11 Hz, ipso-Cb), 138.8 (dm, 1JCF = 240 Hz, p-CF), 
136.6 (dm, 1JCF = 240 Hz, m-CF), 132.8 (d, 2JPC = 9 Hz, o-Ca), 131.7 (d, 4JPC = 2 Hz, p-Ca), 131.4 
(d, 4JPC = 6 Hz, m-Cb), 130.4 (p-Cb), 129.9 (d overlapping with bromobenzene signal, visible in 
DEPT 135 spectrum, 2JPC = 3 Hz, m-Ca), 129.2 (o-Cb), 125.5-123.3 (bs, ipso-CBCF), 104.4 (CCp). 
C6H5Br: 131.5, 129.8, 126.7, 122.5 ; pentane: 34.3, 22.7, 14.4. ipso-Ca not identified.  
1H 1H COSY (500.03 MHz, 300 K, bromobenzene-d5): δ1H / δ1H: 7.30-7.28 / 7.24 (p-CHa / m-
CHa), 7.24 / 7.30-7.28, 7.09 (m-CHa / p-CHa, o-CHa), 7.19-7.13 / 6.95-6.91 (o-CHb, p-CHb / m-
CHb), 7.09 / 7.24 (o-CHa / m-CHa), 6.95-6.91 / 7.19-7.13 (m-CHb / p-CHb, o-CHb). 
1H 13C HMQC (500.03 MHz / 125.77 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 7.30-7.28 / 
131.7 (p-CHa), 7.24 / 129.9 (o-CHb), 7.19-7.13 / 131.4, 129.2 (p-CHb, m-CHa), 7.09 / 132.8 (o-
CHa), 6.95-6.92 / 131.5 (m-CHa), 5.5 / 104.4 (CHCp).  
1H 13C HMBC (500.03 MHz / 125.77 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 7.30-7.28 / 
132.8 (p-CHa / o-CHa), 7.24 / 131.4 (o-CHb / p-CHb), 7.19-7.13 / 144.8, 131.7, 129.2 (p-CHb , 
m-CHa / ipso-C, p-CHa, m-CHa), 7.09 / 132.8, 131.7 (o-CHa / o-CHa, p-CHa), 6.95-6.92 / 131.5, 
131.4 (m-CHb/ m-CHb, p-CHb), 6.06 / 132.8 (HPH / o-CHa), 5.5 / 104.4 (CHCp / CHCp).  
31P{1H} NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: 420.3 (d, 2JPP = 83 Hz, Pb), 23.8 
(d, 2JPP = 85 Hz, Pa). 
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31P NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: 420.3 (d, 2JPP = 83 Hz, Pb), 23.8 (dd, 
1JPH = 342 Hz, 2JPP = 83 Hz, Pa). 
31P{1H} NMR (121.48 MHz, 300 K, tetrahydrofuran-d8): δ31P: 413.7 (d, 2JPP = 83 Hz, Pb), 388.8, 
19.1 (d, 2JPP = 83 Hz, Pa), -17.4, -42.8. 
11B{1H} NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.8 (w = 21 Hz).  
11B NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.8 (w = 21 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.3 (d, 3JFF = 11 Hz, 8F, o-F), 
-161.6 (t, 3JFF = 21 Hz, 8F, p-F), -165.4 (m, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.3 (d, 3JFF = 11 Hz, 8F, o-F), -
161.6 (t, 3JFF = 21 Hz, 8F, p-F), -165.4 (m, 8F, m-F). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C22H20PTi [M-PPh2H]+ 
363.07766; found 363.07672 (Rel. ab: 40%, -0.8 ppm). 
Elemental Analysis: % calcd: C, 57.07; H, 2.45; Found: C, 56.71; H, 2.54. 
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XRD: 
 
 
Experimental. Single red needle-shaped crystals of 
(q02022016_0m) were obtained by recrystallisation 
from diffusion of pentane in a bromobenzene solution. A 
suitable crystal (0.30×0.07×0.02) mm3 was selected and 
mounted on a mylar loop with oil on a Nonius Kappa 
Apex II diffractometer. The crystal was kept at T = 115 K 
during data collection. Using Olex2 (Dolomanov et al., 
2009), the structure was solved with the XT (Sheldrick, 
2015) structure solution program, using the Direct 
Methods solution method. The model was refined with 
version 2017/1 of XL (Sheldrick, 2008) using Least 
Squares minimisation. 
Crystal Data. C58H31BF20P2Ti, Mr = 1228.48, monoclinic, 
P21/c (No. 14), a = 9.0275(6) Å, b = 33.3407(18) Å, c = 
17.1603(11) Å, β = 103.855(4)°, α = γ = 90°, V = 
5014.7(5) Å3, T = 115 K, Z = 4, Z' = 1, µ(MoKα) = 0.351, 
76800 reflections measured, 7870 unique (Rint = 0.1827) 
which were used in all calculations. The final wR2 was 0.1194 
(all data) and R1 was 0.0609 (I > 2(I)). 
  
Compound  q02022016_0m  
    
Formula  C58H31BF20P2Ti  
Dcalc./ g cm-3  1.627  
µ/mm-1  0.351  
Formula Weight  1228.48  
Colour  red  
Shape  needle  
Size/mm3  0.30×0.07×0.02  
T/K  115  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  9.0275(6)  
b/Å  33.3407(18)  
c/Å  17.1603(11)  
α/°  90  
β/°  103.855(4)  
γ/°  90  
V/Å3  5014.7(5)  
Z  4  
Z'  1  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  2.520  
Θmax/°  23.998  
Measured Refl.  76800  
Independent Refl.  7870  
Reflections Used  4343  
Rint  0.1827  
Parameters  742  
Restraints  0  
Largest Peak  0.608  
Deepest Hole  -0.603  
GooF  1.044  
wR2 (all data)  0.1194  
wR2  0.0947  
R1 (all data)  0.1559  
R1  0.0609  
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b. PR2H = PCy2H 51: 
 
Yield: 1.05 g, 83%, with 85% pentane 
1H NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 5.48 (d, 3JPH = 2.5 Hz, 10H, HCp), 3.50 
(d, 1JPH = 320 Hz, 1H, HP-H), 3.01 (m, 2H, CHb), 1.84-1.48 (m, 26H, CH2a/b and CHa), 1.39-0.96 
(m, overlapping with pentane, 16H, CH2a/b). pentane: 0.85 (t). 
1H{31P} NMR (300.0 MHz, 300 K, bromobenzene-d5): δ1H: 5.48 (s, 10H, HCp), 3.50 (s, 1H, HP-
H), 3.01 (m, 2H, CHb), 1.84-1.48 (m, 26H, CH2a/b and CHa), 1.39-0.96 (m, 16H, CH2a/b).  
13C{1H} NMR (125.77 MHz, 300 K, bromobenzene-d5): δ13C: 149.0 (dm, 1JCF = 243 Hz, o-CF), 
138.7 (dm, 1JCF = 240 Hz, p-CF), 136.7 (dm, 1JCF = 238 Hz, m-CF), 125.7-123.8 (ipso-CB), 102.5 
(CHCp), 53.2 (CHb), 39.6 (d, 1JPC = 13 Hz, CHa), 33.7 (br s, CH2 of Cy), 33.6 (br s, CH2 of Cy), 
33.2 (br s, CH2 of Cy), 32.4 (br s, CH2 of Cy), 28.5 (br s, CH2 of Cy), 28.0 (br s, CH2 of Cy), 
27.8 (br s, CH2 of Cy), 26.0 (br s, CH2 of Cy), 25.8 (br s, CH2 of Cy). Pentane: 34.4, 22.7 and 
14.5. 
1H 1H COSY (500.03 MHz, 300 K, bromobenzene-d5): δ1H / δ1H: 3.0 / 1.84-1.48 (CHb / CH2b), 
1.84-1.48 / 3.0, 1.39-0.96 (CH2a/b, CHa/ CH2a, CHb), 1.39-0.96 / 1.84-1.48 (CH2b/a / CHb, CH2a). 
1H 13C HMQC (500.03 MHz / 125.77 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 5.48 / 102.5 
(CHCp), 3.0 / 53.2 (CHb), 3.0 / 39.6, 33.7, 33.2, 32.4, 28.5, 28.0, 26.0, 25.8 (CHa, CH2a/b), 1.84-
1.48 / 34.4, 33.6, 33.2, 28.5, 27.8, 26.0, 25.8 (CH2a/b). 
1H 13C HMBC (500.03 MHz / 125.77 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 5.48 / 102.5 
(CHCp), 3.50 / 33.2 (HPH / CH2a), 3.0 / 53.2 (CHb), 3.0 / 53.2, 39.6, 33.7, 33.2, 32.4, 28.5, 28.0, 
26.0, 25.8 (CHa, CH2a/b / CHb, CHa, CH2a/b), 1.84-1.48 / 53.2, 34.4, 33.6, 33.2, 28.5, 27.8, 26.0, 
25.8 (CH2a/b). 
31P{1H} NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: 500.8 (d, 2JPP =76.7 Hz, Pb), 39.2 
(d, 2JPP = 76.7 Hz, Pa). 
31P NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: 500.8 (d, 2JPP = 76.7 Hz, Pb), 39.2 (dd, 
1JPH = 320 Hz, 2JPP = 76.7 Hz, Pa). 
31P{1H} NMR no lock (242.95 MHz, 300 K, tetrahydrofuran): δ31P: 492.0 (d, 2JPP = 85 Hz, Pb), 
486.5, 34.6 (d, 2JPP = 85 Hz, Pa) , -31.3. 
11B{1H} NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (w = 21 Hz). 
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11B NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (w = 21 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.3 (d, 3JFF = 11 Hz, 8F, o-F), 
-161.8 (t, 3JFF = 21 Hz, 8F, p-F), -165.6 (m, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.3 (d, 3JFF = 11 Hz, 8F, o-F), -
161.8 (t, 3JFF = 21 Hz, 8F, p-F), -165.6 (m, 8F, m-F). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C22H32PTi [M-PCy2H]+ 
375.17266; found 375.17001 (Rel. ab: 60%, -4.1 ppm). 
Elemental Analysis: % calcd with 85% of pentane: C, 57.57; H, 4.37; Found: C, 57.00; H, 
5.00. 
2. Synthesis of 52: 
 
In an Ar glovebox, compound 50 (400 mg, 0.32 mmol) was dissolved in C6H5Br (3 mL) with an 
excess of diphenylacetylene (232 mg, 1.3 mmol) at room temperature and stirred for 72H. The 
evolution of the reaction was followed by 31P{1H} no lock NMR experiments. The starting red 
solution became green. The compound was precipitated by addition to 6 mL of pentane under 
vigorous agitation. An oil formed, the supernatant was discarded and the oil extracted twice 
with pentane. The black-green residue was dissolved in 2 mL of dichloromethane and 
precipitated as described above. Compound 52 was obtained as a light brown powder 
containing 30 mol% of pentane after drying in vacuo (350 mg, 88 %). 
1H NMR (500.03 MHz, 300 K, dichloromethane-d2): δ1H: 7.65 (tm, 3JHH = 7.5 Hz, 2H, p-HP), 
7.59 (apparent td, 3JHH = 7.5 Hz, 4JPH = 2.0 Hz, 4H, m-HP), 7.54 (dd, 3JHH = 7.5 Hz, 3JPH = 11.0 
Hz, 4H, o-HP), 7.29 (t, 3JHH = 7.7 Hz, 2H, m-H1), 7.23 (t, 3JHH = 7.7 Hz, 1H, p-H2), 7.21 (t, 3JHH = 
7.7 Hz, 1H, p-H1), 7.14 (t, 3JHH = 7.7 Hz, 2H, m-H2), 7.06 (d, 3JHH = 7.7 Hz, 2H, o-H2), 6.60 (d, 
3JHH = 7.7 Hz, 2H, o-H1), 6.55 (d, 3JPH = 2.0 Hz, 10H, HCp). Pentane: 1.21-1.00 (m), 0.85 (t). 
1H{31P} NMR (500.03 MHz, 300 K, dichloromethane-d2): δ1H: 7.65 (t, 3JHH = 7.5 Hz, 2H, p-HP), 
7.59 (t, 3JHH = 7.5 Hz, 4H, m-HP), 7.54 (d, 3JHH = 7.5 Hz, 4H, o-HP), 7.29 (t, 3JHH = 7.7 Hz, 2H, 
m-H1), 7.23 (t, 3JHH = 7.7 Hz, 1H, p-H2), 7.21 (t, 3JHH = 7.7 Hz, 1H, p-H1), 7.14 (t, 3JHH = 7.7 Hz, 
2H, m-H2), 7.06 (d, 3JHH = 7.7 Hz, 2H, o-H2), 6.60 (d, 3JHH = 7.7 Hz, 2H, o-H1), 6.55 (s, HCp). 
13C{1H} NMR (125.77 MHz, 300 K, dichloromethane-d2): δ13C: 223.1 (s, C-Ti), 148.7 (d, 1JFC = 
243 Hz, o-CF), 142.0 (d, 2JPC = 25 Hz, ipso-C1), 138.7 (d, 1JFC = 243 Hz, p-CF), 136.8 (br d, 
1JFC = 243 Hz, m-CF), 132.7 (d, 2JPC = 3.0 Hz, ipso-C2), 132.5 (d, 2JPC = 3.0 Hz, p-CP), 132.4 
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(d, 2JPC = 9.0 Hz, o-CP), 130.6 (d overlapping with CH of PPh, 1JPC = 34.6 Hz, ipso-CP), 130.5 
(d overlapping with CH o PPh, 3JPC = 10.0 Hz, m-CP), 130.0 (m-C1), 129.6 (d, 3JPC = 4.0 Hz, o-
C2), 129.3 (m-C2), 128.8 (p-C2), 128.3 (p-C1), 126.0 (d, 4JPC = 2.0 Hz, o-C1), 125.8-123.5 (bs, 
ipso-CB), 120.9 (CCp), 116.2 (d, 1JPC = 45.0 Hz, =CPPh2). Pentane: 34.6, 22.7, 14.2. 
1H 1H COSY (500.03 MHz, 300 K, dichloromethane-d2): δ1H / δ1H: 7.65 / 7.59 (p-CHP / m-CHP), 
7.59 / 7.65, 7.54 (m-CHP / p-CHP, o-CHP), 7.54 / 7.59 (o-CHP / m-CHP), 7.29 / 7.21, 6.60 (m-
CH1 / p-CH1, o-CH1), 7.23 / 7.14, 7.06 (p-CH2 / m-CH2, o-CH2), 7.21 / 7.29 (p-CH1 / m-CH1), 
7.14 / 7.23, 7.06 (m-CH2 / p-CH2, o-CH2), 7.06 / 7.23, 7.14 (o-CH2 / p-CH2, m-CH2), 6.60 / 7.29, 
7.21 (o-CH1 / m-CH1, p-CH1). 
1H 13C HMQC (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.65 / 132.7 
(p-CHP), 7.59 / 130.5 (m-CHP), 7.54 / 132.4(o-CHP), 7.29 / 130.0 (m-CH1), 7.23 / 128.8 (p-CH2), 
7.21 / 128.3 (p-CH1), 7.14 / 129.3 (m-CH2), 7.06 / 129.6 (o-CH2), 6.60 / 126.0 (o-CH1), 6.55 / 
120.9 (CHCp).  
1H 13C HMBC (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 7.65 / 132.4 
(p-CHP / o-CHP), 7.59 / 132.7, 132.4, 130.5 (m-CHP / o-CHP, m-CHP), 7.54 / 132.7 (o-CHP / p-
CHP), 7.29 / 142.0, 130.0, 126.0 (m-CH1 / ipso-C1, m-CH1, o-CH1), 7.23 / 129.6 (p-CH2 / o-
CH2), 7.21 / 142.0, 126.0 (p-CH1 / ipso-C1, o-CH1), 7.14 / 132.5, 129.6, 116.2 (m-CH2 / o-CH2, 
=C-P), 7.06 / 128.8, 116.2 (o-CH2 / p-CH2, =C-P), 6.60 / 223.1, 128.3, 126.0 (o-CH1 / C-Ti, p-
CH1,o-CH1), 6.55 / 120.9 (CHCp). 
31P{1H} NMR (202.46 MHz, 300 K, dichloromethane-d2): δ31P: -26.9 (ν1/2 = 3.3 Hz). 
31P NMR (202.46 MHz, 300 K, dichloromethane-d2): δ31P: -26.9 (ν1/2 = 34.7 Hz). 
11B{1H} NMR (160.42 MHz, 300 K, dichloromethane-d2): δ11B: -16.6 (ν1/2 = 21 Hz).  
11B NMR (160.42 MHz, 300 K, dichloromethane-d2): δ11B: -16.6 (ν1/2 = 21 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -131.3 (d, 3JFF = 15 Hz, 8F, o-F), 
-163.7 (t, 3JFF = 29 Hz, 8F, p-F), -167.5 (m, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -133.0 (d, 3JFF = 15 Hz, 8F, o-F), -
163.7 (t, 3JFF = 19 Hz, 8F, p-F), -167.5 (m, 8F, m-F). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. for C36H30PTi [M]+ 541.15591; 
found 541.15625 (Rel. ab: 100%, 0.6 ppm). 
Elemental Analysis: % calcd: C, 59.05; H, 2.48; Found: C, 59.73; H, 2.44. 
3. General procedure for the synthesis of amidotitanocenes: 
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Cp2TiMe2 (X mmol, 1 eq) and [Ph3C][B(C6F5)4] (1 eq) were combined in a vial inside the 
glovebox and dissolved in 3 mL of C6H5Br. The resulting red solution was stirred for 5 min and 
arylamine (1.1 eq) was added. The solution was stirred for 1h until the color turned to dark 
green. The solution was transferred in a schlenk vessel containing 10 mL of vigorously stirred 
pentane. An heavy green precipitate was formed and left to decant for 5min. The red 
supernatant solution was removed and the green powder was washed twice with pentane (2 x 
5 mL). After drying in vacuo the green powder was dissolved in dichloromethane (2 mL) and 
precipitated again with pentane (10 mL). The light green supernatant solution was removed 
and the desired compound was obtained as a dark green precipitate after evaporation of all 
volatiles in vacuo. 
NB: these compounds were shown to be light sensitive. They were stored in the freezer at -
18°C.20 
c. Synthesis of 53: 
 
X = 0.96 mmol, Yield: 876 mg, 88 %.  
1H NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 7.13 (t, 3JHdHe = 3JHdHc 7.2 Hz, 4H, Hd), 
7.00 (t, 3JHeHd = 7.2 Hz, 2H, He), 6.15 (s, 10H, Ha), 5.75 (d, 3JHcHd = 7.2 Hz, 4H, Hc). Pentane t, 
0.85 (t). 
13C{1H} NMR (125.77 MHz, 300 K, bromobenzene-d5): δ13C: 156.1 (Cb), 148.6 (dm, 1JCF = 240 
Hz, o-CF), 138.6 (dm, 1JCF = 240 Hz, p-CF), 136.7 (dm, 1JCF = 240 Hz, m-CF), 131.7 (Cd), 129.1 
(Ce), 122.6 (Ca), 117.9 (Cc), i-CB(C6F5)4 n.o. 
1H 1H COSY (500.03 MHz, 300 K, 273 K, bromobenzene-d5): δ1H / δ1H: 7.13 / 7.00, 5.75 (Hd / 
He, Hc), 7.00 / 7.13 (He / Hd), 5.75 / 7.13 Hc / Hd). 
1H 13C HMQC (500.03 MHz / 125.77 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 7.13 / 131.7 
(CHd), 7.00 /129.1 (CHe), 6.15 / 122.6 (CHa), 5.75 / 117.9 (CHc). 
1H 13C HMBC (500.03 MHz / 125.77 MHz, 273 K, bromobenzene-d5): δ1H / δ13C: 7.13 / 156.1, 
131.7, 117.9 (CHd / Cb, CHd, CHc), 7.00 / 156.1, 117.9 (CHe / Cb, CHc), 6.15 / 122.6 (CHa), 5.75 
/ 156.1, 129.1, 117.9 (CHc / Cb, CHe, CHc).  
                                               
20
 These complexes were presumed to be too reactive to be observed by ESI HMRS 
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1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 5.75 / -35 (Hc / 
N). 
11B{1H} NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 22 Hz). 
11B NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 22 Hz). 
19F{1H} NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.4 (br s, 8F, o-F), -161.4 (t, 
3JFF = 21 Hz, 4F, p-F), -165.3 (br s, 8F, m-F). 
19F NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.4 (br s, 8F, o-F), -161.4 (t, 3JFF = 
21 Hz, 4F, p-F), -165.3 (m, 8F, m-F). 
Elemental Analysis: % calcd for C46H20BF20NTi: C, 53.89; H, 1.97; N, 1.37; Found: C, 53.89; 
H, 1.97; N, 1.38. 
d. Synthesis of 54: 
 
X= 0.72 mmol, Yield: 635 mg, 85 %.  
1H NMR (600.23 MHz, 300 K, bromobenzene-d5): δ1H: 7.13 (t, 3JHdHe = 3JHdHc 7.3 Hz, 2H, Hd), 6.99 
(t, 3JHeHd = 7.3 Hz, 1H, He), 6.95-6.92 (m, 2H,Hh), 6.20 (s, 10H, Ha), 5.63 (d, 3JHcHd = 7.3 Hz, 2H, 
Hc), 5.61 (d, 3JHgHh = 8.0 Hz, 2H, Hg), 2.23 (s, 3H, Hj). traces of pentane were observed (m, 1.20; 
t, 0.85). 
13C{1H} NMR correlated with dept 135 (125.77 MHz, 300 K, bromobenzene-d5): δ13C: 156.0 (Cb), 
152.7 (Cf), 148.9 (dm, 1JCF = 240 Hz, o-CF), 140.7 (Ci), 138.7 (dm, 1JCF = 240 Hz, p-CF), 136.9 
(dm, 1JCF = 240 Hz, m-CF), 133.0 (Ch), 130.9 (Cd), 128.7 (Ce), 123.0 (Ca), 118.7 (Cc), 116.4 (Cg), 
21.3 (Cj) i-CB(C6F5)4 n.o.  
1H 1H COSY (600.23 MHz, 300 K, 273 K, bromobenzene-d5): δ1H / δ1H: 7.13 / 6.99, 5.63 (Hd / He, 
Hc), 6.99 / 7.13 (He / Hd), 6.95-6.92 / 5.61 (Hh / Hg), 5.63 / 7.13 (Hc / Hd), 5.61 / 6.95-6.92 (Hg / Hh). 
1H 13C HMQC (500.03 MHz / 125.77 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 7.13 / 130.9 
(CHd), 6.99 / 128.7 (CHe), 6.95-6.92 / 133.0 (CHh), 6.20 / 123.0 (CHa), 5.63 / 118.7 (CHc), 5.61 / 
116.4 (CHg), 2.23 / 21.3 (CH3j).  
1H 13C HMBC (500.03 MHz / 125.77 MHz, 273 K, bromobenzene-d5): δ1H / δ13C: 7.13 / 156.0, 
130.9, 118.7 (CHd / Cb, CHd, CHc), 6.99 / 118.7 (CHe / CHc), 6.95-6.92 / 152.7, 133.0, 21.3 (CHh / 
Cf, CHh, CH3j), 6.20 / 123.0 (CHa), 5.63 / 128.7, 118.7 (CHc / CHe, CHc), 5.61 / 140.7, 116.4 (CHg 
/ Ci, CHg), 2.23 / 140.7, 133.0 (CH3j / Ci, CHh). 
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1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 5.63, 5.61 / -32 
(Hc, Hg / N). 
11B{1H} NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 22 Hz). 
11B NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 22 Hz). 
19F{1H} NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.8 (br s, 8F, o-F), -161.8 (t, 3JFF 
= 21 Hz, 4F, p-F), -165.7 (br s, 8F, m-F). 
19F NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.8 (br s, 8F, o-F), -161.8 (t, 3JFF = 21 
Hz, 4F, p-F), -165.7 (m, 8F, m-F). 
Elemental Analysis: % calcd for C46H20BF20NTi: C, 54.31; H, 2.13; N, 1.35; Found: C, 53.65; H, 
2.86; N, 1.26. 
XRD: 
 a  
Experimental. Single dark green needle-shaped 
crystals of (cu_q010616_0m_a) were obtained by 
recrystallisation from slow diffusion of heptane in a 
concentrated C6H5Cl solution. A suitable crystal 
(0.15×0.04×0.03) mm3 was selected and mounted on a 
mylar loop with oil on a Bruker D8 VENTURE 
diffractometer. The crystal was kept at T = 100 K during 
data collection. Using Olex2 (Dolomanov et al., 2009), 
the structure was solved with the ShelXT (Sheldrick, 
2015) structure solution program, using the Direct 
Methods solution method. The model was refined with 
version 2014/7 of XL (Sheldrick, 2008) using Least 
Squares minimisation. 
Crystal Data. C47H22BF20NTi, Mr = 1039.36, monoclinic, 
P21/n (No. 14), a = 8.0825(6) Å, b = 14.1366(10) Å, c = 
35.406(3) Å, β = 96.136(4)°, α = γ = 90°, V = 4022.3(5) Å3, T 
= 100 K, Z = 4, Z' = 1, µ(CuKα) = 3.015, 48078 reflections 
measured, 7074 unique (Rint = 0.0656) which were used in all 
calculations. The final wR2 was 0.0797 (all data) and R1 was 
0.0363 (I > 2(I)). 
Compound  cu_q010616_0m_a  
    
Formula  C47H22BF20NTi  
Dcalc./ g cm-3  1.716  
µ/mm-1  3.015  
Formula Weight  1039.36  
Colour  dark green  
Shape  needle  
Size/mm3  0.15×0.04×0.03  
T/K  100  
Crystal System  monoclinic  
Space Group  P21/n  
a/Å  8.0825(6)  
b/Å  14.1366(10)  
c/Å  35.406(3)  
α/°  90  
β/°  96.136(4)  
γ/°  90  
V/Å3  4022.3(5)  
Z  4  
Z'  1  
Wavelength/Å  1.541840  
Radiation type  CuKα  
Θmin/°  2.510  
Θmax/°  66.681  
Measured Refl.  48078  
Independent Refl.  7074  
Reflections Used  5458  
Rint  0.0656  
Parameters  632  
Restraints  0  
Largest Peak  0.284  
Deepest Hole  -0.402  
GooF  1.018  
wR2 (all data)  0.0797  
wR2  0.0725  
R1 (all data)  0.0568  
R1  0.0363  
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e. Synthesis of 55: 
 
X= 0.96 mmol, 970 mg, 97 %.  
1H NMR (500.03 MHz, 300 K, bromobenzene-d5): δ1H: 7.12 (t, 3JHdHe = 3JHdHc = 7.9 Hz, 2H, Hd), 
6.98 (t, 3JHeHd = 7.9 Hz, 1H, He), 6.68 (d, 3JHgHh = 9.0 Hz, 2H,Hg), 6.24 (s, 10H, Ha), 5.47 (d, 
3JHhHg = 9 Hz, 2H, Hh), 5.43 (d, 3JHcHd = 7.9 Hz, 2H, Hc), 3.54 (s, 3H, Hj). traces of pentane were 
observed (m, 1.20; t, 0.85). 
13C{1H} NMR correlated with dept 135 (125.77 MHz, 300 K, bromobenzene-d5): δ13C: 161.6 
(Ci), 155.7 (Cb), 148.8 (dm, 1JCF = 240 Hz, o-CF), 147.1 (Cf), 138.7 (dm, 1JCF = 240 Hz, p-CF), 
136.8 (dm, 1JCF = 240 Hz, m-CF), 130.4 (Cd), 128.6 (Ce), 125.7-123.9 (ipso-CB), 123.3 (Ca), 
119.2 (Cc), 117.6 (Ch),117.4 (Cg), 55.7 (Cj). 
1H 1H COSY (500.03 MHz, 300 K, 273 K, bromobenzene-d5): δ1H / δ1H: 7.12 / 6.98, 5.43 (Hd / 
He, Hc), 6.98 / 7.12 (He / Hd), 6.68 / 5.47 (Hg / Hh), 5.47 / 6.68 (Hh / Hg), 5.43 / 7.12 (Hc / Hd). 
1H 13C HMQC (500.03 MHz / 125.77 MHz, 300 K, bromobenzene-d5): δ1H / δ13C: 7.12 / 130.4 
(CHd), 6.98 / 128.6 (CHe), 6.68 / 117.4 (CHg), 6.24 / 123.3 (CHa), 5.47 / 117.6 (CHh), 5.43 / 
119.2 (CHc), 3.54 / 55.7 (CH3j). 
1H 13C HMBC (500.03 MHz / 125.77 MHz, 273 K, bromobenzene-d5): δ1H / δ13C: 7.12 / 155.7, 
130.4, 119.2 (CHd / Cb, CHd, CHc), 6.98 / 119.2 (CHe / CHc), 66.68 / 161.6, 147.1, 117.6 (CHg 
/ Ci, Cf, CHh), 6.24 / 123.3 (CHa), 5.47 / 161.6, 117.4 (CHh / Ci, CHg), 5.43 / 128.6, 119.2 (CHc 
/ CHe, CHc), 3.54 / 161.6 (CH3j / Ci). 
1H 15N HMBC (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5): δ1H / δ15N: 5.43 / -30 (Hc / 
N). 
11B{1H} NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 21 Hz). 
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11B NMR (160.42 MHz, 273 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 21 Hz). 
19F{1H} NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.4 (br s, 8F, o-F), -161.3 (t, 
3JFF = 21 Hz, 4F, p-F), -165.2 (br s, 8F, m-F). 
19F NMR (470.45 MHz, 273 K, bromobenzene-d5): δ19F: -131.4 (br s, 8F, o-F), -161.3 (t, 3JFF = 
21 Hz, 4F, p-F), -165.2 (br s, 8F, m-F). 
Elemental Analysis: % calcd for C47H22BF20NOTi: C, 53.49; H, 2.10; N, 1.33; Found: C, 53.14; 
H, 2.12; N, 1.25. 
f. Synthesis of 56: 
 
X= 0.58 mmol, Yield: light orange powder 490 mg, 73 % - with 16% of C6H5Br. 
1H NMR (500.03 MHz, 263 K, tetrahydrofuran-d8): δ1H: 8.12 (m, 4H, Hc), 7.89 (m, 4H, Hd), 6.82 
(s, 10H, Ha). C6H5Br: 7.52, 7.35-7.26, pentane 1.36-1.20 (m), 0.85 (t). 
3C{1H} NMR (125.77 MHz, 263 K, tetrahydrofuran-d8): δ13C: 148.8 (dm, 1JCF = 240 Hz, o-CF), 
147.7, 138.8 (dm, 1JCF = 240 Hz, p-CF), 136.8 (dm, 1JCF = 240 Hz, m-CF) 130.4 (Cd), 126.1-
124.0 (ipso-CB), 120.7 (Ca), 117.8 (Cc). C6H5Br: 132.1, 130.9, 127.7, 122.9, pentane: 34.9, 
23.2, 14.3). 
Traces of solvents were omitted for clarity in the following description. 
1H 1H COSY (500.03 MHz, 263 K, 273 K, tetrahydrofuran-d8): δ1H / δ1H: 8.12 / 7.89 (Hc / Hd). 
1H 13C HMQC (500.03 MHz / 125.77 MHz, 263 K, tetrahydrofuran-d8): δ1H / δ13C: 8.12 / 117.8 
(CHc), 7.89 / 130.4 (CHd), 6.82 / 120.7 (CHa). 
1H 13C HMBC (500.03 MHz / 125.77 MHz, 263 K, tetrahydrofuran-d8): δ1H / δ13C: 8.12 / 130.4 
(CHc / CHd), 7.89 / 147.7, 117.8 (CHd / Cb, CHc), 6.82 / 120.7 (CHa).  
11B{1H} NMR (160.42 MHz, 263 K, tetrahydrofuran-d8): δ11B: -18.6 (ν1/2 = 22 Hz). 
11B NMR (160.42 MHz, 263 K, tetrahydrofuran-d8): δ11B: -18.6 (ν1/2 = 22 Hz). 
19F{1H} NMR (470.45 MHz, 263 K, tetrahydrofuran-d8): δ19F: -134.7(dm, 3JFF = 8 Hz, 8F, o-F), 
-166.4 (t, 3JFF = 20 Hz, 4F, p-F), -170.0 (br t, 3JFF = 17 Hz, 8F, m-F). 
19F NMR (470.45 MHz, 263 K, tetrahydrofuran-d8): δ19F: -137.4(dm, 3JFF = 8 Hz, 8F, o-F), -
166.4 (t, 3JFF = 20 Hz, 4F, p-F), -170.0 (br t, 3JFF = 17 Hz, 8F, m-F). 
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Positive mode ESI HRMS (Positive mode ESI, tetrahydrofuran): m/z calcd. for 
C56H28BF20N6Ti2 [M-B(C6F5)4]+ 1271.11026, found 1271.11567 (Rel. ab: 15%, 4.3 ppm), 
C32H28N6Ti2 [M+e--2B(C6F5)4]+ 592.13289; found 592.13433 (Rel. ab: 35%, 2.4 ppm); 
C16H14N3Ti [M-B(C6F5)4]/2+ 296.06672 found 296.06660 (Rel. ab: 40%, 1.4 ppm). 
Elemental Analysis: % calcd for C80H28B2F40N6Ti2+2THF with dried crystals: C, 50.46; H, 
2.12; N, 4.01; Found: C, 50.72; H, 1.89; N, 3.95. 
XRD: 
 
Experimental. Single yellow prism-shaped crystals of 
(q130617_0m) were obtained by recrystallisation from 
layering a bromobenzene solution, by pentane. A 
suitable crystal (0.07×0.07×0.05) mm3 was selected and 
mounted on a mylar loop with oil on a Nonius Kappa 
Apex II diffractometer. The crystal was kept at T = 115 K 
during data collection. Using Olex2 (Dolomanov et al., 
2009), the structure was solved with the ShelXT 
(Sheldrick, 2015) structure solution program, using the 
Intrinsic Phasing solution method. The model was 
refined with version 2017/1 of XL (Sheldrick, 2008) using 
Least Squares minimisation. 
Crystal Data. C104H76B2F40N6O6Ti2, Mr = 2383.12, triclinic, P-
1 (No. 2), a = 11.7809(18) Å, b = 15.422(2) Å, c = 16.293(3) Å, 
α = 117.416(4)°, β = 107.695(4)°, γ = 91.433(4)°, V = 
2455.3(7) Å3, T = 115 K, Z = 1, Z' = 0.5, µ(MoKα) = 0.299, 
64017 reflections measured, 11266 unique (Rint = 0.0932) which 
were used in all calculations. The final wR2 was 0.1518 (all data) 
and R1 was 0.0556 (I > 2(I)). 
 
 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
Compound  q130617_0m  
    
Formula  C104H76B2F40N6O6Ti2 
Dcalc./ g cm-3  1.612  
µ/mm-1  0.299  
Formula Weight  2383.12  
Colour  yellow  
Shape  prism  
Size/mm3  0.07×0.07×0.05  
T/K  115  
Crystal System  triclinic  
Space Group  P-1  
a/Å  11.7809(18)  
b/Å  15.422(2)  
c/Å  16.293(3)  
α/°  117.416(4)  
β/°  107.695(4)  
γ/°  91.433(4)  
V/Å3  2455.3(7)  
Z  1  
Z'  0.5  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  2.728  
Θmax/°  27.544  
Measured Refl.  64017  
Independent Refl.  11266  
Reflections Used  6099  
Rint  0.0932  
Parameters  721  
Restraints  13  
Largest Peak  0.662  
Deepest Hole  -0.469  
GooF  1.006  
wR2 (all data)  0.1518  
wR2  0.1201  
R1 (all data)  0.1325  
R1  0.0556  
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V. Chapter IV: Synthesis and reactivity of titanocenyl 
iminophosphoranes 
 
A. Bibliographic introduction  
In 2013, Stephan described new organic FLPs based on the use of 
iminophosphoranes. Their combination with the Lewis acid B(C6F5)3 demonstrated their ability 
to activate several small molecules (H2, CO2 and phenylacetylene) as illustrated in Scheme 
V-1.1 
 
Scheme V-1: an iminophosphorane-based organic FLP 
 
 In addition, among the numerous OmFLPs previously reported in I.D.3., two examples 
of cationic Ti-based metallocenes have been described (Scheme I-66 and Scheme I-74).2,3 
Furthermore, in 2015, Dr. Laure Monnereau had investigated the synthesis of titanocenyl 
iminophosphorane of type G in our group (Scheme V-2).4  
 
Scheme V-2: synthetic approach to titanocenyl iminophosphoranes 
 
                                               
1
 Jiang, C.; Stephan, D. W. Dalton Trans. 2013, 42, 630 
2
 Chapman, A. M.; Wass, D. F. Dalton Trans. 2012, 41, 9067 
3
 Normand, A. T.; Richard, P.; Balan, C.; Daniliuc, C. G.; Kehr, G.; Erker, G.; Le Gendre, P. Organometallics. 2015, 34, 2000 
4
 Unpublished results 
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At the time, the incentive for this research was to establish whether the Staudinger reaction 
was applicable to organometallic phosphanes, to synthesize a new series of bimetallic 
complexes.5 In fact, Dr. Monnereau found a straightforward route to titanocenyl 
iminophosphoranes starting from titanocenyl phosphanes of type CpCpP(2)TiCl2. All other 
combinations tested (with CpCpP(0)TiCl2 and CpCpP(1)TiCl2) yielded decomposition of the 
titanocenyl phosphane. The coordination potential of this new series of titanocenyl 
iminophosphorane was tested but all attempt to form heterobimetallic complexes (Rh, Ru, Pt, 
Pd) failed. Taken alone, the iminophosphorane ligand seems to be a weak coordinating ligand. 
As illustrated above, some examples of κ-N coordination of an iminophosphorane to a metallic 
centre have already been described with no additional “chelate” effect. One example was 
described by Elsevier in 1990. With CO ligands, the complexes were quantitatively formed and 
the X-ray structure of one of them was even obtained. Nevertheless, coordination of the 
iminophosphorane was shown to be reversible with L299.6  
 
Scheme V-3: coordination behaviour of a simple iminophosphorane to Rh 
 
Nevertheless, in the light of the publication of Stephan (Scheme V-1), the titanocenyl 
iminophosphoranes were considered under a new light: we were wondering if these 
organometallic iminophophoranes would be able to show FLP-like reactivity as reported for 
organic parents by Stephan. This study is the topic of the following chapter. 
B. Dichloro titanocenyl iminophosphoranes 
The procedure described by Dr. Monnereau was used to synthesize new batches of 
four complexes, to complete their characterization, and try to test them in typical OmFLP 
reactions. Reaction of complexes CpP(2)CpTiCl2 with aryl azides in toluene (1h reaction) 
yielded the corresponding titanocenyl iminophosphorane (57-60) in good yield (Scheme V-4).  
                                               
5
 Staudinger, H.; Meyer, J. Helv. Chim. Acta. 1919, 2, 635 
6
 Imhoff, P.; Elsevier, C. J.; Stam, C. H. Inorganica Chim. Acta. 1990, 175, 209 
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Scheme V-4: synthesis of titanocenyl iminophosphorane 57-60 
 
All compounds were characterized by NMR (1H, 13C, 31P and 2D correlations) and IR 
spectroscopies, positive mode ESI HRMS and elemental analysis. 
The 31P{1H} NMR chemical shift and the shape of the signals are characteristic of the 
formation of these complexes: much broader than the corresponding titanocenyl phosphanes 
and shifted upfield by about 20 ppm for PPh2 derivatives (CpPPh2CpTiCl2 = 30.7 ppm: 57 = 5.3-
3.6 ppm, 58 = 7.5-0.5 ppm), whilst downfield by about 10 ppm for the PCy2 derivatives 
(CpPCy2CpTiCl2 = -7.0 ppm 59 = 22.3-14.0 ppm, 60 = 19.9-13.7 ppm). The 1H NMR spectra of 
these complexes exhibit the same set of signals for the titanocene fragment with two broad 
signals in the 6.31-5.91 and 5.98-5.53 ppm ranges for the substituted Cp ring, and 6.22-5.93 
for the unsubstituted Cp ring. The two signals of the bridging CH2 appear as two multiplets in 
the 3.04-2.34 and 3.42-3.12 ppm ranges for the one bearing the phosphanyl group, and the 
one next to the Cp ring respectively. Relevant chemical shifts are summarized in Table V-1. 
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a (ppm) b (ppm) c (ppm) e (ppm) f (ppm) 
57 PPh2-p-OMe 5.94 5.53 5.91 2.95-2.58 3.18-3.12 
58 PPh2-o-OMe 5.99-5.93 5.64-5.55 6.09-5.99 3.04-2.91 3.26-3.05 
59 PCy2-p-OMe 6.12-6.07 5.80-5.73 6.17-6.12 2.48-2.34 3.40-3.31 
60 PCy2-o-OMe 6.22-6.11 5.98-5.82 6.31-6.22 2.59-2.53 3.42-3.32 
 
Table V-1: selected 1H NMR chemical shifts (600.23 or 500.03 MHz, 300K, C6D6) 
 
 The broadness observed for some signals in the 1H or 31P NMR spectra was studied by 31P{1H} 
NMR spectroscopy by changing the deuterated solvent and by variable temperature analyses, 
but no decoalescing or narrowing of the signals as observed. This may be a characteristic of 
this series of compounds. All our efforts to crystallize one of these titanocenyl 
iminophosphoranes failed and yielded precipitation or oily residues. To help crystallization, 57 
was protonated with H(Et2O)2B(C6F5)4 in dichloromethane (Scheme V-5).  
 
Scheme V-5: protonation reaction of 57 
 
The aminophosphonium 61 was obtained after workup as a brick-red solid. NMR (1H, 11B, 13C, 
19F, 31P and 2D correlation) and IR spectroscopies, positive mode ESI HRMS and elemental 
analysis were performed on this compound. Unfortunately, it did not crystalize either. 
Nevertheless, the 31P{1H} NMR signal in its spectrum is narrower than in 57 as illustrated in 
Spectrum V-1.  
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Spectrum V-1: superposition of 31P{1H} NMR spectra of 61 (bottom) and 57(top) (500 MHz, 300K, C6D6) i: 
unidentified impurities 
 
In the light of this result, one can hypothesize that an interaction exists between the 
P=N moiety and Ti which translates into NMR spectroscopy by the observation of broad signals 
in the 31P{1H} spectra of the titanocenyl iminophosphoranes (57-60). The protonation of 57 
clearly prevents this interaction. 
All these complexes exhibited in their mass spectra the presence of the cluster of peaks 
from [M-NAr+O] (see the experimental part and appendix for details). According to the 
bibliography, iminophosphoranes are well known to form the corresponding phosphine oxide / 
primary amine by hydrolysis, as illustrated in Scheme V-6.5 
Ti Cl
Cl
R2
P N
Ar
H2O
Ti Cl
Cl
R2
P O
+ ArNH2
[M-NAr+O]
 
Scheme V-6: hydrolysis process of the titanocenyl iminophosphoranes 
 
The synthesis of these titanocenyl phosphane oxides were attempted with compounds 57-60, 
in various solvent conditions, but none of them yielded a clean product. The final mixture 
always contained two or more compounds according to 31P{1H} NMR. Consequently, their 
synthesis was abandoned. The synthesis of the four new dichloro titanocenyl 
Ti
Cl
Cl
P
N O
57
i                        i                    
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iminophosphoranes has been successfully achieved. Nevertheless, the iminophosphorane 
function did not exhibit clean hydrolysis as might be expected for this class of compounds.  
On the other hand, the potential as OmFLPs of these titanocenyl iminophosphoranes 
has been evaluated. Preliminary chloride abstraction with silver-based reagents ([Ag][BPh4] or 
AgNTf2) did not lead to effective or clean abstraction. As a result, and considering the 
ineffective chloride abstraction on the (aminomethyl)titanocenes, whichever the chloride 
abstractor, we focused our attention on methide abstraction. 
C. Dimethyl titanocenyl iminophosphoranes 
1. Synthesis 
The question was, after the successful synthesis of potential OmFLPs by generating a 
cationic titanocene fragment, whether any rearrangement would occur after titanocenium 
cation formation. Starting from 57-60, methylation was conducted in the same conditions as 
for other dimethyl titanocenes previously described. Despite repeated attempts, both 
compound 58 and 60 failed to be methylated. The ortho methoxy group seemed to prevent 
clean methylation. Nevertheless, compound 62 and 63 were obtained in good yields (Scheme 
V-7). 
 
Scheme V-7: methylation of the titanocenyl iminophosphoranes 
 
These compounds were characterized by NMR (1H, 13C, 31P and 2D correlations) and 
IR spectroscopies, positive mode ESI HRMS and elemental analysis. By contrast with the 
dichloro precursors, 62 and 63 exhibited much narrower 31P{1H} NMR signals (ν1/2: 38 and 25 
Hz for 62 and 63 vs 240 and 1300 Hz for 57 and 59). As illustrated in Spectrum V-2, a set of 
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two multiplets is observed for the phenyl rings bound to the phosphorus atom (7.80-7.72 and 
7.06-7.01 ppm). The para-substituted phenyl ring showed two multiplets (7.09-7.07 and 6.80 
ppm), whilst two apparent triplets are observed for the monosubstituted Cp ring. The non-
substituted Cp ring exhibits a singlet at 5.64 ppm, as do the methoxy group at 3.39 ppm, and 
the methide groups at -0.06 ppm. The two bridging CH2 groups show two multiplets at 2.76-
2.67 and 2.67-2.58 ppm. These complexes were found to be light- and temperature-sensitive, 
and had to be stored in the glovebox at -18°C. 
 
Spectrum V-2: 1H NMR of 62 (500.03 MHz, 300 K, benzene-d6) 
 
2. Reactivity 
Methide abstraction with [Ph3C][B(C6F5)4] afforded complexes 64 and 65 in moderate to good 
yields (Scheme V-8).  
 
Scheme V-8: synthesis of the cationic species 64 and 65 
 
He  Hf Hc                                Hb 
Hp   Ha                          Ho 
Hm Hi Hj             Hl 
Hh  
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No CH activation was observed for both compounds. They were characterized with standard 
techniques (NMR spectroscopy, HRMS, elemental analysis and X-ray diffraction). The 1H NMR 
spectrum of 64 showed broad signals for the disubstituted phenyl ring at 300 K, due to a 
coalescence phenomenon. The superposition of the 1H NMR spectra obtained between 240 
and 360 K is shown in Spectrum V-3 and Spectrum V-4.  
  
Spectrum V-3: superposition of the 1H NMR spectra of 64 (600.23 MHz, 240 (bottom)-360 K (top), 
bromobenzene-d5) 
 
Spectrum V-4: superposition of the 1H NMR spectra of 64, 6.50-5.80 ppm (600.23 MHz, 240 (bottom)-360 K 
(top), bromobenzene-d5) 
360 K 
340 K 
320 K 
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This coalescence phenomenon is observed for the signals of the phenyl ring bound to nitrogen. 
Steric hindrance around the nitrogen is probably responsible for this phenomenon, and as a 
consequence the rotation of the p-methoxyphenyl ring is slow on the NMR time scale at 
temperatures below 280 K. This compound was fully characterized by NMR spectroscopy at 
360 K. The corresponding 1H NMR spectrum is depicted in Spectrum V-5. 
 
Spectrum V-5: 1H NMR spectrum of 64 (600.23 MHz, 360 K, bromobenzene-d5) 
 
Chirality at titanium is observed as previously, hence the presence of several diastereotopic 
relationships in the 1H NMR spectrum. In these structures, the phosphorous atom is prochiral. 
As a result, the two phenyl rings bound to P are diastereotopic. A set of five signals is observed 
for these two phenyl rings (7.40, 7.30-7.22, 7.22-7.18, 7.18-7.13 and 7.05 ppm), and a set of 
two signals is observed for the para substituted phenyl ring (6.38 and 6.20 ppm, a doublet and 
a doublet of doublets respectively). The classical set of four apparent quartets is observed for 
the signal of the protons of the monosubstituted Cp ring (6.60, 5.75, 5.43 and 5.34 ppm), whilst 
a singlet is observed for the non-substituted Cp ring at 5.67 ppm. The methoxy group and the 
remaining methide exhibit a singlet at 3.41 and 0.70 ppm respectively. Finally, the signals of 
the two bridging CH2 are diasterotopic and appear as two more complex multiplets (2.62-2.54 
and 2.34-2.25 ppm). The 31P{1H} chemical shift is shifted downfield by 36 ppm compared to 
the dimethyl titanocene (62), in agreement with the charge transfer from the iminophosphorane 
moiety to titanium. 
Hj/j Hi Hi’ Hh Hh’ Hc           Hm    Hl He/e’    Hf               Hf’ 
Hp  
Hc’Hb’ 
Ha 
Hb 
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The structure of both cationic species was established by X-ray diffraction analysis. An 
ORTEP view is presented in Figure V-1, and a table resumes selected parameters (Table V-2). 
 
 
Figure V-1: ORTEP view of 64 (left) and 65 (right), counter anions omitted for clarity 
 
 
64 65 
Selected bond length (Å) 
Ti-Ct1 2.084(3) 2.0621(13) 
Ti-Ct2 2.090(4) 2.0733(16) 
Ti-C11 2.181(6) 2.192(2) 
Ti-N 2.143(4) 2.1555(19) 
P-N 1.643(4) 1.6481(19) 
C1-C12 1.497(6) 1.497(4) 
C12-C13 1.522(6) 1.521(3) 
C13-P 1.793(4) 1.804(2) 
Selected angles (°) 
Ct1-Ti-Ct2 127.36(12) 130.83(6) 
N-Ti-C11 92.0(2) 96.28(9) 
P-N-Ti 135.9(2) 136.68(10) 
Ti-N-C14/C26 117.6(3) 113.17(13) 
C14/26-N-P 106.4(3) 110.09(14) 
Σα(N) 359.9(5) 349.93(2) 
P-N-Ti-Ct1 19.20(18) 52.74(16) 
C14/C26-N-Ti-Ct2 -8.0(4) 30.2(4) 
Table V-2: selected parameters from the crystallographic structures of 64 and 65 
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On one hand, the titanocene adopts a bent geometry in both structures, and on the 
other hand, the general parameters of both structures are relatively similar between both 
structures. The P-N bond length can be compared to that of the literature (Scheme V-9). No 
simple analogue of 65 has been found in the Cambridge Crystallographic Data Centre;7 as a 
results, it will be compared to L297 (although this choice can be debatable, since the steric 
influence of the cyclohexyl groups is not taken into account). The P-N bond length observed 
for 64 and 65 is longer than the one reported for L296 and L297 respectively (1.643(4) vs 
1.602(3) Å and 1.6481(19) vs 1.572(3) Å).89 In fact this parameter is closely related to the one 
observed by Stephan on L293-a.  
 
Scheme V-9: P-N bond lenghs reported in the literature 
  
Considering these structural parameters and notably the short Ti-N bond distances 
compared to the sum of the covalent radii (2.143(4) / 2.1555(19) Å , covalent radii Ti-N = 2.31 
± 0.09 Å),10 the question of the nature of the Ti-N bond within these complexes is raised 
(Scheme V-10).  
 
Scheme V-10: the four potential resonance forms for 64 and 65 (counter anion omitted for clarity) 
 
In other words, which resonance form PN-I-IV has the greatest contribution? Similar 
considerations have previously been envisioned by Bourissou on Zr-based constrained 
geometry complexes.11 Furthermore, previous theoretical studies conducted on 
                                               
7
 https://www.ccdc.cam.ac.uk/ 
8
 Böhm, E.; Dehnicke, K.; Beck, J.; Hiller, W.; Strähle, J.; Maurer, A.; Fenske, D. Z. Für Naturforschung B. 1988, 43 
9
 Abboud, K. A.; Villanueva, L. A.; Boncella, J. M. Acta Crystallogr. C. 1993, 49, 1848 
10
 Cordero, B.; Gómez, V.; Platero-Prats, A. E.; Revés, M.; Echeverría, J.; Cremades, E.; Barragán, F.; Alvarez, S. Dalton Trans. 
2008, 2832 
11
 Truflandier, L.; Marsden, C. J.; Freund, C.; Martin-Vaca, B.; Bourissou, D. Eur. J. Inorg. Chem. 2004, 2004, 1939, Oulié, P.; 
Freund, C.; Saffon, N.; Martin-Vaca, B.; Maron, L.; Bourissou, D. Organometallics. 2007, 26, 6793 
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aminophosphonium salts,12 have shown that the dipolar form (R3P+-NR-) is dominant and that 
electrostatic interactions greatly contribute to strengthening the P-N bond. Considering that the 
P-N bond lengths in L296 and L297 are closer to that of aminophosphonium (L293-a), one 
can presume that the P-N bond weakening is correlated to a partial charge transfert from the 
iminophosphorane to the Ti centre tantamount to covalent bonding. DFT calculations were 
then undertaken by Pr. Paul Fleurat-Lessart and Pr. Marek Kubicki, in order to better 
understand the nature of the Ti-N bond in these complexes. 
For this study, two different methods have been used: the Atoms In Molecules theory 
of Bader (AIM) and the Electron Localization Function (ELF) (see general remarks for 
computational details). The AIM method analyses the electron density based on its second 
derivative. It decomposes the electronic density of molecules into atomic basins. Two linked 
atoms share a common surface between their atomic basin. If a covalent bond is observed, a 
red point is represented on the bond path (represented in maroon in Figure V-2) between the 
two basins. Considering the Ti-N bond characterized by the AIM method, a covalent 
contribution is clearly observed. 
 
Figure V-2: calculated structure with the AIM method: covalent contribution (red point), bonding path 
(maroon) conjugation (yellow) 
 
In addition to indications as to the covalent nature of the bonds, the AIM method gives the 
value of electronic charges: it has been calculated for the titanium (+1.7), the nitrogen (-1.6) 
and the phosphorus atom (+3) in 64. Analogous calculations have been conducted on two split 
models as illustrated in Scheme-V-11. Considering first a cationic titanocene fragment 64-Ti+, 
the electronic charge value found for the titanium atom is +1.7. For the iminophosphorane 
moiety (64-PN), the respective electronic charge of the N and P atoms are -1.5 and +3.0. 
                                               
12
 Orzechowski, L.; Jansen, G.; Harder, S. J. Am. Chem. Soc. 2006, 128, 14676 
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These values are very close to those obtained on the complete model of 64 with AIM methods. 
Surprisingly, whilst the Bond Critical Point along the Ti-N bond indicates a covalent bond, there 
is barely any charge transfer between both atoms. This is shown by the fact that both titanium 
and nitrogen charges do not vary between the split models calculations and the complete 
molecule. 
 
Ti
Me
P
N
Ph
Ph
O
64
Complete model
Ti Me P
NPh
Ph
O
64-Ti+
Split models
64-PN
+1.7
-1.6
+3.0
+1.7
-1.5
+3.0
 
Scheme-V-11: models considered in for the NBO calculations 
 
Last, the topology of the ELF was analysed (Figure V-3). In this method, the electronic 
density is split into core electrons, bonding electrons and non-bonding pairs.  
 
Figure V-3: simplified calculated structure of 64 by the ELF method: bonding electron (green), non-
bonding electron (blue) and core electron (red) (only selected covalent contribution are depicted for 
clarity) 
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The resulting structure is depicted in Figure V-3. When a bond is covalent, a green ring 
between both atoms is observed: in our case, the Ti-C11 bond has a high covalent contribution. 
Considering the Ti-N bond on this structure, such a ring is not observed: instead, a blue 
electronic basin is present. This basin represent the two indistinguishable lone pairs of the 
nitrogen atom. This means that the nature of the bond is more ionic than covalent according 
to the ELF method. This is very similar to the AIM results: the bonding basin indicates covalent 
character, but in practice, the interaction looks like a weak dative bond between nitrogen and 
titanium. This suggests that the structure of 64 is somewhere in between PN-II and PN-IV for 
64 in the solid state (Scheme V-10).  
To resume these preliminary results, the nature of the Ti-N bond in 64 seems to be 
quite complex, since AIM and ELF methods are not fully concordant. Some additional 
calculations have to be carried out to exemplify this type of bond by simulating various 
structures. A more precise picture of the nature of this bond cannot be definitively putforth 
without further investigations. 
The reactivity of 64 and 65 towards small molecules was finally investigated in order to 
determine their potential as OmFLPs (Scheme V-12). Compound 64 was found to be 
completely unreactive towards various substrates (H2, CO2, FcCHO,…) as evidenced by 1H 
and 31P{1H} NMR spectroscopy. Compound 65 was only reactive towards H2. Unfortunately, 
the reaction was not clean, and mainly decomposition of 65 was observed. This complex was 
also tested as a catalyst for hydrogenation of styrene. No evidence of phenylethane formation 
was observed by NMR spectroscopy or GCMS analysis. 
Since small molecule activations did not work at all with these complexes, modification 
of the coordination sphere of titanium was attempted. Protonolysis of the methide bound to the 
titanocene was attempted. However, no reaction was observed with alcohols or 
diphenylphosphine. Alternatively, methide abstraction of the second methide bound to titanium 
was attempted, by using [Ph3C][B(C6F5)4] from 64 and 65. As previously described, such 
abstraction are relatievely quick when favoured. The methide abstraction did not occur after 
30 min of reaction, according to 1H and 31P{1H} NMR spectra of both mixtures. The starting 
aminophosphonium were observed with concomittent presence of the methide abstractor. The 
reaction mixture was then left to stir for 12h. Only decomposition products were observed after 
this period of stirring. 
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Scheme V-12: reactivity studies of 64 and 65 
 
In conclusion to this last chapter, a series of dichloro titanocenyl iminophosphoranes 
was achieved according to the procedure previously developed in our group, and two dimethyl 
analogues were obtained. Methide abstraction was effective on both compounds yielding two 
new cationic complexes whose robustness prevented any reactivity to occur. As a result, a 
DFT study has been initiated in order to better understand the nature of the Ti-N bond involved 
in such structures. The preliminary results have to be compared with calculations computed 
on other molecules than 64 in order to highlight a trend for this type of bond. 
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D. Experimental part 
1. Iminophosphorane synthesis 
To a suspension of the desired CpPCpTiCl2 (X mmol, 1 eq) in toluene, 1.1 eq of the 
corresponding p/o-methoxyazide was added slowly at room temperature. The resulting red 
heterogeneous suspension was stirred for 2h, became homogeneous before finishing 
heterogeneous again. A small degassing was observed. The resulting solution was 
evaporated, and the red crude precipitate was dissolved in a few amount of dichloromethane 
before being precipitated by 10 eq of pentane. Supernatant was cannulated at -40°C and 
washed twice with pentane. The resulting red precipitate was finally dried in vacuo to yield the 
desired compound as a brick-red solid. 
a. Synthesis of 57: 
 
X= 0.87 mmol, Yield: 400 mg, 80% 
1H NMR (500.03 MHz, 300 K, benzene-d6): δ1H: 7.89-7.82 (m, 4H, Hh), 7.09 (d, 3JHH= 9.0 Hz, 
2H, Hm), 7.07-7.01 (m, 6H, Hi/j), 6.79 (dd, 3JHH = 9.0 Hz, 4JPH = 1.0 Hz, 2H, Hl), 5.94 (s, 5H, Ha), 
5.91 (m, 3JHH = 4JHH = 2.5 Hz, 2H, Hc), 5.53 (apparent t, 3JHH = 4JHH = 2.5 Hz, 2H, Hb), 3.38 (s, 
3H, Ho), 3.18-3.12 (m, 2H, He), 2.95-2.88 (m, 2H, Hf). 
1H{31P} NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 7.89-7.82 (m, 4H, Hh), 7.09 (d, 3JHH= 9.0 
Hz, 2H, Hm), 7.07-7.01 (m, 6H, Hi/j), 6.79 (dd, 3JHH = 9.0 Hz, 4JPH = 1.0 Hz, 2H, Hl), 5.94 (s, 5H, 
Ha), 5.91 (apparent t, 3JHH = 4JHH = 2.5 Hz, 2H, Hc), 5.53 (apparent t, 3JHH = 4JHH = 2.5 Hz, 2H, 
Hb), 3.38 (s, 3H, Ho), 3.18-3.12 (m, 2H, He), 2.95-2.88 (m, 2H, Hf). 
13C{1H} NMR (125.75 MHz, 300 K, benzene-d6): δ13C: 152.9 (Cn), 144.9-144.5 (Ck), 136.6 (d, 
3JPC = 15.2 Hz, Cd), 132.0 (d, 3JPC = 9.2 Hz, Ci), 131.5 (Ch), 128.8 (d, 2JPC = 11.5 Hz, Ci), 123.7 
(d, 4JPC = 17.3 Hz, Cm), 122.2 (Cc), 119.4 (Ca), 115.0 (Cb), 114.9 (br s, Cl), 55.2 (Co), 27.2 (d, 
1JPC = 67.6 Hz Cf), 23.6 (d, 2JPC = 1.8 Hz Ce). Traces of toluene (129.2, 128.4, 125.6, 21.3) and 
pentane (34.3, 22.6, 14.2) observed, Cg n.o.  
1H 1H COSY (500.03 MHz, 300 K, 273 K, benzene-d6): δ1H / δ1H: 7.89-7.82 / 7.07-7.01 (Hh / 
Hi/j), 7.09 / 6.79 (Hm / Hl), 7.07-7.01 / 7.89-7.82 (Hi/j / Hh), 6.79 / 7.09 (Hl / Hm), 5.91 / 5.53 (Hc / 
Hb), 5.53 / 5.91 (Hb / Hc), 3.18-3.12 / 2.95-2.88 (He / Hf), 2.95-2.88 / 3.18-3.12 (Hf / He). 
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1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.89-7.82 / 132.0 
(CHh), 7.09 / 123.7 (CHm), 7.07-7.01 / 131.5, 128.8 (CHj, CHi), 6.79 / 114.9 (CHl), 5.94 / 119.4 
(CHa), 5.91 / 122.2 (CHc), 5.53 / 115.0 (CHb), 3.38 / 55.2 (CH3o), 3.18-3.12 / 23.6 (CH2e), 2.95-
2.88 / 27.2 (CH2f). 
1H 13C HMBC (600.23 MHz / 150.86 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.89-7.82 / 131.5 
(CHh / CHj), 7.09 / 152.9, 123.7 (CHm / Cn, CHm), 7.07-7.01 / 132.0, 128.8 (CHi/j / CHh, CHi), 
6.79 / 152.9, 144.9-144.5, 114.9 (CHl / Cn, Ck, CHl), 5.94 / 119.4 (CHa), 5.91 / 136.9, 115.0 
(CHc / Cd, CHb), 5.53 / 136.9, 122.2, 115.0 (CHb / Cd, CHc, CHb), 3.38 / 152.9 (CH3o / CHn), 
3.18-3.12 / 136.9, 122.2, 27.2 (CH2e / Cd, CHc, CH2f), 2.95-2.88 / 136.8, 23.6 (CH2f / Cd, CH2e). 
31P{1H} NMR (202.41 MHz, 300 K, benzene-d6): δ31P: bs 5.3-3.6 (w = 240Hz) 
31P NMR (202.41 MHz, 300 K, benzene-d6): δ31P: bs 6.4-1.4 (w = 270 Hz) 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. For: C31H31ONCl2PTi [M+H]+ 
582.09983, found 582.09733 (Rel. ab: 35%, -4.9 ppm); C24H23ClOPTi [M+H2O-ArNH2]+ 
441.0649, found 441.06278 (Rel. ab: 80%, -4.8 ppm); C26H27NOP [M-CpTiCl2]+ 400.18248, 
found 400.18041 (Rel. ab: 100%, -5.2 ppm). 
IR (ATR) ν [cm-1]  
MIR: 2922; 1498 (P=N); 1442; 1229; 1054; 854; 524. 
FIR: 484; 366; 303; 265; 190; 144 
Elemental Analysis: % calcd for C31H30Cl2NOPTi: C, 63.94; H, 5.19; N, 2.41; found: C, 63.37; 
H, 5.24; N, 2.31. 
b. Synthesis of 58: 
 
X=1.08 mmol, Yield: 460 mg, 73% 
1H NMR (500.03 MHz, 300 K, benzene-d6): δ1H: 7.83 (apparent dd, 3JPH = 11.7 Hz, 3JHH= 7.2 
Hz, 4H, Hh), 7.71-7.61 (bs, 1H, Hl), 7.08-7.01 (m overlapping with Hm, 6H, Hi/j), 7.01-6.97 (m 
overlapping with Hi/j, 1H, Hm), 6.77 (t, 3JHH = 3JHH = 7.6 Hz, 1H, Hn), 6.56 (d, 3JHH = 7.6 Hz, 1H, 
Ho), 6.06-5.99 (bs overlapping with Ha, 2H, Hc), 5.99-5.93 (s overlapping with Hc, 5H, Ha), 5.64-
5.55 (bs, 2H, Hb), 3.16-3.05 (m, 2H, He), 2.98 (s overlapping with Hf, 3H, Hq), 3.04-2.91 (bm 
overlapping with Hq, 2H, Hf). 
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1H{31P} NMR (500.03 MHz, 300 K, benzene-d6): δ1H: 7.83 (apparent dd, 3JPH = 11.7 Hz, 3JHH= 
7.2 Hz, 4H, Hh), 7.71-7.61 (bs, 1H, Hl), 7.08-7.01 (m overlapping with Hm, 6H, Hi/j), 7.01-6.97 
(m overlapping with Hi/j, 1H, Hm), 6.77 (t, 3JHH = 3JHH = 7.6 Hz, 1H, Hn), 6.56 (d, 3JHH = 7.6 Hz, 
1H, Ho), 6.06-5.99 (bs overlapping with H, 2Ha, Hc), 5.99-5.93 (s overlapping with Hc, 5H, Ha), 
5.64-5.55 (bs, 2H, Hb), 3.16-3.05 (m, 2H, He), 2.98 (s overlapping with Hf, 3H, Hq), 3.04-2.91 
(bm overlapping with Hq, 2H, Hf). 
13C{1H} NMR (125.75 MHz, 300 K, benzene-d6): δ13C: 152.4 (Cp), 136.6 (Cd), 136.5 (Ck), 131.5 
(d, 2JPC = 9.2 Hz, Ch), 131.0 (br s, Cj), 128.6 (d, 3JPC = 11.1 Hz, Ci), 127.5 (a part of the doublet 
from Cg) 126.0 (d, 3JPC = 21.6 Hz, Cl), 122.4 (Cc), 122.3 (d, 4JPC = 3.0 Hz Cm) 119.5 (Ca), 119.0 
(Cn), 115.6 (br s, Cb), 111.8 (Co), 54.4 (Cq), 29.8 (d, 1JPC = 64.4 Hz Cf), 23.8 (d, 2JPC = 1.6 Hz 
Ce). Traces of pentane (34.5, 22.7, 14.1) observed. 
1H 1H COSY (500.03 MHz, 300 K, 273 K, benzene-d6): δ1H / δ1H: 7.83 / 7.08-7.01 (Hh / Hi/j), 
7.71-7.61 / 7.01-6.97 (Hl / Hm), 7.08-7.01 / 7.83 (Hi/j / Hh), 7.01-6.97 / 7.71-7.61, 6.77 (Hm, Hl, 
Hn), 6.77 / 7.01-6.97, 6.56 (Hn / Hm, Ho), 6.06-5.99 / 5.64-5.55 (Hc / Hb), 5.64-5.55 / 6.06-5.99 
(Hb / Hc), 3.16-3.05 / 3.04-2.91 (He / Hf), 3.04-2.91 / 3.16-3.05 (Hf / He). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.83 / 131.5 (CHh), 
7.71-7.61 / 126.0 (CHl), 7.08-7.01 / 131.0, 128.6 (CHj, CHi), 7.01-6.97 / 122.3 (CHm), 6.77 / 
119.0 (CHn), 6.56 / 111.8 (CHo), 6.06-5.99 / 122.4 (CHc), 5.99-5.93 / 119.5 (CHa), 5.64-5.55 / 
115.6 (CHb), 3.16-3.05 / 23.9 (CH2e), 2.98 / 54.4 (CH3o), 3.04-2.91 / 29.8 (CH2f). 
1H 13C HMBC (600.23 MHz / 150.86 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.83 / 131.0 (CHh / 
CHj), 7.08-7.01 / 131.5, 128.6 (CHi/j / CHh, CHi), 7.01-6.97 / 111.8 (CHm / CHn), 6.77 / 152.4, 
126.0, 111.8 (CHn / Cp, CHl, CHn), 6.56 / 122.3 (CHo / CHm), 5.99-5.93 / 119.5 (CHa), 5.64-5.55 
/ 136.6, 122.4 (CHb / Cd, CHc), 3.16-3.05 / 136.6, 122.4, 29.8 (CH2e / Cd, CHc, CH2f), 2.98 / 
152.4 (CH3o / Cp), 3.04-2.91 / 23.9 (CH2f / CH2e). 
31P{1H} NMR (202.46 MHz, 300 K, benzene-d6): δ31P: bs 7.5-0.5 (ν1/2 = 1100 Hz). 
31P NMR (202.46 MHz, 300 K, benzene-d6): δ31P: bs 7.9 - -0.3 (ν1/2 = 2100 Hz). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. For: C31H31ONCl2PTi [M+H]+ 
582.09983, found 582.09733 (Rel ab: 100%, -3.6 ppm); C24H23ClOPTi [M+H2O-ArNH2]+ 
441.06490, found 441.06285 (Rel. ab: 20%, -4.7 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3050; 1490 (P=N); 1433; 1342; 1259; 1112; 1019; 816; 693. 
FIR: 498; 398; 302; 247; 134. 
Elemental Analysis: % calcd for C31H30Cl2NOPTi: C, 63.94; H, 5.19; N, 2.41; found: C, 63.53; 
H, 5.02; N, 2.46. 
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c. Synthesis of 59: 
 
X= 1.06 mmol, Yield: 530 mg, 84% 
1H NMR (500.03 MHz, 300 K, benzene-d6): δ1H: 7.15-7.10 (m, 2H, Hh), 6.90 (apparent d, 3JHH 
= 6.4 Hz, 5JPH = 3.4 Hz, 2H, Hi), 6.17-6.12 (bs, 2H, Hc), 6.12-6.07 (s, 5H, Ha), 5.80-5.73 (br s, 
2H, Hb), 3.45 (s, 3H, Hk), 3.40-3.31 (m, 2H, He), 2.48-2.34 (m, 2H, Hf), 2.09-2.02 (bm, 2H, CH2 
of Cy), 2.02-1.94 (bm, 2H, CH of Cy), 1.94-1.97 (apparent d, 3JHH = 13.0 Hz, 2H, CH2 of Cy), 
1.70-1.60 (m, 4H, CH2 of Cy), 1.59-1.45 (bm, 6H, CH2 of Cy), 1.13-1.02 (m, 6H, CH2 of Cy). 
1H{31P} NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 7.15-7.10 (m, 2H, Hh), 6.90 (apparent d, 
3JHH = 6.4 Hz, 5JPH = 3.4 Hz, 2H, Hi), 6.17-6.12 (bs, 2H, Hc), 6.12-6.07 (s, 5H, Ha), 5.80-5.73 
(br s, 2H, Hb), 3.45 (s, 3H, Hk), 3.40-3.31 (m, 2H, He), 2.48-2.34 (m, 2H, Hf), 2.09-2.02 (bm, 
2H, CH2 of Cy), 2.02-1.94 (bm, 2H, CH of Cy), 1.94-1.97 (apparent d, 3JHH = 13.0 Hz, 2H, CH2 
of Cy), 1.70-1.60 (m, 4H, CH2 of Cy), 1.59-1.45 (bm, 6H, CH2 of Cy), 1.13-1.02 (m, 6H, CH2 of 
Cy). 
13C{1H} NMR (125.75 MHz, 300 K, benzene-d6): δ13C: 152.7 (Cj), 145.9-144.9 (Cg), 137.8 (d, 
3JPC = 14.1 Hz, Cd), 123.8 (d, 3JPC = 13.2 Hz, Ch), 122.7 (Cc), 119.7 (Ca), 115.1 (Ci), 114.8 (Cb), 
55.4 (Ck), 37.3 (d, 1JPC = 59.7 Hz, CH of Cy), 27.4-27.1 (m, CH2 of Cy), 27.0 (d, JPC = 3.2 Hz, 
CH2 of Cy), 26.3 (CH2 of Cy), 24.4 (d, 2JPC = 2.8 Hz, CH2e), 22.3 (d, 1JPC = 57.4 Hz, CH2f). 
Pentane (34.4, 22.7, 14.1) observed. 
1H 1H COSY (500.03 MHz, 300 K, 273 K, benzene-d6): δ1H / δ1H: 7.15-7.10 / 6.90 (Hh / Hi), 
6.90 / 7.15-7.10 (Hi / Hh), 6.17-6.12 / 5.80-5.73 (Hc / Hb), 5.80-5.73 / 6.17-6.12 (Hb / Hc), 3.40-
3.31 / 2.48-2.34 (He / Hf), 2.48-2.34 / 3.40-3.31 (Hf / He), 2.09-2.02 / 1.70-1.60, 1.59-1.45 (CH2 
of Cy), 2.02-1.94 / 1.51 (CH of Cy / CH2 of Cy), 1.94-1.97 / 1.70-1.60, 1.59-1.45 (CH2 of Cy), 
1.70-1.60 / 2.09-2.02, 1.94-1.97, 1.59-1.45, 1.13-1.02 (CH2 of Cy), 1.59-1.45 / 2.09-2.02, 1.94-
1.97, 1.70-1.60, 1.13-1.02 (CH2 of Cy), 1.13-1.02 / 1.70-1.60, 1.59-1.45 (CH2 of Cy). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.15-7.10 / 123.8 
(CHh), 6.90 / 115.1 (CHi), 6.17-6.12 / 122.7 (CHc), 6.12-6.07 / 119.7 (CHa), 5.80-5.73 / 114.8 
(CHb), 3.45 / 55.4 (CH3k), 3.40-3.31 / 24.4 (CH2e), 2.48-2.34 / 22.3 (CH2f), 2.09-2.02 / 27.0 (CH2 
of Cy), 2.02-1.94 / 37.3 (CH of Cy), 1.94-1.97 / 27.0 (CH2 of Cy), 1.70-1.60 / 27.4-27.1, 26.3, 
24.4 (CH2 of Cy), 1.59-1.45 / 27.4-27.1, 26.3, 24.4 (CH2 of Cy), 1.13-1.02 / 27.4-27.1, 26.3, 
24.4 (CH2 of Cy).  
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1H 13C HMBC (600.23 MHz / 150.86 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.15-7.10 / 152.7, 
123.8, 115.1 (CHh / Cj, CHh, CHi), 6.90 / 152.7, 145.9-144.9, 123.8, 115.1 (CHi / Cj, Cg, CHh, 
CHi), 6.17-6.12 / 137.8, 122.7, 114.8 (CHc / Cd, CHc, CHb), 6.12-6.07 / 119.7 (CHa), 5.80-5.73 
/ 137.8, 122.7, 114.8 (CHb / Cd, CHb), 3.45 / 152.7 (CH3k / Cj), 3.40-3.31 / 137.8, 122.7, 22.3 
(CH2e / Cd, CHc, CH2f), 2.48-2.34 / 24.4 (CH2f / CH2e), 2.09-2.02 / 37.3, 27.4-27.1 (CH2 of Cy / 
CH of Cy, CH2 of Cy), 2.02-1.94 / 27.4-27.1 (CH of Cy / CH2 of Cy), 1.94-1.97, 1.70-1.60, 1.59-
1.45 / 37.3, 27.4-27.1 (CH2 of Cy / CH2 of Cy), 1.13-1.02 / 27.4-27.1, 27.0 (CH2 of Cy / CH2 of 
Cy).  
31P{1H} NMR (202.46 MHz, 300 K, benzene-d6): δ31P: br 22.3-14.0 (ν1/2 = 1300 Hz) 
31P NMR (202.46 MHz, 300 K, benzene-d6): δ31P: br 26.3-14.2 (ν1/2 = 3020 Hz) 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. For: C31H43ONCl2PTi [M+H]+ 
594.19373, found 594.19135 (Rel. ab: 100%, -3.333 ppm); C24H35ClOPTi [M+H2O-ArNH2]+ 
453.15880, found 453.15689 (Rel. ab: 55%, -4.223 ppm); C26H39NOP [M-CpTiCl2]+ 412.27638, 
found 412.27443 (Rel. ab: 75%, -4.725 ppm). 
IR (ATR) ν [cm-1]  
MIR: 2922; 1583; 1498 (P=N); 1442; 1367; 1262; 1053; 817. 
FIR: 524; 407; 366; 304; 267. 
Elemental Analysis: % calcd for C31H42Cl2NOPTi: C, 62.64; H, 7.12; N, 2.36; found: C, 60.37; 
H, 7.45; N, 2.44. 
d. Synthesis of 60: 
 
X= 1.06 mmol, Yield: 460 mg, 73% 
1H NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 7.60-7.39 (bs, 1H, Hh), 6.98 (t, 3JHH = 3JHH = 
7.6 Hz, 1H, Hi), 6.80 (td, 3JHH = 3JHH = 7.6 Hz, 4JHH = 1.7 Hz, 1H, Hj), 6.70 (apparent d, 3JHH = 
7.6 Hz, 1H, Hk), 6.31-6.22 (bs, 2H, Hc), 6.22-6.11 (s, 5H, Ha), 5.98-5.82 (bs, 2H, Hb), 3.48 (s, 
3H, Hm), 3.42-3.32 (bs, 2H, He), 2.59-2.53 (bm, 2H, Hf), 2.15-2.05 (bm, CH of Cy), 1.96 (ddm, 
JHH = 65.1 Hz, JHH = 8.6 Hz, 4H, CH2 of Cy), 1.73-1.58 (dm, 4H, CH2 of Cy), 1.57-1.41 (dm, 6H, 
CH2 of Cy), 1.14-1.01 (m, 6H, CH2 of Cy). Traces of pentane 1.29-1.16 (m), 0.85 (t). 
1H{31P} NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 7.60-7.39 (bs, 1H, Hh), 6.98 (t, 3JHH = 3JHH 
= 7.6 Hz, 1H, Hi), 6.80 (td, 3JHH = 3JHH = 7.6 Hz, 4JHH = 1.7 Hz, 1H, Hj), 6.70 (br d, 3JHH = 7.6 
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Hz, 1H, Hk), 6.31-6.22 (bs, 2H, Hc), 6.22-6.11 (s, 5H, Ha), 5.98-5.82 (bs, 2H, Hb), 3.48 (s, 3H, 
Hm), 3.42-3.32 (br AB system, 2JHH = 8.0 Hz, 2H, He), 2.59-2.53 (br m, 2H, Hf), 2.15-2.05 (br 
m, CH of Cy), 1.96 (br dd, JHH = 65.1 Hz, JHH = 8.6 Hz, 4H, CH2 of Cy), 1.73-1.58 (br m, 4H, 
CH2 of Cy), 1.57-1.41 (br m, 6H, CH2 of Cy), 1.14-1.01 (br m, 6H, CH2 of Cy). Traces of pentane 
1.29-1.16 (m), 0.85 (t). 
13C{1H} NMR (150.94 MHz, 300 K, benzene-d6): δ13C: 152.1 (Cl), 138.0-137.2 (Cg+d), 125.4 (d, 
3JPC = 14.8 Hz, Ch), 122.3 (Cc), 121.8 (Ci), 119.4 (Ca), 119.3 (Cj), 115.2-114.6 (bs, Cb), 111.5 
(Ck), 54.6 (Cm), 39.0-37.4 (bs, CH of Cy), 27.1-26.6 (m, Cf, CH2 of Cy), 26.0 (CH2 of Cy), 24.1 
(d, 3JPC = 3.5 Hz, Ce). Traces of pentane (34.1, 22.3, 13.9). 
1H 1H COSY (600.23 MHz, 300 K, 273 K, benzene-d6): δ1H / δ1H: 7.60-7.39 / 6.98 (Hh / Hi), 
6.98 / 7.60-7.39, 6.80 (Hi / Hh, Hj), 6.80 / 6.98, 6.70 (Hj / Hi, Hk), 6.70 / 6.80 (Hk / Hj), 6.31-6.22 
/ 5.98-5.82 (Hc / Hb), 5.98-5.82 / 6.31-6.22 (Hb / Hc), 3.42-3.32 / 1.51 (He / Hf), 1.51 / 3.42-3.32 
(Hf / He), 2.15-2.05 / 1.57-1.41 (CH of Cy / CH2 of Cy), 1.96 / 1.73-1.58, 1.57-1.41 (CH2 of Cy), 
1.73-1.58 / 1.96, 1.57-1.41, 1.14-1.01 (CH2 of Cy), 1.57-1.41 / 2.15-2.05, 1.96, 1.73-1.58, 1.14-
1.01 (CH2 of Cy / CH of Cy, CH2 of Cy), 1.14-1.01 / 1.73-1.58, 1.57-1.41 (CH2 of Cy). 
 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.60-7.39 / 125.4 
(CHh), 6.98 / 121.8 (CHi), 6.80 / 119.3 (CHj), 6.70 / 111.5 (CHk), 6.31-6.22 / 112.3 (CHa), 6.22-
6.11 / 119.4 (CHc), 5.98-5.829 / 115.2-114.6 (CHb), 3.48 / 54.6 (CH3o), 3.42-3.32 / 24.1 (CH2e), 
2.59-2.53 / 27.1-26.6 (CH2f), 2.15-2.05 / 39.0-37.4 (CH of Cy), 1.96 / 27.1-26.6 (CH2 of Cy), 
1.73-1.58 / 27.1-26.6, 26.0 (CH2 of Cy), 1.57-1.41 / 27.1-26.6, 26.0 (CH2 of Cy), 1.14-1.01 / 
27.1-26.6 (CH2 of Cy). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C: 6.98 / 111.5 (CHi / 
CHk), 6.80 / 152.4, 125.4, 121.8 (CHj / Cl, CHh, CHi), 6.70 / 121.8 (CHk / CHi), 6.22-6.11 / 119.4 
(CHa), 2.15-2.05 / 27.1-26.6 (CH of Cy / CH2 of Cy), 1.96 - 1.14-1.01 / 27.1-26.6 (CH2 of Cy). 
31P{1H} NMR (202.41 MHz, 300 K, benzene-d6): δ31P: br 18.9-15.0 (ν1/2 = 360 Hz) 
31P NMR (202.41 MHz, 300 K, benzene-d6): δ31P: br 19.9-13.7 (ν1/2 = 540 Hz) 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. For: C31H43ONCl2PTi [M+H]+ 
594.19373, found 594.19128 (Rel ab: 100%, -3.451 ppm); ); C24H35ClOPTi [M+H2O-ArNH2]+ 
453.15880, found 453.15667 (Rel. ab: 50%, -4.814 ppm); C26H39NOP [M-CpTiCl2]+ 412.27638, 
found 412.27426 (Rel. ab: 75%, -5.166 ppm). 
IR (ATR) ν [cm-1]  
MIR: 3050; 1583; 1490 (P=N); 1433; 1342; 1223; 1112;; 1019; 819; 737; 693; 517. 
FIR: 518; 488; 395; 245; 132. 
Elemental Analysis: % calcd for C31H42Cl2NOPTi: C, 62.64; H, 7.12; N, 2.36; found: C, 61.76; 
H, 7.63; N, 2.46. 
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2. Synthesis of 61: 
A solution of 57 (50 mg, 86.0 µmol, 1 eq) and H(Et2O)2B(C6F5)4 (71.3 mg, 86.0 µmol, 1 eq) 
were mixed in dichloromethane (2 mL) at 10°C and stirred for 2h. The solution was evaporated, 
and the red residue redissolved in 1 mL of dichloromethane and precipitated by addition of 
pentane (6 mL). The supernatant was removed by cannulation and the red precipitate was 
washed twice with pentane (2 mL) before being dried in vacuo. The desired compound was 
obtained as a red solid (70 mg, 64%). 
 
1H NMR (500.03 MHz, 300 K, benzene-d6): δ1H: 7.31 (apparent dd, 3JHH = 8.4 Hz, 4JHH = 1.3 
Hz, 4H, Hh), 7.06 (apparent t, 3JHH= 7.6 Hz, 2H, Hj), 7.00 (apparent td, 3JHH = 3JHH = 7.6 Hz, 
4JPH = 3.9 Hz, 4H, Hi), 6.58 (d, 3JHH = 8.9 Hz, 2H, Hl), 6.45 (d, 3JHH = 8.9 Hz, 2H, Hm), 5.95 (s, 
5H, Ha), 5.82 (ps t, 3JHH = 4JHH = 2.8 Hz, 2H, Hc), 5.56 (ps t, 3JHH = 4JHH = 2.8 Hz, 2H, Hb), 3.28-
3.19 (m, 2H, Hf), 3.13 (s, 3H, Ho), 3.03-2.94 (m, 2H, He). 
1H{31P} NMR (500.03 MHz, 300 K, benzene-d6): δ1H: 7.31 (m, 4JHH = 1.3 Hz, 4H, Hh), 7.06 
(apparent t, 3JHH= 7.6 Hz, 2H, Hj), 7.00 (apparent t, 3JHH = 3JHH = 7.6 Hz, 4H, Hi), 6.58 (d, 3JHH 
= 8.9 Hz, 2H, Hl), 6.45 (d, 3JHH = 8.9 Hz, 2H, Hm), 5.95 (s, 5H, Ha), 5.82 (ps t, 3JHH = 4JHH = 2.8 
Hz, 2H, Hc), 5.56 (ps t, 3JHH = 4JHH = 2.8 Hz, 2H, Hb), 3.28-3.19 (bm, 2H, Hf), 3.13 (s, 3H, Ho), 
3.03-2.94 (bm, 2H, He). 
13C{1H} NMR (125.75 MHz, 300 K, benzene-d6) correlated with dept 135: δ13C: 158.0 (Cn), 
149.2 (dm, 1JCF = 240 Hz, o-CF), 138.9 (dm, 1JCF = 240 Hz, p-CF), 136.8 (dm, 1JCF = 240 Hz, m-
CF), 135.7 (d, 4JPC = 3.3 Hz Hz, Cj), 132.6 (d, 2JPC = 11.0 Hz Hz, Ch) 131.2 (d, 3JPC = 18.1 Hz 
Hz, Cd), 130.3 (d, 3JPC = 13.0 Hz, Ci), 128.0 (overlapping with solvent peak, Ck) 125.2 (Cc), 
124.0 (d, 3JPC = 5.3 Hz, Cl), 121.3 (br, CB), 120.4 (Ca), 118.6 (d, 1JPC = 98.2 Hz, Cg), 115.3 (Cm), 
112.0 (Cb), 55.0 (Co), 23.4 (d, 1JPC = 65.0 Hz Cf), 22.1 (br s, Ce). Traces of pentane (34.5, 22.7, 
14.1) observed. 
1H 1H COSY (500.03 MHz, 300 K, 273 K, benzene-d6): δ1H / δ1H: 7.31 / 7.00 (Hh / Hi), 7.06 / 
7.00 (Hj / Hi), 7.00 / 7.31, 7.06 (Hi / Hh, Hj), 6.58 / 6.45 (Hl / Hm), 6.45 / 6.58 (Hm / Hl), 5.82 / 
5.56 (Hc / Hb), 5.56 / 5.42 (Hb / Hc), 3.28-3.19 / 3.03-2.94 (Hf / He), 3.03-2.94 / 3.28-3.19 (He / 
Hf). 
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1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.31 / 132.6 (CHh), 
7.06 / 135.7 (CHj), 7.00 / 130.3 (CHi), 6.58 / 124.0 (CHl), 6.45 / 115.3 (CHa), 5.95 / 120.4 (CHc), 
5.82 / 125.2 (CHb), 5.56 / 112.0 (CH3o), 3.28-3.19 / 23.4 (CH2f), 3.13 / 55.0 (CH3o), 3.03-2.94 / 
22.1 (CH2e). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.31 / 135.7, 132.6, 
118.6 (CHh / CHj, CHh, Cg), 7.06 / 132.6, 130.3 (CHj / CHh, CHi), 7.00 / 132.6, 130.3, 118.6 
(CHi / CHh, CHi, Cg), 6.58 / 158.0, 128.0, 124.0, 115.3 (CHl / Cn, Ck, CHl, CHm), 6.45 / 158.0, 
128.0, 124.0, 115.3 (CHm / Cn, Ck, CHl, CHm), 5.95 / 120.4 (CHa), 5.82 / 131.2, 112.0 (CHc / Cd, 
CHb), 5.56 / 131.2, 125.2 (CHb / Cd, CHc), 3.28-3.19 / 22.1 (CH2f / CH2e), 3.13 / 158.0 (CH3o / 
Cn), 131.2, 125.2, 23.4 (CH2e / Cd, CHc, CH2e). 
31P{1H} NMR (202.46 MHz, 300 K, benzene-d6): δ31P: 39.3 (ν1/2 = 10.3 Hz) 
31P NMR (202.46 MHz, 300 K, benzene-d6): δ31P: br 39.3 (ν1/2 = 53.6 Hz) 
11B{1H} NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 22 Hz). 
11B NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 22 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.8 (apparent d, 3JFF = 20.0 Hz, 
8F, o-F), -162.1 (t, 3JFF = 20 Hz, 4F, p-F), -166.1 (apparent t, 3JFF = 20 Hz, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.8 (apparent d, 3JFF = 20.0 Hz, 8F, 
o-F), -162.1 (t, 3JFF = 20 Hz, 4F, p-F), -166.1 (apparent t, 3JFF = 20 Hz, 8F, m-F). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. For: C31H31ONCl2PTi [M]+ 
582.09943, found 582.09911 (Rel. ab: 100%, -0.550 ppm); C24H23ClOPTi [M-ArNH2+H2O]+ 
441.06490, found 441.06430 (Rel. ab: 15%, -1.368 ppm); C26H27NOP [M-CpTiCl2]+ 400.18248, 
found 400.18088 (Rel. ab: 30%, -3.992 ppm). 
Elemental Analysis: % calcd for C55H31BF20Cl2NOPTi: C, 52.33; H, 2.48; N, 1.11; found: C, 
51.33; H, 2.86; N, 1.07. 
3. General protocole for the synthesis of dimethyl-
iminophosphoranyl-titanocenes: 
 
To an ethereal suspension of CpPNCpTiCl2 (X mmol, 1 eq), was added dropwise MeLi (2.1 eq) 
at -78°C protected from light. The resulting solution was stirred 1h at -78°C until an yellow clear 
solution was obtained and left to warm up to room temperature over 30 min. The resulting 
heterogeneous solution was completed with 1 volume of pentane and filtered through 
diatomaceous earth. The yellow filtrate was evaporated in vacuo yielding a light sensitive light 
maroon solid. It has to be stored at -15°C and light protected 
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a. Synthesis of 62: 
 
X= 0.51 mmol, Yield: 180 mg, 65% 
1H NMR (500.03 MHz, 300 K, benzene-d6): δ1H: 7.80-7.72 (m, 4H, Hh), 7.09-7.07 (m, 2H, Hm), 
7.06-7.01 (m, 6H, Hi/j), 6.80 (dd, 3JHH = 9.0 Hz, 4JPH = 1.0 Hz, 2H, Hl), 5.64 (s, 5H, Ha), 5.52 
(apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hc), 5.40 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 3.39 
(s, 3H, Ho), 2.76-2.67 (m, 2H, He), 2.67-2.58 (m, 2H, Hf), -0.06 (s, 6H, Hp). Diethyl ether: 3.27 
(q), 1.12 (t), grease: 0.29 (s). 
H{31P} NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 7.80-7.72 (m, 4H, Hh), 7.09-7.07 (m, 2H, 
Hm), 7.06-7.01 (m, 6H, Hi/j), 6.80 (dd, 3JHH = 9.0 Hz, 4JPH = 1.0 Hz, 2H, Hl), 5.64 (s, 5H, Ha), 
5.52 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hc), 5.40 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 
3.39 (s, 3H, Ho), 2.76-2.67 (m, 2H, He), 2.67-2.58 (m, 2H, Hf), -0.06 (s, 6H, Hp). Diethyl ether: 
3.27 (q), 1.12 (t), grease: 0.29 (s). 
13C{1H} NMR (125.75 MHz, 300 K, benzene-d6): δ13C: 152.8 (Cn), 145.7 (Ck), 132.6 (d, 1JPC = 
92 Hz, Cg), 131.9 (d, 3JPC = 8.9 Hz, Ch), 131.4 (d, 3JPC = 2.8 Hz, Cj), 128.8 (d, 2JPC = 11.1 Hz, 
Ci), 127.7 (Cd determined by HMBC), 124.0 (d, 4JPC = 18.2 Hz, Cm), 115.1 (Cc), 113.7 (Cc), 
113.5 (Ca), 111.9 (Cb), 55.3 (Co), 45.9 (Cp), 30.3 (d, 4JPC = 68 Hz, Cf), 23.0 (Ce). Traces of 
diethyl ether (65.9, 15.6) and grease (1.4) observed.  
1H 1H COSY (500.03 MHz, 300 K, 273 K, benzene-d6): δ1H / δ1H: 7.80-7.72 / 7.06-7.01 (Hh / 
Hi/j), 7.09-7.07 / 6.80 (Hm / Hl), 7.06-7.01 / 7.80-7.72 (Hi/j / Hh), 6.80 / 7.09-7.07 (Hl / Hm), 5.52 / 
5.40 (Hc / Hb), 5.40 / 5.52 (Hb / Hc), 2.76-2.67 / 2.67-2.58 (He / Hf), 2.67-2.58 / 2.76-2.67 (Hf / 
He). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.80-7.72 / 131.9 
(CHh), 7.09-7.07 / 124.0 (CHm), 7.06-7.01 / 131.4, 128.8 (CHj, CHi), 6.80 / 115.1 (CHl), 5.64 / 
113.5 (CHa), 5.52 / 113.7 (CHc), 5.40 / 111.9 (CHb), 3.39 / 55.3 (CH3o), 2.76-2.67 / 23.0 (CH2e), 
2.67-2.58 / 30.3 (CH2f), -0.06 / 45.9 (CH3p). 
1H 13C HMBC (600.23 MHz / 150.86 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.80-7.72 / 131.9 
(CHh / CHj), 7.09-7.07 / 152.8, 145.7, 124.0, 115.1 (CHm / Cn, Ck, CHm, CHl), 7.06-7.01 / 131.9, 
128.8 (CHi/j / CHh, CHi), 6.80 / 152.8, 145.7, 115.1 (CHl / Cn, Ck, CHl), 5.64 / 113.5, 46.6 (CHa, 
CH3p), 5.52 / 127.7, 111.9 (CHc / Cd, CHb), 5.40 / 127.7, 113.7 (CHb / Cd, CHc), 3.39 / 152.8 
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(CH3o / CHn), 2.76-2.67 / 127.7, 113.7, 30.3 (CH2e / Cd, CHc, CH2f), 2.67-2.58 / 127.7, 23.0 
(CH2f / Cd, CH2e), -0.06 / 113.5 (CH3p / CHa). 
31P{1H} NMR (202.46 MHz, 300 K, benzene-d6): δ31P: 1.5 (ν1/2 = 38 Hz). 
31P NMR (202.46 MHz, 300 K, benzene-d6): δ31P: bs 1.5 (ν1/2 = 63.4 Hz). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. For: C33H37ONPTi [M+H]+ 
542.20867, found 542.20604 (Rel. ab: 35%, -4.9 ppm); C31H30ONPTi [M-ArNH2+H2O]+ 
511.15390, found 511.15217 (Rel ab: 100%, -3.4), C26H27NOP [M-CpTiCl2]+ 400.18248, found 
400.18109 (Rel. ab: 65%, -3.5 ppm). 
IR (ATR) ν [cm-1]  
MIR: 2925; 1496 (P=N); 1443; 1338; 1227; 1049; 809; 524; 471. 
FIR: 520; 470; 402; 304; 178. 
Elemental Analysis: % calcd for C33H36NOPTi: C, 73.20; H, 6.70; N, 2.59; found: C, 66.02; H, 
6.60; N, 2.21. 
b. Synthesis of 63: 
 
X= 0.60 mmol, Yield: 200 mg, 62% 
1H NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 7.02 (d, 3JHH = 8.9 Hz, 2H, Hh), 6.89 (d, 3JHH = 
8.9 Hz, 2H, Hi), 5.74 (s overlapping with Hc, 5H, Ha), 5.74-5.72 (m overlapping with Ha, 3JHH = 
4JHH = 2.6 Hz, 5H, Hc), 5.44 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 3.46 (s, 3H, Hk), 2.90-
2.83 (m, 2H, He), 2.10-2.02 (m overlapping with CH2 of Cy, 2H, Hf), 2.02-1.96 (m overlapping 
with Hf, 2H, CH2 of Cy), 1.90-1.77 (m, CH and CH2 of Cy), 1.68-1.58 (m, 4H, CH2 of Cy), 1.57-
1.48 (m, 2H, CH2 of Cy), 11.47-1.33 (m, 4H, CH2 of Cy), 1.14-0.95 (m, 6H, CH2 of Cy), 0.05 (s, 
6H, Hl).Pentane 1.33-1.29 (m), 0.87 (t). 
1H{31P} NMR (600.23 MHz, 300 K, benzene-d6): δ1H: 7.02 (d, 3JHH = 8.9 Hz, 2H, Hh), 6.89 (d, 
3JHH = 8.9 Hz, 2H, Hi), 5.74 (s overlapping with Hc, 5H, Ha), 5.74-5.72 (m overlapping with Ha, 
3JHH = 4JHH = 2.6 Hz, 5H, Hc), 5.44 (apparent t, 3JHH = 4JHH = 2.6 Hz, 2H, Hb), 3.46 (s, 3H, Hk), 
2.90-2.83 (m, 2H, He), 2.10-2.02 (m overlapping with CH2 of Cy, 2H, Hf), 2.02-1.96 (m 
overlapping with Hf, 2H, CH2 of Cy), 1.90-1.77 (m, CH and CH2 of Cy), 1.68-1.58 (m, 4H, CH2 
of Cy), 1.57-1.48 (m, 2H, CH2 of Cy), 11.47-1.33 (m, 4H, CH2 of Cy), 1.14-0.95 (m, 6H, CH2 of 
Cy), 0.05 (s, 6H, Hl).Pentane 1.33-1.29 (m), 0.87 (t). 
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13C{1H} NMR (150.94 MHz, 300 K, benzene-d6): δ13C: 152.2 (br s, Cj), 147.1 (Cg), 129.3 (d, 
3JPC = 13.8 Hz, Cc), 123.9 (d, 3JPC = 14.5 Hz, Ch), 115.0 (Ci), 113.9 (Cc), 113.6 (Ca), 111.6 (Cb), 
55.5 (Ck), 45.8 (Cl), 37.9 (d, 1JPC = 61.2 Hz, CH of Cy), 27.3 (d, JPC = 3.1 Hz CH2 of Cy), 27.2 
(d, JPC = 3.7 Hz CH2 of Cy), 27.1 (d, JPC = 3.8 Hz, CH2 of Cy), 26.4 (CH2 of Cy), 25.7 (d, 1JPC = 
56.2 Hz, CH2f), 24.0 (d, 2JPC = 3.3 Hz, CH2e). Pentane 34.4, 22.7, 14.1. 
1H 1H COSY (600.23 MHz, 300 K, 273 K, benzene-d6): δ1H / δ1H: 7.02 / 6.89 (Hh / Hi), 6.89 / 
7.02 (Hi / Hh), 5.74-5.72 / 5.44 (Hc / Hb), 5.44 / 5.74-5.72 (Hb / Hc), 2.90-2.83 / 2.10-2.02 (He / 
Hf), 2.10-2.02 / 2.90-2.83 (Hf / He), 2.02-1.96 / 1.90-1.77, 1.68-1.58, 11.47-1.33 (CH2 of Cy / 
CH and CH2 of Cy), 1.90-1.77 / 2.02-1.96, 1.68-1.58, 11.47-1.33 (CH and CH2 of Cy / CH2 of 
Cy), 1.68-1.58 / 1.14-0.95 (CH2 of Cy), 1.57-1.48 / 1.14-0.95 (CH2 of Cy), 11.47-1.33 / 2.02-
1.96, 1.90-1.77, 1.14-0.95 (CH2 of Cy / CH and CH2 of Cy), 1.14-0.95 / 1.68-1.58, 1.57-1.48, 
1.38 (CH2 of Cy). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C 7.02 / 123.9 (CHh), 
6.89 / 115.0 (CHi), 5.74 / 113.6 (CHa), 5.74-5.72 / 113.9 (CHc), 5.44 / 111.6 (CHb), 3.46 / 55.5 
(CH3k), 2.90-2.83 / 24.0 (CH2e), 2.10-2.02 / 25.7 (CH2f), 2.02-1.96 / 27.3, 27.2, 27.1 (CH2 of 
Cy), 1.90-1.77 / 37.9, 27.1 (CH and CH2 of Cy), 1.68-1.58 / 27.3, 27.2, 27.1, 25.1 (CH2 of Cy), 
1.57-1.48 / 26.4 (CH2 of Cy), 11.47-1.33 / 27.3, 27.2, 27.1 (CH2 of Cy), 1.14-0.95 / 27.3, 27.2, 
27.1 (CH2 of Cy), 0.05 / 45.8 (CH3l). 
1H 13C HMBC (600.23 MHz / 150.94 MHz, 300 K, benzene-d6): δ1H / δ13C: 7.02 / 152.2, 147.1, 
123.9 (CHh / Cj, Cg, CHh), 6.89 / 152.2, 147.1, 123.9, 115.0 (CHi / Cj, Cg, CHh, CHi), 5.74 / 113.6 
(CHa), 5.74-5.72 / 129.3, 111.6 (CHc / Cd, CHb), 5.44 / 129.3, 113.9, 111.6 (CHb / Cd, CHc, CHb), 
3.46 / 152.2 (CH3k / Cj), 2.90-2.83 / 129.3, 113.9, 25.7 (CH2e / Cd, CHc, CH2f), 2.10-2.02 / 129.3, 
24.0 (CH2f / Cd, CH2e), 2.02-1.96 / 37.9, 27.3 - 26.4 (CH2 of Cy / CH of Cy, CH2 of Cy), 1.90-
1.77 / 37.9, 27.3 - 26.4 (CH and CH2 of Cy / CH and CH2 of Cy), 1.68-1.58 / 37.9, 27.3 - 26.4 
(CH2 of Cy / CH of Cy and CH2 of Cy), 1.57-1.48 - 1.14-0.95 / 27.3 - 26.4 (CH2 of Cy / CH2 of 
Cy). 
31P{1H} NMR (242.97 MHz, 300 K, benzene-d6): δ31P: 15.3 (ν1/2 = 25 Hz). 
31P NMR (242.97 MHz, 300 K, benzene-d6): δ31P: br 15.3 (ν1/2 = 30 Hz). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. For: C33H49ONPTi [M+H]+ 
554.30258, found 554.30218 (Rel. ab 70%, -0.7 ppm); C26H39NOP [M-CpTiCl2]+ 412.27638, 
412.27659 (Rel. ab: 75%, 0.5 ppm). 
IR (ATR) ν [cm-1]  
MIR: 2926; 1496 (P=N); 1443; 1339; 1227; 1050; 810. 
FIR: 520; 466; 400; 253; 176. 
Elemental Analysis: % calcd for C33H48NOPTi: C, 66.52; H, 8.90; N, 2.90; found: C, 71.60; H, 
8.74; N, 2.53. 
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4. General protocole for the synthesis of the 
aminophosphonium: 
 
A solution of CpPNCpTiMe2 (X mmol, 1 eq) and [Ph3C][B(C6F5)4] (1 eq) in C6H5Br (2 mL) 
wasstirred 10 min. The solution which kept a light maroon color, was transferred in a Schlenk 
containing vigourously stirred pentane (15 mL). Yellow supernatant was removed and the 
marron oil was then triturated in pentane (3 mL). The resulting maroon precipitate was isolated 
and dried in vacuo. A small amount of dichloromethane was used to dissolve the compound, 
and pentane (15 mL) was added to the stirred solution. Light yellow supernatant was removed 
and the residue was triturated again in pentane. The resulting maroon solid was dried in vacuo 
yielding the desired compound as a maroon powder.13 
a. Synthesis of 64: 
 
 
X= 0.185 mmol, 180 mg, 81% 
This compound exhibits dynamic signal in 1H NMR. A variable temperature study has been 
carried out in order to find out the best temperature for characterization. 
The compound was characterized at 360 K for 1H and 13C NMR and at 300 K for others. 
1H NMR (600.23 MHz, 360 K, bromobenzene-d5): δ1H: 7.40 (tm, 3JHH = 7.5 Hz, 2H, Hj/j’), 7.30-
7.22 (m, 2H, Hi), 7.22-7.18 (m, 2H, Hi’), 7.18-7.13 (m, 2H, Hh), 7.05 (dm overlapping with the 
one solvent peak, 4JPH = 11.9 Hz, 2H, Hh’), 6.60 (apparent q, 3JHH = 4JHH = 2.4 Hz, 1H, Hc), 6.38 
(d, 3JHH = 8.4 Hz, 2H, Hm), 6.20 (dd, 3JHH = 8.4 Hz, 4JPH = 2.5 Hz, 2H, Hl), 5.75 (apparent q, 3JHH 
= 
4JHH = 2.4 Hz, 1H, Hb), 5.67 (s, 5H, Ha), 5.43 (apparent q, 3JHH = 4JHH = 2.4 Hz, 1H, Hc’), 5.34 
(apparent q, 3JHH = 4JHH = 2.4 Hz, 1H, Hb’), 3.41 (s, 3H, Ho), 2.81-2.69 (m, 2H, He), 2.62-2.54 
(m, 1H, Hf), 2.34-2.25 (m, 1H, Hf), 0.70 (s, 3H, Hp). pentane: 1.29-1.16 (m), 0.85 (t). 
1H{31P} NMR (600.23 MHz, 360 K, bromobenzene-d5): δ1H: 7.40 (t, 3JHH = 7.5 Hz, 2H, Hj/j’), 
7.30-7.24 (m, 2H, Hi), 7.21-7.18 (m, 2H, Hi’), 7.18-7.15 (m, 2H, Hh), 7.05 (d overlapping with 
the one solvent peak, 3JHH = 8.1 Hz, 2H, Hh’), 6.60 (apparent q, 3JHH = 4JHH = 2.4 Hz, 1H, Hc), 
                                               
13
 IR spectroscopy was not measured due to the presence of the counter anion. 
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6.38 (d, 3JHH = 8.4 Hz, 2H, Hm), 6.19 (d, 3JHH = 8.4 Hz, 2H, Hl), 5.75 (apparent q, 3JHH = 4JHH = 
2.4 Hz, 1H, Hb), 5.67 (s, 5H, Ha), 5.43 (apparent q, 3JHH = 4JHH = 2.4 Hz, 1H, Hc’), 5.34 (apparent 
q, 3JHH = 4JHH = 2.4 Hz, 1H, Hb’), 3.40 (s, 3H, Ho), 2.79-2.68 (m, 2H, He), 2.61-2.53 (m, 1H, Hf), 
2.33-2.24 (m, 1H, Hf), 0.70 (s, 3H, Hp). pentane: 1.29-1.16 (m), 0.87 (t). 
13C{1H} NMR (150.94 MHz, 360 K, bromobenzene-d5): correlated with dept 135: δ13C: 157.8 
(Cn), 148.8 (br d, 1JCF = 240 Hz, o-CF), 139.2 (br s, Ck), 138.7 (br d, 1JCF = 240 Hz, p-CF), 136.8 
(br d, 1JCF = 240 Hz, m-CF), 134.2 (d, 4JPC = 2.9 Hz, Cj), 133.8 (d, 4JPC = 2.6 Hz, Cj’), 132.7(d, 
3JPC = 9.2 Hz, Ch), 132.2 (d, 3JPC = 9.2 Hz, Ch’), 131.0 (n.o. Cl), 129.5 (d, 3JPC = 9.2 Hz, Ci), 
129.4 (d, 3JPC = 11.9 Hz, Ci’), 128.9 (d, 3JPC = 3.1Hz, Cd), 124.8 (d, 3JPC = 94.1 Hz, Cg+g’), 121.6 
(Cc), 117.8 (Cb), 115.9 (Ca), 114.3 (Cm), 111.1 (Cb’), 106.7 (Cc’), 55.3(Co), 55.2 (Cp), 28.9 (d, 
1JPC = 71.0 Hz, Cf), 20.6 (d, 2JPC = 5.4 Hz, Ce). Pentane (34.2, 22.4, 14.1), iapparento-CB not 
observed. 
1H 1H COSY (500.03 MHz, 300 K, bromobenzene-d5): δ1H / δ1H: 7.40 / 7.30-7.22, 7.22-7.18, 
7.18-7.13, 7.05 (Hj/j’ / Hi, Hi’, Hh, Hh’), 7.30-7.22 / 7.40 7, 7.18-7.13 (Hi / Hj, Hh), 7.22-7.18 / 7.40, 
7.05 (Hi’ / Hj’, Hh’), 7.18-7.13 / 7.40, 7.30-7.22 (Hh / Hj, Hi), 7.05 / 7.40 , 7.22-7.18 (Hh’ / Hj’, Hi’), 
6.60 / 5.75, 5.43, 5.34 (Hc / Hb, Hc’, Hb’), 6.38 / 6.20 (Hm / Hl), 6.20 / 6.38 (Hl / Hm), 5.75 / 6.60, 
5.43, 5.34 (Hb / Hc, Hc’, Hb’), 5.43 / 6.60, 5.75, 5.34 (Hc’ / Hc, Hb, Hb’), 5.34 / 6.60, 5.75, 5.43 (Hb’ 
/ Hc, Hb, Hc’), 2.81-2.69 / 2.62-2.54, 2.34-2.25 (CH2e / CH2f), 2.62-2.54, 2.34-2.25 / 2.81-2.69 
(CH2f / CH2e). 
1H 13C HMQC (600.23 MHz / 150.94 MHz, 360 K, bromobenzene-d5): δ1H / δ13C: 7.40 / 134.2, 
133.8 (CHj/j’), 7.30-7.22 / 129.5 (CHi), 7.22-7.18 / 129.4 (CHi’), 7.18-7.13 / 132.7 (CHh’), 7.05 / 
132.2 (CHh’), 6.60 / 121.1 (CHc), 6.38 / 114.3 (CHm), 6.20 / 131.6 (CHl), 5.75 / 117.8 (CHb), 
5.67 / 115.9 (CHa), 5.43 / 106.7 (CHc’), 5.34 / 111.1 (CHb’), 3.41 / 55.3 (CH3o), 2.81-2.69 / 20.6 
(CH2e), 2.62-2.54, 2.34-2.25 / 27.3 (CH2f), 0.70 / 55.2 (CH3p).  
1H 13C HMBC (600.23 MHz / 150.94 MHz, 360 K, bromobenzene-d5): δ1H / δ13C: 7.40 / 132.7, 
132.2 (CHj/j’ / CHi, CHi’), 7.30-7.22 / 134.2, 132.7, 129.5, 124.8 (CHi / CHj, CHh, CHi, Cg), 7.05 
/ 134.2, 132.2, 129.5 (CHh’ / CHj’, CHh’, CHi’), 6.60 / 128.9, 117.8, 111.1, 106.7 (CHc / Cd, CHb, 
CHb’, CHc’), 6.38 / 157.8, 139.2, 114.3 (CHm / Cn, Ck, CHm), 6.20 / 157.8, 139.2, 131.6 (CHl / 
Cn, Ck, CHl), 5.75 / 128.9, 121.6, 111.1, 106.7 (CHb / Cd, CHc, CHb’, CHc’), 5.67 / 115.9 (CHa), 
5.43 / 129.8, 121.6, 117.8, 111.1 (CHc’ / Cd, CHc, CHb, CHb’), 5.34 / 128.9, 121.6, 117.8, 106.7 
(CHb’ / Cd, CHc, CHb, CHc’), 3.41 / 157.8 (CH3o / CHn), 2.81-2.69 / 128.9, 121.6, 106.7 (CH2e / 
Cd, CHc, CHc’), 2.62-2.54, 2.34-2.25 / 128.9, 20.6 (CH2f / Cd, CH2f). 
31P{1H} NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: 36.6 (ν1/2. = 2.6 Hz). 
31P NMR (202.46 MHz, 300 K, bromobenzene-d5): δ31P: br 36.6 ν1/2 = 66.8 Hz). 
11B{1H} NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 21 Hz). 
11B NMR (160.42 MHz, 300 K, bromobenzene-d5): δ11B: -15.9 (ν1/2 = 21 Hz). 
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19F{1H} NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.4 (br d, 3JFF = 18.1 Hz, 8F, o-
F), -161.5 (t, 3JFF = 21 Hz, 4F, p-F), -165.4 (br t, 3JFF = 21 Hz, 8F, m-F). 
19F NMR (470.45 MHz, 300 K, bromobenzene-d5): δ19F: -131.4 (br d, 3JFF = 18.1 Hz, 8F, o-F), 
-161.5 (t, 3JFF = 21 Hz, 4F, p-F), -165.4 (br t, 3JFF = 21 Hz, 8F, m-F).  
HRMS (Positive mode ESI, dichloromethane): m/z calcd. For: C31H30NOPTi: [M-CH3]+ 
511.15390, found 511.15262 (Rel. ab: 100%, -2.5 ppm). 
Elemental Analysis: % calcd for C56H33BF20NOPTi: C, 55.88; H, 2.31; N, 1.06; found: C, 
55.80; H, 2.76; N, 1.16. 
XRD: 
 
Experimental. Single orange needle-shaped crystals of 
(q090117_0ma_a) were obtained by recrystallisation from 
diffusion of pentane in a dichloromethane solution at -15°C. A 
suitable crystal (0.37×0.05×0.03) mm3 was selected and 
mounted on a mylar loop with oil on a Nonius Kappa Apex II 
diffractometer. The crystal was kept at T = 115115 K during data 
collection. Using Olex2 (Dolomanov et al., 2009), the structure 
was solved with the ? structure solution program, using the ? 
methods solution method. The model was refined with version 
2017/1 of XL (Sheldrick, 2008) using Least Squares 
minimisation. 
Crystal Data. C59.5H41BF20NOPTi, Mr = 1255.61, monoclinic, 
C2/c (No. 15), a = 39.807(7) Å, b = 12.4929(18) Å, c = 
30.542(5) Å, β = 129.687(7)°, α = γ = 90°, V = 11688(3) Å3, T = 
115115 K, Z = 8, Z' = 1, µ(MoKα) = 0.278, 116678 reflections 
measured, 10212 unique (Rint = 0.0972) which were used in all 
calculations. The final wR2 was 0.2002 (all data) and R1 was 
0.0655 (I > 2(I)). 
 
 
 
Compound  q090117_0ma_a  
    
Formula  C59.5H41BF20NOPTi  
Dcalc./ g cm-3  1.427  
µ/mm-1  0.278  
Formula Weight  1255.61  
Colour  orange  
Shape  needle  
Size/mm3  0.37×0.05×0.03  
T/K  115  
Crystal System  monoclinic  
Space Group  C2/c  
a/Å  39.807(7)  
b/Å  12.4929(18)  
c/Å  30.542(5)  
α/°  90  
β/°  129.687(7)  
γ/°  90  
V/Å3  11688(3)  
Z  8  
Z'  1  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  2.576  
Θmax/°  25.000  
Measured Refl.  116678  
Independent Refl.  10212  
Reflections Used  6917  
Rint  0.0972  
Parameters  762  
Restraints  3  
Largest Peak  1.482  
Deepest Hole  -0.540  
GooF  1.053  
wR2 (all data)  0.2002  
wR2  0.1693  
R1 (all data)  0.1076  
R1  0.0655  
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b. Synthesis of 65: 
 
X=0.180 mmol, 140 mg; 64% 
1H NMR (500.03 MHz, 300 K, dichloromethane-d2): δ1H: 6.97 (dd, 3JHH = 9.0 Hz, 4JHH = 3.1 Hz, 
1H, Hi), 6.85 (dd, 3JHH = 9.0 Hz, 4JHH = 3.1 Hz, 1H, Hi’ overlapping with Hb), 6.84 (m, 1H, Hb 
overlapping with Hi’), 6.75 (dt, 3JHH = 9.0 Hz, 4JHH = 4JPH = 3.1 Hz, 1H, Hh), 6.59 (dt, 3JHH = 9.0 
Hz, 4JHH = 4JPH = 3.1 Hz, 1H, Hh’), 5.85 (apparent q, 3JHH = 4JHH = 2.9 Hz, 1H, Hc), 5.75 (s 
overlapping with Hb’, 5H, Ha), 5.73 (apparent q overlapping with Ha, 3JHH = 4JHH = 2.9 Hz, 1H, 
Hb’), 5.56 (apparent q, 3JHH = 4JHH = 2.9 Hz, 1H, Hc’), 3.84 (s, 3H, Hk), 3.35-3.08 (m, 2H, He), 
2.54-2.38 (m, 2H, Hf), 2.35-2.12 (m, 1H, CH of Cy), 2.08-0.94 (m overlapping with pentane, 
CH’ of Cy and CH2 of Cy), 0.86 (s, 3H, Hl). pentane: 1.35-1.12 (m), 0.88 (t). 
1H{31P} NMR (500.03 MHz, 300 K, dichloromethane-d2): δ1H: 6.97 (dd, 3JHiHh = 9.0 Hz, 4JHiHi’ = 
3.1 Hz, 1H, Hi), 6.85 (dd, 3JHi’Hh’ = 9.0 Hz, 4JHi’Hi = 3.1 Hz, 1H, Hi’ overlapping with Hb), 6.84 (m, 
1H, Hb overlapping with Hi’), 6.75 (dd, 3JHhHi = 9.0 Hz, 4JHhHi’ = 3.1 Hz, 1H, Hh), 6.59 (dd, 3JHh’Hi’ 
= 9.0 Hz, 4JHh’Hi = 3.1 Hz, 1H, Hh’), 5.85 (apparent q, 3JHcHb = 4JHcHb/Hb’ = 2.9 Hz, 1H, Hc), 5.75 
(s, 5H, Ha), 5.73 (apparent q, 3JHb’Hc’/Hb = 4JHb’Hc = 2.9 Hz, 1H, Hb’), 5.56 (apparent q, 3JHc’Hb’ = 
4JHc’Hb/Hc = 2.9 Hz, 1H, Hc’), 3.84 (s, 3H, Hk), 3.35-3.08 (m, 2H, He), 2.54-2.38 (m, 2H, Hf), 2.35-
2.12i (m, 1H, CH of Cy), 2.08-0.94 (m, CH’ of Cy and CH2 of Cy), 0.86 (s, 3H, Hl). 
13C{1H} NMR (125.75 MHz, 300 K, dichloromethane-d2): δ13C: 158.7 (Cj), 148.8 (dm, 1JCF = 240 
Hz, o-CF), 140.8 (d, 2JPC = 6.8 Hz, Cg), 138.8 (dm, 1JCF = 240 Hz, p-CF), 136.9 (dm, 1JCF = 240 
Hz, m-CF), 133.4 (d, 3JPC = 5.7 Hz, Ch’), 129.2 (d, 3JPC = 4.0 Hz, Ch), 126.6 (d, 3JPC = 1.9 Hz, 
Cd), 125.4-123.6 (ipso-CB overlapping with Cb) 124.9 (Cb Overlapping with ipso-CB), 116.2 (Ca), 
115.2 (d, 4JPC = 2.7 Hz, Ci), 114.8 (d, 4JPC = 2.7 Hz, Ci’), 113.2 (Cc’), 112.3 (Cc), 104.1 (Cb’), 56.2 
(Ck), 50.9 (Cl), 40.2 (d, 1JPC = 53.3 Hz, CH’ of Cy’), 36.4 (d, 1JPC = 51.1 Hz, CH of Cy), 28.1 – 
25.7 (m, CH2 of Cy and Cy’), 21.3 (d, 2JPC = 6.2 Hz, Ce), 18.0 (d, 1JPC = 59.3 Hz, Cf). Pentane 
34.7, 22.9, 14.4. 
1H 1H COSY (500.03 MHz, 300 K, 273 K, dichloromethane-d2): δ1H / δ1H: 6.97 / 6.75 (Hi / Hh), 
6.85 / 6.59 (Hi’ / Hh’), 6.84 / 5.85, 5.73, 5.56 (Hb/ Hc, Hb’, Hc’), 6.75 / 6.97 (Hh / Hi), 6.59 / 6.85 
(Hh’ / Hi’), 5.85 / 6.84, 5.73, 5.56 (Hc/ Hb, Hb’, Hc’), 5.73 / 6.84, 5.85, 5.56 (Hb’/ Hb, Hc, Hc’), 5.56 
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/ 6.84, 5.85, 5.73 (Hc’/ Hb, Hc, Hb’), 3.35-3.08 / 2.54-2.38 (He / Hf), 2.54-2.38 / 3.35-3.08 (Hf / 
He), 2.35-2.12 / 2.08 - 0.95 (CH of Cy / CH2 of Cy), 2.08 - 0.95 / 2.35-2.12, 2.08 - 0.95 (CH’ 
and CH2 of Cy / CH of Cy, CH’ and CH2 of Cy). 
1H 13C HMQC (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.97 / 115.2 
(CHi), 6.85 / 114.8 (CHi’), 6.84 / 124.9 (CHb), 6.75 / 129.2 (CHh), 6.59 / 133.4 (CHh’), 5.85 / 
112.3 (CHc), 5.75 / 116.2 (CHa), 5.73 / 104.1 (CHb’), 5.56 / 113.2 (CHc’), 3.84 / 56.2 (CH3k), 
3.35-3.08 / 21.3 (CH2e), 2.54-2.38 / 18.0 (CH2f), 2.35-2.12 / 36.4 (CH of Cy), 2.08 – 0.95 / 40.2, 
28.1-25.7 (CH of Cy’ and CH2 of Cy and Cy’), 0.86 / 50.9 (CH3l). 
1H 13C HMBC (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2): δ1H / δ13C: 6.97 / 140.8, 
114.8 (CHi / Cg, CHi’), 6.85 / 140.8, 115.2 (CHi’ / Cg, CHi), 6.84 / 112.3, 104.1 (CHb / CHc, CHb’), 
6.75 / 158.7, 133.4 (CHh / Cj, CHh’), 6.59 / 158.7, 129.2 (CHh’ / Cj, CHh), 5.85 / 126.6 (CHc / Cd), 
5.75 / 116.2 (CHa / CHa), 5.73 / 126.6, 124.9 (CHb’ / Cd, CHb), 5.56 / 126.6, 104.1 (CHc’ / Cd, 
CHb’), 3.84 / 158.7 (CH3k / Cj), 3.35-3.08 / 126.6, 124.9, 104.1, 18.8 (CH2e / Cd, CHb, CHb’,CH2f), 
2.54-2.38 / 126.6, 21.3 (CH2f / Cd, CH2e), 2.35-2.12, 2.08 - 0.95 / 28.1 – 25.7 (CH and CH2 of 
Cy and Cy’), 0.86 / 124.9 (CH3l / CHb). 
31P{1H} NMR (202.41 MHz, 300 K, dichloromethane-d2): δ31P: 48.3 (ν1/2. = 60.3 Hz). 
31P NMR (202.41 MHz, 300 K, dichloromethane-d2): δ31P: br 48.3 (ν1/2 = 3.3 Hz). 
11B{1H} NMR (160.43 MHz, 300 K, dichloromethane-d2): δ11B: -16.6 (ν1/2 = 22 Hz). 
11B NMR (160.43 MHz, 300 K, dichloromethane-d2): δ11B: -16.6 (ν1/2 = 22 Hz). 
19F{1H} NMR (470.45 MHz, 300 K, dichloromethane-d2): δ19F: -133.1 (apparent d, 3JFF = 19 Hz, 
8F, o-F), -163.6 (t, 3JFF = 19 Hz, 4F, p-F), -167.5 (apparent t, 3JFF = 19 Hz, 8F, m-F). 
19F NMR (470.45 MHz, 273 K, dichloromethane-d2): δ19F: -133.1 (br d, 3JFF = 19 Hz, 8F, o-F), 
-163.6 (t, 3JFF = 19 Hz, 4F, p-F), -167.5 (br t, 3JFF = 19 Hz, 8F, m-F). 
HRMS (Positive mode ESI, dichloromethane): m/z calcd. For: C32H45ONPTi [M]+ 538.27128, 
found 538.27059 (Rel. ab: 60%, -1.3 ppm); C31H42ONPTi [M-CH3]+ 523.24780, found 
523.24775 (Rel. ab: 100%, -0.1ppm); C26H39NOP [M-ArNH2-H2O]+ 412.27638, 412.27644 ppm 
(Rel. ab: 30%, 0.2 ppm). 
Elemental Analysis: % calcd for C56H45BF20NOPTi: C, 55.24; H, 3.73; N, 1.15; found: C, 
55.04; H, 3.30; N, 1.10. 
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XRD: 
 
Experimental. Single orange block-shaped crystals of 
(q300317_0m_a) were obtained by recrystallisation by diffusion 
of pentane to a dichloromethane solution at -15°C. A suitable 
crystal (0.37×0.25×0.25) mm3 was selected and mounted on a 
mylar loop with oil on a Bruker APEX-II CCD diffractometer. 
The crystal was kept at T = 115 K during data collection. Using 
Olex2 (Dolomanov et al., 2009), the structure was solved with 
the ShelXT (Sheldrick, 2015) structure solution program, using 
the Intrinsic Phasing solution method. The model was refined 
with version 2017/1 of XL (Sheldrick, 2008) using Least Squares 
minimisation. 
Crystal Data. C56H45BF20NOPTi, Mr = 1217.61, monoclinic, 
P21/c (No. 14), a = 12.069(2) Å, b = 16.790(3) Å, c = 
28.184(5) Å, β = 101.793(3)°, α = γ = 90°, V = 5590.9(18) Å3, T 
= 115 K, Z = 4, Z' = 1, µ(MoKα) = 0.288, 68733 reflections 
measured, 12917 unique (Rint = 0.0300) which were used in all 
calculations. The final wR2 was 0.1396 (all data) and R1 was 
0.0493 (I > 2(I)).
Compound  q300317_0m_a  
    
Formula  C56H45BF20NOPTi  
Dcalc./ g cm-3  1.447  
µ/mm-1  0.288  
Formula Weight  1217.61  
Colour  orange  
Shape  block  
Size/mm3  0.37×0.25×0.25  
T/K  115  
Crystal System  monoclinic  
Space Group  P21/c  
a/Å  12.069(2)  
b/Å  16.790(3)  
c/Å  28.184(5)  
α/°  90  
β/°  101.793(3)  
γ/°  90  
V/Å3  5590.9(18)  
Z  4  
Z'  1  
Wavelength/Å  0.710730  
Radiation type  MoKα  
Θmin/°  2.114  
Θmax/°  27.623  
Measured Refl.  68733  
Independent Refl.  12917  
Reflections Used  10244  
Rint  0.0300  
Parameters  732  
Restraints  0  
Largest Peak  0.979  
Deepest Hole  -0.681  
GooF  1.030  
wR2 (all data)  0.1396  
wR2  0.1296  
R1 (all data)  0.0645  
R1  0.0493  
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General conclusion 
 
In summary, the present manuscript deals with several new aspects of nitrogen-
functionalized titanocene chemistry. Firstly, it describes a new procedure for the synthesis of 
(aminomethyl)cyclopentadienylides via a benzotriazole route. The five new synthesized 
ligands have been coordinated to titanium or zirconium, forming N-functionalized 
dichlorotitanocenes or dichlororzirconocenes in moderate to good yields, and in satisfactory 
purity for the formers, but in moderate purity for the latters. The (aminomethyl)titanocenes have 
been further derivatized with various X-Ligand (OAr, Me, OTf). Secondly, various procedures 
for the generation of cationic (aminomethyl)titanocenes have been attempted. In particular, 
methide abstraction from dimethyl titanocene complexes led to unexpected rearrangements of 
the amine moiety via CH activation, leading to the discovery of i) a cationic amidotitanocene 
(36 and 41), and ii) an unprecedented iminium carbene titanocene (43). The mechanism of the 
first reactions was not investigated, considering that it is reminiscent of Hofmann degradation. 
The formation of the titanium carbene species has been investigated in details and it appears 
that the mechanism of this reaction is quite complex. The evidence gathered so far, suggests 
an autocatalytic process (potentially accompanied by side reactions), in which the methide 
abstractor is induced in more than one step. In light of these results, amines are not the best 
choice for FLP chemistry since the literature is rife with similar cases of CH activation reactions 
of amine compounds. 
The third part of this thesis develops a straightforward synthesis of cationic phosphido- 
phosphine and amido-titanocenes. The latter show very good activity in the catalytic 
hydrogenation of various unsaturated substrates such as styrene, 3,3-dimethylbut-1-ene and 
diphenylacetylene. Nevertheless, the catalysts are poorly active towards electron-deficient 
substrates such as perfluorostyrene, and they do not seem to tolerate N-containing substrates 
such as imines. It would be interesting to investigate the selectivity of these catalysts on 
prochiral substrates, in order to develop an asymmetric hydrogenation. One could further 
develop this family of catalyst by modifying the steric and electronic properties of the 
metallocenic fragment. 
In parallel to this work, an alternative synthesis of titanocenyl iminophosphoranes (57-
60) has been further explored, following preliminary results obtained by Dr. Monnereau in the 
laboratory of Pr. Pierre Le Gendre. After methylation of dichloro titanocene precursors, methide 
abstraction yields 64 and 65, two titanocenyl iminophosphoniums presenting a very strong Ti-
N bond, the nature of which has been studied theoretically; further investigations are currently 
underway. 
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 In this study of OmFLPs based on N/Ti+ combinations, none of the obtained cationic 
complexes showed FLP reactivity. Nevertheless, some new aspects of the organometallic 
chemistry of titanium have been discovered along the way. Frustrated Lewis pairs are not 
always an achievable goal, but in the case of this thesis, they were just as a good starting point 
as any.
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A. Appendix Chapter II 
 
1. Coupound 1-K: 
 
Spectrum 0-1: 1H NMR of 1-K (600.23 MHz, 300K, tetrahydrofuran-d8) 
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Spectrum 0-2: 13C{1H} NMR of 1-K (150.94 MHz, 300 K, tetrahydrofuran-d8) 
 
Spectrum 0-3: 1H 1H COSY of 1-K (600.23 MHz, 300 K, tetrahydrofuran-d8) 
 
Spectrum 0-4: 1H 13C HMQC of 1-K (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8) 
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Spectrum 0-5: 1H 13C HMBC of 1-K (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8) 
 
Spectrum 0-6: HRMS of 1-K (Negative mode ESI, dimethylsulfoxide) 
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2. Compound 2-K: 
 
Spectrum 0-7: 1H NMR of 2-K (600.23 MHz, 300 K, dimethylsulfoxide-d6) 
 
Spectrum 0-8: 13C{1H} NMR of 2-K (150.94 MHz, 300 K, dimethylsulfoxide-d6) 
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Spectrum 0-9: 1H 1H COSY of 2-K (600.23 MHz, 300 K, dimethylsulfoxide-d6) 
 
Spectrum 0-10: 1H 13C HMQC of 2-K (600.23 MHz / 150.94 MHz, 300 K, dimethylsulfoxide-d6) 
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Spectrum 0-11: 1H 13C HMBC of 2-K (600.23 MHz / 150.94 MHz, 300 K, dimethylsulfoxide-d6)
 
Spectrum 0-12: HRMS of 2-K (Negative mode ESI, dimethylsulfoxide) 
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3. Compound 3-K: 
 
 
Spectrum 0-13: 1H NMR of 3-K (500.03 MHz, 300 K, dimethylsulfoxide-d6) 
 
Spectrum 0-14: 13C{1H} NMR of 3-K (125.77 MHz, 300 K dimethylsulfoxide-d6) 
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Spectrum 0-15: 1H 1H COSY of 3-K (500.03 MHz, 300 K, dimethylsulfoxide-d6) 
 
Spectrum 0-16: 1H 13C HMQC of 3-K (500.03 MHz / 125.77 MHz, 300 K, dimethylsulfoxide-d6) 
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Spectrum 0-17: 1H 13C HMBC of 3-K (500.03 MHz / 125.77 MHz, 300 K, dimethylsulfoxide-d6 
 
 
Spectrum 0-18: HRMS of 3-K (Negative mode ESI, dimethylsulfoxide) 
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4. Compound 4-K: 
 
 
Spectrum 0-19: 1H NMR of 4-K (600.23 MHz, 300 K, dimethylsulfoxyde-d6) 
 
Spectrum 0-20: 13C{1H} NMR of 4-K (150.94 MHz, 300 K, dimethylsulfoxyde-d6) 
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Spectrum 0-21: 1H 1H COSY of 4-K (600.23 MHz / 600 MHz, 300 K, dimethylsulfoxyde-d6) 
 
Spectrum 0-22: 1H 13C HMQC of 4-K (600.23 MHz / 150.94 MHz, 300 K, dimethylsulfoxyde-d6) 
Appendix 
275 
 
 
Spectrum 0-23: 1H 13C HMBC of (600.23 MHz / 150.94 MHz, 300 K, dimethylsulfoxyde-d6) 
 
 
Spectrum 0-24: HRMS of 4-K (Negative mode ESI, dimethylsulfoxide) 
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5. Compound 5-K 
 
Spectrum 0-25: 1H NMR of 5-K (600.23 MHz, 300 K, tetrahydrofuran-d8) 
 
Spectrum 0-26: 13C{1H} NMR of 5-K (150.94 MHz, 300 K, tetrahydrofuran-d8) 
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Spectrum 0-27: 1H 1H COSY of 5-K (600.23 MHz, 300 K, tetrahydrofuran-d8) 
 
Spectrum 0-28: 1H 13C HMQC of 5-K (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8) 
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Spectrum 0-29: 1H 13C HMBC of 5-K (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8) 
 
Spectrum 0-30: HRMS of 5-K (Negative mode ESI, dimethylsulfoxide) 
6. Compound 9: 
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Spectrum 0-31: 1H NMR of 9 (600.23 MHz, 300 K, benzene-d6) 
 
Spectrum 0-32: 13C{1H} NMR of 9 (125.77 MHz, 300 K, benzene-d6) 
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Spectrum 0-33: 1H 1H COSY of 9 (600.23 MHz, 300 K, benzene-d6) 
 
Spectrum 0-34: 1H 13C HMQC of 9 (600.23 MHz / 150.94 MHz, 300 K, benzene-d6) 
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Spectrum 0-35: 1H 13C HMBC of 9 (600.23 MHz / 150.94 MHz, 300 K, benzene-d6) 
 
Spectrum 0-36: 1H 15N HMBC of 9 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-37: HRMS of 9 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-38: MIR of 9 
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Spectrum 0-39: FIR of 9 
 
7. Compound 10: 
 
Spectrum 0-40: 1H NMR of 10 (600 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-41: 13C{1H} NMR of 10 (150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-42: 1H 1H COSY of 10 (600.23 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-43: 1H 13C HMQC of 10 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-44: 1H 13C HMBC of 10 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-45: 1H 15N HMBC of 10 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-46: HRMS of 10 (Positive mode ESI, dichloromethane) 
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Spectrum 0-47: MIR of 10 
 
Spectrum 0-48: FIR of 10 
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8. Compound 11: 
 
Spectrum 0-49: 1H NMR of 11 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-50: 13C{1H} NMR of 11 (150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-51: 1H 1H COSY of 11 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-52: 1H 13C HMQC of 11 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-53: 1H 13C HMBC of 11 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-54: 1H 15N HMBC of 11 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-55: HRMS of 11 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-56: MIR of 11 
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Spectrum 0-57: FIR of 11 
 
9. Compound 12: 
 
Spectrum 0-58: 1H NMR of 12 (600.23 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-59: 13C{1H} NMR of 12 (150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-60: 1H 1H COSY of 12 (600.23 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-61: 1H 13C HMQC of 12 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-62: 1H 13C HMBC of 12 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-63: 1H 15N HMBC of 12 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-64 : HRMS of 12 (Positive mode ESI, dichloromethane) 
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Spectrum 0-65 : MIR of 12 
 
Spectrum 0-66 : FIR of 12 
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10. Compound 13: 
 
Spectrum 0-67: 1H NMR of 13 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-68: 13C{1H} NMR of 13 (150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-69: 1H 1H COSY of 13 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-70: 1H 13C HMQC of 13 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-71: 1H 13C HMBC of 13 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-72: 1H 15N HMBC of 13 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
Appendix 
 
300 
 
 
Spectrum 0-73: HRMS of 13 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-74: MIR of 13 
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Spectrum 0-75: FIR of 13 
11. Compound 14: 
 
Spectrum 0-76: 1H NMR of 14 (600 MHz, 300 K, chloroform-d1) 
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Spectrum 0-77: 13C{1H} NMR of 14 (150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-78: 1H 1H COSY of 14 (500.03 MHz, 300 K, chloroform-d1) 
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Spectrum 0-79: 1H 13C HMQC of 14 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-80: 1H 13C HMBC of 14 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
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Spectrum 0-81: HRMS of 14 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-82: MIR of 14 
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Spectrum 0-83: FIR of 14 
12. Compound 15: 
 
Spectrum 0-84: 1H NMR of 15 (600 MHz, 300 K, chloroform-d1) 
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Spectrum 0-85: 13C{1H} NMR of 15 (150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-86: 1H 1H COSY of 15 (600.23 MHz, 300 K, chloroform-d1 
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Spectrum 0-87: 1H 13C HMQC of 15 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-88: 1H 13C HMBC of 15 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
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Spectrum 0-89: HRMS of 15
 
(Positive mode ESI, dichloromethane) 
 
Spectrum 0-90: MIR of 15 
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Spectrum 0-91: FIR of 15 
 
13. Compound 16: 
 
Spectrum 0-92: 1H NMR of 16 (600.23 MHz, 300 K, chloroform-d1) 
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Spectrum 0-93: 13C{1H} NMR of 16 (150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-94: 1H 1H COSY of 16 (600.23 MHz, 300 K, chloroform-d1) 
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Spectrum 0-95: 1H 13C HMQC of 16 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-96: 1H 13C HMBC of 16 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
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Spectrum 0-97: HRMS of 16 (Positive mode ESI, dichloromethane-methanol) 
 
Spectrum 0-98: MIR of 16 
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Spectrum 0-99: FIR of 16 
14. Compound 17: 
 
Spectrum 0-100: 1H NMR of 17 (600.23 MHz, 300 K, chloroform-d1) 
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Spectrum 0-101: 13C{1H} NMR of 17 (150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-102: 1H 1H COSY of 17 (600.23 MHz, 300 K, chloroform-d1) 
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Spectrum 0-103: 1H 13C HMQC of 17 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-104: 1H 13C HMBC of 17 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
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Spectrum 0-105: HRMS of 17 (Positive mode ESI, dichloromethane-methanol) 
 
Spectrum 0-106: MIR of 17 
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Spectrum 0-107: FIR of 17 
15. Compound 18: 
 
Spectrum 0-108: 1H NMR of 18 (600.23 MHz, 300 K, chloroform-d1) 
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Spectrum 0-109: 13C{1H} NMR of 18 (150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-110: 1H 1H COSY of 18 (600.23 MHz, 300 K, chloroform-d1) 
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Spectrum 0-111: 1H 13C HMQC of 18 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
 
Spectrum 0-112: 1H 13C HMBC of 18 (600.23 MHz / 150.94 MHz, 300 K, chloroform-d1) 
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Spectrum 0-113: HRMS of 18 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-114: MIR of 18 
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Spectrum 0-115: FIR of 18 
16. Compound 19: 
 
Spectrum 0-116: 1H NMR of 19 (600.23 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-117: 13C{1H} NMR of 19 (150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-118: 1H 1H COSY of 19 (600.23 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-119: 1H 13C HMQC of 19 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-120: 1H 13C HMBC of 19 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-121: 1H 15N HMBC of 19 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-122: HRMS of 19 (Positive mode ESI, dichloromethane) 
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Spectrum 0-123: MIR of 19 
 
Spectrum 0-124: FIR of 19 
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17. Compound 20: 
 
Spectrum 0-125: 1H NMR of 20 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-126: 13C{1H} NMR of 20 (150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-127: 1H 1H COSY of 20 (600.23 MHz, 300 K, dichloromethane-d2) 
 
 
Spectrum 0-128: 1H 13C HMQC of 20 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
Appendix 
 
328 
 
 
Spectrum 0-129: 1H 13C HMBC of 20 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-130: 1H 15N HMBC of 20 (600.23 MHz / 43.3 MHz, 300 K, benzene-d6) 
Appendix 
329 
 
 
Spectrum 0-131: HRMS of 20 (Positive mode ESI, dichloromethane) 
18. Compound 21: 
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Spectrum 0-132: 1H NMR of 21 (600.23 MHz, 300 K, benzene-d6) 
 
Spectrum 0-133: 13C{1H} NMR of 21 (150.94 MHz, 300 K, benzene-d6) 
 
Spectrum 0-134: 1H 1H COSY of 21 (600.23 MHz, 300 K, benzene-d6) 
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Spectrum 0-135: 1H 13C HMQC of 21 (600.23 MHz / 150.94 MHz, 300 K, benzene-d6) 
 
Spectrum 0-136: 1H 13C HMBC of 21 (600.23 MHz / 150.94 MHz, 300 K, benzene-d6) 
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Spectrum 0-137: 1H 15N HMBC of 21 (600.23 MHz / 43.3 MHz, 300 K, benzene-d6) 
 
Spectrum 0-138: HRMS (Positive mode ESI, dichloromethane / MeOH) 
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Spectrum 0-139: MIR of 21 
 
Spectrum 0-140: FIR of 21 
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19. Compound 22: 
 
Spectrum 0-141: 1H NMR of 22 (600.23 MHz, 300 K, benzene-d6) 
 
Spectrum 0-142: 13C{1H} NMR of 22 (150.94 MHz, 300 K, benzene-d6) 
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Spectrum 0-143: 1H 1H COSY of 22 (600.23 MHz, 300 K, benzene-d6) 
 
Spectrum 0-144: 1H 13C HMQC of 22 (600.23 MHz / 150.94 MHz, 300 K, benzene-d6 
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Spectrum 0-145: 1H 13C HMBC of 22 (600.23 MHz / 150.94 MHz, 300 K, benzene-d6) 
 
Spectrum 0-146: 1H 15N HMBC of 22 (600.23 MHz / 43.3 MHz, 300 K, benzene-d6) 
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Spectrum 0-147: MIR of 22 
 
Spectrum 0-148: FIR of 22 
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20. Compound 23: 
 
Spectrum 0-149: 1H NMR of 23 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-150: 13C{1H} NMR of 23 (150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-151: 1H 1H COSY of 23 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-152: 1H 13C HMQC of 23 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-153: 1H 13C HMBC of 23 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-154: 1H 15N HMBC of 23 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-155: MIR of 23 
 
Spectrum 0-156: FIR of 23 
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21. Compound 24: 
 
Spectrum 0-157: 1H NMR of 24 (600.23 MHz, 300 K, tetrahydrofuran-d8) 
 
Spectrum 0-158: 13C{1H} NMR of 24 (150.94 MHz, 300 K, tetrahydrofuran-d8) 
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Spectrum 0-159: 1H 1H COSY of 24 (600.23 MHz, 300 K, tetrahydrofuran-d8) 
 
Spectrum 0-160: 1H 13C HMQC of 24 (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8) 
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Spectrum 0-161: 1H 13C HMBC of 24 (600.23 MHz / 150.94 MHz, 300 K, tetrahydrofuran-d8) 
 
Spectrum 0-162: 1H 15N HMBC of 24 (600.23 MHz / 43.3 MHz, 300 K, tetrahydrofuran-d8) 
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Spectrum 0-163: MIR of 24 
 
Spectrum 0-164: FIR of 24 
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B. Appendix Chapter III 
1. Compound 25: 
 
Spectrum 0-165: superposition of the 1H NMR spectra from 300K to 260 K (500.03 MHz, 260 K, 
dichloromethane-d2) 
 
Spectrum 0-166: 1H NMR of 25 (500.03 MHz, 260 K, dichloromethane-d2) 
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Spectrum 0-167: 13C{1H} NMR of 25 (125.75 MHz, 260 K, dichloromethane-d2) 
 
Spectrum 0-168: 1H 1H COSY of 25 (500.03 MHz, 260 K, dichloromethane-d2) 
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Spectrum 0-169: 1H 13C HMQC of 25 (500.03 MHz / 125.75 MHz, 260 K, dichloromethane-d2) 
 
Spectrum 0-170: H 13C HMBC of 25 (500.03 MHz / 125.75 MHz, 260 K, dichloromethane-d2) 
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Spectrum 0-171: 11B{1H} and 11B (οpiαχιφιεδ) of 25 (160.42 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-172: 19F{1H}
 
and 19F NMR of 25 (470.45 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-173: 1H 15N HMBC of 25 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-174: HRMS of 25 (Positive mode ESI, dichloromethane) 
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2. Compound 26: 
 
Spectrum 0-175: 1H NMR of 26 (500.03 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-176: 13C{1H} NMR of 26 (125.77 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-177: 1H 1H COSY of 26 (500.03 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-178: 1H 13C HMQC of 26 (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-179: 1H 13C HMBC of 26 (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-180: 1H 15N HMBC of 26 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-181: HRMS of 26 (Positive mode ESI, dichloromethane) 
3. Compound 27: 
 
Spectrum 0-182: 1H NMR of 27 (600.23 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-183: 13C{1H} NMR of 27 (125.77 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-184: 1H 1H COSY of 27 (500.03 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-185: 1H 13C HMQC of 27 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-186: 1H 13C HMBC of 27 (600.23 MHz / 150.944 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-187: 1H 15N HMBC of 27 (600.23 MHz / 60.83 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-188: HRMS of 27 (Positive mode ESI, dichloromethane) 
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Spectrum 0-189: MIR of 27 
 
Spectrum 0-190: FIR of 27 
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4. Compound 28: 
 
Spectrum 0-191: 1H NMR of 28 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-192: 13C{1H} NMR of 28 (150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-193: 1H 1H COSY of 28 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-194: 1H 13C HMQC of 28 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-195: 1H 13C HMBC of 28 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-196: 1H 15N HMBC of 28 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-197: HRMS of 28 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-198: MIR of 28 
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Spectrum 0-199: FIR of 28 
5. Compound 29: 
 
Spectrum 0-200: 1H NMR of 29 (600.23 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-201: 13C{1H} NMR of 29 (150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-202: 1H 1H COSY of 29 (600.23 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-203: 1H 13C HMQC of 29 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-204: 1H 13C HMBC of 29 (600.23 MHz / 150.94 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-205: 1H 15N HMBC of 29 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-206: HRMS of 29 (Positive mode ESI, dichloromethane) 
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Spectrum 0-207: MIR of 29 
 
Spectrum 0-208: FIR of 29 
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6. Attempted synthesis 27-III: 
 
Spectrum 0-209: 1H NMR spectrum of 27-III (600.23 MHz, 300K, tetrahydrofuran-d8) 
 
Spectrum 0-210: EPR spectrum of 27-III (9.437703 GHz, 295 K, pentane) 
Solvent peaks 
Grease 
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7. Attempted synthesis of 29-III: 
 
Spectrum 0-211: 1H NMR spectrum of 29-III (500.53 MHz, 300K, tetrahydrofuran-d8) 
 
Spectrum 0-212: EPR spectrum of 29-III (9.437952 GHz, 295 K, pentane) 
Solvent peaks 
Grease 
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8. Compound 30: 
 
Spectrum 0-213: 1H NMR of 30 (500.03 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-214: 13C{1H} NMR of 30 (125.77 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-215: 1H 1H COSY of 30 (500.03 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-216: 1H 13C HMQC of 30 (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-217: 1H 13C HMBC of 30 (500.03 MHz / 125.77 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-218: 19F{1H} and 19F(οpiαχιφιεδ) NMR of 30 (470.45 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-219: 1H 15N HMBC of 30 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-220: HRMS of 30 (Positive mode ESI, dichloromethane) 
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9. Compound 32: 
 
Spectrum 0-221: 1H NMR of 32 (500.03 MHz, 300 K, benzene-d6) 
 
Spectrum 0-222: 13C{1H} NMR of 32 (125.75 MHz, 300 K, benzene-d6) 
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Spectrum 0-223: 1H 1H GCOSY of 32 (500.03 MHz, 300 K, benzene-d6) 
 
Spectrum 0-224: 1H 13C HMQC of 32 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
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Spectrum 0-225: 1H 13C HMBC of 32 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-226: 1H 15N HMBC of 32 (600.23 MHz / 43.3 MHz, 300 K, benzene-d6) 
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Spectrum 0-227: HRMS of 32 (Positive mode ESI, dichloromethane + methanol) 
 
10. Compound 33: 
 
Spectrum 0-228: 1H NMR of 33 (500.03 MHz, 300 K, benzene-d6) 
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Spectrum 0-229: 13C{1H} NMR of 33 (125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-230: 1H 1H COSY of 33 (500.03 MHz, 300 K, benzene-d6) 
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Spectrum 0-231: 1H 13C HMQC of 33 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-232: 1H 13C HMBC of 33 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
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Spectrum 0-233: 1H 15N HMBC of 33 (600.23 MHz / 43.3 MHz, 300 K, benzene-d6) 
 
Spectrum 0-234: HRMS of 33 (Positive mode ESI, dichloromethane) 
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11. Compound 34: 
 
Spectrum 0-235: 1H NMR of 34 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-236: 13C{1H} NMR of 34 (150.9 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-237: 1H 1H COSY of 34 (600.23 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-238: 1H 13C HMQC of 34 (600.23 MHz / 150.9 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-239: 1H 13C HMBC of 34 (600.23 MHz / 150.9 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-240: 1H 15N HMBC of 34 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-241: HRMS of 34 (Positive mode ESI, dichloromethane + methanol) 
 
Spectrum 0-242: MIR of 34 
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Spectrum 0-243: FIR of 34 
 
12. Compound 35: 
 
Spectrum 0-244: 1H NMR of 35 (600.23 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-245: 13C{1H} NMR of 35 (150.9 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-246: 1H 1H COSY of 35 (600.23 MHz, 300 K, dichloromethane-d2): 
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Spectrum 0-247: 1H 13C HMQC of 35 (600.23 MHz / 150.9 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-248: 1H 13C HMBC of 35 (600.23 MHz / 150.9 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-249: 1H 15N HMBC of 35 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-250: HRMS of 35 (Positive mode ESI, dichloromethane + methanol) 
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Spectrum 0-251: MIR of 35 
 
Spectrum 0-252: FIIR of 35 
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13. Compound 36: 
 
Spectrum 0-253: 1H NMR of 36 (500.03 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-254: 13C{1H} NMR of 36 (125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-255: 1H 1H COSY of 36 (500.03 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-256: 1H 13C HMQC of 36 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-257: 1H 13C HMBC of 36 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-258: 1H 15N HMBC of 36 (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-259: 11B{1H} and 11B (opacified) NMR of 36 (160.42 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-260: 19F{1H} and 19F(opacified) NMR of 36 (470.45 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-261: HRMS of 36 (Positive mode ESI, bromobenzene) 
 
14. Compound 37: 
 
Spectrum 0-262: 1H NMR of 37 (500.03 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-263: Superposition of 1H NMR spectrum (bottom) and 1H{31P} spectrum (top) of 37 
 
Spectrum 0-264: 13C{1H} NMR of 37 (125.75 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-265: 1H 1H COSY of 37 (500.03 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-266: 1H 13C HMBC of 37 (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-267: 1H 13C HMBC of 37 (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-268: 1H 15N HMBC of 37 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-269: 11B{1H} NMR and 11B (opacified) of 37 (160.42 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-270: 19F{1H} NMR and 19F (opacified) of 37 (470.45 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-271: 31P{1H} NMR and 31P (opacified) of 37 (202.46 MHz, 300 K, dichloromethane-d2) 
 
 
Spectrum 0-272: HRMS of 37 (Positive mode ESI, dichloromethane) 
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15. Compound 38: 
 
Spectrum 0-273: 1H NMR of 38 (500.03 MHz, 263 K, bromobenzene-d5) 
 
Spectrum 0-274: 13C{1H} NMR of 38 (125.75 MHz, 263 K, bromobenzene-d5) 
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Spectrum 0-275: 1H 1H COSY of 38 (500.03 MHz, 263 K, bromobenzene-d5) 
 
Spectrum 0-276: 1H 13C HMQC 38 (500.03 MHz / 125.03 MHz, 263 K, bromobenzene-d5) 
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Spectrum 0-277: 1H 13C HMBC of 38 (500.03 MHz / 125.03 MHz, 263 K, bromobenzene-d5) 
 
Spectrum 0-278: 11B{1H} and 11B (opacified) NMR of 38 (160.42 MHz, 263 K, bromobenzene-d5) 
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Spectrum 0-279: 19F{1H} and 19F (opacified) NMR of 38 (470.45 MHz, 263 K, bromobenzene-d5) 
 
Spectrum 0-280: 1H 15N HMBC of 38 (600.23 MHz / 43.3 MHz, 263 K, bromobenzene-d5) 
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Spectrum 0-281: HRMS of 38 (Positive mode ESI, bromobenzene) 
16. Compound 39: 
 
Spectrum 0-282: 1H NMR of 39 (500.03 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-283: 13C{1H} NMR of 39 (125.75 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-284: 13C{1H} NMR of 39 (125.75 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-285: 1H 13C HMQC of 39 (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-286: 1H 13C HMBC of 39 (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-287: 1H 15N HMBC of 39 (600.23 MHz / 43.3 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-288: 11B{1H} and 11B (opacified) NMR of 39 (160.42 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-289: 19F{1H} and 19F (opacified) NMR of 39 (470.45 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-290 HRMS of 39 (Positive mode ESI, tetrahydrofuran) 
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17. Compound 40: 
 
Spectrum 0-291: 1H NMR of 40 (500.03 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-292: 13C{1H} NMR of 40 (125.75 MHz, 300 K, bromobenzene-d5) 
Appendix 
 
410 
 
 
 
Spectrum 0-293: 13C{1H} NMR (top) superposed with dept135 NMR (bottom) of 40 (125.75 MHz, 300 K, 
bromobenzene-d5) 
 
Spectrum 0-294: 1H 1H COSY of 40 (500.03 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-295: 1H 13C HMQC of 40 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-296: 1H 13C HMBC of 40 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-297: 11B{1H} and 11B (opacified) NMR of 40 (160.42 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-298: 19F{1H} and 19F (opacified) NMR of 40 (470.45 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-299: 1H 15N HMBC of 40 (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-300: HRMS of 40 (Positive mode ESI, bromobenzene) 
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18. Compound 41: 
 
Spectrum 0-301: 1H NMR of 41 (500.03 MHz, 300 K, bromobenzene-d5) 
 
 
Spectrum 0-302: 13C{1H} NMR of 41 (125.75 MHz, 300 K, bromobenzene-d5) 
Appendix 
415 
 
 
Spectrum 0-303: 13C{1H} (top) correlated with dept135 (bottom) NMR of 41 (125.75 MHz, 300 K, 
bromobenzene-d5) 
 
Spectrum 0-304: 1H 1H COSY of 41 (500.03 MHz, 300 K, 300 K, bromobenzene-d5) 
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Spectrum 0-305: 1H 13C HMQC of 41 (500.03 MHz / 125.03 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-306: 1H 13C HMBC of 41 (500.03 MHz / 125.03 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-307: 1H 15N HMBC of 41 (500.03 MHz / 43.3 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-308: 11B{1H} and 11B (opacified) NMR of 41 (160.42 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-309: 19F{1H} and 19F (opacified) NMR of 41 (470.45 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-310: HRMS of 41 
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19. Compound 46-OPEt3: 
 
Spectrum 0-311: EPR of 46-OPEt3 (9.439232 GHz, 300K, bromobenzene) 
 
Spectrum 0-312: HRMS of 46-OPEt3 (Positive mode ESI, bromobenzene) 
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Spectrum 0-313: HRMS of 46-OPEt3 (Positive mode ESI, bromobenzene) 
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20. Reactivity studies: 
a. In situ characterization of 42: 
 
Spectrum 0-314: 1H NMR of 42 (500.03 MHz, 258 K, bromobenzene-d5) 
 
Spectrum 0-315: 13C{1H} NMR of 42 (125.75 MHz, 258 K, bromobenzene-d5) 
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Spectrum 0-316: 13C{1H} NMR (top) of 42 correlated with dept135 (bottom) (125.75 MHz, 258 K, 
bromobenzene-d5) 
 
Spectrum 0-317: 1H 1H COSY of 42 (500.03 MHz, 300 K, 258 K, bromobenzene-d5) 
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Spectrum 0-318: 1H 13C HMQC of 42 (600.23 MHz / 150.94 MHz, 258 K, bromobenzene-d5) 
 
Spectrum 0-319: 1H 13C HMBC of 42 (600.23 MHz / 150.94 MHz, 258 K, bromobenzene-d5) 
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Spectrum 0-320: 11B{1H} and 11B(opacified) NMR
 
of 42 (160.42 MHz, 258 K, bromobenzene-d5) 
 
Spectrum 0-321: 19F{1H} and 19F(opacified) NMR of 42 (470.45 MHz, 258 K, bromobenzene-d5) 
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Spectrum 0-322: 1H 15N HMBC of 42 (600.23 MHz / 43.3 MHz, 258 K, bromobenzene-d5) 
 
Spectrum 0-323: HRMS of 42 (Positive mode ESI, bromobenzene) 
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Spectrum 0-324: EPR spectrum of 42 (9.9.428487 GHz, 295K, bromobenzene) 
b. In situ characterization of 43: 
 
Spectrum 0-325: 1H NMR of 43 (500.03 MHz, 273 K, bromobenzene-d5) 
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Spectrum 0-326: 13C{1H} NMR of 43 (125.75 MHz, 273 K, bromobenzene-d5) 
 
Spectrum 0-327: 13C{1H} NMR of 43 (top) correlated with dept 135 (bottom) (25.75 MHz, 273 K, 
bromobenzene-d5) 
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Spectrum 0-328: 1H 1H COSY of 43 (500.03 MHz, 273 K, bromobenzene-d5) 
 
 
Spectrum 0-329: 1H 13C HMQC of 43 (600.23 MHz / 150.94 MHz, 273 K, bromobenzene-d5) 
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Spectrum 0-330: 1H 13C HMBC of 43 (600.23 MHz / 150.94 MHz, 273 K, bromobenzene-d5) 
 
Spectrum 0-331: 11B{1H} and 11B(opacified) NMR
 
of 43 (160.42 MHz, 273 K, bromobenzene-d5) 
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Spectrum 0-332: 19F{1H} and 19F(opacified) NMR of 43 (470.45 MHz, 273 K, bromobenzene-d5) 
 
Spectrum 0-333: 1H 15N HMBC of 43 (600.23 MHz / 43.3 MHz, 273 K, bromobenzene-d5) 
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Spectrum 0-334: HRMS of 43 (Positive mode ESI, bromobenzene) 
 
 
Spectrum 0-335: HRMS of 43 (Positive mode ESI, bromobenzene) 
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Spectrum 0-336: EPR spectrum of 43 (9.436937 GHz, 295K, bromobenzene) 
 
c. Attempted synthesis 44: 
 
Spectrum 0-337: 1H NMR of 44 (600.23 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-338: 1H{31P} NMR (top) superposed with 1H NMR (bottom) of 44 (500.03 MHz, 300 K, 
bromobenzene-d5) 
 
 
Spectrum 0-339: 13C{1H} NMR of 44 (125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-340: 1H 1H COSY of 44 (500.03 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-341: 1H 13C HMQC of 44 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-342: 1H 13C HMBC of 44 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-343: 31P{1H} and 31P (opacified) NMR of 44 (202.46 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-344: 11B{1H} and 11B (opacified) NMR of 44 (160.42 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-345: 19F{1H} and 19F (opacified) NMR of 44 (470.45 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-346: 1H 15N HMBC of 44 (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-347: EPR of 44 (9.444823 GHz, 295K, bromobenzene) 
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Spectrum 0-348: HRMS of 44 (Positive mode ESI, bromobenzene) 
 
d. Attempted synthesis 45: 
 
Spectrum 0-349: 1H NMR of 45 (500.03 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-350: 1H{31P} NMR (top) superposed with 1H NMR (bottom) of 45 (600.23 MHz, 300 K, 
bromobenzene-d5) 
 
 
Spectrum 0-351: 13C{1H} NMR of 45 (125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-352: 1H 1H COSY of 45 (500.03 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-353: 1H 13C HMQC of 45 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-354: 1H 13C HMBC of 45 (600.23 MHz / 150.86 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-355: 31P{1H} and 31P (opacified) NMR of 45 (202.46 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-356: 11B{1H} and 11B (opacified) NMR of 45 (160.42 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-357: 19F{1H} and 19F (opacified) NMR of 45 (470.45 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-358: 1H 15N HMBC of 45 (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5)
Sectrum 0-359: EPR of 45 (9.445560 GHz, 300K, bromobenzene) 
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Spectrum 0-360: HRMS of 45 (Positive mode ESI, bromobenzene) 
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Spectrum 0-361: HRMS of 45 (Positive mode ESI, bromobenzene) 
 
e. In situ characterization of 47: 
 
Spectrum 0-362: 1H NMR of 47 (600.23 MHz, 273 K, bromobenzene-d5) 
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re
 
Spectrum 0-363: 13C{1H} NMR of 47 (125.75 MHz, 273 K, bromobenzene-d5) 
 
Spectrum 0-364: 13C{1H} NMR (top) correlated with dept135 (bottom) of 47 (125.75 MHz, 273 K, 
bromobenzene-d5) 
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Spectrum 0-365: 1H 1H COSY of 47 (500.03 MHz, 273 K, bromobenzene-d5) 
 
Spectrum 0-366: 1H 1H NOESY of 47 (600.23 MHz, 273 K, bromobenzene-d5 
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Spectrum 0-367: 1H 13C HMQC of 47 (500.03 MHz / 125.75 MHz, 273 K, bromobenzene-d5) 
 
Spectrum 0-368: 1H 13C HMBC of 47 (500.03 MHz / 125.75 MHz, 273 K, bromobenzene-d5) 
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Spectrum 0-369: 11B{1H} and 11B (opacified) NMR of 47 (160.42 MHz, 273 K, bromobenzene-d5) 
 
Spectrum 0-370: 19F{1H} and 19F (opacified) NMR of 47 (470.45 MHz, 273 K, bromobenzene-d5) 
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Spectrum 0-371: 1H 15N HMBC of 47 (600.23 MHz / 43.3 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-372: HRMS of 47 (Positive mode ESI, bromobenzene) 
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f. In situ characterization of 48: 
 
Spectrum 0-373: 1H NMR of 48 (600.23 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-374: 1H{31P} NMR of 48 (600.23 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-375: 1H{31P} NMR of 48 (600.23 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-376: 31P{1H} NMR of 48 (243.0 MHz, 300 K, bromobenzene-d5) 
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21. EPR study: 
a. In situ characterization of 46: 
The same procedure as 46-OPEt3 was followed but EPR spectroscopy was recorded without 
stabilization with any phosphine oide. 
 
 
 
b. Crude EPR of 46-OPEt3: 
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c. Crude EPR of 45: 
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d. Additional experiment: 
Slow addition of Ph3C+ on 34 then EPR measurement: 
 
 
Attenuation: 20 dB 
Gain: 50 dB 
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C. Appendix Chapter IV 
22. Compound 50: 
 
Spectrum 0-377: 1H NMR of 50 (500.03 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-378: 1H{31P} NMR (top) correlated with 1H (bottom) of 50 (500.03 MHz, 300 K, bromobenzene-
d5) 
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Spectrum 0-379: 13C{1H} NMR of 50 (125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-380: dept135 NMR of 50 (125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-381: 31P{1H} and 31P (opacified) NMR of 50 (202.41 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-382: 1H 1H COSY of 50 (500.03 MHz, 300 K, 273 K, bromobenzene-d5) 
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Spectrum 0-383: 1H 13C HMQC of 50 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-384: 1H 13C HMBC of 50 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-385: 11B{1H} and 11B NMR of 50 (160.43 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-386: 19F{1H} and 19F NMR of 50 (470.45 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-387: HRMS of 50 (Positive mode ESI, dichloromethane) 
23. Compound 51: 
 
Spectrum 0-388: 1H NMR of 51 (500.03 MHz, 300 K, bromobenzene-d5) 
Appendix 
463 
 
 
Spectrum 0-389: 1H{31P} NMR (top) correlated with 1H (bottom) of 51 (500.03 MHz, 300 K, bromobenzene-
d5) 
 
Spectrum 0-390: 13C{1H} NMR of 51 (125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-391: 31P{1H} and 31P (opacified) NMR of 51 (202.41 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-392: 1H 1H COSY of 51 (500.03 MHz, 300 K, 273 K, bromobenzene-d5) 
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Spectrum 0-393: 1H 13C HMQC of 51 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-394: 1H 13C HMBC of 51 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
Appendix 
 
466 
 
 
Spectrum 0-395: 11B{1H} and 11B NMR of 51 (160.43 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-396: 19F{1H} and 19F NMR of 51 (470.45 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-397: HRMS of 51 (Positive mode ESI, dichloromethane) 
24. Compound 52: 
 
Spectrum 0-398: 1H NMR of 52 (500.03 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-399: 1H{31P} NMR (top) correlated with 1H (bottom) of 52 (500.03 MHz, 300 K, bromobenzene-
d5) 
 
Spectrum 0-400: 13C{1H} NMR of 52 (125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-401: 31P{1H} and 31P (opacified) NMR of 52 (202.41 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-402: 1H 1H COSY of 52 (500.03 MHz, 300 K, 273 K, bromobenzene-d5) 
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Spectrum 0-403: 1H 13C HMQC of 52 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-404: 1H 13C HMBC of 52 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-405: 11B{1H} and 11B NMR of 52 (160.43 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-406: 19F{1H} and 19F NMR of 52 (470.45 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-407: HRMS of 52 (Positive mode ESI, bromobenzene) 
25. Compound 53: 
 
 
Spectrum 0-408: 1H NMR of 53 (500.03 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-409: 13C{1H} NMR of 53 (125.75 MHz, 300 K, bromobenzene-d5) 
 
 
Spectrum 0-410: 1H 1H COSY of 53 (500.03 MHz, 300 K, 273 K, bromobenzene-d5) 
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Spectrum 0-411: 1H 13C HMQC of 53 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-412: 1H 13C HMBC of 53 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-413: 1H 15N HMBC of 53 (500.03 MHz / 43.3 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-414: 11B{1H} and 11B NMR of 53 (160.43 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-415: 19F{1H} and 19F NMR of 53 (470.45 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-416: EPR spectrum of 53 (9.440489 GHz, 295 K, Bromobenzene) 
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26. Compound 54: 
 
Spectrum 0-417: 1H NMR of 54 (500.03 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-418: 13C{1H} NMR of 54 (125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-419: 1H 1H COSY of 54 (500.03 MHz, 300 K, 273 K, bromobenzene-d5) 
 
Spectrum 0-420: 1H 13C HMQC of 54 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-421: 1H 13C HMBC of 54 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-422: 1H 15N HMBC of 54 (500.03 MHz / 43.3 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-423: 11B{1H} and 11B NMR of 54 (160.43 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-424: 19F{1H} and 19F NMR of 54 (470.45 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-425: EPR spectrum of 54 (9.439933 GHz, 295 K, Bromobenzene) 
 
27. Compound 55: 
 
Spectrum 0-426: 1H NMR of 55 (500.03 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-427: 13C{1H} NMR of 55 (125.75 MHz, 300 K, bromobenzene-d5) 
 
 
Spectrum 0-428: 1H 1H COSY of 55 (500.03 MHz, 300 K, 273 K, bromobenzene-d5) 
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Spectrum 0-429: 1H 13C HMQC of 55 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-430: 1H 13C HMBC of 55 (500.03 MHz / 125.75 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-431: 1H 15N HMBC of 55 (500.03 MHz / 43.3 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-432: 11B{1H} and 11B NMR of 55 (160.43 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-433: 19F{1H} and 19F NMR of 55 (470.45 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-434: EPR spectrum of 55 (9.439554 GHz, 295 K, Bromobenzene) 
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28. Compound 56: 
 
Spectrum 0-435: 1H NMR of 56 (500.03 MHz, 300 K, tetrahydrofuran-d5) 
 
Spectrum 0-436: 13C{1H} NMR of 56 (125.75 MHz, 300 K, tetrahydrofuran-d5) 
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Spectrum 0-437: 1H 1H COSY of 56 (500.03 MHz, 300 K, 273 K, tetrahydrofuran-d5) 
 
Spectrum 0-438: 1H 13C HMQC of 56 (500.03 MHz / 125.75 MHz, 300 K, tetrahydrofuran-d5) 
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Spectrum 0-439: 1H 13C HMBC of 56 (500.03 MHz / 125.75 MHz, 300 K, tetrahydrofuran-d5) 
 
Spectrum 0-440: 11B{1H} and 11B NMR of 56 (160.43 MHz, 300 K, tetrahydrofuran-d5) 
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Spectrum 0-441: 19F{1H} and 19F NMR of 56 (470.45 MHz, 300 K, tetrahydrofuran-d5) 
 
Spectrum 0-442: HRMS of 56 (Positive mode ESI, tetrahydrofuran) 
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Spectrum 0-443: HRMS of 56 (Positive mode ESI, tetrahydrofuran) 
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Spectrum 0-444: EPR spectrum of 56 (9.439554 GHz, 295 K, Bromobenzene)  
 
 
29. Reactivity studies: 
a. EPR study: 
 
A 0.02M solution of amido Ti(IV) complexes in THF was irradiated in three sequences of 20 
min with a medium pressure Hg lamp (Heraeus TQ 150). 
The EPR spectrum before irradiation revealed the presence of the [Cp2Ti(THF)2]+ cation along 
with an unknown, minor product. After irradiation, only [Cp2Ti(THF)2]+ was observed. The NMR 
indicated that the only P-containing NMR active species were HPPh2 and (PPh2)2, while the 
only B-containing NMR active species was B(C6F5)4-. 
N.B.: The 31P{1H} NMR spectrum of 50 in d8-THF was also recorded, suggesting the presence 
(in addition to 50) of free HPPh2 (δ = -42.9 ppm) and of the putative phosphidotitanocene cation 
[Cp2Ti(PPh2)(THF)n]+ (δ = 388.7 ppm). 
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(1) Compound 50: 
 
Spectrum 0-445 : EPR before irradiation (THF, 295 K) 
 
Spectrum 0-446: EPR after irradiation (THF, 295 K) 
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Spectrum 0-447: 31P{1H} NMR (202 MHz, d8-THF, 300K), no irradiation. 
 
Spectrum 0-448:11B{1H} NMR (160 MHz) and 31P{1H} NMR (202 MHz) (THF, 300K, no lock) after irradiation 
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(2) Compound 51: 
The EPR spectrum before irradiation revealed the presence of the [Cp2Ti(THF)2]+ cation along 
with an unknown, minor product. After irradiation, only [Cp2Ti(THF)2]+ was observed. The NMR 
indicated that the main P-containing NMR active species was HPCy2, while the only B-
containing NMR active species was B(C6F5)4-. 
N.B.: The 31P{1H} NMR spectrum of 3f in THF (no lock) was also recorded, showing extensive 
decomposition. 
 
Spectrum 0-449:EPR before irradiation (THF, 295 K) 
 
Spectrum 0-450: EPR after irradiation (THF, 295 K) 
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Spectrum 0-451: 31P{1H} NMR (243 MHz, THF, 300K, no lock), no irradiation. 
 
Spectrum 0-452: 11B{1H} NMR (160 MHz) and 31P{1H} NMR (202 MHz) (THF, 300K, no lock) after irradiation 
 
The final irradiated residue after evaporation was analysed by NMR spectroscopy. While all 
1H NMR showed complex mixture, the only B- and F-containing NMR active species was 
B(C6F5)4-. 
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(3) Compound 53: 
 
 
Spectrum 0-453: EPR before irradiation (9.439089GHz, 295 K, THF) 
 
Spectrum 0-454: EPR spectrum after irradiation (9.434780 GHz, 295 K, THF) 
Appendix 
497 
 
 
Spectrum 0-455 : 11B{1H} and 19F{1H} NMR spectra of 53 after irradiation (500.03 MHz, 300 K, 
tetrahydrofuran-d8) 
(4) Compound 54: 
 
Spectrum 0-456: EPR spectrum of 54 before irradiation (9.438876 GHZ, 295 K THF) 
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Spectrum 0-457: EPR spectrum of 54 after irradiation (9.435437, 295 K, THF) 
 
Spectrum 0-458: 11B{1H} and 19F{1H} NMR spectra of 54 after irradiation (500.03 MHz, 300 K, 
tetrahydrofuran-d8) 
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(5) Compound 55: 
 
Spectrum 0-459 : EPR spectrum of 55 before irradiation (9.437043, 295 k, THF) 
 
Spectrum 0-460: EPR spectra of 55 after irradiation (9.435333, 295 K, THF) 
Attenuation: 30 dB 
Gain: 40 dB 
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Spectrum 0-461: 11B{1H} and 19F{1H} NMR spectra of 55 after irradiation (500.03 MHz, 300 K, 
tetrahydrofuran-d8) 
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b. Catalytic hydrogenation 
 
Procedure A: for catalytic hydrogenation: A 0.048 M solution of trimethoxybenzene (TMB) was 
prepared in C6H5Br. Protocol for a classical run: The substrate (960.0 µmol) and the catalyst 
(19.2  µmol, 2 mol%) were introduced in a 25 mL Schlenk tube and 1.0 mL of the TMB solution 
was added οpiαχιφιεδ the Glovebox. The resulting solution was frozen, and degassed. An 
aliquot of the resulting solution was collected mixed up with CDCl3 and the mixture was 
analyzed by 1H NMR spectroscopy. 
Procedure B: (for higher loading and concentration run) The substrate (480.0 µmol) and the 
catalyst (19.2  µmol, 4 mol%) were introduced in a 25 mL Schlenk tube and 0.50 mL of the 
TMB solution was added οpiαχιφιεδ the Glovebox. The resulting solution was frozen, and 
degassed. An aliquot of the resulting solution was collected mixed up with CDCl3 and the 
mixture was analyzed by 1H NMR spectroscopy. 
1H NMR spectra of representative catalytic runs: 
 
Spectrum 0-462: Hydrogenation of styrene with 53 (600.23 MHz, 300K, Chloroform-d1) 
trimethoxybenzene 
ethylbenzene 
styrene 
Bromobenzene  
 chloroform-d1 
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Spectrum 0-463 : Hydogenation of 3,3-dimethylbutene with 53 (500.03 MHz, 300K, Chloroform-d1) 
 
Spectrum 0-464: Hydogenation of perfluorostyrene with 53 (500.03 MHz, 300K, Chloroform-d1) 
2,2-dimethylbutane 
3,3-dimethylbutene trimethoxybenzene 
Bromobenzene  
 chloroform-d1 
Bromobenzene  
 chloroform-d1 
ethylperfluorobenzene 
perfluorostyrene trimethoxybenzene 
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Spectrum 0-465: Hydogenation of diphenylacetylene with 53 (500.03 MHz, 300K, Chloroform-d1) 
 
Spectrum 0-466: Hydogenation of benzalanaline with 53 (500.03 MHz, 300K, Chloroform-d1) 
  
trimethoxybenzene diphenylethane 
Cis-stillbene 
diphenylacetylene 
Bromobenzene  
 chloroform-d1 
trimethoxybenzene 
Bromobenzene  
 chloroform-d1 
benzalanaline 
N-benzylaniline 
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D. Appendix Chapter V 
 
 
30. Compound 57: 
 
Spectrum 0-467: 1H NMR of 57 (500.03 MHz, 300 K, benzene-d6) 
 
Spectrum 0-468: 1H{31P} NMR (top) correlated with 1H NMR (bottom) of 57 (600.23 MHz, 300 K, benzene-d6) 
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Spectrum 0-469: 13C{1H} NMR of 57 (125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-470: 1H 1H COSY of 57 (500.03 MHz, 300 K, 273 K, benzene-d6) 
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Spectrum 0-471: 1H 13C HMQC of 57 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-472: 1H 13C HMBC of 57 (600.23 MHz / 150.86 MHz, 300 K, benzene-d6) 
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Spectrum 0-473: HRMS of 57 (Positive mode ESI, dichloromethane) 
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Spectrum 0-474: MIR of 57 
 
Spectrum 0-475: FIR of 57 
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31. Compound 58: 
 
Spectrum 0-476: 1H NMR of 58 (500.03 MHz, 300 K, benzene-d6) 
 
Spectrum 0-477: 1H{31P} NMR (top) superposed with 1H NMR (bottom) of 58 (500.03 MHz, 300 K, benzene-
d6) 
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Spectrum 0-478: 13C{1H} NMR of 58 (125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-479: 1H 1H COSY of 58 (500.03 MHz, 300 K, 273 K, benzene-d6) 
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Spectrum 0-480: 1H 13C HMQC of 58 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-481: 1H 13C HMBC of 58 (600.23 MHz / 150.86 MHz, 300 K, benzene-d6) 
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Spectrum 0-482: 31P{1H} and 31P (opacified) NMR of 58 (202.46 MHz, 300 K, benzene-d6) 
 
Spectrum 0-483: HRMS of 58 (Positive mode ESI, dichloromethane) 
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Spectrum 0-484: HRMS of 58 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-485: MIR of 58 
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Spectrum 0-486: FIR of 58 
32. Compound 59:  
 
Spectrum 0-487: 1H NMR of 59 (500.03 MHz, 300 K, benzene-d6) 
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Spectrum 0-488: 1H{31P} NMR (top) correlated with 1H NMR (bottom) of 59 (500.03 MHz, 300 K, benzene-d6) 
 
Spectrum 0-489: 13C{1H} NMR of 59 (125.75 MHz, 300 K, benzene-d6) 
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Spectrum 0-490: 1H 1H COSY of 59 (500.03 MHz, 300 K, 273 K, benzene-d6) 
 
Spectrum 0-491: 1H 13C HMQC of 59 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
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Spectrum 0-492: 1H 13C HMBC of 59 (600.23 MHz / 150.86 MHz, 300 K, benzene-d6) 
 
Spectrum 0-493: 31P{1H} and 31P(opacified) NMR of 59 (202.46 MHz, 300 K, benzene-d6) 
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Spectrum 0-494: HRMS of 59 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-495: HRMS of 59 (Positive mode ESI, dichloromethane) 
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Spectrum 0-496: HRMS of 59 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-497: MIR of 59 
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Spectrum 0-498: FIR of 59 
33. Compound 60: 
 
 
Spectrum 0-499: 1H NMR of 60 (600.23 MHz, 300 K, benzene-d6) 
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Spectrum 0-500: 1H{31P} NMR (top) correlated with 1H NMR (bottom) of 60 (600.23 MHz, 300 K, benzene-d6) 
 
Spectrum 0-501: 13C{1H} NMR of 60 (150.94 MHz, 300 K, benzene-d6) 
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Spectrum 0-502: 1H 1H COSY of 60 (600.23 MHz, 300 K, 273 K, benzene-d6) 
 
Spectrum 0-503: 1H 13C HMQC of 60 (600.23 MHz / 150.94 MHz, 300 K, benzene-d6) 
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Spectrum 0-504: 1H 13C HMBC of 60 (600.23 MHz / 150.94 MHz, 300 K, benzene-d6) 
 
Spectrum 0-505: 31P{1H} and 31P(opacified) NMR of 60 (202.41 MHz, 300 K, benzene-d6) 
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Spectrum 0-506: HRMS of 60 (Positive mode ESI, dichloromethane) 
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Spectrum 0-507: HRMS of 60 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-508: MIR of 60 
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Spectrum 0-509: FIR of 60 
34. Compound 61: 
 
Spectrum 0-510: 1H NMR of 61 (500.03 MHz, 300 K, benzene-d6) 
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Spectrum 0-511: 1H{31P} NMR (top) correlated with 1H NMR (bottom) of 61 (500.03 MHz, 300 K, benzene-d6) 
 
Spectrum 0-512: 13C{1H} NMR of 61 (125.75 MHz, 300 K, benzene-d6) 
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Spectrum 0-513: 13C{1H} and dept135 NMR superposition of 61 (125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-514: 1H 1H COSY of 61 (500.03 MHz, 300 K, 273 K, benzene-d6) 
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Spectrum 0-515: 1H 13C HMQC of 61 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-516: 1H 13C HMBC of 61 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
Appendix 
 
530 
 
 
Spectrum 0-517: 31P{1H} and 31P (opacified) NMR of 61 (202.46 MHz, 300 K, benzene-d6) 
 
Spectrum 0-518: 11B{1H} and 11B NMR(opacified) of 61 (160.42 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-519: 19F{1H} and 19F NMR(opacified) of 61 (470.45 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-520: HRMS of 61 (Positive mode ESI, dichloromethane) 
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Spectrum 0-521: HRMS of 61 (Positive mode ESI, dichloromethane) 
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35. Compound 62: 
 
Spectrum 0-522: 1H NMR of 62 (500.03 MHz, 300 K, benzene-d6) 
 
Spectrum 0-523: 1H{31P} NMR (top) correlated with 1H (bottom) of 62 (600.23 MHz, 300 K, benzene-d6) 
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Spectrum 0-524: 13C{1H} NMR of 62 (125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-525: 1H 1H COSY of 62 (500.03 MHz, 300 K, 273 K, benzene-d6) 
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Spectrum 0-526: 1H 13C HMQC of 62 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-527: 1H 13C HMBC of 62 (600.23 MHz / 150.86 MHz, 300 K, benzene-d6) 
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Spectrum 0-528: 31P{1H} and 31P (opacified) NMR
 
of 62 (202.46 MHz, 300 K, benzene-d6)
 
Spectrum 0-529: HRMS of 62 (Positive mode ESI, dichloromethane) 
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Spectrum 0-530: HRMS of 62 (Positive mode ESI, dichloromethane) 
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Spectrum 0-531: MIR of 62 
 
Spectrum 0-532: FIR of 62 
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36. Compound 63: 
 
Spectrum 0-533: 1H NMR of 63 (500.03 MHz, 300 K, benzene-d6) 
 
Spectrum 0-534: 1H{31P} NMR (top) correlated with 1H (bottom) of 63 (600.23 MHz, 300 K, benzene-d6) 
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Spectrum 0-535: 13C{1H} NMR of 63 (125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-536: 1H 1H COSY of 63 (500.03 MHz, 300 K, 273 K, benzene-d6) 
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Spectrum 0-537: 1H 13C HMQC of 63 (500.03 MHz / 125.75 MHz, 300 K, benzene-d6) 
 
Spectrum 0-538: 1H 13C HMBC of 63 (600.23 MHz / 150.86 MHz, 300 K, benzene-d6) 
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Spectrum 0-539: 31P{1H} and 31P (opacified) NMR
 
of 63 (202.46 MHz, 300 K, benzene-d6)
 
Spectrum 0-540: HRMS of 63 (Positive mode ESI, dichloromethane) 
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Spectrum 0-541: HRMS of 63 (Positive mode ESI, dichloromethane) 
 
Spectrum 0-542: MIR of 63 
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Spectrum 0-543: FIR of 63 
 
37. Compound 64: 
 
Spectrum 0-544 1H NMR superposition of 64 (600 MHz, 240-360K, bromobenzene-d5) 
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Spectrum 0-545: 1H NMR superposition 3.00-1.75 ppm of 64 (600 MHz, 240-360K, bromobenzene-d5) 
 
Spectrum 0-546: 1H NMR superposition 7.6-4.8 ppm of 64 (600 MHz, 240-360K, bromobenzene-d5) 
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Spectrum 0-547: 1H NMR of 64 (600.23 MHz, 360 K, bromobenzene-d5) 
 
Spectrum 0-548: 1H{31P} NMR of 64 (600.23 MHz, 360 K, bromobenzene-d5) 
Appendix 
547 
 
v
 
Spectrum 0-549: 31P{1H} NMR of 64 (202.46 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-550: 13C{1H} NMR of 64 (150.94 MHz, 360 K, bromobenzene-d5) 
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Spectrum 0-551: 13C{1H} NMR (top) correlated with dep135 (bottom) of 64 (150.94 MHz, 360 K, 
bromobenzene-d5) 
 
Spectrum 0-552: 1H 1H COSY of 64 (500.03 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-553: 1H 13C HMQC of 64 (600.23 MHz / 150.94 MHz, 360 K, bromobenzene-d5) 
 
Spectrum 0-554: 1H 13C HMBC of 64 (600.23 MHz / 150.94 MHz, 360 K, bromobenzene-d5) 
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Spectrum 0-555: 11B{1H} and 11B (opacified) NMR of 64 (160.42 MHz, 300 K, bromobenzene-d5) 
 
Spectrum 0-556: 19F{1H} and 19F (opacified) NMR of 64 (470.45 MHz, 300 K, bromobenzene-d5) 
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Spectrum 0-557: HRMS of 64 (ESI positive mod, dichloromethane) 
 
38. Compound 65: 
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Spectrum 0-558: 1H NMR of 65 (500.03 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-559: 1H{31P} NMR (top) correlated with 1H (bottom) of 65 (500.03 MHz, 300 K, dichloromethane-
d2) 
 
Spectrum 0-560: 13C{1H} NMR of 65 (125.75 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-561: 31P{1H} and 31P (opacified) NMR of 65 (202.41 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-562: 1H 1H COSY of 65 (500.03 MHz, 300 K, 273 K, dichloromethane-d2) 
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Spectrum 0-563: 1H 13C HMQC of 65 (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2 
 
Spectrum 0-564: 1H 13C HMBC of 65 (500.03 MHz / 125.75 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-565: 11B{1H} and 11B NMR of 65 (160.43 MHz, 300 K, dichloromethane-d2) 
 
Spectrum 0-566: 19F{1H} and 19F NMR of 65 (470.45 MHz, 300 K, dichloromethane-d2) 
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Spectrum 0-567: HRMS of 65 (Positive mode ESI, dichloromethane) 
 
 
Spectrum 0-568: HRMS of 65 (Positive mode ESI, dichloromethane) 
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Titre: Nouveaux complexes cationiques du groupe 4 comme potentielles paires frustrées de 
Lewis organométalliques: synthèse, réactivité, catalyse. 
Mot-Clés: groupe 4, métallocènes, amine, paires frustrées de Lewis, catalyse, activation CH 
Résumé:L’association d’une base de Lewis 
et d’un acide de Lewis tous deux encombrés 
a montré une réactivité nouvelle à l’égard de 
petites molécules telles que le dihydrogène. 
Un nouveau concept, appelé « paires 
frustrées de Lewis », a ainsi vu le jour en 
2006. Initialement basé sur l’emploi de 
réactifs organiques issus des éléments 
principaux du tableau périodique (P/B, N/B, 
P/Al, N/Al …), ce concept a ensuite été 
étendu aux métaux de transition.  Nous nous 
sommes intéressés à la synthèse de 
complexes de titane et de zirconium 
cationiques (acide de Lewis) associés à une 
amine en guise de base de Lewis. Le premier 
chapitre développe les travaux 
précédemment effectués sur la synthèse de 
complexes de titane ou de zirconium 
comportant une fonction amine, ainsi que les 
concepts clefs nécessaires à la 
compréhension de ce mémoire. La seconde 
partie de ce manuscrit porte sur la synthèse 
de nouveaux complexes de titane ou de 
zirconium ayant une fonction amine  
pendante. L’étude de ces composés ne 
montre aucune interaction entre l’atome 
d’azote et le métal. La réactivité de ces 
complexes organométalliques (N/Ti+) a été 
ensuite étudiée dans un troisième chapitre. 
Le concept initialement envisagé n’a pu être 
appliqué sur ces complexes, car ils ont 
démontré une forte instabilité. En effet, des 
réarrangements ont lieu par activation de 
liaison CH au voisinage de l’azote. La 
quatrième partie de ce mémoire développe la 
synthèse de nouveaux complexes 
cationiques de titane directement liés à une 
phosphine ou une amine. Certains de ces 
complexes se sont montrés actifs vis-à-vis de 
l’hydrogénation catalytique de petites 
molécules. Dans une dernière partie, la 
synthèse de complexes titanocéniques 
cationiques portant une fonction 
iminophosphorane est développée, suivie 
d’une étude de leur réactivité en tant que 
paires frustrées de Lewis organométalliques. 
 
 
Title: New cationic group 4 metallocenes as potential organometallic frustrated Lewis pairs: 
synthesis, reactivity and catalysis. 
Keywords: group 4, metallocenes, amine, frustrated Lewis pair, catalysis, CH activation 
Abstract: The concept of “frustrated Lewis 
pairs”, developed in 2006, is based on the 
cooperative use of a bulky Lewis acid with a 
bulky Lewis base in order to activate small 
molecules such as dihydrogen. Numerous 
examples based on purely organic derivatives 
(e.g. phosphine/borane), have been 
developed over the years. More recently, new 
organometallic frustrated Lewis pairs have 
been described. In such system, one of the 
Lewis partner is a transition metal. The 
introduction of transition metals and hence of 
coordination chemistry, in the frustrated Lewis 
pair systems, broaden considerably the 
scope. of the possibilities in this field, 
particularly for catalytic purpose.  
The present manuscript describes the 
synthesis of potential organometallic 
frustrated Lewis pairs based on the 
combination of an amine and a cationic 
titanium or zirconium complex. Their 
synthesis and reactivity are the topic of the 
second and the third chapter respectively. 
The fourth part of this thesis deals with the 
synthesis of new cationic titanium complexes 
directly bound to a phosphane or an amine. 
Some of these compounds are shown to be 
catalytically active towards hydrogenation of 
small molecules. Lastly, the potential as 
organometallic frustrated Lewis pairs of 
cationic titanium complexes bearing an 
iminophosphorane function, was developed. 
 
 
